This is the multi-page printable view of this section. Click here to print.
Gene Ontology (GO)
The Gene Ontology (GO) provides a framework and set of concepts for describing the functions of gene products from all organisms.
- 1: ((1,6)-alpha-glucosyl)poly((1,4)-alpha-glucosyl)glycogenin => poly{(1,4)-alpha-glucosyl} glycogenin + alpha-D-glucose [GO_0004135]
- 2: (2'-deoxy)adenosine + ATP => (d)AMP + ADP (ADK) [GO_0004001]
- 3: (d)ADP + ADP <=> (d)AMP + ATP (AK1) [GO_0004017]
- 4: (d)CDP or UDP + ADP <=> (d)CMP or UMP + ATP (CMPK1) [GO_0050145]
- 5: (d)GMP + ATP <=> (d)GDP + ADP (GUK1) [GO_0004385]
- 6: (d)NTP + ADP <=> (d)NDP + ATP (NME1,2,3) [GO_0004550]
- 7: (S)-2-hydroxy-acid oxidase activity [GO_0003973]
- 8: [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity [GO_0008467]
- 9: [heparan sulfate]-glucosamine N-sulfotransferase activity [GO_0015016]
- 10: [pyruvate dehydrogenase (lipoamide)] phosphatase activity [GO_0004741]
- 11: 1-acyl LPE is acylated to PE by LPEAT [GO_0003841]
- 12: 1-acyl LPE is hydrolyzed to GPETA by PLA2G4C [GO_0004622]
- 13: 1-acylglycerophosphocholine O-acyltransferase activity [GO_0047184]
- 14: 1-phosphatidylinositol 4-kinase activator activity [GO_0098744]
- 15: 1-phosphatidylinositol binding [GO_0005545]
- 16: 1-phosphatidylinositol-3-kinase regulator activity [GO_0046935]
- 17: 1-phosphatidylinositol-5-phosphate 4-kinase activity [GO_0016309]
- 18: 1-PP-IP5 is phosphorylated to 1,5-(PP)2-IP4 by IP6K1/3 in the cytosol [GO_0000829]
- 19: 1,2-diacyl-glycerol + acyl-CoA => triacylglycerol + CoASH [DGAT2] [GO_0004144]
- 20: 1,4-alpha-glucan branching enzyme activity [GO_0003844]
- 21: 1,4-alpha-oligoglucan phosphorylase activity [GO_0004645]
- 22: 1/3 PP-IP5 is dephosphorylated to IP6 by NUDT(1) in the cytosol [GO_0052842]
- 23: 14-3-3 protein binding [GO_0071889]
- 24: 17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO_0044594]
- 25: 17-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO_0072582]
- 26: 17-beta-ketosteroid reductase activity [GO_0072555]
- 27: 2 H2O2 => O2 + 2 H2O [GO_0004096]
- 28: 2 iron, 2 sulfur cluster binding [GO_0051537]
- 29: 2-(3-amino-3-carboxypropyl)histidine synthase activity [GO_0090560]
- 30: 2-hydroxy-3-methylhexadecanoyl-CoA lyase activity [GO_0106360]
- 31: 2-hydroxyacyl-CoA lyase activity [GO_0106359]
- 32: 2-hydroxyglutarate dehydrogenase activity [GO_0047545]
- 33: 2-hydroxyphytanoyl-CoA => pristanal + formyl-CoA [GO_0016830]
- 34: 2-iminobutanoate deaminase activity [GO_0120242]
- 35: 2-iminobutanoate/2-iminopropanoate deaminase [GO_0120241]
- 36: 2-MAG and DAG are transacylated to TAG by PNPLA2/3 [GO_0016411]
- 37: 2-oxoglutarate + NADPH + H+ => (R)-2-hydroxyglutarate + NADP+ [mutant IDH1] [GO_0051990]
- 38: 2-oxoglutarate-dependent dioxygenase activity [GO_0016706]
- 39: 2-Phospho-D-glycerate <=> 3-Phospho-D-glycerate [GO_0004619]
- 40: 2-Phospho-D-glycerate <=> Phosphoenolpyruvate + H2O [GO_0004634]
- 41: 2'-deoxyribonucleotide biosynthetic process [GO_0009265]
- 42: 2'-deoxyribonucleotide metabolic process [GO_0009394]
- 43: 2xENPP1 hydrolyzes FAD to FMN [GO_0004551]
- 44: 2xPDKX:2xZn2+ phosphorylates PDX [GO_0008478]
- 45: 2xPNPO:2xFMN oxidizes PXAP to PXLP [GO_0004733]
- 46: 2xPPCS ligates PPanK with Cys [GO_0004632]
- 47: 2xTRAP hydrolyzes FMN to RIB [GO_0003993]
- 48: 3 iron, 4 sulfur cluster binding [GO_0051538]
- 49: 3-dehydrosphinganine reductase activity [GO_0047560]
- 50: 3-demethoxyubiquinol 3-hydroxylase activity [GO_0008682]
- 51: 3-hydroxyacyl-CoA dehydratase activity [GO_0018812]
- 52: 3-ketohexacosanoyl-CoA + CoASH => tetracosanoyl-CoA + acetyl-CoA [GO_0003988]
- 53: 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity [GO_0003863]
- 54: 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO_0004315]
- 55: 3'-5' DNA/RNA helicase activity [GO_0033679]
- 56: 3'-5' exonuclease activity [GO_0008408]
- 57: 3'-5' RNA helicase activity [GO_0034458]
- 58: 3',2'-cyclic GMP-AMP synthase activity [GO_0140700]
- 59: 4 iron, 4 sulfur cluster binding [GO_0051539]
- 60: 4-hydroxyphenylpyruvate dioxygenase activity [GO_0003868]
- 61: 4-methylcholesta-8(9),24-dien-3-one is reduced to 4-methylcholesta-8(9),24-dien-3beta-ol [GO_0000253]
- 62: 4-methylcholesta-8(9),24-dien-3beta-ol is oxidized to 4-carboxycholesta-8(9),24-dien-3beta-ol [GO_0000254]
- 63: 4a-hydroxytetrahydrobiopterin => q-dihydrobiopterin + H2O [GO_0008124]
- 64: 4xPALM-C-p-2S-ABCA1 tetramer transports PL from transport vesicle membrane to plasma membrane [GO_0005548]
- 65: 5-hydroxy-L-tryptophan decarboxylase activity [GO_0036467]
- 66: 5-Phosphoribosylamine + Glycine + ATP => GAR + ADP + Pi [GO_0004637]
- 67: 5,10-methylenetetrahydrofolate-dependent methyltransferase activity [GO_0042083]
- 68: 5,6-dihydrothymine + H2O => beta-ureidoisobutyrate [GO_0004157]
- 69: 5'-(N(7)-methylguanosine 5'-triphospho)-[mRNA] hydrolase activity [GO_0140933]
- 70: 5'-3' exodeoxyribonuclease activity [GO_0035312]
- 71: 5'-3' exoribonuclease activity [GO_0004534]
- 72: 5'-3' RNA polymerase activity [GO_0034062]
- 73: 5'-deoxynucleotidase activity [GO_0002953]
- 74: 5'-nucleotidase activity [GO_0008253]
- 75: 5beta-cholestan-7alpha,27-diol-3-one is reduced to 5beta-cholestan-3alpha,7alpha,27-triol [GO_0004033]
- 76: 5S rRNA binding [GO_0008097]
- 77: 5S rRNA primary transcript binding [GO_0008098]
- 78: 6-phosphofructokinase activity [GO_0003872]
- 79: 6,7-dihydropteridine reductase activity [GO_0004155]
- 80: 7-beta-hydroxysteroid dehydrogenase (NADP+) activity [GO_0047022]
- 81: 7S RNA binding [GO_0008312]
- 82: A-type (transient outward) potassium channel activity [GO_0005250]
- 83: abacavir monophosphate + H2O => carbovir monophosphate + cyclopropylamine [GO_0004000]
- 84: ABC-type fatty-acyl-CoA transporter activity [GO_0015607]
- 85: ABC-type polyamine transporter activity [GO_0015417]
- 86: ABC-type transporter activity [GO_0140359]
- 87: ABC-type xenobiotic transporter activity [GO_0008559]
- 88: ABC7, mABC1 and mABC2 mediate heme transport [GO_0015439]
- 89: ABCC4 accumulation of dense granule contents [GO_0015662]
- 90: AcCho is hydrolyzed to Cho and acetate by ACHE [GO_0003990]
- 91: ACE hydrolyzes Angiotensin-(1-9) to Angiotensin-(1-7) [GO_0070573]
- 92: ACE2 hydrolyzes Angiotensin-(1-8) to Angiotensin-(1-7) [GO_0004181]
- 93: acetaldehyde dehydrogenase (acetylating) activity [GO_0008774]
- 94: acetate CoA-transferase activity [GO_0008775]
- 95: acetate ester transmembrane transporter activity [GO_1901375]
- 96: acetate ester transport [GO_1901374]
- 97: acetate-CoA ligase activity [GO_0003987]
- 98: acetoacetyl-CoA reductase activity [GO_0018454]
- 99: acetoacetyl-CoA+acetyl-CoA => HMG-CoA + CoASH [GO_0004421]
- 100: acetyl-CoA + 7 malonyl-CoA + 14 NADHP + 14 H+ => palmitate + 7 CO2 + 14 NADP+ + 8 CoASH + 6 H2O [GO_0004312]
- 101: Acetyl-CoA + H2O + Oxaloacetate => Citrate + CoA [GO_0004108]
- 102: acetyl-CoA binding [GO_1905502]
- 103: acetyl-CoA C-acetyltransferase activity [GO_0003985]
- 104: acetylation-dependent protein binding [GO_0140033]
- 105: acetylcholine binding [GO_0042166]
- 106: acetylcholine receptor activator activity [GO_0030549]
- 107: acetylcholine receptor activity [GO_0015464]
- 108: acetylcholine receptor binding [GO_0033130]
- 109: acetylcholine receptor inhibitor activity [GO_0030550]
- 110: acetylcholine receptor regulator activity [GO_0030548]
- 111: acetylcholine receptor signaling pathway [GO_0095500]
- 112: acetylcholine secretion [GO_0061526]
- 113: acetylcholine secretion, neurotransmission [GO_0014055]
- 114: acetylcholine transport [GO_0015870]
- 115: acetylcholine-gated cation-selective channel activity [GO_0022848]
- 116: acetylesterase activity [GO_0008126]
- 117: acetylpyruvate hydrolase activity [GO_0018773]
- 118: acetyltransferase activator activity [GO_0010698]
- 119: acid secretion [GO_0046717]
- 120: acid sphingomyelin phosphodiesterase activity [GO_0061750]
- 121: acid-amino acid ligase activity [GO_0016881]
- 122: acid-ammonia (or amide) ligase activity [GO_0016880]
- 123: acid-sensing ion channel activity [GO_0044736]
- 124: acid-thiol ligase activity [GO_0016878]
- 125: acidic amino acid transmembrane transporter activity [GO_0015172]
- 126: acidic amino acid transport [GO_0015800]
- 127: Acidification of Tf:TfR1 containing endosome [GO_0015078]
- 128: acinar cell differentiation [GO_0090425]
- 129: acinar cell proliferation [GO_1990863]
- 130: acireductone dioxygenase [iron(II)-requiring] activity [GO_0010309]
- 131: acireductone synthase activity [GO_0043874]
- 132: ACP phosphopantetheine attachment site binding [GO_0044620]
- 133: Acrosin Cleavage [GO_0002020]
- 134: ACSBG1,2 ligates CoA-SH to VLCFA, forming VLCFA-CoA [GO_0031957]
- 135: ACSL3,4 ligates coenzyme A (CoA-SH) to palmitate yielding palmitoyl-coenzyme A in the pancreatic beta cell [GO_0090433]
- 136: actin binding [GO_0003779]
- 137: actin cytoskeleton [GO_0015629]
- 138: actin cytoskeleton organization [GO_0030036]
- 139: actin filament [GO_0005884]
- 140: actin filament binding [GO_0051015]
- 141: actin filament bundle [GO_0032432]
- 142: actin filament bundle assembly [GO_0051017]
- 143: actin filament bundle organization [GO_0061572]
- 144: actin filament organization [GO_0007015]
- 145: actin filament-based movement [GO_0030048]
- 146: actin filament-based process [GO_0030029]
- 147: actin filament-based transport [GO_0099515]
- 148: actin monomer binding [GO_0003785]
- 149: actin-based cell projection [GO_0098858]
- 150: actinin binding [GO_0042805]
- 151: action potential [GO_0001508]
- 152: Activated Adenylyl cyclase synthesizes cyclic AMP [GO_0004016]
- 153: Activated ERK1/2 threonine-phosphorylates FGFR4-associated FRS2. [GO_0004707]
- 154: Activated human MKK3/MKK6 phosphorylates p38 MAPK complexed with MAPKAPK2 or MAPKAPK3 [GO_0004708]
- 155: Activated JNK phosphorylates c-JUN [GO_0004705]
- 156: Activated MAP2Ks phosphorylate MAPKs downstream of inactive BRAF mutants [GO_0004712]
- 157: Activated type I receptor phosphorylates R-Smad1/5/8 directly [GO_0004675]
- 158: activation of cysteine-type endopeptidase activity involved in apoptotic process [GO_0006919]
- 159: Activation of highly calcium permeable postsynaptic nicotinic acetylcholine receptors [GO_0015276]
- 160: Activation of NLK [GO_0004674]
- 161: Activation of TWIK-related K+ channel (TREK) [GO_0005267]
- 162: active ion transmembrane transporter activity [GO_0022853]
- 163: Active PKA, CaMK IV do not phosphorylate MECP2 mutants R306C,(R306H) at T308 [GO_0010857]
- 164: Active PLCG1 hydrolyses PIP2 [GO_0004435]
- 165: active transmembrane transporter activity [GO_0022804]
- 166: activin binding [GO_0048185]
- 167: activin receptor activity [GO_0017002]
- 168: activin receptor activity, type I [GO_0016361]
- 169: activin receptor activity, type II [GO_0016362]
- 170: activin receptor binding [GO_0070697]
- 171: activin receptor signaling pathway [GO_0032924]
- 172: actomyosin [GO_0042641]
- 173: actomyosin structure organization [GO_0031032]
- 174: acyl binding [GO_0000035]
- 175: acyl carnitine transmembrane transport [GO_1902616]
- 176: acyl carnitine transmembrane transporter activity [GO_0015227]
- 177: acyl carnitine transport [GO_0006844]
- 178: acyl carrier activity [GO_0000036]
- 179: acyl-CoA binding [GO_0120227]
- 180: acyl-CoA desaturase activity [GO_0016215]
- 181: acyl-CoA hydrolase activity [GO_0047617]
- 182: acylglycerol biosynthetic process [GO_0046463]
- 183: acylglycerol kinase activity [GO_0047620]
- 184: acylglycerol metabolic process [GO_0006639]
- 185: acylphosphatase activity [GO_0003998]
- 186: acyltransferase activity, acyl groups converted into alkyl on transfer [GO_0046912]
- 187: acyltransferase activity, transferring groups other than amino-acyl groups [GO_0016747]
- 188: ADAM10:Zn2+:TSPANs cleaves APP(18-770) [GO_1902945]
- 189: ADAT1 deaminates adenosine-37 in tRNA(Ala) [GO_0008251]
- 190: Addition of GlcNAc to the glycan on the A arm [GO_0003827]
- 191: Addition of GlcNAc to the Tn antigen forms a Core 3 glycoprotein [GO_0008499]
- 192: Addition of isopentenyl pyrophosphate to DMAPP [GO_0004161]
- 193: Addition of N-acetyl-D-glucosamine to Dolichyl phosphate [GO_0003975]
- 194: adenine nucleotide transmembrane transporter activity [GO_0000295]
- 195: adenine nucleotide transport [GO_0051503]
- 196: adenosine 3',5'-bisphosphate transmembrane transport [GO_0071106]
- 197: adenosine 3',5'-bisphosphate transmembrane transporter activity [GO_0071077]
- 198: adenosine 5'-monophosphoramidase activity [GO_0043530]
- 199: adenosine-phosphate deaminase activity [GO_0047623]
- 200: adenosylhomocysteinase activity [GO_0004013]
- 201: adenosylmethionine decarboxylase activity [GO_0004014]
- 202: adenyl nucleotide binding [GO_0030554]
- 203: adenyl ribonucleotide binding [GO_0032559]
- 204: adenylate cyclase activator activity [GO_0010856]
- 205: adenylate cyclase binding [GO_0008179]
- 206: adenylate cyclase inhibiting G protein-coupled glutamate receptor activity [GO_0001640]
- 207: adenylate cyclase inhibitor activity [GO_0010855]
- 208: adenylate cyclase regulator activity [GO_0010854]
- 209: adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway [GO_0007196]
- 210: adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO_0007193]
- 211: adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO_0007188]
- 212: adenylosuccinate synthase activity [GO_0004019]
- 213: adenylyltransferase activity [GO_0070566]
- 214: ADH5 oxidises S-HMGSH to S-FGSH [GO_0051903]
- 215: adipokinetic hormone binding [GO_0097004]
- 216: adipokinetic hormone receptor activity [GO_0097003]
- 217: adipokinetic hormone receptor binding [GO_0097005]
- 218: adiponectin binding [GO_0055100]
- 219: adipose tissue development [GO_0060612]
- 220: ADP binding [GO_0043531]
- 221: ADP metabolic process [GO_0046031]
- 222: ADP phosphatase activity [GO_0043262]
- 223: ADP transmembrane transporter activity [GO_0015217]
- 224: ADP transport [GO_0015866]
- 225: ADP-ribose diphosphatase activity [GO_0047631]
- 226: ADP-ribosylglutamate hydrolase activity [GO_0140293]
- 227: adrenergic receptor activity [GO_0004935]
- 228: adrenergic receptor signaling pathway [GO_0071875]
- 229: adult behavior [GO_0030534]
- 230: adult feeding behavior [GO_0008343]
- 231: adult locomotory behavior [GO_0008344]
- 232: adult walking behavior [GO_0007628]
- 233: aerobic respiration [GO_0009060]
- 234: aggressive behavior [GO_0002118]
- 235: aging [GO_0007568]
- 236: alanine + tRNA(Ala) + ATP => Ala-tRNA(Ala) + AMP + pyrophosphate [GO_0004813]
- 237: alanine transmembrane transporter activity [GO_0022858]
- 238: alanine transport [GO_0032328]
- 239: alanine-glyoxylate transaminase activity [GO_0008453]
- 240: alanine-oxo-acid transaminase activity [GO_0047635]
- 241: ALAS condenses SUCC-CoA and Gly to form dALA [GO_0003870]
- 242: alcohol binding [GO_0043178]
- 243: alcohol dehydrogenase (NAD+) activity [GO_0004022]
- 244: alcohol dehydrogenase (NADP+) activity [GO_0008106]
- 245: alcohol dehydrogenase [NAD(P)+] activity [GO_0018455]
- 246: alcohol dehydrogenase activity, zinc-dependent [GO_0004024]
- 247: alcohol metabolic process [GO_0006066]
- 248: ALD3A1 oxidises 4HPCP to CXPA [GO_0004030]
- 249: aldehyde biosynthetic process [GO_0046184]
- 250: aldehyde decarbonylase activity [GO_0071771]
- 251: aldehyde dehydrogenase (NAD+) activity [GO_0004029]
- 252: aldehyde dehydrogenase (NAD+) inhibitor activity [GO_0140631]
- 253: aldehyde oxidase activity [GO_0004031]
- 254: aldehyde-lyase activity [GO_0016832]
- 255: ALDH4A1 oxidises L-GluSS to Glu [GO_0003842]
- 256: alditol:NADP+ 1-oxidoreductase activity [GO_0004032]
- 257: aldose 1-epimerase activity [GO_0004034]
- 258: alkali metal ion binding [GO_0031420]
- 259: alkaloid biosynthetic process [GO_0009821]
- 260: alkaloid catabolic process [GO_0009822]
- 261: alkaloid metabolic process [GO_0009820]
- 262: alkane 1-monooxygenase activity [GO_0018685]
- 263: alkanesulfonate transmembrane transporter activity [GO_0042959]
- 264: alkanesulfonate transport [GO_0042918]
- 265: allantois development [GO_1905069]
- 266: allatostatin receptor activity [GO_0008261]
- 267: alpha-1,3-glucosidase activity [GO_0090600]
- 268: alpha-actinin binding [GO_0051393]
- 269: alpha-amino acid biosynthetic process [GO_1901607]
- 270: alpha-amino acid catabolic process [GO_1901606]
- 271: alpha-amino acid metabolic process [GO_1901605]
- 272: alpha-aminoadipate + alpha-ketoglutarate <=> alpha-ketoadipate + glutamate [GO_0047536]
- 273: alpha-catenin binding [GO_0045294]
- 274: alpha-D-glucose 6-phosphate + NADP+ => D-glucono-1,5-lactone 6-phosphate + NADPH + H+ [GO_0004345]
- 275: alpha-galactosidase activity [GO_0004557]
- 276: alpha-glucosidase activity [GO_0090599]
- 277: alpha-ketoglutarate transmembrane transporter activity [GO_0015139]
- 278: alpha-ketoglutarate transport [GO_0015742]
- 279: alpha-tubulin binding [GO_0043014]
- 280: alpha,alpha-trehalase activity [GO_0004555]
- 281: alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity [GO_0003825]
- 282: ALPI dimer hydrolyses phosphate monoesters [GO_0004035]
- 283: AMDHD2 hydrolyses GlcNGc-6-P to GlcN6P and CCA [GO_0008448]
- 284: ameboidal-type cell migration [GO_0001667]
- 285: amide binding [GO_0033218]
- 286: amide biosynthetic process [GO_0043604]
- 287: amide transmembrane transporter activity [GO_0042887]
- 288: amide transport [GO_0042886]
- 289: amidine-lyase activity [GO_0016842]
- 290: amidophosphoribosyltransferase activity [GO_0004044]
- 291: amine binding [GO_0043176]
- 292: amine biosynthetic process [GO_0009309]
- 293: amine catabolic process [GO_0009310]
- 294: amine metabolic process [GO_0009308]
- 295: amine transmembrane transporter activity [GO_0005275]
- 296: amine transport [GO_0015837]
- 297: amine-lyase activity [GO_0016843]
- 298: amino acid binding [GO_0016597]
- 299: amino acid homeostasis [GO_0080144]
- 300: amino acid kinase activity [GO_0019202]
- 301: amino acid transmembrane transport [GO_0003333]
- 302: amino acid transport [GO_0006865]
- 303: amino acid:cation symporter activity [GO_0005416]
- 304: amino acid:sodium symporter activity [GO_0005283]
- 305: amino-acid racemase activity [GO_0047661]
- 306: aminoacyl-tRNA editing activity [GO_0002161]
- 307: aminoacyl-tRNA hydrolase activity [GO_0004045]
- 308: aminoacyl-tRNA ligase activity [GO_0004812]
- 309: aminoacyl-tRNA metabolism involved in translational fidelity [GO_0106074]
- 310: aminoacylase activity [GO_0004046]
- 311: aminoacyltransferase activity [GO_0016755]
- 312: aminoglycan biosynthetic process [GO_0006023]
- 313: aminoglycan catabolic process [GO_0006026]
- 314: aminoglycan metabolic process [GO_0006022]
- 315: ammonia ligase activity [GO_0016211]
- 316: ammonia-lyase activity [GO_0016841]
- 317: ammonium excretion [GO_0140734]
- 318: ammonium homeostasis [GO_0097272]
- 319: ammonium ion binding [GO_0070405]
- 320: ammonium ion metabolic process [GO_0097164]
- 321: ammonium transmembrane transport [GO_0072488]
- 322: ammonium transport [GO_0015696]
- 323: AMP binding [GO_0016208]
- 324: AMP biosynthetic process [GO_0006167]
- 325: AMP deaminase activity [GO_0003876]
- 326: AMP metabolic process [GO_0046033]
- 327: AMP transmembrane transporter activity [GO_0080122]
- 328: AMP transport [GO_0080121]
- 329: AMT transfers NH2CH2 from GCSH:SAMDLL to THF [GO_0004047]
- 330: amylase activity [GO_0016160]
- 331: amyloid precursor protein catabolic process [GO_0042987]
- 332: amyloid precursor protein metabolic process [GO_0042982]
- 333: amyloid-beta binding [GO_0001540]
- 334: An unknown carrier transports mitochondrial glyoxylate to the cytosol [GO_0022857]
- 335: An unknown oxidase oxidises D-UBGN to UBN [GO_0016627]
- 336: anaphase-promoting complex binding [GO_0010997]
- 337: anatomical structure development [GO_0048856]
- 338: anatomical structure formation involved in morphogenesis [GO_0048646]
- 339: anatomical structure homeostasis [GO_0060249]
- 340: anatomical structure maturation [GO_0071695]
- 341: anatomical structure morphogenesis [GO_0009653]
- 342: anchoring junction [GO_0070161]
- 343: androgen secretion [GO_0035935]
- 344: anesthesia-resistant memory [GO_0007615]
- 345: angioblast cell differentiation [GO_0035779]
- 346: angiogenesis [GO_0001525]
- 347: angiogenesis involved in coronary vascular morphogenesis [GO_0060978]
- 348: animal organ development [GO_0048513]
- 349: animal organ formation [GO_0048645]
- 350: animal organ maturation [GO_0048799]
- 351: animal organ morphogenesis [GO_0009887]
- 352: anion binding [GO_0043168]
- 353: anion channel activity [GO_0005253]
- 354: anion homeostasis [GO_0055081]
- 355: anion transmembrane transport [GO_0098656]
- 356: anion transmembrane transporter activity [GO_0008509]
- 357: anion transport [GO_0006820]
- 358: anion:cation symporter activity [GO_0015296]
- 359: anion:sodium symporter activity [GO_0015373]
- 360: ankyrin binding [GO_0030506]
- 361: annealing activity [GO_0140666]
- 362: anterior/posterior pattern specification [GO_0009952]
- 363: anterograde trans-synaptic signaling [GO_0098916]
- 364: Anthrax lef cleaves target cell MAP2K7 (MEK7) [GO_0008237]
- 365: antigen binding [GO_0003823]
- 366: antioxidant activity [GO_0016209]
- 367: aorta development [GO_0035904]
- 368: aorta morphogenesis [GO_0035909]
- 369: aorta smooth muscle tissue morphogenesis [GO_0060414]
- 370: aortic smooth muscle cell differentiation [GO_0035887]
- 371: AP-1 adaptor complex binding [GO_0035650]
- 372: AP-2 adaptor complex binding [GO_0035612]
- 373: apical ectodermal ridge formation [GO_1905139]
- 374: apolipoprotein binding [GO_0034185]
- 375: apoptotic chromosome condensation [GO_0030263]
- 376: apoptotic nuclear changes [GO_0030262]
- 377: apoptotic process [GO_0006915]
- 378: apoptotic process involved in blood vessel morphogenesis [GO_1902262]
- 379: apoptotic process involved in development [GO_1902742]
- 380: apoptotic process involved in endocardial cushion morphogenesis [GO_0003277]
- 381: apoptotic process involved in heart morphogenesis [GO_0003278]
- 382: apoptotic process involved in morphogenesis [GO_0060561]
- 383: apoptotic process involved in outflow tract morphogenesis [GO_0003275]
- 384: apoptotic process involved in tube lumen cavitation [GO_0060609]
- 385: apoptotic signaling pathway [GO_0097190]
- 386: appendage development [GO_0048736]
- 387: appendage morphogenesis [GO_0035107]
- 388: arginine kinase activity [GO_0004054]
- 389: arginine N-methyltransferase activity [GO_0016273]
- 390: arginine-tRNA ligase activity [GO_0004814]
- 391: argininosuccinate lyase activity [GO_0004056]
- 392: argininosuccinate synthase activity [GO_0004055]
- 393: arginyltransferase activity [GO_0004057]
- 394: ARHGAP35 stimulates RHOA GTPase activity [GO_0003924]
- 395: aromatic amino acid transmembrane transporter activity [GO_0015173]
- 396: aromatic amino acid transport [GO_0015801]
- 397: aromatic compound biosynthetic process [GO_0019438]
- 398: aromatic compound catabolic process [GO_0019439]
- 399: aromatic-L-amino-acid decarboxylase activity [GO_0004058]
- 400: Arp2/3 complex binding [GO_0071933]
- 401: arterial endothelial cell differentiation [GO_0060842]
- 402: artery development [GO_0060840]
- 403: artery morphogenesis [GO_0048844]
- 404: ARV1 transports CHOL from ER membrane to plasma membrane [GO_0015248]
- 405: arylamine N-acetyltransferase activity [GO_0004060]
- 406: arylesterase activity [GO_0004064]
- 407: ascending aorta development [GO_0035905]
- 408: ascending aorta morphogenesis [GO_0035910]
- 409: asioloorosomucoid beta-1,3-glucuronosyltransferase activity [GO_0046988]
- 410: asparagine-tRNA ligase activity [GO_0004816]
- 411: aspartate + glutamine + ATP <=> asparagine + glutamate + AMP + pyrophosphate [ASNS] [GO_0004066]
- 412: aspartate + tRNA(Asp) + ATP => Asp-tRNA(Asp) + AMP + pyrophosphate [GO_0004815]
- 413: aspartate 1-decarboxylase activity [GO_0004068]
- 414: aspartate transmembrane transport [GO_0015810]
- 415: aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO_1902944]
- 416: aspartic-type endopeptidase inhibitor activity [GO_0019828]
- 417: aspartic-type peptidase activity [GO_0070001]
- 418: ASPG hydrolyses L-Asn to L-Asp [GO_0004067]
- 419: Association of GABA B receptor with G protein beta-gamma subunits [GO_0004965]
- 420: associative learning [GO_0008306]
- 421: asymmetric cell division [GO_0008356]
- 422: asymmetric neuroblast division [GO_0055059]
- 423: asymmetric stem cell division [GO_0098722]
- 424: ATG3 transfers LC3 from ATG7 to ATG3 [GO_0019776]
- 425: Atg8-specific peptidase activity [GO_0019786]
- 426: ATP + 3-Phospho-D-glycerate <=> ADP + 1,3-bisphospho-D-glycerate [GO_0004618]
- 427: ATP biosynthetic process [GO_0006754]
- 428: ATP citrate synthase activity [GO_0003878]
- 429: ATP generation from ADP [GO_0006757]
- 430: ATP metabolic process [GO_0046034]
- 431: ATP transmembrane transporter activity [GO_0005347]
- 432: ATP transport [GO_0015867]
- 433: ATP-dependent activity [GO_0140657]
- 434: ATP-dependent activity, acting on DNA [GO_0008094]
- 435: ATP-dependent activity, acting on RNA [GO_0008186]
- 436: ATP-dependent chromatin remodeler activity [GO_0140658]
- 437: ATP-dependent DNA damage sensor activity [GO_0140664]
- 438: ATP-dependent FeS chaperone activity [GO_0140663]
- 439: ATP-dependent H2AZ histone chaperone activity [GO_0140849]
- 440: ATP-dependent histone chaperone activity [GO_0140674]
- 441: ATP-dependent NAD(P)H-hydrate dehydratase activity [GO_0047453]
- 442: ATP-dependent protein binding [GO_0043008]
- 443: ATP-dependent protein folding chaperone [GO_0140662]
- 444: ATP:ADP antiporter activity [GO_0005471]
- 445: ATP2C1/2:Mg2+ transport cytosolic Ca2+ to Golgi lumen [GO_0005388]
- 446: ATPase activator activity [GO_0001671]
- 447: ATPase activity, coupled to transmembrane movement of ions, rotational mechanism [GO_0044769]
- 448: ATPase binding [GO_0051117]
- 449: ATPase coupled ion transmembrane transporter activity involved in regulation of postsynaptic membrane potential [GO_0099581]
- 450: ATPase inhibitor activity [GO_0042030]
- 451: ATPase regulator activity [GO_0060590]
- 452: ATPase-coupled cation transmembrane transporter activity [GO_0019829]
- 453: ATPase-coupled inorganic anion transmembrane transporter activity [GO_0043225]
- 454: ATPase-coupled ion transmembrane transporter activity [GO_0042625]
- 455: ATPase-coupled lipid transmembrane transporter activity [GO_0034040]
- 456: atrial cardiac muscle tissue development [GO_0003228]
- 457: atrial cardiac muscle tissue morphogenesis [GO_0055009]
- 458: atrial septum development [GO_0003283]
- 459: atrial septum morphogenesis [GO_0060413]
- 460: atrioventricular node cell development [GO_0060928]
- 461: atrioventricular node cell differentiation [GO_0060922]
- 462: atrioventricular node development [GO_0003162]
- 463: Auto phosphorylation of TAK1 bound to p-IRAK2:pUb oligo-TRAF6: free K63 pUb:TAB1:TAB2/TAB3 [GO_0008349]
- 464: Autoglucosylation of GYG1 complexed with GYS1-a [GO_0008466]
- 465: autonomic nervous system development [GO_0048483]
- 466: Autophosphorylation of LYN kinase [GO_0004713]
- 467: AV node cell action potential [GO_0086016]
- 468: AV node cell to bundle of His cell communication [GO_0086067]
- 469: AV node cell to bundle of His cell signaling [GO_0086027]
- 470: axial mesoderm development [GO_0048318]
- 471: axial mesoderm formation [GO_0048320]
- 472: axial mesoderm morphogenesis [GO_0048319]
- 473: axis specification [GO_0009798]
- 474: axo-dendritic protein transport [GO_0099640]
- 475: axo-dendritic transport [GO_0008088]
- 476: axon [GO_0030424]
- 477: axon cytoplasm [GO_1904115]
- 478: axon development [GO_0061564]
- 479: axon guidance [GO_0007411]
- 480: axon guidance receptor activity [GO_0008046]
- 481: axonal dopamine secretion [GO_0099124]
- 482: axonemal microtubule [GO_0005879]
- 483: axonemal microtubule depolymerization [GO_0060404]
- 484: axoneme [GO_0005930]
- 485: axoneme assembly [GO_0035082]
- 486: axonogenesis [GO_0007409]
- 487: azole transmembrane transport [GO_0045117]
- 488: azole transmembrane transporter activity [GO_1901474]
- 489: B3GALTL transfers glucose to O-fucosyl-proteins [GO_0016757]
- 490: B4GALNT2 transfers GalNAc to Type 2 MSGG to form Sda [GO_0008376]
- 491: backward locomotion [GO_0043057]
- 492: Bacterial GUSB hydrolyses BDG to BIL [GO_0004553]
- 493: banded collagen fibril [GO_0098643]
- 494: basal RNA polymerase II transcription machinery binding [GO_0001099]
- 495: basal transcription machinery binding [GO_0001098]
- 496: basement membrane [GO_0005604]
- 497: basement membrane assembly [GO_0070831]
- 498: basement membrane collagen trimer [GO_0098651]
- 499: basement membrane disassembly [GO_0034769]
- 500: basement membrane organization [GO_0071711]
- 501: basic amino acid transmembrane transport [GO_1990822]
- 502: basic amino acid transport [GO_0015802]
- 503: BBOX1:AscH-:Fe2+ dimer dioxygenates TEABT and 2OG to form CAR and SUCCA [GO_0008336]
- 504: BCAP Signalosome phosphorylates PI(4,5)P2 forming PI(3,4,5)P3 [GO_0035004]
- 505: behavior [GO_0007610]
- 506: behavioral response to nutrient [GO_0051780]
- 507: behavioral response to pain [GO_0048266]
- 508: behavioral response to starvation [GO_0042595]
- 509: benzene-containing compound metabolic process [GO_0042537]
- 510: beta-1,3-galactosyltransferase activity [GO_0048531]
- 511: beta-1,4-mannosyltransferase activity [GO_0019187]
- 512: beta-alanyl-dopamine hydrolase activity [GO_0003832]
- 513: beta-alanyl-histamine hydrolase activity [GO_0031964]
- 514: beta-catenin binding [GO_0008013]
- 515: beta-catenin destruction complex binding [GO_1904713]
- 516: beta-galactosidase activity [GO_0004565]
- 517: beta-glucosidase activity [GO_0008422]
- 518: beta-hydroxyisobutyryl-CoA + H2O => beta-hydroxyisobutyrate + CoA [GO_0003860]
- 519: beta-mannosidase activity [GO_0004567]
- 520: beta-N-acetylglucosaminidase activity [GO_0016231]
- 521: beta-tubulin binding [GO_0048487]
- 522: beta-ureidoisobutyrate + H2O => 3-aminoisobutyrate + NH4+ + CO2 [GO_0003837]
- 523: bHLH transcription factor binding [GO_0043425]
- 524: bicarbonate transmembrane transporter activity [GO_0015106]
- 525: bicarbonate transport [GO_0015701]
- 526: bidentate ribonuclease III activity [GO_0016443]
- 527: bile acid and bile salt transport [GO_0015721]
- 528: bile acid biosynthetic process [GO_0006699]
- 529: bile acid catabolic process [GO_0030573]
- 530: bile acid metabolic process [GO_0008206]
- 531: bile acid secretion [GO_0032782]
- 532: bilirubin transmembrane transporter activity [GO_0015127]
- 533: bilirubin transport [GO_0015723]
- 534: biliverdin reductase (NAD(P)+) activity [GO_0004074]
- 535: binding [GO_0005488]
- 536: biological adhesion [GO_0022610]
- 537: biological phase [GO_0044848]
- 538: biological process involved in interspecies interaction between organisms [GO_0044419]
- 539: biological regulation [GO_0065007]
- 540: biological_process [GO_0008150]
- 541: biosynthetic process [GO_0009058]
- 542: BIR domain binding [GO_1990525]
- 543: bis(5'-adenosyl)-hexaphosphatase activity [GO_0034431]
- 544: bis(5'-adenosyl)-pentaphosphatase activity [GO_0034432]
- 545: bisphosphoglycerate 3-phosphatase activity [GO_0034417]
- 546: bisphosphoglycerate phosphatase activity [GO_0034416]
- 547: blastocyst development [GO_0001824]
- 548: blastocyst formation [GO_0001825]
- 549: blastocyst growth [GO_0001832]
- 550: bleb [GO_0032059]
- 551: bleb assembly [GO_0032060]
- 552: blood circulation [GO_0008015]
- 553: blood vessel development [GO_0001568]
- 554: blood vessel endothelial cell differentiation [GO_0060837]
- 555: blood vessel maturation [GO_0001955]
- 556: blood vessel morphogenesis [GO_0048514]
- 557: blue light photoreceptor activity [GO_0009882]
- 558: blue light signaling pathway [GO_0009785]
- 559: BMP binding [GO_0036122]
- 560: BMP receptor activity [GO_0098821]
- 561: BMP receptor binding [GO_0070700]
- 562: BMP signaling pathway [GO_0030509]
- 563: body fluid secretion [GO_0007589]
- 564: body morphogenesis [GO_0010171]
- 565: bone cell development [GO_0098751]
- 566: bone development [GO_0060348]
- 567: bone growth [GO_0098868]
- 568: bone marrow development [GO_0048539]
- 569: bone maturation [GO_0070977]
- 570: bone morphogenesis [GO_0060349]
- 571: bounding membrane of organelle [GO_0098588]
- 572: box C/D RNA binding [GO_0034512]
- 573: box H/ACA snoRNA binding [GO_0034513]
- 574: brain development [GO_0007420]
- 575: brain morphogenesis [GO_0048854]
- 576: brainstem development [GO_0003360]
- 577: branched-chain amino acid transmembrane transporter activity [GO_0015658]
- 578: branched-chain amino acid transport [GO_0015803]
- 579: branched-chain-amino-acid transaminase activity [GO_0004084]
- 580: branching involved in blood vessel morphogenesis [GO_0001569]
- 581: branching involved in labyrinthine layer morphogenesis [GO_0060670]
- 582: branching involved in pancreas morphogenesis [GO_0061114]
- 583: branching morphogenesis of a nerve [GO_0048755]
- 584: branching morphogenesis of an epithelial tube [GO_0048754]
- 585: bronchiole development [GO_0060435]
- 586: bronchiole morphogenesis [GO_0060436]
- 587: bronchus cartilage development [GO_0060532]
- 588: bronchus cartilage morphogenesis [GO_0060533]
- 589: bronchus development [GO_0060433]
- 590: bronchus morphogenesis [GO_0060434]
- 591: Btn-ACACA:2Mn2+ polymer carboxylates Ac-CoA to form Mal-CoA [GO_0003989]
- 592: butyryl-CoA dehydrogenase activity [GO_0004085]
- 593: Butyrylcholinesterase hydrolyzes acyl Ghrelin [GO_0016788]
- 594: C-acetyltransferase activity [GO_0016453]
- 595: C-acyltransferase activity [GO_0016408]
- 596: C-methyltransferase activity [GO_0008169]
- 597: C-palmitoyltransferase activity [GO_0016454]
- 598: C2H2 zinc finger domain binding [GO_0070742]
- 599: C4-dicarboxylate transmembrane transporter activity [GO_0015556]
- 600: C4-dicarboxylate transport [GO_0015740]
- 601: Ca2+ influx into the post-synaptic cell [GO_0005231]
- 602: CAAX-protein geranylgeranyltransferase activity [GO_0004662]
- 603: cadherin binding [GO_0045296]
- 604: cadherin binding involved in cell-cell adhesion [GO_0098641]
- 605: cadmium ion transmembrane transport [GO_0070574]
- 606: cadmium ion transmembrane transporter activity [GO_0015086]
- 607: cadmium ion transport [GO_0015691]
- 608: CAIR + Aspartate + ATP => SAICAR + ADP + Pi [GO_0004639]
- 609: calcitonin binding [GO_0032841]
- 610: calcitonin family binding [GO_0097644]
- 611: calcitonin family receptor activity [GO_0097642]
- 612: calcitonin receptor activity [GO_0004948]
- 613: calcium activated cation channel activity [GO_0005227]
- 614: calcium channel inhibitor activity [GO_0019855]
- 615: calcium channel regulator activity [GO_0005246]
- 616: Calcium Influx through Voltage-gated Calcium Channels [GO_0005245]
- 617: calcium ion binding [GO_0005509]
- 618: calcium ion homeostasis [GO_0055074]
- 619: calcium ion sequestering activity [GO_0140314]
- 620: calcium ion transmembrane import into cytosol [GO_0097553]
- 621: calcium ion transmembrane transport [GO_0070588]
- 622: calcium ion transmembrane transporter activity [GO_0015085]
- 623: calcium ion transport [GO_0006816]
- 624: calcium sensitive guanylate cyclase activator activity [GO_0008048]
- 625: calcium- and calmodulin-responsive adenylate cyclase activity [GO_0008294]
- 626: calcium-activated potassium channel activity [GO_0015269]
- 627: calcium-dependent ATPase activity [GO_0030899]
- 628: calcium-dependent phospholipase A2 activity [GO_0047498]
- 629: calcium-dependent phospholipid binding [GO_0005544]
- 630: calcium-dependent protein binding [GO_0048306]
- 631: calcium-dependent protein kinase inhibitor activity [GO_0008427]
- 632: calcium-dependent protein kinase regulator activity [GO_0010858]
- 633: calcium-dependent protein serine/threonine kinase activity [GO_0009931]
- 634: calcium-dependent protein serine/threonine phosphatase activity [GO_0004723]
- 635: calcium-dependent protein serine/threonine phosphatase regulator activity [GO_0008597]
- 636: calcium-induced calcium release activity [GO_0048763]
- 637: calcium-mediated signaling [GO_0019722]
- 638: calcium-release channel activity [GO_0015278]
- 639: calmodulin binding [GO_0005516]
- 640: calmodulin dependent kinase signaling pathway [GO_0099004]
- 641: calmodulin-activated 3',5'-cyclic-GMP phosphodiesterase activity [GO_0048101]
- 642: calmodulin-dependent protein phosphatase activity [GO_0033192]
- 643: Calpain cleaves p35 to p25 [GO_0004198]
- 644: camera-type eye development [GO_0043010]
- 645: camera-type eye morphogenesis [GO_0048593]
- 646: camera-type eye photoreceptor cell differentiation [GO_0060219]
- 647: CaMKK phosphorylates CAMK4 [GO_0004683]
- 648: cAMP binding [GO_0030552]
- 649: cAMP response element binding [GO_0035497]
- 650: cAMP response element binding protein binding [GO_0008140]
- 651: cAMP-dependent protein kinase activity [GO_0004691]
- 652: cAMP-dependent protein kinase regulator activity [GO_0008603]
- 653: cAMP-mediated signaling [GO_0019933]
- 654: Cap-bound mRNA is activated by helicases [GO_0003724]
- 655: carbohydrate binding [GO_0030246]
- 656: carbohydrate biosynthetic process [GO_0016051]
- 657: carbohydrate catabolic process [GO_0016052]
- 658: carbohydrate derivative binding [GO_0097367]
- 659: carbohydrate derivative biosynthetic process [GO_1901137]
- 660: carbohydrate derivative catabolic process [GO_1901136]
- 661: carbohydrate derivative metabolic process [GO_1901135]
- 662: carbohydrate derivative transmembrane transporter activity [GO_1901505]
- 663: carbohydrate derivative transport [GO_1901264]
- 664: carbohydrate homeostasis [GO_0033500]
- 665: carbohydrate kinase activity [GO_0019200]
- 666: carbohydrate metabolic process [GO_0005975]
- 667: carbohydrate phosphorylation [GO_0046835]
- 668: carbohydrate transmembrane transport [GO_0034219]
- 669: carbohydrate transmembrane transporter activity [GO_0015144]
- 670: carbohydrate transport [GO_0008643]
- 671: carbohydrate:cation symporter activity [GO_0005402]
- 672: carbohydrate:proton symporter activity [GO_0005351]
- 673: carbon-halide lyase activity [GO_0016848]
- 674: carbon-nitrogen ligase activity, with glutamine as amido-N-donor [GO_0016884]
- 675: carbon-nitrogen lyase activity [GO_0016840]
- 676: carbon-oxygen lyase activity [GO_0016835]
- 677: carbon-oxygen lyase activity, acting on phosphates [GO_0016838]
- 678: carbon-sulfur lyase activity [GO_0016846]
- 679: Carbonic anhydrase dehydrates bicarbonate (cytosol) [GO_0004089]
- 680: carbonyl reductase (NADPH) activity [GO_0004090]
- 681: carboxyl-O-methyltransferase activity [GO_0010340]
- 682: carboxylic acid binding [GO_0031406]
- 683: carboxylic acid biosynthetic process [GO_0046394]
- 684: carboxylic acid catabolic process [GO_0046395]
- 685: carboxylic acid metabolic process [GO_0019752]
- 686: carboxylic acid transmembrane transport [GO_1905039]
- 687: carboxylic acid transmembrane transporter activity [GO_0046943]
- 688: carboxylic acid transport [GO_0046942]
- 689: carcinine transmembrane transporter activity [GO_1905131]
- 690: CARD domain binding [GO_0050700]
- 691: cardiac atrium development [GO_0003230]
- 692: cardiac atrium formation [GO_0003210]
- 693: cardiac atrium morphogenesis [GO_0003209]
- 694: cardiac blood vessel endothelial cell differentiation [GO_0060946]
- 695: cardiac cell development [GO_0055006]
- 696: cardiac chamber development [GO_0003205]
- 697: cardiac chamber formation [GO_0003207]
- 698: cardiac chamber morphogenesis [GO_0003206]
- 699: cardiac conduction [GO_0061337]
- 700: cardiac conduction system development [GO_0003161]
- 701: cardiac endothelial cell differentiation [GO_0003348]
- 702: cardiac fibroblast cell development [GO_0060936]
- 703: cardiac fibroblast cell differentiation [GO_0060935]
- 704: cardiac glial cell development [GO_0060952]
- 705: cardiac glial cell differentiation [GO_0060950]
- 706: cardiac left atrium formation [GO_0003216]
- 707: cardiac left atrium morphogenesis [GO_0003212]
- 708: cardiac left ventricle formation [GO_0003218]
- 709: cardiac left ventricle morphogenesis [GO_0003214]
- 710: cardiac muscle adaptation [GO_0014887]
- 711: cardiac muscle cell action potential [GO_0086001]
- 712: cardiac muscle cell apoptotic process [GO_0010659]
- 713: cardiac muscle cell development [GO_0055013]
- 714: cardiac muscle cell differentiation [GO_0055007]
- 715: cardiac muscle cell myoblast differentiation [GO_0060379]
- 716: cardiac muscle cell proliferation [GO_0060038]
- 717: cardiac muscle contraction [GO_0060048]
- 718: cardiac muscle hypertrophy [GO_0003300]
- 719: cardiac muscle myoblast proliferation [GO_0110021]
- 720: cardiac muscle tissue development [GO_0048738]
- 721: cardiac muscle tissue growth [GO_0055017]
- 722: cardiac muscle tissue growth involved in heart morphogenesis [GO_0003245]
- 723: cardiac muscle tissue morphogenesis [GO_0055008]
- 724: cardiac myofibril [GO_0097512]
- 725: cardiac myofibril assembly [GO_0055003]
- 726: cardiac neural crest cell development involved in heart development [GO_0061308]
- 727: cardiac neural crest cell development involved in outflow tract morphogenesis [GO_0061309]
- 728: cardiac neural crest cell differentiation involved in heart development [GO_0061307]
- 729: cardiac neuron development [GO_0060959]
- 730: cardiac neuron differentiation [GO_0060945]
- 731: cardiac pacemaker cell development [GO_0060926]
- 732: cardiac pacemaker cell differentiation [GO_0060920]
- 733: cardiac right atrium formation [GO_0003217]
- 734: cardiac right atrium morphogenesis [GO_0003213]
- 735: cardiac right ventricle formation [GO_0003219]
- 736: cardiac right ventricle morphogenesis [GO_0003215]
- 737: cardiac septum cell differentiation [GO_0003292]
- 738: cardiac septum development [GO_0003279]
- 739: cardiac septum morphogenesis [GO_0060411]
- 740: cardiac skeleton development [GO_0003204]
- 741: cardiac ventricle development [GO_0003231]
- 742: cardiac ventricle formation [GO_0003211]
- 743: cardiac ventricle morphogenesis [GO_0003208]
- 744: cardioblast differentiation [GO_0010002]
- 745: cardiocyte differentiation [GO_0035051]
- 746: cardiogenic plate morphogenesis [GO_0003142]
- 747: cargo adaptor activity [GO_0140312]
- 748: carnitine O-acetyltransferase activity [GO_0004092]
- 749: carnitine O-acyltransferase activity [GO_0016406]
- 750: cartilage development [GO_0051216]
- 751: cartilage development involved in endochondral bone morphogenesis [GO_0060351]
- 752: cartilage morphogenesis [GO_0060536]
- 753: caspase binding [GO_0089720]
- 754: catabolic process [GO_0009056]
- 755: catalytic activity [GO_0003824]
- 756: catalytic activity, acting on a glycoprotein [GO_0140103]
- 757: catalytic activity, acting on a nucleic acid [GO_0140640]
- 758: catalytic activity, acting on a protein [GO_0140096]
- 759: catalytic activity, acting on a rRNA [GO_0140102]
- 760: catalytic activity, acting on a tRNA [GO_0140101]
- 761: catalytic activity, acting on DNA [GO_0140097]
- 762: catalytic activity, acting on RNA [GO_0140098]
- 763: catalytic complex [GO_1902494]
- 764: catechol oxidase activity [GO_0004097]
- 765: catechol-containing compound biosynthetic process [GO_0009713]
- 766: catechol-containing compound catabolic process [GO_0019614]
- 767: catechol-containing compound metabolic process [GO_0009712]
- 768: catecholamine binding [GO_1901338]
- 769: catecholamine biosynthetic process [GO_0042423]
- 770: catecholamine catabolic process [GO_0042424]
- 771: catecholamine metabolic process [GO_0006584]
- 772: catecholamine secretion [GO_0050432]
- 773: catecholamine secretion, neurotransmission [GO_0160043]
- 774: catecholamine transport [GO_0051937]
- 775: catecholamine uptake [GO_0090493]
- 776: cation binding [GO_0043169]
- 777: cation efflux transmembrane transporter activity [GO_0046583]
- 778: cation homeostasis [GO_0055080]
- 779: cation transmembrane transport [GO_0098655]
- 780: cation transmembrane transporter activity [GO_0008324]
- 781: cation transport [GO_0006812]
- 782: cation:chloride symporter activity [GO_0015377]
- 783: CCR4-NOT complex binding [GO_1905762]
- 784: CD27 receptor binding [GO_0005175]
- 785: CD320 transports extracellular TCII:Cbl to endosome [GO_0038024]
- 786: CD38 hydrolyses NAD+ to NAM and ADP-ribose [GO_0003953]
- 787: CD4 biosynthetic process [GO_0045222]
- 788: CDK12 phosphorylates RNA Pol II CTD at DNA repair genes [GO_0004693]
- 789: CDP-alcohol phosphatidyltransferase activity [GO_0017169]
- 790: CDP-choline pathway [GO_0006657]
- 791: CDP-DAG is converted to PI by CDIPT [GO_0003881]
- 792: cell adhesion [GO_0007155]
- 793: cell adhesion involved in heart morphogenesis [GO_0061343]
- 794: cell adhesion mediator activity [GO_0098631]
- 795: cell adhesion molecule binding [GO_0050839]
- 796: cell adhesion receptor activity [GO_0004895]
- 797: cell body [GO_0044297]
- 798: cell chemotaxis [GO_0060326]
- 799: cell communication [GO_0007154]
- 800: cell communication involved in cardiac conduction [GO_0086065]
- 801: cell cortex [GO_0005938]
- 802: cell cortex region [GO_0099738]
- 803: cell cycle [GO_0007049]
- 804: cell cycle DNA replication [GO_0044786]
- 805: cell cycle DNA replication DNA unwinding [GO_1902297]
- 806: cell cycle phase [GO_0022403]
- 807: cell cycle process [GO_0022402]
- 808: cell death [GO_0008219]
- 809: cell development [GO_0048468]
- 810: cell differentiation [GO_0030154]
- 811: cell differentiation in hindbrain [GO_0021533]
- 812: cell differentiation in spinal cord [GO_0021515]
- 813: cell differentiation involved in embryonic placenta development [GO_0060706]
- 814: cell division [GO_0051301]
- 815: cell fate commitment [GO_0045165]
- 816: cell fate commitment involved in formation of primary germ layer [GO_0060795]
- 817: cell fate commitment involved in pattern specification [GO_0060581]
- 818: cell growth [GO_0016049]
- 819: cell growth involved in cardiac muscle cell development [GO_0061049]
- 820: cell junction [GO_0030054]
- 821: cell junction assembly [GO_0034329]
- 822: cell junction disassembly [GO_0150146]
- 823: cell junction maintenance [GO_0034331]
- 824: cell junction organization [GO_0034330]
- 825: cell leading edge [GO_0031252]
- 826: cell leading edge cell cortex [GO_1904269]
- 827: cell maturation [GO_0048469]
- 828: cell migration [GO_0016477]
- 829: cell migration in hindbrain [GO_0021535]
- 830: cell migration involved in coronary angiogenesis [GO_0060981]
- 831: cell migration involved in coronary vasculogenesis [GO_0060980]
- 832: cell migration involved in endocardial cushion formation [GO_0003273]
- 833: cell migration involved in gastrulation [GO_0042074]
- 834: cell migration involved in heart development [GO_0060973]
- 835: cell migration involved in heart formation [GO_0060974]
- 836: cell migration involved in vasculogenesis [GO_0035441]
- 837: cell morphogenesis [GO_0000902]
- 838: cell morphogenesis involved in differentiation [GO_0000904]
- 839: cell morphogenesis involved in neuron differentiation [GO_0048667]
- 840: cell motility [GO_0048870]
- 841: cell motility involved in camera-type eye morphogenesis [GO_0003411]
- 842: cell part morphogenesis [GO_0032990]
- 843: cell periphery [GO_0071944]
- 844: cell population proliferation [GO_0008283]
- 845: cell projection [GO_0042995]
- 846: cell projection assembly [GO_0030031]
- 847: cell projection membrane [GO_0031253]
- 848: cell projection morphogenesis [GO_0048858]
- 849: cell projection organization [GO_0030030]
- 850: cell proliferation in hindbrain [GO_0021534]
- 851: cell proliferation in midbrain [GO_0033278]
- 852: cell proliferation involved in compound eye morphogenesis [GO_0035736]
- 853: cell proliferation involved in embryonic placenta development [GO_0060722]
- 854: cell proliferation involved in endocardial cushion morphogenesis [GO_1905315]
- 855: cell proliferation involved in heart morphogenesis [GO_0061323]
- 856: cell proliferation involved in outflow tract morphogenesis [GO_0061325]
- 857: cell surface receptor signaling pathway [GO_0007166]
- 858: cell surface receptor signaling pathway involved in cell-cell signaling [GO_1905114]
- 859: cell-cell adhesion [GO_0098609]
- 860: cell-cell adhesion mediator activity [GO_0098632]
- 861: cell-cell fusion [GO_0140253]
- 862: cell-cell junction [GO_0005911]
- 863: cell-cell junction assembly [GO_0007043]
- 864: cell-cell junction disassembly [GO_0150147]
- 865: cell-cell junction organization [GO_0045216]
- 866: cell-cell signaling [GO_0007267]
- 867: cell-cell signaling by wnt [GO_0198738]
- 868: cell-cell signaling involved in cardiac conduction [GO_0086019]
- 869: cell-cell signaling involved in cell fate commitment [GO_0045168]
- 870: cell-cell signaling involved in lung development [GO_0060495]
- 871: cell-cell signaling involved in placenta development [GO_0060673]
- 872: cell-cell signaling via exosome [GO_0099156]
- 873: cellular aldehyde metabolic process [GO_0006081]
- 874: cellular amide metabolic process [GO_0043603]
- 875: cellular amine metabolic process [GO_0044106]
- 876: cellular amino acid biosynthetic process [GO_0008652]
- 877: cellular amino acid catabolic process [GO_0009063]
- 878: cellular amino acid metabolic process [GO_0006520]
- 879: cellular ammonium homeostasis [GO_0097275]
- 880: cellular anatomical entity [GO_0110165]
- 881: cellular anion homeostasis [GO_0030002]
- 882: cellular aromatic compound metabolic process [GO_0006725]
- 883: cellular biogenic amine biosynthetic process [GO_0042401]
- 884: cellular biogenic amine catabolic process [GO_0042402]
- 885: cellular biogenic amine metabolic process [GO_0006576]
- 886: cellular biosynthetic process [GO_0044249]
- 887: cellular calcium ion homeostasis [GO_0006874]
- 888: cellular carbohydrate biosynthetic process [GO_0034637]
- 889: cellular carbohydrate catabolic process [GO_0044275]
- 890: cellular carbohydrate metabolic process [GO_0044262]
- 891: cellular catabolic process [GO_0044248]
- 892: cellular cation homeostasis [GO_0030003]
- 893: cellular chemical homeostasis [GO_0055082]
- 894: cellular component assembly [GO_0022607]
- 895: cellular component assembly involved in morphogenesis [GO_0010927]
- 896: cellular component biogenesis [GO_0044085]
- 897: cellular component disassembly [GO_0022411]
- 898: cellular component disassembly involved in execution phase of apoptosis [GO_0006921]
- 899: cellular component maintenance [GO_0043954]
- 900: cellular component morphogenesis [GO_0032989]
- 901: cellular component organization [GO_0016043]
- 902: cellular component organization or biogenesis [GO_0071840]
- 903: cellular detoxification [GO_1990748]
- 904: cellular developmental process [GO_0048869]
- 905: cellular divalent inorganic anion homeostasis [GO_0072501]
- 906: cellular divalent inorganic cation homeostasis [GO_0072503]
- 907: cellular glucan metabolic process [GO_0006073]
- 908: cellular glucose homeostasis [GO_0001678]
- 909: cellular homeostasis [GO_0019725]
- 910: cellular ion homeostasis [GO_0006873]
- 911: cellular ketone metabolic process [GO_0042180]
- 912: cellular lipid metabolic process [GO_0044255]
- 913: cellular localization [GO_0051641]
- 914: cellular macromolecule biosynthetic process [GO_0034645]
- 915: cellular macromolecule catabolic process [GO_0044265]
- 916: cellular macromolecule localization [GO_0070727]
- 917: cellular macromolecule metabolic process [GO_0044260]
- 918: cellular metabolic process [GO_0044237]
- 919: cellular metal ion homeostasis [GO_0006875]
- 920: cellular modified amino acid biosynthetic process [GO_0042398]
- 921: cellular modified amino acid metabolic process [GO_0006575]
- 922: cellular monovalent inorganic anion homeostasis [GO_0030320]
- 923: cellular monovalent inorganic cation homeostasis [GO_0030004]
- 924: cellular nitrogen compound biosynthetic process [GO_0044271]
- 925: cellular nitrogen compound catabolic process [GO_0044270]
- 926: cellular nitrogen compound metabolic process [GO_0034641]
- 927: cellular oxidant detoxification [GO_0098869]
- 928: cellular phosphate ion homeostasis [GO_0030643]
- 929: cellular pigmentation [GO_0033059]
- 930: cellular polysaccharide biosynthetic process [GO_0033692]
- 931: cellular polysaccharide catabolic process [GO_0044247]
- 932: cellular polysaccharide metabolic process [GO_0044264]
- 933: cellular process [GO_0009987]
- 934: cellular process involved in reproduction in multicellular organism [GO_0022412]
- 935: cellular protein localization [GO_0034613]
- 936: cellular protein metabolic process [GO_0044267]
- 937: cellular protein modification process [GO_0006464]
- 938: cellular respiration [GO_0045333]
- 939: cellular response to abiotic stimulus [GO_0071214]
- 940: cellular response to acetylcholine [GO_1905145]
- 941: cellular response to alcohol [GO_0097306]
- 942: cellular response to alkaloid [GO_0071312]
- 943: cellular response to antibiotic [GO_0071236]
- 944: cellular response to biotic stimulus [GO_0071216]
- 945: cellular response to blue light [GO_0071483]
- 946: cellular response to BMP stimulus [GO_0071773]
- 947: cellular response to caffeine [GO_0071313]
- 948: cellular response to catecholamine stimulus [GO_0071870]
- 949: cellular response to chemical stimulus [GO_0070887]
- 950: cellular response to chemical stress [GO_0062197]
- 951: cellular response to cytokine stimulus [GO_0071345]
- 952: cellular response to DNA damage stimulus [GO_0006974]
- 953: cellular response to dopamine [GO_1903351]
- 954: cellular response to endogenous stimulus [GO_0071495]
- 955: cellular response to environmental stimulus [GO_0104004]
- 956: cellular response to farnesol [GO_0097308]
- 957: cellular response to fibroblast growth factor stimulus [GO_0044344]
- 958: cellular response to growth factor stimulus [GO_0071363]
- 959: cellular response to hormone stimulus [GO_0032870]
- 960: cellular response to insulin stimulus [GO_0032869]
- 961: cellular response to light stimulus [GO_0071482]
- 962: cellular response to lipid [GO_0071396]
- 963: cellular response to lipopolysaccharide [GO_0071222]
- 964: cellular response to molecule of bacterial origin [GO_0071219]
- 965: cellular response to monoamine stimulus [GO_0071868]
- 966: cellular response to nitrogen compound [GO_1901699]
- 967: cellular response to organic cyclic compound [GO_0071407]
- 968: cellular response to organic substance [GO_0071310]
- 969: cellular response to organonitrogen compound [GO_0071417]
- 970: cellular response to oxidative stress [GO_0034599]
- 971: cellular response to oxygen radical [GO_0071450]
- 972: cellular response to oxygen-containing compound [GO_1901701]
- 973: cellular response to peptide [GO_1901653]
- 974: cellular response to peptide hormone stimulus [GO_0071375]
- 975: cellular response to purine-containing compound [GO_0071415]
- 976: cellular response to radiation [GO_0071478]
- 977: cellular response to reactive oxygen species [GO_0034614]
- 978: cellular response to salt [GO_1902075]
- 979: cellular response to steroid hormone stimulus [GO_0071383]
- 980: cellular response to stimulus [GO_0051716]
- 981: cellular response to stress [GO_0033554]
- 982: cellular response to superoxide [GO_0071451]
- 983: cellular response to toxic substance [GO_0097237]
- 984: cellular response to xenobiotic stimulus [GO_0071466]
- 985: cellular sodium ion homeostasis [GO_0006883]
- 986: cellular sulfate ion homeostasis [GO_0030642]
- 987: cellular trivalent inorganic anion homeostasis [GO_0072502]
- 988: cellular_component [GO_0005575]
- 989: central nervous system development [GO_0007417]
- 990: central nervous system formation [GO_0021556]
- 991: central nervous system maturation [GO_0021626]
- 992: central nervous system morphogenesis [GO_0021551]
- 993: central nervous system neuron development [GO_0021954]
- 994: central nervous system neuron differentiation [GO_0021953]
- 995: central nervous system vasculogenesis [GO_0022009]
- 996: ceramide + H2O <=> stearate + sphingosine [endoplasmic reticulum] [GO_0017040]
- 997: ceramide 1-phosphate binding [GO_1902387]
- 998: ceramide 1-phosphate transfer activity [GO_1902388]
- 999: ceramide 1-phosphate transport [GO_1902389]
- 1000: ceramide binding [GO_0097001]
- 1001: Ceramide glucosyltransferase (UGCG) catalyses the transfer of glucose to ceramide [GO_0008120]
- 1002: ceramide phosphoethanolamine synthase activity [GO_0002950]
- 1003: ceramide transfer activity [GO_0120017]
- 1004: ceramide transport [GO_0035627]
- 1005: CERK phosphorylates CERA to form C1P [GO_0001729]
- 1006: CES1trimer hydrolyses ACEI pro-drugs to ACEIs [GO_0052689]
- 1007: CES2 hydrolyzes ASA- [GO_0106435]
- 1008: CFTR F508del is degraded by the 26S proteasome [GO_0004175]
- 1009: cGAS produces cyclic GMP-AMP [GO_0061501]
- 1010: cGMP binding [GO_0030553]
- 1011: cGMP biosynthetic process [GO_0006182]
- 1012: cGMP metabolic process [GO_0046068]
- 1013: cGMP:CNG transports Na+ and Ca2+ into the rod outer segment [GO_0005221]
- 1014: channel activator activity [GO_0099103]
- 1015: channel inhibitor activity [GO_0016248]
- 1016: channel regulator activity [GO_0016247]
- 1017: chaperone binding [GO_0051087]
- 1018: chemical homeostasis [GO_0048878]
- 1019: chemical homeostasis within a tissue [GO_0048875]
- 1020: chemical synaptic transmission [GO_0007268]
- 1021: chemical synaptic transmission, postsynaptic [GO_0099565]
- 1022: chemoattractant activity [GO_0042056]
- 1023: chemoattractant activity involved in axon guidance [GO_1902379]
- 1024: chemoattraction of axon [GO_0061642]
- 1025: chemokine activity [GO_0008009]
- 1026: chemokine receptor binding [GO_0042379]
- 1027: chemorepellent activity [GO_0045499]
- 1028: chemorepulsion of axon [GO_0061643]
- 1029: chemosensory behavior [GO_0007635]
- 1030: chemotaxis [GO_0006935]
- 1031: chitin binding [GO_0008061]
- 1032: chitin deacetylase activity [GO_0004099]
- 1033: chitin synthase activity [GO_0004100]
- 1034: chitinase activity [GO_0004568]
- 1035: chloride channel inhibitor activity [GO_0019869]
- 1036: chloride transmembrane transport [GO_1902476]
- 1037: chloride transport [GO_0006821]
- 1038: chlorophyllide a oxygenase [overall] activity [GO_0010277]
- 1039: Cho is acetylated to AcCho by CHAT [GO_0004102]
- 1040: Cho is phosphorylated to PCho by CHK dimer [GO_0004103]
- 1041: cholangiocyte apoptotic process [GO_1902488]
- 1042: cholangiocyte proliferation [GO_1990705]
- 1043: cholesterol binding [GO_0015485]
- 1044: cholesterol dehydrogenase activity [GO_0102294]
- 1045: cholesterol O-acyltransferase activity [GO_0034736]
- 1046: cholesterol transfer activity [GO_0120020]
- 1047: cholesterol-protein transferase activity [GO_0140853]
- 1048: choline transport [GO_0015871]
- 1049: choline:sodium symporter activity [GO_0005307]
- 1050: cholinesterase activity [GO_0004104]
- 1051: chondroblast differentiation [GO_0060591]
- 1052: chondrocyte development [GO_0002063]
- 1053: chondrocyte development involved in endochondral bone morphogenesis [GO_0003433]
- 1054: chondrocyte differentiation [GO_0002062]
- 1055: chondrocyte differentiation involved in endochondral bone morphogenesis [GO_0003413]
- 1056: chondrocyte morphogenesis [GO_0090171]
- 1057: chondrocyte morphogenesis involved in endochondral bone morphogenesis [GO_0003414]
- 1058: chordate embryonic development [GO_0043009]
- 1059: chorion development [GO_0060717]
- 1060: chorionic trophoblast cell development [GO_0060719]
- 1061: chorionic trophoblast cell differentiation [GO_0060718]
- 1062: chorionic trophoblast cell proliferation [GO_0097360]
- 1063: chromatin [GO_0000785]
- 1064: chromatin assembly [GO_0031497]
- 1065: chromatin assembly or disassembly [GO_0006333]
- 1066: chromatin binding [GO_0003682]
- 1067: chromatin disassembly [GO_0031498]
- 1068: chromatin DNA binding [GO_0031490]
- 1069: chromatin insulator sequence binding [GO_0043035]
- 1070: chromatin loop anchoring activity [GO_0140587]
- 1071: chromatin organization [GO_0006325]
- 1072: chromatin remodeling [GO_0006338]
- 1073: chromatin silencing complex [GO_0005677]
- 1074: chromatin-protein adaptor activity [GO_0140463]
- 1075: chromo shadow domain binding [GO_0070087]
- 1076: chromosome [GO_0005694]
- 1077: chromosome condensation [GO_0030261]
- 1078: chromosome localization [GO_0050000]
- 1079: chromosome organization [GO_0051276]
- 1080: chromosome organization involved in meiotic cell cycle [GO_0070192]
- 1081: chromosome segregation [GO_0007059]
- 1082: Chymase hydrolyzes Angiotensin-(1-10) to Angiotensin-(1-8) [GO_0008236]
- 1083: ciliary basal body-plasma membrane docking [GO_0097711]
- 1084: ciliary body morphogenesis [GO_0061073]
- 1085: ciliary membrane [GO_0060170]
- 1086: ciliary plasm [GO_0097014]
- 1087: ciliary transition zone [GO_0035869]
- 1088: ciliary transition zone assembly [GO_1905349]
- 1089: cilium [GO_0005929]
- 1090: cilium assembly [GO_0060271]
- 1091: cilium disassembly [GO_0061523]
- 1092: cilium organization [GO_0044782]
- 1093: circadian behavior [GO_0048512]
- 1094: circadian mating behavior [GO_0035648]
- 1095: circadian rhythm [GO_0007623]
- 1096: circadian sleep/wake cycle [GO_0042745]
- 1097: circadian sleep/wake cycle process [GO_0022410]
- 1098: circadian sleep/wake cycle, sleep [GO_0050802]
- 1099: circulatory system development [GO_0072359]
- 1100: circulatory system process [GO_0003013]
- 1101: cis-regulatory region sequence-specific DNA binding [GO_0000987]
- 1102: cis-trans isomerase activity [GO_0016859]
- 1103: citrate <=> isocitrate [GO_0003994]
- 1104: citrate secondary active transmembrane transporter activity [GO_0071913]
- 1105: citrate synthase activity [GO_0036440]
- 1106: citrate transmembrane transporter activity [GO_0015137]
- 1107: citrate transport [GO_0015746]
- 1108: class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO_0140078]
- 1109: class II DNA-(apurinic or apyrimidinic site) endonuclease activity [GO_0052720]
- 1110: clathrin adaptor activity [GO_0035615]
- 1111: clathrin binding [GO_0030276]
- 1112: clathrin heavy chain binding [GO_0032050]
- 1113: clathrin light chain binding [GO_0032051]
- 1114: CLCN4/5/6 exchange Cl- for H+ [GO_0015297]
- 1115: cleavage involved in rRNA processing [GO_0000469]
- 1116: Cleavage of 5-hydroxyluracil by UNG glycosylase [GO_0004844]
- 1117: Cleavage of formamidopyrimidine (FapyA) by NTHL1 glycosylase [GO_0008534]
- 1118: Cleavage of S protein into S1:S2 [GO_0004252]
- 1119: cloaca development [GO_0035844]
- 1120: cloacal gland development [GO_1904484]
- 1121: club cell differentiation [GO_0060486]
- 1122: CMP biosynthetic process [GO_0009224]
- 1123: CMP metabolic process [GO_0046035]
- 1124: CNDP2:2Mn2+ dimer hydrolyses CysGly [GO_0004180]
- 1125: co-SMAD binding [GO_0070410]
- 1126: CoA carboxylase activity [GO_0016421]
- 1127: CoA hydrolase activity [GO_0016289]
- 1128: CoA-ligase activity [GO_0016405]
- 1129: CoA-transferase activity [GO_0008410]
- 1130: COASY transfers an adenylyl group from ATP to PPANT [GO_0004595]
- 1131: cobalamin binding [GO_0031419]
- 1132: cocaine binding [GO_0019811]
- 1133: coenzyme A transmembrane transport [GO_0035349]
- 1134: coenzyme A transmembrane transporter activity [GO_0015228]
- 1135: coenzyme A transport [GO_0015880]
- 1136: cognition [GO_0050890]
- 1137: cohesin loader activity [GO_0061775]
- 1138: cohesin unloader activity [GO_0140670]
- 1139: collagen binding [GO_0005518]
- 1140: collagen biosynthetic process [GO_0032964]
- 1141: collagen catabolic process [GO_0030574]
- 1142: collagen fibril binding [GO_0098633]
- 1143: collagen fibril organization [GO_0030199]
- 1144: collagen metabolic process [GO_0032963]
- 1145: collagen network [GO_0098645]
- 1146: collagen receptor activity [GO_0038064]
- 1147: collagen trimer [GO_0005581]
- 1148: collagen type II trimer [GO_0005585]
- 1149: collagen type IV trimer [GO_0005587]
- 1150: collagen-activated signaling pathway [GO_0038065]
- 1151: collagen-activated tyrosine kinase receptor signaling pathway [GO_0038063]
- 1152: collagen-containing extracellular matrix [GO_0062023]
- 1153: colon smooth muscle contraction [GO_1990765]
- 1154: columnar/cuboidal epithelial cell development [GO_0002066]
- 1155: columnar/cuboidal epithelial cell differentiation [GO_0002065]
- 1156: columnar/cuboidal epithelial cell maturation [GO_0002069]
- 1157: common bile duct development [GO_0061009]
- 1158: Complex I oxidises NADH to NAD+, reduces CoQ to QH2 [GO_0008137]
- 1159: complex of collagen trimers [GO_0098644]
- 1160: compound eye development [GO_0048749]
- 1161: compound eye morphogenesis [GO_0001745]
- 1162: compound eye photoreceptor cell differentiation [GO_0001751]
- 1163: compound eye retinal cell apoptotic process [GO_1990010]
- 1164: compound eye retinal cell programmed cell death [GO_0046667]
- 1165: COMT transfers Met to DOPAC to form HVA [GO_0008168]
- 1166: connective tissue development [GO_0061448]
- 1167: contractile fiber [GO_0043292]
- 1168: conus arteriosus development [GO_0003238]
- 1169: conus arteriosus formation [GO_0003240]
- 1170: conus arteriosus morphogenesis [GO_0003239]
- 1171: COP9 signalosome deneddylates nuclear CRL4 E3 ubiquitin ligase complex [GO_0019784]
- 1172: COPII receptor activity [GO_0097020]
- 1173: copper chaperone activity [GO_0016531]
- 1174: copper ion binding [GO_0005507]
- 1175: copper ion transmembrane transport [GO_0035434]
- 1176: copper ion transmembrane transporter activity [GO_0005375]
- 1177: copper ion transport [GO_0006825]
- 1178: COPRS:CCND1:CDK4:PRMT5:pT5-WDR77 methylates arginine-4 of histone H4 (H4R3) [GO_0008469]
- 1179: copulation [GO_0007620]
- 1180: corazonin receptor activity [GO_0035237]
- 1181: corazonin receptor binding [GO_0071858]
- 1182: Core MLL complex methylates H3K4Me2-Nucleosome at the GP1BA gene promoter [GO_0042800]
- 1183: Core MLL complex, SMYD3, PRDM9 methylate dimethyl-lysine-5 of histone H3 (H3K4) [GO_0018024]
- 1184: core promoter sequence-specific DNA binding [GO_0001046]
- 1185: coreceptor activity [GO_0015026]
- 1186: coreceptor activity involved in epidermal growth factor receptor signaling pathway [GO_0060724]
- 1187: coreceptor activity involved in Wnt signaling pathway [GO_0071936]
- 1188: cornea development in camera-type eye [GO_0061303]
- 1189: coronary vasculature development [GO_0060976]
- 1190: coronary vasculature morphogenesis [GO_0060977]
- 1191: coronary vein morphogenesis [GO_0003169]
- 1192: corticotropin-releasing hormone binding [GO_0051424]
- 1193: courtship behavior [GO_0007619]
- 1194: CPO transforms COPRO3 to PPGEN9 [GO_0004109]
- 1195: CPT1A,B transfers PALM to CAR [GO_0004095]
- 1196: cranial ganglion development [GO_0061550]
- 1197: cranial ganglion formation [GO_0061560]
- 1198: cranial ganglion maturation [GO_0061558]
- 1199: cranial ganglion morphogenesis [GO_0061559]
- 1200: cranial nerve development [GO_0021545]
- 1201: cranial nerve formation [GO_0021603]
- 1202: cranial nerve maturation [GO_0021605]
- 1203: cranial nerve morphogenesis [GO_0021602]
- 1204: cranial skeletal system development [GO_1904888]
- 1205: CRD domain binding [GO_0071906]
- 1206: creatine + ATP => phosphocreatine + ADP [CK octamer] [GO_0004111]
- 1207: Crotonoyl-CoA+H2O<=>(S)-3-Hydroxybutanoyl-CoA [GO_0004300]
- 1208: CRYL1 dimer dehydrogenates L-gulonate to 3-dehydro-L-gulonate [GO_0050104]
- 1209: CS is cleaved from its proteoglycan [GO_0016798]
- 1210: CTU1:CTU2:URM1 thiolates uridine-34 in tRNAs [GO_0016783]
- 1211: cullin family protein binding [GO_0097602]
- 1212: CYB5Rs reduce MetHb to HbA [GO_0004128]
- 1213: CYBRD1:Heme reduces Fe3+ to Fe2+ [GO_0016722]
- 1214: cyclase activator activity [GO_0010853]
- 1215: cyclase activity [GO_0009975]
- 1216: cyclase inhibitor activity [GO_0010852]
- 1217: cyclase regulator activity [GO_0010851]
- 1218: cyclic GMP-AMP synthase activity [GO_0140699]
- 1219: cyclic nucleotide binding [GO_0030551]
- 1220: cyclic nucleotide biosynthetic process [GO_0009190]
- 1221: cyclic nucleotide metabolic process [GO_0009187]
- 1222: cyclic nucleotide-dependent protein kinase activity [GO_0004690]
- 1223: cyclic nucleotide-gated ion channel activity [GO_0043855]
- 1224: cyclic purine nucleotide metabolic process [GO_0052652]
- 1225: cyclic pyranopterin monophosphate synthase activity [GO_0061799]
- 1226: cyclic-nucleotide phosphodiesterase activity [GO_0004112]
- 1227: cyclic-nucleotide-mediated signaling [GO_0019935]
- 1228: cyclin binding [GO_0030332]
- 1229: cyclin-dependent protein kinase activity [GO_0097472]
- 1230: cyclin-dependent protein serine/threonine kinase activator activity [GO_0061575]
- 1231: cyclin-dependent protein serine/threonine kinase inhibitor activity [GO_0004861]
- 1232: cyclin-dependent protein serine/threonine kinase regulator activity [GO_0016538]
- 1233: Cyclisation of GTP to precursor Z [GO_1904047]
- 1234: cyclo-ligase activity [GO_0016882]
- 1235: cyclohydrolase activity [GO_0019238]
- 1236: cyclosporin A binding [GO_0016018]
- 1237: CYP24A1 24-hydroxylates CTL [GO_0030342]
- 1238: CYP2D6 4-hydroxylates debrisoquine [GO_0016712]
- 1239: CYP4F8 19-hydroxylates PGH2 [GO_0004497]
- 1240: cysteine biosynthetic process [GO_0019344]
- 1241: cysteine metabolic process [GO_0006534]
- 1242: cysteine synthase activity [GO_0004124]
- 1243: cysteine-S-conjugate beta-lyase activity [GO_0047804]
- 1244: cysteine-type deNEDDylase activity [GO_0140757]
- 1245: cysteine-type endopeptidase activator activity [GO_0140608]
- 1246: cysteine-type endopeptidase activator activity involved in apoptotic process [GO_0008656]
- 1247: cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO_0097200]
- 1248: cysteine-type endopeptidase inhibitor activity [GO_0004869]
- 1249: cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO_0043027]
- 1250: cysteine-type endopeptidase regulator activity involved in apoptotic process [GO_0043028]
- 1251: cystic duct development [GO_0035628]
- 1252: cytidine catabolic process [GO_0006216]
- 1253: cytidine deaminase activity [GO_0004126]
- 1254: cytidine deamination [GO_0009972]
- 1255: cytidine kinase activity [GO_0043771]
- 1256: cytidine metabolic process [GO_0046087]
- 1257: cytidylate kinase activity [GO_0004127]
- 1258: cytidylyltransferase activity [GO_0070567]
- 1259: cytochrome-c oxidase activity [GO_0004129]
- 1260: cytokine activity [GO_0005125]
- 1261: cytokine binding [GO_0019955]
- 1262: cytokine receptor activity [GO_0004896]
- 1263: cytokine receptor binding [GO_0005126]
- 1264: cytokine-mediated signaling pathway [GO_0019221]
- 1265: cytokinesis [GO_0000910]
- 1266: cytoplasm [GO_0005737]
- 1267: cytoplasm organization [GO_0007028]
- 1268: cytoplasmic microtubule [GO_0005881]
- 1269: cytoplasmic microtubule bundle [GO_1905720]
- 1270: cytoplasmic microtubule depolymerization [GO_0010938]
- 1271: cytoplasmic microtubule organization [GO_0031122]
- 1272: cytoplasmic region [GO_0099568]
- 1273: cytoplasmic vesicle [GO_0031410]
- 1274: cytoplasmic vesicle membrane [GO_0030659]
- 1275: cytoskeletal anchor activity [GO_0008093]
- 1276: cytoskeletal motor activator activity [GO_0140660]
- 1277: cytoskeletal motor activity [GO_0003774]
- 1278: cytoskeletal motor inhibitor activity [GO_0140661]
- 1279: cytoskeletal motor regulator activity [GO_0140659]
- 1280: cytoskeletal protein binding [GO_0008092]
- 1281: cytoskeletal protein-membrane anchor activity [GO_0106006]
- 1282: cytoskeletal regulatory protein binding [GO_0005519]
- 1283: cytoskeleton [GO_0005856]
- 1284: cytoskeleton organization [GO_0007010]
- 1285: cytoskeleton-dependent intracellular transport [GO_0030705]
- 1286: Cytosolic chenodeoxycholoyl-CoA or choloyl-CoA are conjugated with glycine or taurine [GO_0016746]
- 1287: Cytosolic PHD2,3 hydroxylates proline residues on HIF1A [GO_0031545]
- 1288: D-amino acid transmembrane transporter activity [GO_0042943]
- 1289: D-amino acid transport [GO_0042940]
- 1290: D-amino-acid oxidase activity [GO_0003884]
- 1291: D-arabinose 1-dehydrogenase [NAD(P)+] activity [GO_0045290]
- 1292: D-fructose 1,6-bisphosphate + H2O => D-fructose 6-phosphate + orthophosphate [GO_0042132]
- 1293: D-fructose 6-phosphate + ATP => D-fructose 2,6-bisphosphate + ADP [GO_0003873]
- 1294: D-fructose 6-phosphate <=> alpha-D-Glucose 6-phosphate [GO_0004347]
- 1295: D-glucono-1,5-lactone 6-phosphate + H2O => 6-phospho-D-gluconate [GO_0017057]
- 1296: D-glyceraldehyde 3-phosphate + orthophosphate + NAD+ <=> 1,3-bisphospho-D-glycerate + NADH + H+ [GO_0004365]
- 1297: D-loop dissociation and strand annealing [GO_0003678]
- 1298: D-ribulokinase activity [GO_0019150]
- 1299: D-ribulose 5-phosphate <=> ribose 5-phosphate [GO_0004751]
- 1300: D-xylose 1-dehydrogenase (NADP+) activity [GO_0047837]
- 1301: D5 dopamine receptor binding [GO_0031752]
- 1302: dA, dG, or dI + ATP => dAMP, dGMP, or dIMP + ADP (DGUOK) [GO_0019136]
- 1303: damaged DNA binding [GO_0003684]
- 1304: dAMP biosynthetic process [GO_0006170]
- 1305: dAMP metabolic process [GO_0046053]
- 1306: DARPP-32 phosphorylated on T34 binds to PP1, inhibiting its function [GO_0019888]
- 1307: DARPP-32 phosphorylated on Thr75 binds to PKA, inhibiting its function [GO_0004862]
- 1308: DCLRE1C (ARTEMIS) processes DNA DSB ends [GO_0004519]
- 1309: DCXR tetramer reduces L-xylulose to xylitol [GO_0050038]
- 1310: DDHD1,2 hydrolyse PA [GO_0004620]
- 1311: DDT-dehydrochlorinase activity [GO_0018833]
- 1312: deacetylase activity [GO_0019213]
- 1313: DEAD/H-box RNA helicase binding [GO_0017151]
- 1314: deaminated base DNA N-glycosylase activity [GO_0097506]
- 1315: death domain binding [GO_0070513]
- 1316: decarboxylation-driven active transmembrane transporter activity [GO_0015451]
- 1317: defecation [GO_0030421]
- 1318: Defective ABCC9 (in KCNJ11:ABCC9) does not transport K+ from extracellular region to cytosol [GO_0005242]
- 1319: Defective ALG9 does not add the last mannose to the N-glycan precursor [GO_0000026]
- 1320: Defective B3GAT3 does not transfer GlcA to tetrasaccharide linker [GO_0015018]
- 1321: Defective CFTR does not transport Cl- from cytosol to extracellular region [GO_0015108]
- 1322: Defective CHSY1 does not transfer GalNAc to chondroitin [GO_0047238]
- 1323: Defective CYP11B2 does not oxidise CORST [GO_0008395]
- 1324: Defective DPM3 does not transfer mannose to DOLP to form DOLPman [GO_0004582]
- 1325: Defective EXT1 (in EXT1:EXT2) does not transfer GlcNAc to the heparan chain [GO_0050508]
- 1326: Defective EXT2 (in EXT1:EXT2) does not transfer GlcA to heparan [GO_0050509]
- 1327: Defective FMO3 does not N-oxidise TMA [GO_0004499]
- 1328: Defective GALK1 does not phosphorylate Gal [GO_0004335]
- 1329: Defective GALT does not transfer UMP to Gal1P [GO_0008108]
- 1330: Defective GCK does not phosphorylate Glc to form G6P [GO_0004340]
- 1331: Defective GCLC does not ligate L-Glu to L-Cys [GO_0004357]
- 1332: Defective GFPT1 does not transfer an amino group from L-Gln to F6P to form GlcN6P [GO_0004360]
- 1333: Defective GGT1 does not hydrolyse glutamate from AFXBO-SG, AFNBO-SG [GO_0036374]
- 1334: Defective GNS does not hydrolyse 6-sulfate from GlcNAc6S [GO_0008449]
- 1335: Defective GSS does not synthesize GSH [GO_0004363]
- 1336: Defective HEXA does not cleave the terminal GalNAc from keratan sulfate [GO_0004563]
- 1337: Defective MAN1B1 does not hydrolyse 1,2-linked mannose (a branch) [GO_0004571]
- 1338: Defective MAOA does not oxidatively deaminate 5HT [GO_0008131]
- 1339: Defective MAT1A does not transfer Ado from ATP to L-Met [GO_0004478]
- 1340: Defective MGAT2 does not transfer GlcNAc to N-glycans [GO_0008455]
- 1341: Defective OPLAH does not hydrolyse OPRO [GO_0017168]
- 1342: Defective RDH12 does not reduce atRAL to atROL [GO_0052650]
- 1343: Defective RHAG does not transport NH4+ from cytosol to extracellular region (rbc) [GO_0008519]
- 1344: Defective SLC11A2 does not cotransport Fe2+, H+ from extracellular region to cytosol [GO_0005381]
- 1345: Defective SLC12A6 does not cotransport K+, Cl- from cytosol to extracellular region [GO_0015379]
- 1346: Defective SLC20A2 does not cotransport Pi, Na+ from extracellular region to cytosol [GO_0005436]
- 1347: Defective SLC22A18 does not exchange extracellular organic cations for cytosolic H+ [GO_0015299]
- 1348: Defective SLC24A4 does not exchange extracellular 4Na+ for cytosolic Ca2+, K+ [GO_0008273]
- 1349: Defective SLC26A2 does not cotransport extracellular SO4(2-), H+ to cytosol [GO_0015116]
- 1350: Defective SLC37A4 does not exchange G6P and Pi across the ER membrane [GO_0061513]
- 1351: Defective SLC4A1 does not exchange Cl- for HCO3- (in erythrocytes) [GO_0005452]
- 1352: Defective SLC5A7 does not cotransport Cho, Cl-, Na+ from extracellular region to cytosol [GO_0015220]
- 1353: Defective UGT1A1 does not transfer GlcA from UDP-GlcA to BMG [GO_0015020]
- 1354: Dehydration of methylthio-ribulose-P [GO_0046570]
- 1355: dehydroascorbic acid transport [GO_0070837]
- 1356: dehydrodolichyl diphosphate synthase activity [GO_0045547]
- 1357: delayed rectifier potassium channel activity [GO_0005251]
- 1358: delta(3,5)-delta(2,4)-dienoyl-CoA isomerase activity [GO_0051750]
- 1359: demethylase activity [GO_0032451]
- 1360: denatured protein binding [GO_0031249]
- 1361: dendrite [GO_0030425]
- 1362: dendrite cytoplasm [GO_0032839]
- 1363: dendritic tree [GO_0097447]
- 1364: deoxyadenosine kinase activity [GO_0004136]
- 1365: deoxycytidine kinase activity [GO_0004137]
- 1366: deoxyguanosine kinase activity [GO_0004138]
- 1367: deoxyhypusine monooxygenase activity [GO_0019135]
- 1368: deoxyribodipyrimidine photo-lyase activity [GO_0003904]
- 1369: deoxyribonuclease I activity [GO_0004530]
- 1370: deoxyribonucleoside monophosphate biosynthetic process [GO_0009157]
- 1371: deoxyribonucleoside monophosphate metabolic process [GO_0009162]
- 1372: deoxyribonucleotide biosynthetic process [GO_0009263]
- 1373: deoxyribonucleotide metabolic process [GO_0009262]
- 1374: deoxyribose phosphate biosynthetic process [GO_0046385]
- 1375: deoxyribose phosphate metabolic process [GO_0019692]
- 1376: dephospho-CoA kinase activity [GO_0004140]
- 1377: dephosphorylation [GO_0016311]
- 1378: Dephosphorylation of AKT by PP2A [GO_0008195]
- 1379: Dephosphorylation of CD3-zeta by PD-1 bound phosphatases [GO_0004725]
- 1380: Dephosphorylation of phospho-Cdh1 [GO_0004721]
- 1381: DERA cleaves dR5P to GA3P and CH3CHO [GO_0004139]
- 1382: dermal bone morphogenesis [GO_0061972]
- 1383: dermatome development [GO_0061054]
- 1384: descending aorta development [GO_0035906]
- 1385: descending aorta morphogenesis [GO_0035911]
- 1386: deSUMOylase activity [GO_0016929]
- 1387: detection of abiotic stimulus [GO_0009582]
- 1388: detection of biotic stimulus [GO_0009595]
- 1389: detection of calcium ion [GO_0005513]
- 1390: detection of carbon dioxide [GO_0003031]
- 1391: detection of chemical stimulus [GO_0009593]
- 1392: detection of chemical stimulus involved in sensory perception [GO_0050907]
- 1393: detection of chemical stimulus involved in sensory perception of bitter taste [GO_0001580]
- 1394: detection of chemical stimulus involved in sensory perception of pain [GO_0050968]
- 1395: detection of chemical stimulus involved in sensory perception of salty taste [GO_0001583]
- 1396: detection of chemical stimulus involved in sensory perception of smell [GO_0050911]
- 1397: detection of chemical stimulus involved in sensory perception of sour taste [GO_0001581]
- 1398: detection of chemical stimulus involved in sensory perception of sweet taste [GO_0001582]
- 1399: detection of chemical stimulus involved in sensory perception of taste [GO_0050912]
- 1400: detection of chemical stimulus involved in sensory perception of umami taste [GO_0046535]
- 1401: detection of cold stimulus involved in thermoception [GO_0120169]
- 1402: detection of external biotic stimulus [GO_0098581]
- 1403: detection of external stimulus [GO_0009581]
- 1404: detection of high humidity [GO_0098516]
- 1405: detection of high humidity stimulus involved in sensory perception [GO_0098514]
- 1406: detection of hot stimulus involved in thermoception [GO_0120168]
- 1407: detection of humidity [GO_0098513]
- 1408: detection of humidity stimulus involved in sensory perception [GO_0098512]
- 1409: detection of hydrogen ion [GO_0003030]
- 1410: detection of light stimulus [GO_0009583]
- 1411: detection of light stimulus involved in sensory perception [GO_0050962]
- 1412: detection of light stimulus involved in visual perception [GO_0050908]
- 1413: detection of low humidity [GO_0098517]
- 1414: detection of low humidity stimulus involved in sensory perception [GO_0098515]
- 1415: detection of mechanical stimulus [GO_0050982]
- 1416: detection of mechanical stimulus involved in equilibrioception [GO_0050973]
- 1417: detection of mechanical stimulus involved in sensory perception [GO_0050974]
- 1418: detection of mechanical stimulus involved in sensory perception of pain [GO_0050966]
- 1419: detection of mechanical stimulus involved in sensory perception of sound [GO_0050910]
- 1420: detection of mechanical stimulus involved in sensory perception of touch [GO_0050976]
- 1421: detection of mechanical stimulus involved in sensory perception of wind [GO_0071066]
- 1422: detection of molecule of fungal origin [GO_0032491]
- 1423: detection of osmotic stimulus [GO_0043575]
- 1424: detection of pH by chemoreceptor signaling [GO_0003022]
- 1425: detection of pheromone [GO_0043695]
- 1426: detection of stimulus [GO_0051606]
- 1427: detection of stimulus involved in sensory perception [GO_0050906]
- 1428: detection of stimulus involved in sensory perception of pain [GO_0062149]
- 1429: detection of temperature stimulus [GO_0016048]
- 1430: detection of temperature stimulus involved in sensory perception [GO_0050961]
- 1431: detection of temperature stimulus involved in sensory perception of pain [GO_0050965]
- 1432: detection of temperature stimulus involved in thermoception [GO_0050960]
- 1433: detection of visible light [GO_0009584]
- 1434: detoxification [GO_0098754]
- 1435: detoxification of inorganic compound [GO_0061687]
- 1436: detoxification of nitrogen compound [GO_0051410]
- 1437: deubiquitinase activator activity [GO_0035800]
- 1438: deubiquitinase activity [GO_0101005]
- 1439: development of primary female sexual characteristics [GO_0046545]
- 1440: development of primary sexual characteristics [GO_0045137]
- 1441: developmental cell growth [GO_0048588]
- 1442: developmental growth [GO_0048589]
- 1443: developmental growth involved in morphogenesis [GO_0060560]
- 1444: developmental induction [GO_0031128]
- 1445: developmental maturation [GO_0021700]
- 1446: developmental pigmentation [GO_0048066]
- 1447: developmental process [GO_0032502]
- 1448: developmental process involved in reproduction [GO_0003006]
- 1449: DHAP is converted to 1-acyl GO3P by GNPAT [GO_0016287]
- 1450: DHDDS:NUS1 elongates E,E-FPP with (n)IPPP to form pPPP [GO_0016765]
- 1451: diacylglycerol binding [GO_0019992]
- 1452: diacylglycerol cholinephosphotransferase activity [GO_0004142]
- 1453: diacylglycerol diphosphate phosphatase activity [GO_0000810]
- 1454: diacylglycerol kinase activity [GO_0004143]
- 1455: diaphragm development [GO_0060539]
- 1456: diaphragm morphogenesis [GO_0060540]
- 1457: dibutyl phthalate binding [GO_0035275]
- 1458: dicarboxylic acid biosynthetic process [GO_0043650]
- 1459: dicarboxylic acid catabolic process [GO_0043649]
- 1460: dicarboxylic acid metabolic process [GO_0043648]
- 1461: dicarboxylic acid transport [GO_0006835]
- 1462: digestion [GO_0007586]
- 1463: Digestion of 1-6 linkages of limit dextrins to yield maltose, maltotriose, longer maltosides, and glucose [GO_0004558]
- 1464: Digestion of linear starch (amylose) by extracellular amylase [GO_0004556]
- 1465: Digestion of triacylglycerols by extracellular PTL:colipase [GO_0047372]
- 1466: digestive system development [GO_0055123]
- 1467: digestive system process [GO_0022600]
- 1468: digestive tract development [GO_0048565]
- 1469: digestive tract morphogenesis [GO_0048546]
- 1470: dihydrofolate reductase activity [GO_0004146]
- 1471: dihydrolipoyllysine-residue acetyltransferase activity [GO_0004742]
- 1472: dihydrolipoyllysine-residue succinyltransferase activity [GO_0004149]
- 1473: dihydroorotate dehydrogenase activity [GO_0004152]
- 1474: dihydropterin deaminase activity [GO_0004153]
- 1475: dihydropyrimidine dehydrogenase (NADP+) activity [GO_0017113]
- 1476: dihydroxyacetone phosphate <=> D-glyceraldehyde 3-phosphate [GO_0004807]
- 1477: DIMT1 dimethylates adenosine-1850,1851 of 18S rRNA yielding 6-dimethyladenosine-1850,1851 [GO_0000179]
- 1478: dioxygenase activity [GO_0051213]
- 1479: dipeptidase activity [GO_0016805]
- 1480: dipeptide transmembrane transport [GO_0035442]
- 1481: dipeptide transmembrane transporter activity [GO_0071916]
- 1482: dipeptide transport [GO_0042938]
- 1483: dipeptidyl-peptidase activity [GO_0008239]
- 1484: diphenyl phthalate binding [GO_0035274]
- 1485: diphosphoinositol-pentakisphosphate kinase activity [GO_0033857]
- 1486: diphosphoinositol-polyphosphate diphosphatase activity [GO_0008486]
- 1487: diphosphotransferase activity [GO_0016778]
- 1488: direct ossification [GO_0036072]
- 1489: directional locomotion [GO_0033058]
- 1490: disaccharide metabolic process [GO_0005984]
- 1491: disaccharide transmembrane transporter activity [GO_0015154]
- 1492: disaccharide transport [GO_0015766]
- 1493: disordered domain specific binding [GO_0097718]
- 1494: Dissociation of cytosolic HSF1:HSP90:HDAC6:PTGES3 upon sensing protein aggregates [GO_0051787]
- 1495: disulfide oxidoreductase activity [GO_0015036]
- 1496: diterpenoid metabolic process [GO_0016101]
- 1497: diuretic hormone activity [GO_0008613]
- 1498: diuretic hormone receptor activity [GO_0008036]
- 1499: divalent inorganic anion homeostasis [GO_0072505]
- 1500: divalent inorganic cation homeostasis [GO_0072507]
- 1501: DNA 5'-adenosine monophosphate hydrolase activity [GO_0033699]
- 1502: DNA bending complex [GO_1990104]
- 1503: DNA binding [GO_0003677]
- 1504: DNA binding, bending [GO_0008301]
- 1505: DNA biosynthetic process [GO_0071897]
- 1506: DNA conformation change [GO_0071103]
- 1507: DNA damage sensor activity [GO_0140612]
- 1508: DNA demethylase activity [GO_0035514]
- 1509: DNA duplex unwinding [GO_0032508]
- 1510: DNA geometric change [GO_0032392]
- 1511: DNA metabolic process [GO_0006259]
- 1512: DNA packaging [GO_0006323]
- 1513: DNA packaging complex [GO_0044815]
- 1514: DNA photolyase activity [GO_0003913]
- 1515: DNA polymerase activity [GO_0034061]
- 1516: DNA polymerase binding [GO_0070182]
- 1517: DNA polymerase processivity factor activity [GO_0030337]
- 1518: DNA repair [GO_0006281]
- 1519: DNA replication [GO_0006260]
- 1520: DNA replication origin binding [GO_0003688]
- 1521: DNA secondary structure binding [GO_0000217]
- 1522: DNA synthesis involved in DNA replication [GO_0090592]
- 1523: DNA synthesis involved in mitochondrial DNA replication [GO_0110166]
- 1524: DNA synthesis involved in mitotic DNA replication [GO_1904860]
- 1525: DNA topoisomerase activity [GO_0003916]
- 1526: DNA topoisomerase binding [GO_0044547]
- 1527: DNA topoisomerase type I (single strand cut, ATP-independent) activity [GO_0003917]
- 1528: DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activator activity [GO_0072587]
- 1529: DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity [GO_0003918]
- 1530: DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) inhibitor activity [GO_0008657]
- 1531: DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) regulator activity [GO_0072586]
- 1532: DNA translocase activity [GO_0015616]
- 1533: DNA transport [GO_0051027]
- 1534: DNA unwinding involved in DNA replication [GO_0006268]
- 1535: DNA-binding transcription activator activity [GO_0001216]
- 1536: DNA-binding transcription activator activity, RNA polymerase II-specific [GO_0001228]
- 1537: DNA-binding transcription factor activity [GO_0003700]
- 1538: DNA-binding transcription factor activity, RNA polymerase II-specific [GO_0000981]
- 1539: DNA-binding transcription factor binding [GO_0140297]
- 1540: DNA-binding transcription repressor activity [GO_0001217]
- 1541: DNA-binding transcription repressor activity, RNA polymerase II-specific [GO_0001227]
- 1542: DNA-DNA tethering activity [GO_0106260]
- 1543: DNA-templated DNA replication [GO_0006261]
- 1544: DNA-templated transcription [GO_0006351]
- 1545: DNA-templated transcription termination [GO_0006353]
- 1546: DNA/RNA helicase activity [GO_0033677]
- 1547: dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity [GO_0042281]
- 1548: dopamine beta-monooxygenase activity [GO_0004500]
- 1549: dopamine binding [GO_0035240]
- 1550: dopamine neurotransmitter receptor activity [GO_0004952]
- 1551: dopamine neurotransmitter receptor activity, coupled via Gi/Go [GO_0001591]
- 1552: dopamine neurotransmitter receptor activity, coupled via Gs [GO_0001588]
- 1553: dopamine receptor binding [GO_0050780]
- 1554: dopamine receptor signaling pathway [GO_0007212]
- 1555: dopamine secretion [GO_0014046]
- 1556: dopamine secretion, neurotransmission [GO_0061527]
- 1557: dopamine transport [GO_0015872]
- 1558: dopamine uptake [GO_0090494]
- 1559: dopamine:sodium symporter activity [GO_0005330]
- 1560: dopaminechrome tautomerase activity [GO_0106417]
- 1561: dormancy process [GO_0022611]
- 1562: dorsal aorta development [GO_0035907]
- 1563: dorsal aorta morphogenesis [GO_0035912]
- 1564: dorsal/ventral axis specification [GO_0009950]
- 1565: dorsal/ventral pattern formation [GO_0009953]
- 1566: double-stranded DNA 3'-5' exodeoxyribonuclease activity [GO_0008311]
- 1567: double-stranded DNA binding [GO_0003690]
- 1568: double-stranded DNA exodeoxyribonuclease activity [GO_0008309]
- 1569: double-stranded DNA helicase activity [GO_0036121]
- 1570: double-stranded RNA adenosine deaminase activity [GO_0003726]
- 1571: double-stranded RNA binding [GO_0003725]
- 1572: double-stranded RNA-specific ribonuclease activity [GO_0032296]
- 1573: double-stranded telomeric DNA binding [GO_0003691]
- 1574: DPH5 transfers four methyl groups from AdoMet to aminocarboxypropyl EEF2 [GO_0004164]
- 1575: DPH6 ligates ammonium to diphthine-EEF2 [GO_0017178]
- 1576: DPH7 hydrolyzes a methyl group on Me-diphthine EEF2 [GO_0051723]
- 1577: dUTP diphosphatase activity [GO_0004170]
- 1578: dynactin binding [GO_0034452]
- 1579: dynein complex binding [GO_0070840]
- 1580: dynein heavy chain binding [GO_0045504]
- 1581: dynein intermediate chain binding [GO_0045505]
- 1582: dynein light chain binding [GO_0045503]
- 1583: dynein light intermediate chain binding [GO_0051959]
- 1584: E-box binding [GO_0070888]
- 1585: ecdysis-triggering hormone activity [GO_0008255]
- 1586: ecdysone binding [GO_0035100]
- 1587: ecdysone oxidase activity [GO_0047875]
- 1588: ECI2 isomerizes 3Z-enoyl-CoA to 2E-enoyl-CoA [GO_0004165]
- 1589: eclosion [GO_0007562]
- 1590: eclosion rhythm [GO_0008062]
- 1591: ectoderm development [GO_0007398]
- 1592: ectoderm formation [GO_0001705]
- 1593: ectodermal cell differentiation [GO_0010668]
- 1594: ectodermal digestive tract development [GO_0007439]
- 1595: ectodermal placode development [GO_0071696]
- 1596: ectodermal placode formation [GO_0060788]
- 1597: ectodermal placode morphogenesis [GO_0071697]
- 1598: Ectonucleotide pyrophosphatase/phosphodiesterase 7 (ENPP7) hydrolyses sphingomyelin [GO_0004767]
- 1599: ectopic germ cell programmed cell death [GO_0035234]
- 1600: eEF1A complexes with GTP [GO_0019001]
- 1601: efflux transmembrane transporter activity [GO_0015562]
- 1602: egg chorion [GO_0042600]
- 1603: egg coat [GO_0035805]
- 1604: eIF2 activation [GO_0003743]
- 1605: elastic fiber [GO_0071953]
- 1606: elastic fiber assembly [GO_0048251]
- 1607: electron transfer activity [GO_0009055]
- 1608: Electron transfer from ubiquinol to cytochrome c of complex III [GO_0008121]
- 1609: electron transport chain [GO_0022900]
- 1610: electron-transferring-flavoprotein dehydrogenase activity [GO_0004174]
- 1611: Elongation of gamma-lenolenoyl-CoA to dihomo-gamma-lenolenoyl-CoA [GO_0009922]
- 1612: Elongation Of The Telomeric Chromosome End [GO_0003720]
- 1613: embryo development [GO_0009790]
- 1614: embryo development ending in birth or egg hatching [GO_0009792]
- 1615: embryonic camera-type eye development [GO_0031076]
- 1616: embryonic camera-type eye formation [GO_0060900]
- 1617: embryonic camera-type eye morphogenesis [GO_0048596]
- 1618: embryonic cleavage [GO_0040016]
- 1619: embryonic development via the syncytial blastoderm [GO_0001700]
- 1620: embryonic epithelial tube formation [GO_0001838]
- 1621: embryonic eye morphogenesis [GO_0048048]
- 1622: embryonic heart tube development [GO_0035050]
- 1623: embryonic heart tube formation [GO_0003144]
- 1624: embryonic heart tube formation via epithelial folding [GO_0003145]
- 1625: embryonic heart tube morphogenesis [GO_0003143]
- 1626: embryonic morphogenesis [GO_0048598]
- 1627: embryonic organ development [GO_0048568]
- 1628: embryonic organ morphogenesis [GO_0048562]
- 1629: embryonic placenta development [GO_0001892]
- 1630: embryonic placenta morphogenesis [GO_0060669]
- 1631: embryonic process involved in female pregnancy [GO_0060136]
- 1632: endocardial cell development [GO_0060958]
- 1633: endocardial cell differentiation [GO_0060956]
- 1634: endocardial cushion development [GO_0003197]
- 1635: endocardial cushion formation [GO_0003272]
- 1636: endocardial cushion morphogenesis [GO_0003203]
- 1637: endocardial endothelium development [GO_0061147]
- 1638: endocardium development [GO_0003157]
- 1639: endocardium formation [GO_0060214]
- 1640: endocardium morphogenesis [GO_0003160]
- 1641: endochondral bone growth [GO_0003416]
- 1642: endochondral bone morphogenesis [GO_0060350]
- 1643: endocrine hormone secretion [GO_0060986]
- 1644: endocrine pancreas development [GO_0031018]
- 1645: endocrine process [GO_0050886]
- 1646: endocrine system development [GO_0035270]
- 1647: endocytosis [GO_0006897]
- 1648: endodeoxyribonuclease activator activity [GO_0140656]
- 1649: endodeoxyribonuclease activity [GO_0004520]
- 1650: endoderm development [GO_0007492]
- 1651: endoderm formation [GO_0001706]
- 1652: endodermal cell differentiation [GO_0035987]
- 1653: endodermal-mesodermal cell signaling [GO_0003133]
- 1654: endomembrane system [GO_0012505]
- 1655: endomembrane system organization [GO_0010256]
- 1656: endomitotic cell cycle [GO_0007113]
- 1657: endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters [GO_0016893]
- 1658: endonucleolytic cleavage involved in rRNA processing [GO_0000478]
- 1659: endonucleolytic cleavage involved in tRNA processing [GO_1905267]
- 1660: endopeptidase activator activity [GO_0061133]
- 1661: endopeptidase inhibitor activity [GO_0004866]
- 1662: endopeptidase regulator activity [GO_0061135]
- 1663: endoplasmic reticulum signal peptide binding [GO_0030942]
- 1664: endopolyphosphatase activity [GO_0000298]
- 1665: endoribonuclease activity, cleaving miRNA-paired mRNA [GO_0090624]
- 1666: endoribonuclease activity, cleaving siRNA-paired mRNA [GO_0070551]
- 1667: endoribonuclease activity, producing 5'-phosphomonoesters [GO_0016891]
- 1668: endoribonuclease inhibitor activity [GO_0060698]
- 1669: endothelial cell apoptotic process [GO_0072577]
- 1670: endothelial cell development [GO_0001885]
- 1671: endothelial cell differentiation [GO_0045446]
- 1672: endothelial cell morphogenesis [GO_0001886]
- 1673: endothelial cell proliferation [GO_0001935]
- 1674: endothelial tube formation [GO_0120331]
- 1675: endothelial tube morphogenesis [GO_0061154]
- 1676: endothelium development [GO_0003158]
- 1677: energy derivation by oxidation of organic compounds [GO_0015980]
- 1678: energy reserve metabolic process [GO_0006112]
- 1679: energy taxis [GO_0009453]
- 1680: eNoSC dimethylates histone H3 at lysine-9 [GO_0046974]
- 1681: enteric smooth muscle cell differentiation [GO_0035645]
- 1682: enteroendocrine cell differentiation [GO_0035883]
- 1683: entrainment of circadian clock [GO_0009649]
- 1684: entrainment of circadian clock by photoperiod [GO_0043153]
- 1685: entry into diapause [GO_0055115]
- 1686: entry into reproductive diapause [GO_0055116]
- 1687: enucleate erythrocyte development [GO_0048822]
- 1688: enucleate erythrocyte differentiation [GO_0043353]
- 1689: enucleate erythrocyte maturation [GO_0043354]
- 1690: envelope [GO_0031975]
- 1691: Envoplakin, periplakin, involucrin, SPR binding mediated by TGM1 crosslinking [GO_0003810]
- 1692: enzyme activator activity [GO_0008047]
- 1693: enzyme binding [GO_0019899]
- 1694: enzyme inhibitor activity [GO_0004857]
- 1695: enzyme regulator activity [GO_0030234]
- 1696: enzyme-linked receptor protein signaling pathway [GO_0007167]
- 1697: enzyme-substrate adaptor activity [GO_0140767]
- 1698: EP300,CREBBP acetylate FOXO4 [GO_0061733]
- 1699: ephrin receptor activity [GO_0005003]
- 1700: ephrin receptor binding [GO_0046875]
- 1701: ephrin receptor signaling pathway [GO_0048013]
- 1702: epicardium morphogenesis [GO_1905223]
- 1703: epidermal cell differentiation [GO_0009913]
- 1704: epidermal cell division [GO_0010481]
- 1705: epidermal growth factor binding [GO_0048408]
- 1706: epidermal growth factor receptor activity [GO_0005006]
- 1707: epidermal growth factor receptor binding [GO_0005154]
- 1708: epidermal growth factor receptor signaling pathway [GO_0007173]
- 1709: epidermal stem cell homeostasis [GO_0036334]
- 1710: epidermis development [GO_0008544]
- 1711: epidermis morphogenesis [GO_0048730]
- 1712: epigenetic maintenance of chromatin in transcription-competent conformation [GO_0045815]
- 1713: epithelial cell apoptotic process [GO_1904019]
- 1714: epithelial cell development [GO_0002064]
- 1715: epithelial cell differentiation [GO_0030855]
- 1716: epithelial cell differentiation involved in embryonic placenta development [GO_0060671]
- 1717: epithelial cell maturation [GO_0002070]
- 1718: epithelial cell morphogenesis [GO_0003382]
- 1719: epithelial cell morphogenesis involved in gastrulation [GO_0003381]
- 1720: epithelial cell proliferation [GO_0050673]
- 1721: epithelial cell proliferation involved in liver morphogenesis [GO_0072575]
- 1722: epithelial cell proliferation involved in lung morphogenesis [GO_0060502]
- 1723: epithelial to mesenchymal transition [GO_0001837]
- 1724: epithelial tube branching involved in lung morphogenesis [GO_0060441]
- 1725: epithelial tube formation [GO_0072175]
- 1726: epithelial tube morphogenesis [GO_0060562]
- 1727: epithelium development [GO_0060429]
- 1728: EPM2A dimer dephosphorylates phosphoglycogen-GYG2 [GO_0019203]
- 1729: Equilibrative transport (export) of nucleosides and free bases by solute carrier family 29 (nucleoside transporters), member 1 [GO_0005337]
- 1730: equilibrioception [GO_0050957]
- 1731: ER retention sequence binding [GO_0046923]
- 1732: ERBB signaling pathway [GO_0038127]
- 1733: erythrocyte apoptotic process [GO_1902217]
- 1734: erythrocyte development [GO_0048821]
- 1735: erythrocyte differentiation [GO_0030218]
- 1736: erythrocyte homeostasis [GO_0034101]
- 1737: erythrocyte maturation [GO_0043249]
- 1738: ESD dimer hydrolyses S-FGSH to GSH [GO_0018738]
- 1739: esophagus development [GO_1903702]
- 1740: establishment of cell polarity [GO_0030010]
- 1741: establishment of cell polarity involved in ameboidal cell migration [GO_0003365]
- 1742: establishment of cell polarity involved in gastrulation cell migration [GO_0003379]
- 1743: establishment of chromosome localization [GO_0051303]
- 1744: establishment of epithelial cell polarity [GO_0090162]
- 1745: establishment of Golgi localization [GO_0051683]
- 1746: establishment of localization [GO_0051234]
- 1747: establishment of localization in cell [GO_0051649]
- 1748: establishment of neuroblast polarity [GO_0045200]
- 1749: establishment of organelle localization [GO_0051656]
- 1750: establishment of pigment granule localization [GO_0051905]
- 1751: establishment of planar polarity [GO_0001736]
- 1752: establishment of protein localization [GO_0045184]
- 1753: establishment of protein localization to chromatin [GO_0071169]
- 1754: establishment of protein localization to chromosome [GO_0070199]
- 1755: establishment of protein localization to extracellular region [GO_0035592]
- 1756: establishment of protein localization to membrane [GO_0090150]
- 1757: establishment of protein localization to organelle [GO_0072594]
- 1758: establishment of protein localization to plasma membrane [GO_0061951]
- 1759: establishment of protein localization to vacuole [GO_0072666]
- 1760: establishment of RNA localization [GO_0051236]
- 1761: establishment of tissue polarity [GO_0007164]
- 1762: establishment of vesicle localization [GO_0051650]
- 1763: establishment or maintenance of cell polarity [GO_0007163]
- 1764: establishment or maintenance of cytoskeleton polarity [GO_0030952]
- 1765: establishment or maintenance of cytoskeleton polarity involved in ameboidal cell migration [GO_0003371]
- 1766: establishment or maintenance of cytoskeleton polarity involved in gastrulation [GO_0003380]
- 1767: establishment or maintenance of microtubule cytoskeleton polarity [GO_0030951]
- 1768: establishment or maintenance of neuroblast polarity [GO_0045196]
- 1769: establishment or maintenance of transmembrane electrochemical gradient [GO_0010248]
- 1770: estrogen response element binding [GO_0034056]
- 1771: ETA is phosphorylated to PETA by CHK/ETNK [GO_0004305]
- 1772: ethanolamine-phosphate phospho-lyase activity [GO_0050459]
- 1773: ethanolaminephosphotransferase activity [GO_0004307]
- 1774: euchromatin binding [GO_1990188]
- 1775: eukaryotic initiation factor 4E binding [GO_0008190]
- 1776: eukaryotic initiation factor 4G binding [GO_0031370]
- 1777: eukaryotic initiation factor eIF2 binding [GO_0071074]
- 1778: Exchange of oxygen with sulfur in MoCo [GO_0008265]
- 1779: excitatory chemical synaptic transmission [GO_0098976]
- 1780: excitatory postsynaptic potential [GO_0060079]
- 1781: excretion [GO_0007588]
- 1782: execution phase of apoptosis [GO_0097194]
- 1783: EXO1 interacting with MSH2:MSH6 excises single strand DNA containing a mismatch [GO_0008409]
- 1784: exocrine pancreas development [GO_0031017]
- 1785: exocrine system development [GO_0035272]
- 1786: exocytic process [GO_0140029]
- 1787: exocytic vesicle [GO_0070382]
- 1788: exocytic vesicle membrane [GO_0099501]
- 1789: exocytosis [GO_0006887]
- 1790: exodeoxyribonuclease activity [GO_0004529]
- 1791: exodeoxyribonuclease activity, producing 5'-phosphomonoesters [GO_0016895]
- 1792: exon-exon junction complex binding [GO_1990448]
- 1793: exonuclease activity [GO_0004527]
- 1794: exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters [GO_0016796]
- 1795: exonucleolytic trimming involved in rRNA processing [GO_0000459]
- 1796: exopeptidase activity [GO_0008238]
- 1797: exoribonuclease activator activity [GO_0044692]
- 1798: exoribonuclease activity [GO_0004532]
- 1799: exoribonuclease activity, producing 5'-phosphomonoesters [GO_0016896]
- 1800: exosomal secretion [GO_1990182]
- 1801: export from cell [GO_0140352]
- 1802: Exportin-5 recognizes 3' overhang of pre-miRNA [GO_0003723]
- 1803: external encapsulating structure [GO_0030312]
- 1804: external encapsulating structure organization [GO_0045229]
- 1805: external genitalia morphogenesis [GO_0035261]
- 1806: extracellular amino acid transport [GO_0006860]
- 1807: extracellular carbohydrate transport [GO_0006859]
- 1808: extracellular exosome [GO_0070062]
- 1809: extracellular exosome assembly [GO_0071971]
- 1810: extracellular exosome biogenesis [GO_0097734]
- 1811: extracellular ligand-gated ion channel activity [GO_0005230]
- 1812: extracellular matrix [GO_0031012]
- 1813: extracellular matrix assembly [GO_0085029]
- 1814: extracellular matrix binding [GO_0050840]
- 1815: extracellular matrix disassembly [GO_0022617]
- 1816: extracellular matrix organization [GO_0030198]
- 1817: extracellular matrix organization involved in endocardium development [GO_0061148]
- 1818: extracellular matrix protein binding [GO_1990430]
- 1819: extracellular matrix structural constituent [GO_0005201]
- 1820: extracellular membrane-bounded organelle [GO_0065010]
- 1821: extracellular negative regulation of signal transduction [GO_1900116]
- 1822: extracellular non-membrane-bounded organelle [GO_0043264]
- 1823: extracellular organelle [GO_0043230]
- 1824: extracellular region [GO_0005576]
- 1825: extracellular regulation of signal transduction [GO_1900115]
- 1826: extracellular space [GO_0005615]
- 1827: extracellular structure organization [GO_0043062]
- 1828: extracellular transport [GO_0006858]
- 1829: extracellular vesicle [GO_1903561]
- 1830: extracellular vesicle biogenesis [GO_0140112]
- 1831: extracellularly glutamate-gated chloride channel activity [GO_0008068]
- 1832: extracellularly glutamate-gated ion channel activity [GO_0005234]
- 1833: extraembryonic membrane development [GO_1903867]
- 1834: eye development [GO_0001654]
- 1835: eye morphogenesis [GO_0048592]
- 1836: eye photoreceptor cell development [GO_0042462]
- 1837: eye photoreceptor cell differentiation [GO_0001754]
- 1838: face development [GO_0060324]
- 1839: face morphogenesis [GO_0060325]
- 1840: FAD binding [GO_0071949]
- 1841: FAD transmembrane transport [GO_0035350]
- 1842: FAD transmembrane transporter activity [GO_0015230]
- 1843: FAD transport [GO_0015883]
- 1844: FANCD2 deubiquitination by USP1:WDR48 [GO_0004843]
- 1845: farnesyltranstransferase activity [GO_0004311]
- 1846: fat cell apoptotic process [GO_1904606]
- 1847: fat cell differentiation [GO_0045444]
- 1848: fat cell proliferation [GO_0070341]
- 1849: fatty acid alpha-hydroxylase activity [GO_0080132]
- 1850: fatty acid amide hydrolase activity [GO_0017064]
- 1851: fatty acid binding [GO_0005504]
- 1852: fatty acid biosynthetic process [GO_0006633]
- 1853: fatty acid derivative binding [GO_1901567]
- 1854: fatty acid ligase activity [GO_0015645]
- 1855: fatty acid metabolic process [GO_0006631]
- 1856: fatty acid omega-hydroxylase activity [GO_0120250]
- 1857: fatty acid transport [GO_0015908]
- 1858: fatty-acyl-CoA binding [GO_0000062]
- 1859: fatty-acyl-CoA reductase (alcohol-forming) activity [GO_0080019]
- 1860: fatty-acyl-CoA transport [GO_0015916]
- 1861: FECH binds Fe2+ to PRIN9 to form heme [GO_0004325]
- 1862: feeding behavior [GO_0007631]
- 1863: female gamete generation [GO_0007292]
- 1864: female germ cell nucleus [GO_0001674]
- 1865: female germ-line stem cell asymmetric division [GO_0048132]
- 1866: female gonad development [GO_0008585]
- 1867: female gonad morphogenesis [GO_0061040]
- 1868: female mating behavior [GO_0060180]
- 1869: female meiosis chromosome segregation [GO_0016321]
- 1870: female meiotic nuclear division [GO_0007143]
- 1871: female pregnancy [GO_0007565]
- 1872: female sex differentiation [GO_0046660]
- 1873: ferric iron binding [GO_0008199]
- 1874: ferrous iron binding [GO_0008198]
- 1875: ferrous iron transmembrane transporter activity [GO_0015093]
- 1876: fertilization [GO_0009566]
- 1877: FFAT motif binding [GO_0033149]
- 1878: FGAR + L-Glutamine + ATP + H2O => FGAM + L-Glutamate + ADP + Pi [GO_0004642]
- 1879: Fgd1 reactivates F420 [GO_0016614]
- 1880: FGFR1-associated PI3K phosphorylates PIP2 to PIP3 [GO_0046934]
- 1881: fibrillar collagen trimer [GO_0005583]
- 1882: fibrin multimer, crosslinked:tissue plasminogen activator (one-chain) + plasminogen activator inhibitor 1 -> fibrin multimer, crosslinked:tissue plasminogen activator (one-chain):plasminogen activator inhibitor 1 [GO_0004867]
- 1883: fibrinogen binding [GO_0070051]
- 1884: fibrinogen complex [GO_0005577]
- 1885: fibroblast apoptotic process [GO_0044346]
- 1886: fibroblast growth factor binding [GO_0017134]
- 1887: fibroblast growth factor receptor activity [GO_0005007]
- 1888: fibroblast growth factor receptor binding [GO_0005104]
- 1889: fibroblast growth factor receptor signaling pathway [GO_0008543]
- 1890: fibroblast proliferation [GO_0048144]
- 1891: fibroblast proliferation involved in heart morphogenesis [GO_0061385]
- 1892: filamin binding [GO_0031005]
- 1893: first spliceosomal transesterification activity [GO_0000384]
- 1894: FK506 binding [GO_0005528]
- 1895: flap endonuclease activity [GO_0048256]
- 1896: flavin adenine dinucleotide binding [GO_0050660]
- 1897: flavin-linked sulfhydryl oxidase activity [GO_0016971]
- 1898: flight [GO_0060361]
- 1899: flippase activity [GO_0140327]
- 1900: fluid transport [GO_0042044]
- 1901: FMN binding [GO_0010181]
- 1902: FMN transmembrane transporter activity [GO_0044610]
- 1903: FN3KRP phosphorylates PsiAm, RibAm [GO_0016301]
- 1904: folic acid transport [GO_0015884]
- 1905: foregut morphogenesis [GO_0007440]
- 1906: formaldehyde dehydrogenase activity [GO_0018467]
- 1907: formate transmembrane transporter activity [GO_0015499]
- 1908: formate transport [GO_0015724]
- 1909: formate-tetrahydrofolate ligase activity [GO_0004329]
- 1910: formation of anatomical boundary [GO_0048859]
- 1911: formation of animal organ boundary [GO_0010160]
- 1912: formation of primary germ layer [GO_0001704]
- 1913: formation of translation initiation ternary complex [GO_0001677]
- 1914: forward locomotion [GO_0043056]
- 1915: four-way junction DNA binding [GO_0000400]
- 1916: frizzled binding [GO_0005109]
- 1917: fructokinase activity [GO_0008865]
- 1918: fructose transmembrane transport [GO_0015755]
- 1919: fructose-6-phosphate binding [GO_0070095]
- 1920: fructose-bisphosphate aldolase activity [GO_0004332]
- 1921: FTMT 24mer oxidises 4Fe2+ to 4Fe(3+)O(OH) [GO_0004322]
- 1922: fucosylation [GO_0036065]
- 1923: fucosyltransferase activity [GO_0008417]
- 1924: Fumarate + H2O <=> (S)-Malate [GO_0004333]
- 1925: FUOM isomerises alpha-Fuc to beta-Fuc [GO_0016857]
- 1926: FUT4,5,9,(10,11) transfer Fuc to Type 2 chains to form LeX [GO_0046920]
- 1927: FXN:NFS1:ISD11:ISCU assembles 2Fe-2S iron-sulfur cluster [GO_0031071]
- 1928: G protein activity [GO_0003925]
- 1929: G protein-coupled acetylcholine receptor activity [GO_0016907]
- 1930: G protein-coupled acetylcholine receptor signaling pathway [GO_0007213]
- 1931: G protein-coupled acetylcholine receptor signaling pathway involved in positive regulation of acetylcholine secretion, neurotransmission [GO_1904065]
- 1932: G protein-coupled adenosine receptor activity [GO_0001609]
- 1933: G protein-coupled adenosine receptor signaling pathway [GO_0001973]
- 1934: G protein-coupled amine receptor activity [GO_0008227]
- 1935: G protein-coupled glutamate receptor activity [GO_0098988]
- 1936: G protein-coupled glutamate receptor binding [GO_0035256]
- 1937: G protein-coupled glutamate receptor signaling pathway [GO_0007216]
- 1938: G protein-coupled neurotransmitter receptor activity [GO_0099528]
- 1939: G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO_0099579]
- 1940: G protein-coupled peptide receptor activity [GO_0008528]
- 1941: G protein-coupled photoreceptor activity [GO_0008020]
- 1942: G protein-coupled purinergic receptor signaling pathway [GO_0035588]
- 1943: G protein-coupled receptor activity involved in regulation of postsynaptic membrane potential [GO_0099530]
- 1944: G protein-coupled receptor binding [GO_0001664]
- 1945: G protein-coupled receptor kinase activity [GO_0004703]
- 1946: G protein-coupled receptor signaling pathway [GO_0007186]
- 1947: G protein-coupled serotonin receptor activity [GO_0004993]
- 1948: G protein-coupled serotonin receptor signaling pathway [GO_0098664]
- 1949: G-protein alpha-subunit binding [GO_0001965]
- 1950: G-protein beta-subunit binding [GO_0031681]
- 1951: G-protein beta/gamma-subunit complex binding [GO_0031683]
- 1952: G-protein coupled receptor activity [GO_0004930]
- 1953: G-quadruplex DNA binding [GO_0051880]
- 1954: G/U mismatch-specific uracil-DNA glycosylase activity [GO_0043739]
- 1955: GABA receptor activity [GO_0016917]
- 1956: GABA receptor binding [GO_0050811]
- 1957: GABA-A receptor activity [GO_0004890]
- 1958: GABA-gated chloride ion channel activity [GO_0022851]
- 1959: galactose binding [GO_0005534]
- 1960: galactosidase activity [GO_0015925]
- 1961: galactoside binding [GO_0016936]
- 1962: galactosyl beta-1,3 N-acetylgalactosamine beta-1,3-glucuronosyltransferase activity [GO_0046989]
- 1963: Galactosylation of collagen propeptide hydroxylysines by PLOD3 [GO_0050211]
- 1964: galactosyltransferase activity [GO_0008378]
- 1965: GALE:NAD+ dimer reversibly epimerises UDP-Gal to UDP-Glc [GO_0003978]
- 1966: gall bladder development [GO_0061010]
- 1967: gamete generation [GO_0007276]
- 1968: gamma-aminobutyric acid secretion [GO_0014051]
- 1969: gamma-aminobutyric acid secretion, neurotransmission [GO_0061534]
- 1970: gamma-aminobutyric acid transmembrane transporter activity [GO_0015185]
- 1971: gamma-aminobutyric acid transport [GO_0015812]
- 1972: gamma-aminobutyric acid:sodium:chloride symporter activity [GO_0005332]
- 1973: gamma-glutamyl-peptidase activity [GO_0034722]
- 1974: gamma-glutamylaminecyclotransferase activity [GO_0061929]
- 1975: gamma-glutamylcyclotransferase activity [GO_0003839]
- 1976: gamma-tubulin binding [GO_0043015]
- 1977: ganglion development [GO_0061548]
- 1978: ganglion formation [GO_0061554]
- 1979: ganglion maturation [GO_0061553]
- 1980: ganglion morphogenesis [GO_0061552]
- 1981: gap junction channel activity [GO_0005243]
- 1982: gap junction hemi-channel activity [GO_0055077]
- 1983: gas homeostasis [GO_0033483]
- 1984: gas transport [GO_0015669]
- 1985: gastric acid secretion [GO_0001696]
- 1986: gastric mucosal blood circulation [GO_1990768]
- 1987: gastro-intestinal system smooth muscle contraction [GO_0014831]
- 1988: gastrulation [GO_0007369]
- 1989: gated channel activity [GO_0022836]
- 1990: GCH1 reduces GTP to dihydroneopterin triphosphate [GO_0003934]
- 1991: GDP binding [GO_0019003]
- 1992: GDP metabolic process [GO_0046710]
- 1993: GDP phosphatase activity [GO_0004382]
- 1994: GDP-D-glucose phosphorylase activity [GO_0080048]
- 1995: GDP-dissociation inhibitor activity [GO_0005092]
- 1996: GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity [GO_0004377]
- 1997: gene expression [GO_0010467]
- 1998: gene expression involved in extracellular matrix organization [GO_1901148]
- 1999: general transcription initiation factor activity [GO_0140223]
- 2000: general transcription initiation factor binding [GO_0140296]
- 2001: generation of neurons [GO_0048699]
- 2002: generation of precursor metabolites and energy [GO_0006091]
- 2003: genitalia development [GO_0048806]
- 2004: genitalia morphogenesis [GO_0035112]
- 2005: geranyltranstransferase activity [GO_0004337]
- 2006: germ cell development [GO_0007281]
- 2007: germ cell nucleus [GO_0043073]
- 2008: germ cell proliferation [GO_0036093]
- 2009: germ-line stem cell division [GO_0042078]
- 2010: germarium-derived egg chamber formation [GO_0007293]
- 2011: germline stem cell asymmetric division [GO_0098728]
- 2012: GGT transfers GSH to 16S,17S-epoxy-DHA to form PCTR1 [GO_0004364]
- 2013: Gi/o-coupled serotonin receptor activity [GO_0001586]
- 2014: gland development [GO_0048732]
- 2015: gland morphogenesis [GO_0022612]
- 2016: glandular epithelial cell development [GO_0002068]
- 2017: glandular epithelial cell differentiation [GO_0002067]
- 2018: glandular epithelial cell maturation [GO_0002071]
- 2019: Glc6P is isomerised to I3P by ISYNA1 in the cytosol [GO_0004512]
- 2020: GlcNAc1P is dephosphorylated to UDP-N-acetyl-glucosamine [GO_0003977]
- 2021: glial cell apoptotic process [GO_0034349]
- 2022: glial cell development [GO_0021782]
- 2023: glial cell differentiation [GO_0010001]
- 2024: glial cell growth [GO_0042065]
- 2025: glial cell projection [GO_0097386]
- 2026: glial cell proliferation [GO_0014009]
- 2027: glial cell-neuron signaling [GO_0150098]
- 2028: glioblast division [GO_0048860]
- 2029: gliogenesis [GO_0042063]
- 2030: glucagon secretion [GO_0070091]
- 2031: glucan biosynthetic process [GO_0009250]
- 2032: glucan catabolic process [GO_0009251]
- 2033: glucan metabolic process [GO_0044042]
- 2034: gluconeogenesis [GO_0006094]
- 2035: gluconolactonase activity [GO_0004341]
- 2036: glucosamine 6-phosphate N-acetyltransferase activity [GO_0004343]
- 2037: glucosamine-6-phosphate deaminase activity [GO_0004342]
- 2038: glucose 6-phosphate metabolic process [GO_0051156]
- 2039: glucose binding [GO_0005536]
- 2040: glucose catabolic process [GO_0006007]
- 2041: glucose homeostasis [GO_0042593]
- 2042: glucose metabolic process [GO_0006006]
- 2043: glucose transmembrane transport [GO_1904659]
- 2044: glucose-6-phosphate 1-epimerase activity [GO_0047938]
- 2045: glucose-6-phosphate transmembrane transporter activity [GO_0015152]
- 2046: glucose-6-phosphate transport [GO_0015760]
- 2047: glucosidase activity [GO_0015926]
- 2048: Glucosylation of collagen propeptide hydroxylysines [GO_0033823]
- 2049: Glucosylceramidase cleaves the glucosidic bond of glucocerebroside to form ceramide [GO_0004348]
- 2050: glucosyltransferase activity [GO_0046527]
- 2051: glutamate 5-kinase activity [GO_0004349]
- 2052: glutamate binding [GO_0016595]
- 2053: glutamate dehydrogenase (NAD+) activity [GO_0004352]
- 2054: glutamate dehydrogenase [NAD(P)+] activity [GO_0004353]
- 2055: glutamate receptor activity [GO_0008066]
- 2056: glutamate receptor binding [GO_0035254]
- 2057: glutamate receptor signaling pathway [GO_0007215]
- 2058: glutamate secretion [GO_0014047]
- 2059: glutamate secretion, neurotransmission [GO_0061535]
- 2060: glutamate synthase (NADH) activity [GO_0016040]
- 2061: glutamate synthase activity [GO_0015930]
- 2062: glutamate synthase activity, NAD(P)H as acceptor [GO_0045181]
- 2063: glutamate-5-semialdehyde dehydrogenase activity [GO_0004350]
- 2064: glutamate-ammonia ligase activity [GO_0004356]
- 2065: glutamate-cysteine ligase catalytic subunit binding [GO_0035226]
- 2066: glutamate-cysteine ligase regulator activity [GO_1990609]
- 2067: glutamate-gated calcium ion channel activity [GO_0022849]
- 2068: glutamate:sodium symporter activity [GO_0015501]
- 2069: glutamine + H2O => glutamate + NH4+ [GLS] [GO_0004359]
- 2070: glutamine + tRNA(Gln) + ATP => Gln-tRNA(Gln) + AMP + pyrophosphate [GO_0004819]
- 2071: glutaminyl-peptide cyclotransferase activity [GO_0016603]
- 2072: glutathione binding [GO_0043295]
- 2073: glutathione biosynthetic process [GO_0006750]
- 2074: glutathione disulfide oxidoreductase activity [GO_0015038]
- 2075: Glutathione is taken up by the bacterium [GO_1904680]
- 2076: glutathione metabolic process [GO_0006749]
- 2077: glutathione oxidoreductase activity [GO_0097573]
- 2078: glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity [GO_0043891]
- 2079: glycerate dehydrogenase activity [GO_0008465]
- 2080: glycerol kinase activity [GO_0004370]
- 2081: glycerol-3-phosphate dehydrogenase (quinone) activity [GO_0004368]
- 2082: glycerol-3-phosphate dehydrogenase [NAD(P)+] activity [GO_0047952]
- 2083: glycerol-3-phosphate O-acyltransferase activity [GO_0004366]
- 2084: glycerolipid biosynthetic process [GO_0045017]
- 2085: glycerolipid metabolic process [GO_0046486]
- 2086: glycerophosphocholine phosphodiesterase activity [GO_0047389]
- 2087: glycerophosphodiester phosphodiesterase activity [GO_0008889]
- 2088: glycerophospholipid biosynthetic process [GO_0046474]
- 2089: glycerophospholipid metabolic process [GO_0006650]
- 2090: glycine binding [GO_0016594]
- 2091: glycine N-acyltransferase activity [GO_0047961]
- 2092: glycine secretion [GO_0061536]
- 2093: glycine secretion, neurotransmission [GO_0061537]
- 2094: glycine transmembrane transporter activity [GO_0015187]
- 2095: glycine transport [GO_0015816]
- 2096: glycine-gated chloride ion channel activity [GO_0022852]
- 2097: glycine-tRNA ligase activity [GO_0004820]
- 2098: glycogen binding [GO_2001069]
- 2099: glycogen biosynthetic process [GO_0005978]
- 2100: glycogen catabolic process [GO_0005980]
- 2101: glycogen metabolic process [GO_0005977]
- 2102: glycogen phosphorylase (PYGM) dimer b + 2 ATP => glycogen phosphorylase (PYGM) dimer a + 2 ADP [GO_0004689]
- 2103: glycolipid binding [GO_0051861]
- 2104: glycolipid mannosyltransferase activity [GO_0004376]
- 2105: glycolytic process [GO_0006096]
- 2106: glycolytic process through fructose-6-phosphate [GO_0061615]
- 2107: glycoprotein 3-alpha-L-fucosyltransferase activity [GO_0018392]
- 2108: glycoprotein biosynthetic process [GO_0009101]
- 2109: glycoprotein catabolic process [GO_0006516]
- 2110: glycoprotein metabolic process [GO_0009100]
- 2111: glycoprotein transport [GO_0034436]
- 2112: glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity [GO_0016263]
- 2113: glycosaminoglycan binding [GO_0005539]
- 2114: glycosaminoglycan biosynthetic process [GO_0006024]
- 2115: glycosaminoglycan catabolic process [GO_0006027]
- 2116: glycosaminoglycan metabolic process [GO_0030203]
- 2117: glycosphingolipid binding [GO_0043208]
- 2118: glycosyl compound catabolic process [GO_1901658]
- 2119: glycosyl compound metabolic process [GO_1901657]
- 2120: glycosylation [GO_0070085]
- 2121: Glycosylation of Pre-NOTCH by FRINGE [GO_0033829]
- 2122: glycylpeptide N-tetradecanoyltransferase activity [GO_0004379]
- 2123: glyoxylate reductase (NADP+) activity [GO_0030267]
- 2124: glyoxylate reductase activity [GO_0106345]
- 2125: GMDS dehydrates GDP-Man to GDP-DHDMan [GO_0008446]
- 2126: GMP biosynthetic process [GO_0006177]
- 2127: GMP metabolic process [GO_0046037]
- 2128: GMP synthase activity [GO_0003921]
- 2129: GNMT tetramer transfers methyl group from AdoMet to Gly to form AdoHyc and SARC [GO_0017174]
- 2130: Golgi apparatus [GO_0005794]
- 2131: Golgi disassembly [GO_0090166]
- 2132: Golgi inheritance [GO_0048313]
- 2133: Golgi localization [GO_0051645]
- 2134: Golgi membrane [GO_0000139]
- 2135: Golgi membrane fusion [GO_0036504]
- 2136: Golgi organization [GO_0007030]
- 2137: Golgi reassembly [GO_0090168]
- 2138: Golgi to plasma membrane protein transport [GO_0043001]
- 2139: Golgi to plasma membrane transport [GO_0006893]
- 2140: Golgi to secretory granule transport [GO_0055107]
- 2141: Golgi to transport vesicle transport [GO_0055108]
- 2142: Golgi to vacuole transport [GO_0006896]
- 2143: Golgi transport complex binding [GO_0140164]
- 2144: Golgi vesicle transport [GO_0048193]
- 2145: Golgi-associated vesicle [GO_0005798]
- 2146: Golgi-associated vesicle membrane [GO_0030660]
- 2147: gonad development [GO_0008406]
- 2148: gonad morphogenesis [GO_0035262]
- 2149: gonadal mesoderm development [GO_0007506]
- 2150: GPI anchor binding [GO_0034235]
- 2151: GPX5,6 reduce H2O2 to H2O [GO_0004602]
- 2152: Gq/11-coupled serotonin receptor activity [GO_0001587]
- 2153: gravitaxis [GO_0042332]
- 2154: GRK1,4,7 phosphorylate MII to p-MII [GO_0050254]
- 2155: grooming behavior [GO_0007625]
- 2156: Group 3 - Selective Cl- transport [GO_0005254]
- 2157: group II metabotropic glutamate receptor activity [GO_0001641]
- 2158: Growing HA is extruded from the cell by ABCC5 [GO_0008514]
- 2159: growth [GO_0040007]
- 2160: growth factor activity [GO_0008083]
- 2161: growth factor binding [GO_0019838]
- 2162: growth factor receptor binding [GO_0070851]
- 2163: growth involved in heart morphogenesis [GO_0003241]
- 2164: GSTO dimers reduce DeHA to AscH- [GO_0045174]
- 2165: GTP 3',8'-cyclase activity [GO_0061798]
- 2166: GTP cyclohydrolase activity [GO_0003933]
- 2167: GTP cyclohydrolase binding [GO_0044549]
- 2168: GTP cyclohydrolase I regulator activity [GO_0060308]
- 2169: GTP-dependent protein binding [GO_0030742]
- 2170: GTPase activating protein binding [GO_0032794]
- 2171: GTPase binding [GO_0051020]
- 2172: GTPase inhibitor activity [GO_0005095]
- 2173: GTPase regulator activity [GO_0030695]
- 2174: GU repeat RNA binding [GO_1990605]
- 2175: guanine deaminase activity [GO_0008892]
- 2176: guanyl ribonucleotide binding [GO_0032561]
- 2177: guanyl-nucleotide exchange factor activity [GO_0005085]
- 2178: guanylate cyclase activator activity [GO_0030250]
- 2179: guanylate cyclase activity [GO_0004383]
- 2180: guanylate cyclase inhibitor activity [GO_0030251]
- 2181: guanylate cyclase regulator activity [GO_0030249]
- 2182: guanylyltransferase activity [GO_0070568]
- 2183: GUSB tetramer hydrolyses GlcA-1,3-GlcNAc [GO_0004566]
- 2184: H2O2 diffuses from the mitochondrial matrix to the cytosol [GO_0015267]
- 2185: HAGH hydrolyses (R)-S-LGSH to GSH and LACT [GO_0004416]
- 2186: hatching [GO_0035188]
- 2187: hatching behavior [GO_0035187]
- 2188: HCO3- transport through ion channel [GO_0017081]
- 2189: HDAC4 deacetylates RUNX3 [GO_0033558]
- 2190: head development [GO_0060322]
- 2191: head morphogenesis [GO_0060323]
- 2192: heart capillary growth [GO_0003248]
- 2193: heart contraction [GO_0060047]
- 2194: heart development [GO_0007507]
- 2195: heart formation [GO_0060914]
- 2196: heart growth [GO_0060419]
- 2197: heart morphogenesis [GO_0003007]
- 2198: heart process [GO_0003015]
- 2199: heart rudiment development [GO_0003313]
- 2200: heart rudiment formation [GO_0003315]
- 2201: heart rudiment morphogenesis [GO_0003314]
- 2202: heat shock protein binding [GO_0031072]
- 2203: hedgehog family protein binding [GO_0097108]
- 2204: hedgehog receptor activity [GO_0008158]
- 2205: hematopoietic or lymphoid organ development [GO_0048534]
- 2206: hematopoietic progenitor cell differentiation [GO_0002244]
- 2207: hematopoietic stem cell differentiation [GO_0060218]
- 2208: hematopoietic stem cell homeostasis [GO_0061484]
- 2209: hematopoietic stem cell proliferation [GO_0071425]
- 2210: heme binding [GO_0020037]
- 2211: heme transmembrane transport [GO_0035351]
- 2212: heme transport [GO_0015886]
- 2213: hemopoiesis [GO_0030097]
- 2214: heparan sulfate N-deacetylase activity [GO_0102140]
- 2215: heparan sulfate proteoglycan binding [GO_0043395]
- 2216: heparan sulfate sulfotransferase activity [GO_0034483]
- 2217: heparin binding [GO_0008201]
- 2218: hepatic duct development [GO_0061011]
- 2219: hepatic immune response [GO_0002384]
- 2220: hepaticobiliary system development [GO_0061008]
- 2221: hepaticobiliary system process [GO_0061007]
- 2222: hepatoblast apoptotic process [GO_1902489]
- 2223: hepatoblast differentiation [GO_0061017]
- 2224: hepatocyte apoptotic process [GO_0097284]
- 2225: hepatocyte differentiation [GO_0070365]
- 2226: hepatocyte homeostasis [GO_0036333]
- 2227: heterochromatin [GO_0000792]
- 2228: heterochromatin assembly [GO_0031507]
- 2229: heterochromatin boundary formation [GO_0033696]
- 2230: heterochromatin organization [GO_0070828]
- 2231: heterocycle biosynthetic process [GO_0018130]
- 2232: heterocycle catabolic process [GO_0046700]
- 2233: heterocycle metabolic process [GO_0046483]
- 2234: heterocyclic compound binding [GO_1901363]
- 2235: heterotrimeric G-protein binding [GO_0032795]
- 2236: hexacosanoyl-CoA + O2 => trans-2,3-dehydrohexacosanoyl-CoA + H2O2 [GO_0003997]
- 2237: hexokinase activity [GO_0004396]
- 2238: hexosaminidase activity [GO_0015929]
- 2239: hexose biosynthetic process [GO_0019319]
- 2240: hexose catabolic process [GO_0019320]
- 2241: hexose metabolic process [GO_0019318]
- 2242: hexose phosphate transmembrane transporter activity [GO_0015119]
- 2243: hexose phosphate transport [GO_0015712]
- 2244: hexose transmembrane transport [GO_0008645]
- 2245: hexose-phosphate:inorganic phosphate antiporter activity [GO_0015526]
- 2246: hexosyltransferase activity [GO_0016758]
- 2247: HHAT palmitoylates Hh N-terminal fragment [GO_0008374]
- 2248: high mobility group box 1 binding [GO_0070379]
- 2249: high voltage-gated calcium channel activity [GO_0008331]
- 2250: high-affinity basic amino acid transmembrane transporter activity [GO_0005287]
- 2251: high-affinity L-arginine transmembrane transporter activity [GO_0005289]
- 2252: hindbrain development [GO_0030902]
- 2253: hindbrain formation [GO_0021576]
- 2254: hindbrain maturation [GO_0021578]
- 2255: hindbrain morphogenesis [GO_0021575]
- 2256: hindbrain-spinal cord boundary formation [GO_0021906]
- 2257: hindgut contraction [GO_0043133]
- 2258: hindgut development [GO_0061525]
- 2259: hindgut morphogenesis [GO_0007442]
- 2260: His-Purkinje system cell development [GO_0060933]
- 2261: His-Purkinje system cell differentiation [GO_0060932]
- 2262: His-Purkinje system development [GO_0003164]
- 2263: histamine secretion [GO_0001821]
- 2264: histamine secretion, neurotransmission [GO_0061538]
- 2265: histamine transport [GO_0051608]
- 2266: histamine-gated chloride channel activity [GO_0019182]
- 2267: histidine + tRNA(His) + ATP => His-tRNA(His) + AMP + pyrophosphate [GO_0004821]
- 2268: histone acetyltransferase binding [GO_0035035]
- 2269: histone acetyltransferase regulator activity [GO_0035034]
- 2270: histone binding [GO_0042393]
- 2271: histone chaperone activity [GO_0140713]
- 2272: histone deacetylase binding [GO_0042826]
- 2273: histone deacetylase inhibitor activity [GO_0046811]
- 2274: histone deacetylase regulator activity [GO_0035033]
- 2275: histone deacetylation [GO_0016575]
- 2276: histone glutamine N-methyltransferase activity [GO_1990259]
- 2277: histone H2A acetyltransferase activity [GO_0043998]
- 2278: histone H2A kinase activity [GO_0140995]
- 2279: histone H2A methyltransferase activity [GO_0140940]
- 2280: histone H2AT120 kinase activity [GO_1990244]
- 2281: histone H3 acetyltransferase activity [GO_0010484]
- 2282: histone H3 demethylase activity [GO_0141052]
- 2283: histone H3 kinase activity [GO_0140996]
- 2284: histone H3 methyltransferase activity [GO_0140938]
- 2285: histone H3K14 acetyltransferase activity [GO_0036408]
- 2286: histone H3K18 acetyltransferase activity [GO_0043993]
- 2287: histone H3K23 acetyltransferase activity [GO_0043994]
- 2288: histone H3K27 acetyltransferase activity [GO_0044017]
- 2289: histone H3K27 dimethyltransferase activity [GO_0140952]
- 2290: histone H3K27 monomethyltransferase activity [GO_0140953]
- 2291: histone H3K27 trimethyltransferase activity [GO_0140951]
- 2292: histone H3K27me2/H3K27me3 demethylase activity [GO_0071558]
- 2293: histone H3K36 demethylase activity [GO_0051864]
- 2294: histone H3K36 methyltransferase activity [GO_0046975]
- 2295: histone H3K36me2/H3K36me3 demethylase activity [GO_0140681]
- 2296: histone H3K4 demethylase activity [GO_0032453]
- 2297: histone H3K4me/H3K4me2/H3K4me3 demethylase activity [GO_0034647]
- 2298: histone H3K79 methyltransferase activity [GO_0031151]
- 2299: histone H3K9 dimethyltransferase activity [GO_0140942]
- 2300: histone H3K9 monomethyltransferase activity [GO_0140948]
- 2301: histone H3K9 trimethyltransferase activity [GO_0140949]
- 2302: histone H3K9me2/H3K9me3 demethylase activity [GO_0140684]
- 2303: histone H3R17 methyltransferase activity [GO_0035642]
- 2304: histone H3R2 methyltransferase activity [GO_0070611]
- 2305: histone H3R3 demethylase activity [GO_0033749]
- 2306: histone H3S10 kinase activity [GO_0035175]
- 2307: histone H3T3 kinase activity [GO_0072354]
- 2308: histone H4 acetyltransferase activity [GO_0010485]
- 2309: histone H4 demethylase activity [GO_0141058]
- 2310: histone H4 methyltransferase activity [GO_0140939]
- 2311: histone H4K20 methyltransferase activity [GO_0042799]
- 2312: histone H4K20 trimethyltransferase activity [GO_0140943]
- 2313: histone H4K20me methyltransferase activity [GO_0140941]
- 2314: histone H4R3 methyltransferase activity [GO_0044020]
- 2315: histone kinase activity [GO_0035173]
- 2316: histone methyltransferase activity [GO_0042054]
- 2317: histone methyltransferase binding [GO_1990226]
- 2318: histone modification [GO_0016570]
- 2319: histone modifying activity [GO_0140993]
- 2320: histone octamer slider activity [GO_0140751]
- 2321: histone pre-mRNA stem-loop binding [GO_0071207]
- 2322: histone reader activity [GO_0140566]
- 2323: histone serine kinase activity [GO_0035174]
- 2324: histone threonine kinase activity [GO_0035184]
- 2325: HMG box domain binding [GO_0071837]
- 2326: HMGCR dimer reduces bHMG-CoA to MVA [GO_0004420]
- 2327: HMOX1 dimer, HMOX2 cleave heme [GO_0004392]
- 2328: holocytochrome-c synthase activity [GO_0004408]
- 2329: homeostasis of number of cells [GO_0048872]
- 2330: homeostasis of number of cells within a tissue [GO_0048873]
- 2331: homeostatic process [GO_0042592]
- 2332: hormone activity [GO_0005179]
- 2333: hormone binding [GO_0042562]
- 2334: hormone metabolic process [GO_0042445]
- 2335: hormone receptor binding [GO_0051427]
- 2336: hormone secretion [GO_0046879]
- 2337: hormone transport [GO_0009914]
- 2338: hormone-mediated signaling pathway [GO_0009755]
- 2339: HRSP12 deaminates 2AA to 2OBUTA [GO_0019239]
- 2340: HS6STs sulfate GlcN at C6 in heparan sulfate/heparin [GO_0017095]
- 2341: HSD17B2 oxidises estradiol (E2) to estrone (E1) [GO_0004303]
- 2342: HSD17B4 dehydrogenates 3-hydroxyhexacosanoyl-CoA [GO_0003857]
- 2343: HSF1 acetylation at Lys80 [GO_0034212]
- 2344: HSP110s exchange ATP for ADP on HSP70s:ADP [GO_0000774]
- 2345: Hsp70 protein binding [GO_0030544]
- 2346: Hsp90 protein binding [GO_0051879]
- 2347: Hv1 Mediated H+ Permeability [GO_0022843]
- 2348: hyaluronan biosynthetic process [GO_0030213]
- 2349: hyaluronan catabolic process [GO_0030214]
- 2350: hyaluronan metabolic process [GO_0030212]
- 2351: hyaluronic acid binding [GO_0005540]
- 2352: hydro-lyase activity [GO_0016836]
- 2353: hydrolase activity, acting on acid anhydrides [GO_0016817]
- 2354: hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides [GO_0016818]
- 2355: hydrolase activity, acting on acid carbon-carbon bonds [GO_0016822]
- 2356: hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances [GO_0016823]
- 2357: hydrolase activity, acting on acid phosphorus-nitrogen bonds [GO_0016825]
- 2358: hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides [GO_0016812]
- 2359: hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines [GO_0016814]
- 2360: hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides [GO_0016811]
- 2361: hydrolase activity, acting on carbon-sulfur bonds [GO_0046508]
- 2362: hydrolase activity, acting on ether bonds [GO_0016801]
- 2363: hydrolase activity, hydrolyzing N-glycosyl compounds [GO_0016799]
- 2364: Hydroperoxy reductase reduces 4(S)-Hp-17(S)-HDHA to RvD6 [GO_0016491]
- 2365: hydroxyisourate hydrolase activity [GO_0033971]
- 2366: hydroxylysine kinase activity [GO_0047992]
- 2367: hydroxymethyl-, formyl- and related transferase activity [GO_0016742]
- 2368: hydroxymethylbilane synthase activity [GO_0004418]
- 2369: hydroxypyruvate isomerase activity [GO_0008903]
- 2370: hydroxypyruvate reductase activity [GO_0016618]
- 2371: I-SMAD binding [GO_0070411]
- 2372: I(1,3,4,5,6)P5 is phosphorylated to 5-PP-IP4 by IP6K1/2 in the nucleus [GO_0000827]
- 2373: I(1,4,5)P3 is phosphorylated to I(1,3,4,5)P4 by IPMK in the nucleus [GO_0008440]
- 2374: I(1,4)P2 is dephosphorylated to I4P by INPP1 in the cytosol [GO_0004441]
- 2375: I1P is dephosphorylated to Ins by IMPA1/2 in the cytosol [GO_0008934]
- 2376: identical protein binding [GO_0042802]
- 2377: IFNL1:IFNLR1:p-JAK1:IL10RB:p-TYK2 phosphorylates IFNLR1 [GO_0004714]
- 2378: IL12B dimerizes [GO_0003756]
- 2379: IL4R, IL2RG, JAK1 in IL4-bound IL4R1:JAK1 are phosphorylated [GO_0004715]
- 2380: imaginal disc growth factor receptor binding [GO_0008084]
- 2381: immune effector process [GO_0002252]
- 2382: immune receptor activity [GO_0140375]
- 2383: immune response [GO_0006955]
- 2384: immune system development [GO_0002520]
- 2385: immune system process [GO_0002376]
- 2386: IMP cyclohydrolase activity [GO_0003937]
- 2387: IMP dehydrogenase activity [GO_0003938]
- 2388: IMPAD1 hydrolyses PAP to AMP [GO_0008441]
- 2389: import into cell [GO_0098657]
- 2390: import into nucleus [GO_0051170]
- 2391: Importin-8 imports AGO2:miRNA into the nucleus [GO_0017056]
- 2392: in utero embryonic development [GO_0001701]
- 2393: indolalkylamine biosynthetic process [GO_0046219]
- 2394: indolalkylamine metabolic process [GO_0006586]
- 2395: indole alkaloid biosynthetic process [GO_0035835]
- 2396: indole alkaloid metabolic process [GO_0035834]
- 2397: indole-containing compound biosynthetic process [GO_0042435]
- 2398: indole-containing compound catabolic process [GO_0042436]
- 2399: indole-containing compound metabolic process [GO_0042430]
- 2400: inhibition of neuroepithelial cell differentiation [GO_0002085]
- 2401: inner cell mass cell differentiation [GO_0001826]
- 2402: inner cell mass cell proliferation [GO_0001833]
- 2403: inorganic anion transmembrane transport [GO_0098661]
- 2404: inorganic anion transmembrane transporter activity [GO_0015103]
- 2405: inorganic anion transport [GO_0015698]
- 2406: inorganic cation transmembrane transport [GO_0098662]
- 2407: inorganic cation transmembrane transporter activity [GO_0022890]
- 2408: inorganic ion homeostasis [GO_0098771]
- 2409: inorganic ion transmembrane transport [GO_0098660]
- 2410: inorganic molecular entity transmembrane transporter activity [GO_0015318]
- 2411: inorganic phosphate transmembrane transporter activity [GO_0005315]
- 2412: inositol 1,4,5 trisphosphate binding [GO_0070679]
- 2413: inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO_0005220]
- 2414: inositol bisphosphate phosphatase activity [GO_0016312]
- 2415: inositol hexakisphosphate 5-kinase activity [GO_0000832]
- 2416: inositol hexakisphosphate binding [GO_0000822]
- 2417: inositol monophosphate phosphatase activity [GO_0052834]
- 2418: inositol pentakisphosphate 2-kinase activity [GO_0035299]
- 2419: inositol phosphate phosphatase activity [GO_0052745]
- 2420: inositol phosphate-mediated signaling [GO_0048016]
- 2421: inositol tetrakisphosphate 5-kinase activity [GO_0047326]
- 2422: inositol tetrakisphosphate kinase activity [GO_0051765]
- 2423: inositol tetrakisphosphate phosphatase activity [GO_0052743]
- 2424: inositol trisphosphate kinase activity [GO_0051766]
- 2425: inositol trisphosphate phosphatase activity [GO_0046030]
- 2426: inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity [GO_0051717]
- 2427: inositol-1,4,5-trisphosphate 6-kinase activity [GO_0000823]
- 2428: inositol-polyphosphate 5-phosphatase activity [GO_0004445]
- 2429: insemination [GO_0007320]
- 2430: insulin binding [GO_0043559]
- 2431: insulin catabolic process [GO_1901143]
- 2432: insulin metabolic process [GO_1901142]
- 2433: insulin receptor activity [GO_0005009]
- 2434: insulin receptor binding [GO_0005158]
- 2435: insulin receptor signaling pathway [GO_0008286]
- 2436: insulin receptor substrate binding [GO_0043560]
- 2437: insulin secretion [GO_0030073]
- 2438: Insulin secretory granule docks at the plasma membrane [GO_0000149]
- 2439: insulin-like growth factor binding [GO_0005520]
- 2440: insulin-like growth factor receptor binding [GO_0005159]
- 2441: integral component of Golgi membrane [GO_0030173]
- 2442: integral component of membrane [GO_0016021]
- 2443: integral component of muscle cell projection membrane [GO_0061455]
- 2444: integral component of nuclear outer membrane [GO_0031309]
- 2445: integral component of organelle membrane [GO_0031301]
- 2446: integral component of pigment granule membrane [GO_0090740]
- 2447: integral component of plasma membrane [GO_0005887]
- 2448: integral component of synaptic membrane [GO_0099699]
- 2449: integral component of vacuolar membrane [GO_0031166]
- 2450: integrin binding [GO_0005178]
- 2451: intercellular transport [GO_0010496]
- 2452: intermediate mesoderm development [GO_0048389]
- 2453: intermediate mesoderm formation [GO_0048391]
- 2454: intermediate mesoderm morphogenesis [GO_0048390]
- 2455: intermembrane lipid transfer [GO_0120009]
- 2456: internal genitalia morphogenesis [GO_0035260]
- 2457: interphase [GO_0051325]
- 2458: interstitial cell of Cajal differentiation [GO_0061453]
- 2459: intestinal absorption [GO_0050892]
- 2460: intestinal epithelial cell development [GO_0060576]
- 2461: intestinal epithelial cell differentiation [GO_0060575]
- 2462: intestinal epithelial cell maturation [GO_0060574]
- 2463: intestinal lipid catabolic process [GO_0044258]
- 2464: intestine smooth muscle contraction [GO_0014827]
- 2465: intracellular anatomical structure [GO_0005622]
- 2466: intracellular calcium activated chloride channel activity [GO_0005229]
- 2467: intracellular cAMP-activated cation channel activity [GO_0005222]
- 2468: intracellular cGMP-activated cation channel activity [GO_0005223]
- 2469: intracellular chloride channel activity [GO_0061778]
- 2470: intracellular ligand-gated ion channel activity [GO_0005217]
- 2471: intracellular lipid transport [GO_0032365]
- 2472: intracellular membrane-bounded organelle [GO_0043231]
- 2473: intracellular non-membrane-bounded organelle [GO_0043232]
- 2474: intracellular nucleoside transport [GO_0015859]
- 2475: intracellular organelle [GO_0043229]
- 2476: intracellular organelle lumen [GO_0070013]
- 2477: intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity [GO_0097682]
- 2478: intracellular protein transmembrane transport [GO_0065002]
- 2479: intracellular protein transport [GO_0006886]
- 2480: intracellular receptor signaling pathway [GO_0030522]
- 2481: intracellular signal transduction [GO_0035556]
- 2482: intracellular signal transduction involved in positive regulation of cell growth [GO_1905427]
- 2483: intracellular sodium activated potassium channel activity [GO_0005228]
- 2484: intracellular sterol transport [GO_0032366]
- 2485: intracellular transport [GO_0046907]
- 2486: intracellular vesicle [GO_0097708]
- 2487: intraciliary transport [GO_0042073]
- 2488: intraciliary transport involved in cilium assembly [GO_0035735]
- 2489: intraciliary transport particle [GO_0030990]
- 2490: intrahepatic bile duct development [GO_0035622]
- 2491: intramembrane lipid transporter activity [GO_0140303]
- 2492: intramembranous bone growth [GO_0098867]
- 2493: intramembranous bone morphogenesis [GO_1904770]
- 2494: intramembranous ossification [GO_0001957]
- 2495: intramolecular lyase activity [GO_0016872]
- 2496: intramolecular oxidoreductase activity, interconverting aldoses and ketoses [GO_0016861]
- 2497: intramolecular oxidoreductase activity, transposing C=C bonds [GO_0016863]
- 2498: intramolecular oxidoreductase activity, transposing S-S bonds [GO_0016864]
- 2499: intramolecular transferase activity [GO_0016866]
- 2500: intramolecular transferase activity, phosphotransferases [GO_0016868]
- 2501: intrinsic component of Golgi membrane [GO_0031228]
- 2502: intrinsic component of membrane [GO_0031224]
- 2503: intrinsic component of nuclear outer membrane [GO_0031308]
- 2504: intrinsic component of organelle membrane [GO_0031300]
- 2505: intrinsic component of plasma membrane [GO_0031226]
- 2506: intrinsic component of synaptic membrane [GO_0099240]
- 2507: intrinsic component of vacuolar membrane [GO_0031310]
- 2508: inward rectifier potassium channel inhibitor activity [GO_0070320]
- 2509: ion binding [GO_0043167]
- 2510: ion channel activity [GO_0005216]
- 2511: ion channel inhibitor activity [GO_0008200]
- 2512: ion channel modulating, G protein-coupled receptor signaling pathway [GO_0099105]
- 2513: ion channel regulator activity [GO_0099106]
- 2514: ion channel regulator activity involved in G protein-coupled receptor signaling pathway [GO_0099107]
- 2515: ion gated channel activity [GO_0022839]
- 2516: ion homeostasis [GO_0050801]
- 2517: ion transmembrane transport [GO_0034220]
- 2518: ion transmembrane transporter activity [GO_0015075]
- 2519: ion transport [GO_0006811]
- 2520: ionotropic glutamate receptor activity [GO_0004970]
- 2521: ionotropic glutamate receptor binding [GO_0035255]
- 2522: ionotropic glutamate receptor signaling pathway [GO_0035235]
- 2523: IP3R tetramer:I(1,4,5)P3:4xCa2+ transports Ca2+ from platelet dense tubular system to cytosol [GO_0005262]
- 2524: IP6 is phosphorylated to 5-PP-IP5 by IP6K1/3 in the cytosol [GO_0000828]
- 2525: IRAK1 phosphorylates Pellino upon TLR7/8 or 9 activation [GO_0004672]
- 2526: IRE1alpha hydrolyzes Xbp1 mRNA and Xbp1 mRNA is spliced [GO_0004521]
- 2527: iRHOM2 transports ADAM17:Zn2+ from Golgi to the plasma membrane [GO_0140318]
- 2528: iris morphogenesis [GO_0061072]
- 2529: iron coordination entity transport [GO_1901678]
- 2530: iron ion binding [GO_0005506]
- 2531: iron ion sequestering activity [GO_0140315]
- 2532: iron ion transmembrane transport [GO_0034755]
- 2533: iron ion transmembrane transporter inhibitor activity [GO_0097690]
- 2534: iron ion transport [GO_0006826]
- 2535: iron-responsive element binding [GO_0030350]
- 2536: iron-sulfur cluster binding [GO_0051536]
- 2537: isocitrate + NADP+ => 2-oxoglutarate + CO2 + NADPH + H+ [GO_0004450]
- 2538: isocitrate dehydrogenase (NAD+) activity [GO_0004449]
- 2539: isocitrate dehydrogenase [NAD(P)+] activity [GO_0004448]
- 2540: isoleucine + tRNA(Ile) + ATP => Ile-tRNA(Ile) + AMP + pyrophosphate [GO_0004822]
- 2541: Isomerization of 3-trans-decenoyl-CoA to form trans-dec-2-enoyl-CoA [GO_0016860]
- 2542: Isomerization of GlcNAc6P to GlcNAc1P [GO_0004610]
- 2543: isoprenoid binding [GO_0019840]
- 2544: isoprenoid metabolic process [GO_0006720]
- 2545: isovaleryl-CoA dehydrogenase activity [GO_0008470]
- 2546: JAK3 in IL7:p-Y449-IL7R:JAK1:IL2RG:JAK3 is phosphorylated [GO_0019199]
- 2547: JMJD1C demethylates H3K9 mono- and di-methylation [GO_0032454]
- 2548: JNK cascade [GO_0007254]
- 2549: jump response [GO_0007630]
- 2550: JUN kinase binding [GO_0008432]
- 2551: JUN kinase kinase kinase activity [GO_0004706]
- 2552: JUN kinase kinase kinase kinase activity [GO_0042656]
- 2553: JUN kinase phosphatase activity [GO_0008579]
- 2554: juvenile hormone binding [GO_0005500]
- 2555: juvenile hormone epoxide hydrolase activity [GO_0008096]
- 2556: juvenile hormone response element binding [GO_0070594]
- 2557: K+-independent Li+/Ca2+ exchanger transport [GO_0015368]
- 2558: K11-linked polyubiquitin modification-dependent protein binding [GO_0071795]
- 2559: K48-linked polyubiquitin modification-dependent protein binding [GO_0036435]
- 2560: K63-linked polyubiquitin modification-dependent protein binding [GO_0070530]
- 2561: kainate selective glutamate receptor activity [GO_0015277]
- 2562: KAMKMT transfers 3xCH3 groups from 3xAdoMet to CALM1 [GO_0018025]
- 2563: karyogamy [GO_0000741]
- 2564: KAT5 acetylates ATM at DNA DSBs [GO_0016407]
- 2565: KAT7-containing ING4/5 complexes acetylate Me3K-histone H3 [GO_0004402]
- 2566: KBTBD7:CUL3:RBX1 ubiquitinates NF1 [GO_0061630]
- 2567: KCNJ11 tetramer:ABCC8 tetramer binds 4xATP, closing the channel [GO_0005524]
- 2568: KDEL sequence binding [GO_0005046]
- 2569: KDM2A, KDM2B, KDM4A demethylate MeK37-histone H3 [GO_0032452]
- 2570: ketone biosynthetic process [GO_0042181]
- 2571: ketone catabolic process [GO_0042182]
- 2572: kinase activator activity [GO_0019209]
- 2573: kinase binding [GO_0019900]
- 2574: kinase inhibitor activity [GO_0019210]
- 2575: kinase regulator activity [GO_0019207]
- 2576: kinesin binding [GO_0019894]
- 2577: kynurenine aminotransferase activity [GO_0036137]
- 2578: kynurenine metabolic process [GO_0070189]
- 2579: kynurenine-oxoglutarate transaminase activity [GO_0016212]
- 2580: L-alanine transmembrane transporter activity [GO_0015180]
- 2581: L-alanine transport [GO_0015808]
- 2582: L-allo-threonine aldolase activity [GO_0008732]
- 2583: L-alpha-amino acid transmembrane transport [GO_1902475]
- 2584: L-amino acid transmembrane transporter activity [GO_0015179]
- 2585: L-amino acid transport [GO_0015807]
- 2586: L-arginine transmembrane transport [GO_1903826]
- 2587: L-arginine transmembrane transporter activity [GO_0061459]
- 2588: L-ascorbate oxidase activity [GO_0008447]
- 2589: L-ascorbic acid binding [GO_0031418]
- 2590: L-aspartate transmembrane transport [GO_0070778]
- 2591: L-aspartate transmembrane transporter activity [GO_0015183]
- 2592: L-aspartate:2-oxoglutarate aminotransferase activity [GO_0004069]
- 2593: L-cystine transmembrane transporter activity [GO_0015184]
- 2594: L-cystine transport [GO_0015811]
- 2595: L-dopa decarboxylase activator activity [GO_0036478]
- 2596: L-dopa decarboxylase activity [GO_0036468]
- 2597: L-galactose dehydrogenase activity [GO_0010349]
- 2598: L-glutamate import [GO_0051938]
- 2599: L-glutamate transmembrane transport [GO_0015813]
- 2600: L-glutamate transmembrane transporter activity [GO_0005313]
- 2601: L-glutamine aminotransferase activity [GO_0070548]
- 2602: L-iditol 2-dehydrogenase activity [GO_0003939]
- 2603: L-isoleucine transaminase activity [GO_0052656]
- 2604: L-kynurenine metabolic process [GO_0097052]
- 2605: L-lactate dehydrogenase activity [GO_0004459]
- 2606: L-leucine transaminase activity [GO_0052654]
- 2607: L-leucine transmembrane transporter activity [GO_0015190]
- 2608: L-lysine transmembrane transport [GO_1903401]
- 2609: L-lysine transmembrane transporter activity [GO_0015189]
- 2610: L-lysine transport [GO_1902022]
- 2611: L-methionine-(S)-S-oxide reductase activity [GO_0036456]
- 2612: L-methionine:thioredoxin-disulfide S-oxidoreductase activity [GO_0033744]
- 2613: L-ornithine transmembrane transport [GO_1903352]
- 2614: L-phosphoserine phosphatase activity [GO_0036424]
- 2615: L-serine ammonia-lyase activity [GO_0003941]
- 2616: L-serine-phosphatidylcholine phosphatidyltransferase activity [GO_0106258]
- 2617: L-serine-phosphatidylethanolamine phosphatidyltransferase activity [GO_0106245]
- 2618: L-threonine ammonia-lyase activity [GO_0004794]
- 2619: L-tyrosine aminotransferase activity [GO_0070547]
- 2620: L-valine transaminase activity [GO_0052655]
- 2621: labyrinthine layer blood vessel development [GO_0060716]
- 2622: labyrinthine layer development [GO_0060711]
- 2623: labyrinthine layer formation [GO_0060714]
- 2624: labyrinthine layer morphogenesis [GO_0060713]
- 2625: lactate dehydrogenase activity [GO_0004457]
- 2626: lactoylglutathione lyase activity [GO_0004462]
- 2627: lamin binding [GO_0005521]
- 2628: laminin binding [GO_0043236]
- 2629: laminin receptor activity [GO_0005055]
- 2630: large conductance calcium-activated potassium channel activity [GO_0060072]
- 2631: large ribosomal subunit rRNA binding [GO_0070180]
- 2632: larval behavior [GO_0030537]
- 2633: larval locomotory behavior [GO_0008345]
- 2634: larval turning behavior [GO_0035179]
- 2635: lateral mesoderm development [GO_0048368]
- 2636: lateral mesoderm formation [GO_0048370]
- 2637: lateral mesoderm morphogenesis [GO_0048369]
- 2638: latrotoxin receptor activity [GO_0016524]
- 2639: LCMT2 methylates yW-72 yielding yW-58 at nucleotide 37 of tRNA(Phe) [GO_0008175]
- 2640: leading edge membrane [GO_0031256]
- 2641: leak channel activity [GO_0022840]
- 2642: learning [GO_0007612]
- 2643: learning or memory [GO_0007611]
- 2644: left lung development [GO_0060459]
- 2645: left lung morphogenesis [GO_0060460]
- 2646: left ventricular cardiac muscle tissue morphogenesis [GO_0003220]
- 2647: lens development in camera-type eye [GO_0002088]
- 2648: lens morphogenesis in camera-type eye [GO_0002089]
- 2649: lens placode formation [GO_0001743]
- 2650: leucine binding [GO_0070728]
- 2651: leucine-tRNA ligase activity [GO_0004823]
- 2652: leucokinin receptor activity [GO_0042071]
- 2653: leukocyte apoptotic process [GO_0071887]
- 2654: leukocyte differentiation [GO_0002521]
- 2655: leukocyte homeostasis [GO_0001776]
- 2656: leukocyte mediated immunity [GO_0002443]
- 2657: leukocyte proliferation [GO_0070661]
- 2658: ligand-activated transcription factor activity [GO_0098531]
- 2659: ligand-gated anion channel activity [GO_0099095]
- 2660: ligand-gated calcium channel activity [GO_0099604]
- 2661: ligand-gated cation channel activity [GO_0099094]
- 2662: ligand-gated channel activity [GO_0022834]
- 2663: ligand-gated ion channel signaling pathway [GO_1990806]
- 2664: ligase activity [GO_0016874]
- 2665: ligase activity, forming carbon-carbon bonds [GO_0016885]
- 2666: ligase activity, forming carbon-nitrogen bonds [GO_0016879]
- 2667: ligase activity, forming carbon-oxygen bonds [GO_0016875]
- 2668: ligase activity, forming carbon-sulfur bonds [GO_0016877]
- 2669: ligase activity, forming phosphoric ester bonds [GO_0016886]
- 2670: ligase regulator activity [GO_0055103]
- 2671: light-activated ion channel activity [GO_0010461]
- 2672: LIM domain binding [GO_0030274]
- 2673: limb development [GO_0060173]
- 2674: limit dextrin-glycogenin => ((1,6)-alpha-glucosyl)poly((1,4)-alpha-glucosyl) glycogenin [GO_0004134]
- 2675: linear polyubiquitin binding [GO_1990450]
- 2676: lipase activator activity [GO_0060229]
- 2677: lipase activity [GO_0016298]
- 2678: LIPG dimer hydrolyzes HDL-associated TAG to DAG and LCFA [GO_0004465]
- 2679: lipid antigen binding [GO_0030882]
- 2680: lipid binding [GO_0008289]
- 2681: lipid biosynthetic process [GO_0008610]
- 2682: lipid catabolic process [GO_0016042]
- 2683: lipid digestion [GO_0044241]
- 2684: lipid export from cell [GO_0140353]
- 2685: lipid homeostasis [GO_0055088]
- 2686: lipid import into cell [GO_0140354]
- 2687: lipid kinase activity [GO_0001727]
- 2688: lipid localization [GO_0010876]
- 2689: lipid metabolic process [GO_0006629]
- 2690: lipid modification [GO_0030258]
- 2691: lipid phosphatase activity [GO_0042577]
- 2692: lipid phosphorylation [GO_0046834]
- 2693: lipid storage [GO_0019915]
- 2694: lipid transfer activity [GO_0120013]
- 2695: lipid translocation [GO_0034204]
- 2696: lipid transport [GO_0006869]
- 2697: lipid transport involved in lipid storage [GO_0010877]
- 2698: lipo-PDH decarboxylates PYR to Ac-CoA [GO_0004738]
- 2699: lipopolysaccharide binding [GO_0001530]
- 2700: lipopolysaccharide immune receptor activity [GO_0001875]
- 2701: lipopolysaccharide-mediated signaling pathway [GO_0031663]
- 2702: lipoprotein lipase activator activity [GO_0060230]
- 2703: lipoprotein particle binding [GO_0071813]
- 2704: lipoprotein particle receptor activity [GO_0030228]
- 2705: lipoprotein particle receptor binding [GO_0070325]
- 2706: lipoteichoic acid binding [GO_0070891]
- 2707: lipoyl(octanoyl) transferase activity [GO_0033819]
- 2708: lipoyltransferase activity [GO_0017118]
- 2709: liver development [GO_0001889]
- 2710: liver morphogenesis [GO_0072576]
- 2711: lncRNA binding [GO_0106222]
- 2712: Loading of acetylcholine in synaptic vesicles [GO_0005277]
- 2713: Loading of PCNA - Sliding Clamp Formation on the C-strand of the telomere [GO_0003689]
- 2714: loading of Serotonin in synaptic vesicles [GO_0008504]
- 2715: localization [GO_0051179]
- 2716: localization of cell [GO_0051674]
- 2717: localization within membrane [GO_0051668]
- 2718: locomotion [GO_0040011]
- 2719: locomotion involved in locomotory behavior [GO_0031987]
- 2720: locomotor rhythm [GO_0045475]
- 2721: locomotory behavior [GO_0007626]
- 2722: locus ceruleus development [GO_0021703]
- 2723: locus ceruleus formation [GO_0021705]
- 2724: locus ceruleus maturation [GO_0021706]
- 2725: locus ceruleus morphogenesis [GO_0021704]
- 2726: long-chain fatty acid metabolic process [GO_0001676]
- 2727: long-chain fatty acid transport [GO_0015909]
- 2728: long-chain fatty acid transporter activity [GO_0005324]
- 2729: long-chain fatty acid-CoA ligase activity [GO_0004467]
- 2730: long-chain fatty acyl-CoA binding [GO_0036042]
- 2731: long-chain-3-hydroxyacyl-CoA dehydrogenase activity [GO_0016509]
- 2732: long-chain-acyl-CoA dehydrogenase activity [GO_0004466]
- 2733: long-chain-fatty-acyl-CoA reductase activity [GO_0050062]
- 2734: Long-range resection of DNA DSBs by EXO1 or DNA2 [GO_0004536]
- 2735: long-term memory [GO_0007616]
- 2736: low voltage-gated calcium channel activity [GO_0008332]
- 2737: low-density lipoprotein particle binding [GO_0030169]
- 2738: low-density lipoprotein particle receptor activity [GO_0005041]
- 2739: low-density lipoprotein particle receptor binding [GO_0050750]
- 2740: lpdC dimer reactivates dlaT [GO_0004148]
- 2741: LRAT esterifies RBP1:atROL and FACYLs to atREs [GO_0016416]
- 2742: LTA4H:Zn2+ hydrolyses 16S,17S-epoxy-DHA to (N)PD1 [GO_0004301]
- 2743: lung cell differentiation [GO_0060479]
- 2744: lung ciliated cell differentiation [GO_0061141]
- 2745: lung connective tissue development [GO_0060427]
- 2746: lung development [GO_0030324]
- 2747: lung epithelial cell differentiation [GO_0060487]
- 2748: lung epithelium development [GO_0060428]
- 2749: lung growth [GO_0060437]
- 2750: lung morphogenesis [GO_0060425]
- 2751: lung neuroendocrine cell differentiation [GO_0061100]
- 2752: lung secretory cell differentiation [GO_0061140]
- 2753: lung vasculature development [GO_0060426]
- 2754: luteinization [GO_0001553]
- 2755: LYPLA2 hydrolyses PALM-C3,4-GAP43 [GO_0008474]
- 2756: Lys48-specific deubiquitinase activity [GO_1990380]
- 2757: lysine + tRNA(Lys) + ATP => Lys-tRNA(Lys) + AMP + pyrophosphate [GO_0004824]
- 2758: lysine-acetylated histone binding [GO_0070577]
- 2759: lysophosphatidic acid acyltransferase activity [GO_0042171]
- 2760: lysophosphatidic acid phosphatase activity [GO_0052642]
- 2761: lysophospholipid acyltransferase activity [GO_0071617]
- 2762: LYZ hydrolyzes peptidoglycans in the bacterial cell wall [GO_0003796]
- 2763: M phase [GO_0000279]
- 2764: m7G(5')pppN diphosphatase activator activity [GO_1990521]
- 2765: m7G(5')pppN diphosphatase activity [GO_0050072]
- 2766: macrolide binding [GO_0005527]
- 2767: macromolecule biosynthetic process [GO_0009059]
- 2768: macromolecule catabolic process [GO_0009057]
- 2769: macromolecule deacylation [GO_0098732]
- 2770: macromolecule depalmitoylation [GO_0098734]
- 2771: macromolecule glycosylation [GO_0043413]
- 2772: macromolecule localization [GO_0033036]
- 2773: macromolecule metabolic process [GO_0043170]
- 2774: macromolecule methylation [GO_0043414]
- 2775: macromolecule modification [GO_0043412]
- 2776: macromolecule transmembrane transporter activity [GO_0022884]
- 2777: magnesium ion binding [GO_0000287]
- 2778: magnesium ion transmembrane transport [GO_1903830]
- 2779: magnesium ion transport [GO_0015693]
- 2780: maintenance of location [GO_0051235]
- 2781: maintenance of location in cell [GO_0051651]
- 2782: maintenance of presynaptic active zone structure [GO_0048790]
- 2783: maintenance of synapse structure [GO_0099558]
- 2784: malate + NAD+ <=> oxaloacetate + NADH + H+ [GO_0030060]
- 2785: malate dehydrogenase (decarboxylating) (NAD+) activity [GO_0004471]
- 2786: malate dehydrogenase activity [GO_0016615]
- 2787: malate transmembrane transport [GO_0071423]
- 2788: malate transmembrane transporter activity [GO_0015140]
- 2789: malate transport [GO_0015743]
- 2790: male courtship behavior [GO_0008049]
- 2791: male courtship behavior, veined wing extension [GO_0048065]
- 2792: male courtship behavior, veined wing generated song production [GO_0045433]
- 2793: male courtship behavior, veined wing vibration [GO_0016545]
- 2794: male mating behavior [GO_0060179]
- 2795: maleylacetoacetate isomerase activity [GO_0016034]
- 2796: malic enzyme activity [GO_0004470]
- 2797: malonate-semialdehyde dehydrogenase (acetylating) activity [GO_0018478]
- 2798: maltose alpha-glucosidase activity [GO_0032450]
- 2799: maltose metabolic process [GO_0000023]
- 2800: MAN2B1 hydrolyses GlcNAc (Man)5 to GlcNAc (Man)3 [GO_0004559]
- 2801: manganese ion binding [GO_0030145]
- 2802: manganese ion transmembrane transport [GO_0071421]
- 2803: manganese ion transmembrane transporter activity [GO_0005384]
- 2804: manganese ion transport [GO_0006828]
- 2805: mannose binding [GO_0005537]
- 2806: mannose-1-phosphate guanylyltransferase (GTP) activity [GO_0004475]
- 2807: mannose-6-phosphate isomerase activity [GO_0004476]
- 2808: mannose(a1-4)glucosaminyl-acyl-PI + phosphatidylethanolamine -> (ethanolamineP) mannose(al1-4)glucosaminyl-acyl-PI + diacylglycerol [GO_0051377]
- 2809: mannosidase activity [GO_0015923]
- 2810: mannosyl-oligosaccharide 1,6-alpha-mannosidase activity [GO_0052767]
- 2811: mannosyl-oligosaccharide mannosidase activity [GO_0015924]
- 2812: mannosylation [GO_0097502]
- 2813: mannosyltransferase activity [GO_0000030]
- 2814: MAP kinase phosphatase activity [GO_0033549]
- 2815: MAP kinase tyrosine phosphatase activity [GO_0033550]
- 2816: MAP kinase tyrosine/serine/threonine phosphatase activity [GO_0017017]
- 2817: MAP-kinase scaffold activity [GO_0005078]
- 2818: MAPK cascade [GO_0000165]
- 2819: mastication [GO_0071626]
- 2820: mating [GO_0007618]
- 2821: mating behavior [GO_0007617]
- 2822: MCM8 mediated fork unwinding [GO_0004386]
- 2823: ME1:Mg2+ tetramer oxidatively decarboxylates MAL to PYR [GO_0004473]
- 2824: mechanosensitive cation channel activity [GO_0140135]
- 2825: mechanosensitive ion channel activity [GO_0008381]
- 2826: mechanosensitive voltage-gated sodium channel activity [GO_0101013]
- 2827: MECR dimer reduces tdec2-CoA to DEC-CoA [GO_0019166]
- 2828: medium-chain fatty acid omega-hydroxylase activity [GO_0140981]
- 2829: medium-chain fatty acid-CoA ligase activity [GO_0031956]
- 2830: medium-chain-acyl-CoA dehydrogenase activity [GO_0070991]
- 2831: medium-term memory [GO_0072375]
- 2832: medulla oblongata development [GO_0021550]
- 2833: medulla oblongata formation [GO_0021580]
- 2834: medulla oblongata maturation [GO_0021582]
- 2835: medulla oblongata morphogenesis [GO_0021579]
- 2836: megakaryocyte development [GO_0035855]
- 2837: megakaryocyte differentiation [GO_0030219]
- 2838: meiotic cell cycle [GO_0051321]
- 2839: meiotic cell cycle phase [GO_0098762]
- 2840: meiotic cell cycle process [GO_1903046]
- 2841: meiotic cell cycle process involved in oocyte maturation [GO_1903537]
- 2842: meiotic chromosome condensation [GO_0010032]
- 2843: meiotic chromosome segregation [GO_0045132]
- 2844: meiotic interphase [GO_0051328]
- 2845: meiotic M phase [GO_0051327]
- 2846: meiotic nuclear division [GO_0140013]
- 2847: meiotic nuclear membrane disassembly [GO_0051078]
- 2848: membrane [GO_0016020]
- 2849: membrane assembly [GO_0071709]
- 2850: membrane biogenesis [GO_0044091]
- 2851: membrane bone morphogenesis [GO_0061973]
- 2852: membrane disassembly [GO_0030397]
- 2853: membrane docking [GO_0022406]
- 2854: membrane fission [GO_0090148]
- 2855: membrane fusion [GO_0061025]
- 2856: membrane invagination [GO_0010324]
- 2857: membrane organization [GO_0061024]
- 2858: membrane protein complex [GO_0098796]
- 2859: membrane-bounded organelle [GO_0043227]
- 2860: membrane-enclosed lumen [GO_0031974]
- 2861: membranous septum morphogenesis [GO_0003149]
- 2862: memory [GO_0007613]
- 2863: mesenchymal cell apoptotic process [GO_0097152]
- 2864: mesenchymal cell development [GO_0014031]
- 2865: mesenchymal cell differentiation [GO_0048762]
- 2866: mesenchymal cell differentiation involved in bone development [GO_1901706]
- 2867: mesenchymal cell differentiation involved in lung development [GO_0060915]
- 2868: mesenchymal cell differentiation involved in renal system development [GO_2001012]
- 2869: mesenchymal cell proliferation [GO_0010463]
- 2870: mesenchymal cell proliferation involved in lung development [GO_0060916]
- 2871: mesenchymal to epithelial transition [GO_0060231]
- 2872: mesenchyme development [GO_0060485]
- 2873: mesenchyme morphogenesis [GO_0072132]
- 2874: mesoderm development [GO_0007498]
- 2875: mesoderm formation [GO_0001707]
- 2876: mesoderm morphogenesis [GO_0048332]
- 2877: mesodermal cell differentiation [GO_0048333]
- 2878: Met1-linked polyubiquitin deubiquitinase activity [GO_0061815]
- 2879: metabolic process [GO_0008152]
- 2880: metal cation:monoatomic cation antiporter activity [GO_0140828]
- 2881: metal cluster binding [GO_0051540]
- 2882: metal ion binding [GO_0046872]
- 2883: metal ion homeostasis [GO_0055065]
- 2884: metal ion sensor activity [GO_0140784]
- 2885: metal ion sequestering activity [GO_0140487]
- 2886: metal ion transmembrane transporter activity [GO_0046873]
- 2887: metal ion transport [GO_0030001]
- 2888: metal-dependent deNEDDylase activity [GO_0140758]
- 2889: metal-dependent deubiquitinase activity [GO_0140492]
- 2890: metalloaminopeptidase activity [GO_0070006]
- 2891: metallochaperone activity [GO_0016530]
- 2892: metalloendopeptidase inhibitor activity [GO_0008191]
- 2893: metalloexopeptidase activity [GO_0008235]
- 2894: metencephalon development [GO_0022037]
- 2895: methionine + tRNA(Met) + ATP => Met-tRNA(Met) + AMP + pyrophosphate [GO_0004825]
- 2896: methionine adenosyltransferase regulator activity [GO_0048270]
- 2897: methyl transfer-driven active transmembrane transporter activity [GO_0015452]
- 2898: methyl-CpG binding [GO_0008327]
- 2899: methylated histone binding [GO_0035064]
- 2900: methylation [GO_0032259]
- 2901: Methylation of N-acetyl-5-HT to form melatonin [GO_0008172]
- 2902: methylation-dependent protein binding [GO_0140034]
- 2903: methylenetetrahydrofolate dehydrogenase (NAD+) activity [GO_0004487]
- 2904: methylenetetrahydrofolate dehydrogenase (NADP+) activity [GO_0004488]
- 2905: methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity [GO_0004486]
- 2906: methylmalonate semialdehyde + NAD+ + CoA => propionyl-CoA + CO2 + NADH + H+ [GO_0004491]
- 2907: methylmalonyl semialdehyde + NADH + H+ <=> beta-hydroxyisobutyrate + NAD+ [GO_0008442]
- 2908: Methylthio-ribulose-P = Methylthio-ribose-P [GO_0046523]
- 2909: METTL1:WDR4 methylates guanosine-46 of tRNA(Phe) yielding 7-methylguanosine-46 [GO_0008176]
- 2910: Mevalonate is phosphorylated to mevalonate-5-phosphate [GO_0004496]
- 2911: MGMT/hAGT mediated DNA Damage Reversal [GO_0003908]
- 2912: MHC protein binding [GO_0042287]
- 2913: MIA40:ERV1 (CHCHD4:GFER) oxidizes cysteine residues to cystine disulfide bonds [GO_0015035]
- 2914: microfilament motor activity [GO_0000146]
- 2915: microtubule [GO_0005874]
- 2916: microtubule bundle [GO_0097427]
- 2917: microtubule bundle formation [GO_0001578]
- 2918: microtubule cytoskeleton [GO_0015630]
- 2919: microtubule cytoskeleton organization [GO_0000226]
- 2920: microtubule cytoskeleton organization involved in mitosis [GO_1902850]
- 2921: microtubule depolymerization [GO_0007019]
- 2922: microtubule minus-end binding [GO_0051011]
- 2923: microtubule motor activity [GO_0003777]
- 2924: microtubule nucleation [GO_0007020]
- 2925: microtubule plus end polymerase [GO_0061863]
- 2926: microtubule plus-end binding [GO_0051010]
- 2927: microtubule polymerization [GO_0046785]
- 2928: microtubule polymerization based movement [GO_0099098]
- 2929: microtubule polymerization based protein transport [GO_0099112]
- 2930: microtubule polymerization or depolymerization [GO_0031109]
- 2931: microtubule-based movement [GO_0007018]
- 2932: microtubule-based process [GO_0007017]
- 2933: microtubule-based protein transport [GO_0099118]
- 2934: microtubule-based transport [GO_0099111]
- 2935: microvillus [GO_0005902]
- 2936: microvillus assembly [GO_0030033]
- 2937: microvillus organization [GO_0032528]
- 2938: midbrain development [GO_0030901]
- 2939: midbrain morphogenesis [GO_1904693]
- 2940: midbrain-hindbrain boundary development [GO_0030917]
- 2941: midbrain-hindbrain boundary initiation [GO_0021547]
- 2942: midbrain-hindbrain boundary maturation [GO_0021732]
- 2943: midbrain-hindbrain boundary morphogenesis [GO_0021555]
- 2944: midgut development [GO_0007494]
- 2945: minor groove of adenine-thymine-rich DNA binding [GO_0003680]
- 2946: minus-end-directed microtubule motor activity [GO_0008569]
- 2947: MIOX oxidises Ins to GlcA [GO_0050113]
- 2948: miRNA binding [GO_0035198]
- 2949: miRNA-mediated gene silencing [GO_0035195]
- 2950: miRNA-mediated gene silencing by mRNA destabilization [GO_0035279]
- 2951: mismatch base pair DNA N-glycosylase activity [GO_0000700]
- 2952: mismatched DNA binding [GO_0030983]
- 2953: mitochondrial calcium ion homeostasis [GO_0051560]
- 2954: mitochondrial chromosome [GO_0000262]
- 2955: mitochondrial chromosome packaging [GO_0090139]
- 2956: mitochondrial DNA metabolic process [GO_0032042]
- 2957: mitochondrial DNA replication [GO_0006264]
- 2958: mitochondrial envelope [GO_0005740]
- 2959: mitochondrial gene expression [GO_0140053]
- 2960: mitochondrial genome maintenance [GO_0000002]
- 2961: mitochondrial matrix [GO_0005759]
- 2962: mitochondrial membrane [GO_0031966]
- 2963: mitochondrial membrane organization [GO_0007006]
- 2964: mitochondrial mRNA catabolic process [GO_0000958]
- 2965: mitochondrial nucleoid [GO_0042645]
- 2966: mitochondrial promoter sequence-specific DNA binding [GO_0001018]
- 2967: mitochondrial protein catabolic process [GO_0035694]
- 2968: mitochondrial protein-containing complex [GO_0098798]
- 2969: mitochondrial protein-transporting ATPase activity [GO_0008566]
- 2970: mitochondrial ribosome [GO_0005761]
- 2971: mitochondrial ribosome binding [GO_0097177]
- 2972: mitochondrial RNA catabolic process [GO_0000957]
- 2973: mitochondrial RNA metabolic process [GO_0000959]
- 2974: mitochondrial RNA modification [GO_1900864]
- 2975: mitochondrial RNA processing [GO_0000963]
- 2976: mitochondrial single-subunit type RNA polymerase binding [GO_0001001]
- 2977: Mitochondrial tetrahydrofolate export across the inner mitochondrial membrane [GO_0008517]
- 2978: mitochondrial transcription [GO_0006390]
- 2979: mitochondrial transcription factor activity [GO_0034246]
- 2980: mitochondrial translation [GO_0032543]
- 2981: mitochondrial translational elongation [GO_0070125]
- 2982: mitochondrial translational initiation [GO_0070124]
- 2983: mitochondrial translational termination [GO_0070126]
- 2984: mitochondrial tRNA methylation [GO_0070901]
- 2985: mitochondrial tRNA modification [GO_0070900]
- 2986: mitochondrial tRNA processing [GO_0090646]
- 2987: mitochondrion [GO_0005739]
- 2988: mitochondrion organization [GO_0007005]
- 2989: mitochondrion targeting sequence binding [GO_0030943]
- 2990: mitogen-activated protein kinase binding [GO_0051019]
- 2991: mitogen-activated protein kinase kinase binding [GO_0031434]
- 2992: mitotic cell cycle [GO_0000278]
- 2993: mitotic cell cycle phase [GO_0098763]
- 2994: mitotic cell cycle process [GO_1903047]
- 2995: mitotic cell cycle, embryonic [GO_0045448]
- 2996: mitotic chromosome condensation [GO_0007076]
- 2997: mitotic DNA replication [GO_1902969]
- 2998: mitotic DNA replication DNA duplex unwinding [GO_1902971]
- 2999: mitotic interphase [GO_0051329]
- 3000: mitotic M phase [GO_0000087]
- 3001: mitotic nuclear division [GO_0140014]
- 3002: mitotic nuclear membrane disassembly [GO_0007077]
- 3003: mitotic nuclear membrane organization [GO_0101024]
- 3004: mitotic sister chromatid segregation [GO_0000070]
- 3005: modification-dependent macromolecule catabolic process [GO_0043632]
- 3006: modification-dependent protein binding [GO_0140030]
- 3007: modification-dependent protein catabolic process [GO_0019941]
- 3008: modified amino acid binding [GO_0072341]
- 3009: modified amino acid transmembrane transporter activity [GO_0072349]
- 3010: modified amino acid transport [GO_0072337]
- 3011: modulation of chemical synaptic transmission [GO_0050804]
- 3012: modulation of excitatory postsynaptic potential [GO_0098815]
- 3013: molecular adaptor activity [GO_0060090]
- 3014: molecular carrier activity [GO_0140104]
- 3015: molecular condensate scaffold activity [GO_0140693]
- 3016: molecular function activator activity [GO_0140677]
- 3017: molecular function inhibitor activity [GO_0140678]
- 3018: molecular function regulator [GO_0098772]
- 3019: molecular tag activity [GO_0141047]
- 3020: molecular transducer activity [GO_0060089]
- 3021: molecular_function [GO_0003674]
- 3022: molybdenum ion binding [GO_0030151]
- 3023: molybdopterin molybdotransferase activity [GO_0061599]
- 3024: monoamine transport [GO_0015844]
- 3025: monocarboxylate:sodium symporter activity [GO_0140161]
- 3026: monocarboxylic acid binding [GO_0033293]
- 3027: monocarboxylic acid biosynthetic process [GO_0072330]
- 3028: monocarboxylic acid catabolic process [GO_0072329]
- 3029: monocarboxylic acid metabolic process [GO_0032787]
- 3030: monocarboxylic acid transport [GO_0015718]
- 3031: mononuclear cell differentiation [GO_1903131]
- 3032: mononuclear cell proliferation [GO_0032943]
- 3033: monosaccharide binding [GO_0048029]
- 3034: monosaccharide biosynthetic process [GO_0046364]
- 3035: monosaccharide catabolic process [GO_0046365]
- 3036: monosaccharide metabolic process [GO_0005996]
- 3037: monosaccharide transmembrane transport [GO_0015749]
- 3038: monosaccharide transmembrane transporter activity [GO_0015145]
- 3039: monovalent cation:proton antiporter activity [GO_0005451]
- 3040: monovalent inorganic anion homeostasis [GO_0055083]
- 3041: monovalent inorganic cation homeostasis [GO_0055067]
- 3042: morphogen activity [GO_0016015]
- 3043: morphogenesis of a branching epithelium [GO_0061138]
- 3044: morphogenesis of a branching structure [GO_0001763]
- 3045: morphogenesis of a polarized epithelium [GO_0001738]
- 3046: morphogenesis of an endothelium [GO_0003159]
- 3047: morphogenesis of an epithelial bud [GO_0060572]
- 3048: morphogenesis of an epithelial fold [GO_0060571]
- 3049: morphogenesis of an epithelial fold involved in embryonic heart tube formation [GO_0003152]
- 3050: morphogenesis of an epithelial sheet [GO_0002011]
- 3051: morphogenesis of an epithelium [GO_0002009]
- 3052: morphogenesis of embryonic epithelium [GO_0016331]
- 3053: motor neuron apoptotic process [GO_0097049]
- 3054: movement of cell or subcellular component [GO_0006928]
- 3055: MPC1:MPC2 cotransports PYR, H+ from cytosol to mitochondrial matrix [GO_0050833]
- 3056: MRN:CtIP exonucleolytically hydrolyzes DNA 3' to SPO11 and SPO11:double-strand break dissociates to SPO11:oligonucleotide and resected 5' end [GO_0008296]
- 3057: mRNA 3'-UTR AU-rich region binding [GO_0035925]
- 3058: mRNA 3'-UTR binding [GO_0003730]
- 3059: mRNA 5'-phosphatase activity [GO_0140818]
- 3060: mRNA 5'-UTR binding [GO_0048027]
- 3061: mRNA base-pairing translational repressor activity [GO_1903231]
- 3062: mRNA binding [GO_0003729]
- 3063: mRNA cap binding complex binding [GO_0140262]
- 3064: mRNA catabolic process [GO_0006402]
- 3065: mRNA destabilization [GO_0061157]
- 3066: mRNA metabolic process [GO_0016071]
- 3067: mRNA polyadenylation [GO_0004652]
- 3068: mRNA regulatory element binding translation repressor activity [GO_0000900]
- 3069: MRSBs reduce L-methyl-(R)-S-oxide to L-methionine [GO_0033743]
- 3070: MscR reduces nitrosomycothiol to ammonia [GO_0016620]
- 3071: MsrA/B reduces peptide-methionine S/R-sulfoxides [GO_0008113]
- 3072: MTA2-NuRD complex deacetylates TP53 [GO_0004407]
- 3073: MTHFD2, D2L oxidise 5,10-methylene-THF to 5,10-methenyl-THF [GO_0004477]
- 3074: MTHFS transforms 5-formyl-THFPG to 5,10-methenyl-THFPG [GO_0030272]
- 3075: mucopolysaccharide metabolic process [GO_1903510]
- 3076: mucus secretion [GO_0070254]
- 3077: multi-ciliated epithelial cell differentiation [GO_1903251]
- 3078: multi-multicellular organism process [GO_0044706]
- 3079: multi-organism process [GO_0051704]
- 3080: multi-organism reproductive process [GO_0044703]
- 3081: multicellular organism development [GO_0007275]
- 3082: multicellular organism growth [GO_0035264]
- 3083: multicellular organism reproduction [GO_0032504]
- 3084: multicellular organismal homeostasis [GO_0048871]
- 3085: multicellular organismal movement [GO_0050879]
- 3086: multicellular organismal process [GO_0032501]
- 3087: multicellular organismal reproductive process [GO_0048609]
- 3088: multicellular organismal response to stress [GO_0033555]
- 3089: multicellular organismal signaling [GO_0035637]
- 3090: muscle adaptation [GO_0043500]
- 3091: muscle alpha-actinin binding [GO_0051371]
- 3092: muscle cell apoptotic process [GO_0010657]
- 3093: muscle cell cellular homeostasis [GO_0046716]
- 3094: muscle cell development [GO_0055001]
- 3095: muscle cell differentiation [GO_0042692]
- 3096: muscle cell projection [GO_0036194]
- 3097: muscle cell projection membrane [GO_0036195]
- 3098: muscle cell proliferation [GO_0033002]
- 3099: muscle contraction [GO_0006936]
- 3100: muscle hypertrophy [GO_0014896]
- 3101: muscle organ development [GO_0007517]
- 3102: muscle organ morphogenesis [GO_0048644]
- 3103: muscle structure development [GO_0061061]
- 3104: muscle system process [GO_0003012]
- 3105: muscle tissue development [GO_0060537]
- 3106: muscle tissue morphogenesis [GO_0060415]
- 3107: muscular septum morphogenesis [GO_0003150]
- 3108: musculoskeletal movement [GO_0050881]
- 3109: myeloid cell apoptotic process [GO_0033028]
- 3110: myeloid cell development [GO_0061515]
- 3111: myeloid cell differentiation [GO_0030099]
- 3112: myeloid cell homeostasis [GO_0002262]
- 3113: myeloid leukocyte differentiation [GO_0002573]
- 3114: myeloid leukocyte mediated immunity [GO_0002444]
- 3115: myeloid progenitor cell differentiation [GO_0002318]
- 3116: myoblast development [GO_0048627]
- 3117: myoblast differentiation [GO_0045445]
- 3118: myoblast division [GO_0014872]
- 3119: myoblast maturation [GO_0048628]
- 3120: myoblast proliferation [GO_0051450]
- 3121: myofibril [GO_0030016]
- 3122: myofibril assembly [GO_0030239]
- 3123: myoinhibitory hormone activity [GO_0016085]
- 3124: myosin binding [GO_0017022]
- 3125: myosin head/neck binding [GO_0032028]
- 3126: myosin heavy chain binding [GO_0032036]
- 3127: myosin II binding [GO_0045159]
- 3128: myosin II heavy chain binding [GO_0032038]
- 3129: myosin II light chain binding [GO_0032033]
- 3130: myosin III binding [GO_0031473]
- 3131: myosin light chain binding [GO_0032027]
- 3132: myosin light chain kinase activity [GO_0004687]
- 3133: myosin phosphatase activity [GO_0017018]
- 3134: myosin phosphatase regulator activity [GO_0017020]
- 3135: myosin V binding [GO_0031489]
- 3136: myosin VI binding [GO_0070853]
- 3137: myosin VI head/neck binding [GO_0070855]
- 3138: myosin VI heavy chain binding [GO_0070854]
- 3139: myosin VI light chain binding [GO_0070856]
- 3140: myostimulatory hormone activity [GO_0016084]
- 3141: myosuppressin receptor activity [GO_0035013]
- 3142: myotome development [GO_0061055]
- 3143: myotube cell development [GO_0014904]
- 3144: myotube differentiation [GO_0014902]
- 3145: myristoyl-CoA+FAD<=>trans-Tetradec-2-enoyl-CoA+FADH2 [GO_0003995]
- 3146: myristoyltransferase activity [GO_0019107]
- 3147: N-acetylation of serotonin [GO_0004059]
- 3148: N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity [GO_0050510]
- 3149: N-acetylglucosamine 6-O-sulfotransferase activity [GO_0001517]
- 3150: N-acetylglucosamine kinase activity [GO_0045127]
- 3151: N-acetyllactosamine beta-1,3-glucuronosyltransferase activity [GO_0046987]
- 3152: N-acylneuraminate cytidylyltransferase activity [GO_0008781]
- 3153: N-acylneuraminate-9-phosphatase activity [GO_0050124]
- 3154: N-acylneuraminate-9-phosphate synthase activity [GO_0047444]
- 3155: N-acyltransferase activity [GO_0016410]
- 3156: N-glycan trimming of Spike [GO_0033919]
- 3157: N-hydroxy-2-acetylaminofluorene + PAPS => 2-acetylaminofluorene-N-sulfate + PAP [GO_0008146]
- 3158: N-methyltransferase activity [GO_0008170]
- 3159: N-succinyltransferase activity [GO_0016749]
- 3160: N6-methyladenosine-containing RNA binding [GO_1990247]
- 3161: NAAA hydrolyses NAEs to FAs and ethanolamine [GO_0016810]
- 3162: NAADP-sensitive calcium-release channel activity [GO_0072345]
- 3163: NAD binding [GO_0051287]
- 3164: NAD transmembrane transport [GO_0035352]
- 3165: NAD transmembrane transporter activity [GO_0051724]
- 3166: NAD transport [GO_0043132]
- 3167: NAD-dependent histone deacetylase activity [GO_0017136]
- 3168: NAD-independent histone deacetylase activity [GO_0045129]
- 3169: NAD(P)H dehydrogenase (quinone) activity [GO_0003955]
- 3170: NAD+ binding [GO_0070403]
- 3171: NAD+ kinase activity [GO_0003951]
- 3172: NAD+-protein ADP-ribosyltransferase activity [GO_1990404]
- 3173: NADH binding [GO_0070404]
- 3174: NADH dehydrogenase (quinone) activity [GO_0050136]
- 3175: NADH dehydrogenase activity [GO_0003954]
- 3176: NADP binding [GO_0050661]
- 3177: NADP phosphatase activity [GO_0019178]
- 3178: NADPH binding [GO_0070402]
- 3179: NADPH phosphatase activity [GO_0102757]
- 3180: NADPH-adrenodoxin reductase activity [GO_0015039]
- 3181: NADSYN1 hexamer amidates NAAD to NAD+ [GO_0003952]
- 3182: narrow pore channel activity [GO_0022842]
- 3183: NAT10 acetylates cytidine-1337 and cytidine-1842 of 18S rRNA yielding 4-acetylcytidine-1377 and 4-acetylcytidine-1842 [GO_0008080]
- 3184: NatC acetylates ARFFRP1 [GO_0004596]
- 3185: NCEH1 hydrolyzes cholesterol esters [GO_0004771]
- 3186: ncRNA metabolic process [GO_0034660]
- 3187: ncRNA processing [GO_0034470]
- 3188: NEDD8 conjugating enzyme activity [GO_0061654]
- 3189: NEDD8 ligase activity [GO_0061663]
- 3190: NEDD8 transferase activity [GO_0019788]
- 3191: negative chemotaxis [GO_0050919]
- 3192: negative energy taxis [GO_0052129]
- 3193: negative gravitaxis [GO_0048060]
- 3194: negative phototaxis [GO_0046957]
- 3195: negative regulation of 1-phosphatidylinositol 4-kinase activity [GO_0043127]
- 3196: negative regulation of 1-phosphatidylinositol-3-kinase activity [GO_0061902]
- 3197: negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO_0090217]
- 3198: negative regulation of acetylcholine secretion, neurotransmission [GO_0014058]
- 3199: negative regulation of acetylcholine-gated cation channel activity [GO_1903049]
- 3200: negative regulation of acid-sensing ion channel activity [GO_1901586]
- 3201: negative regulation of acinar cell proliferation [GO_1904698]
- 3202: negative regulation of aconitate hydratase activity [GO_1904233]
- 3203: negative regulation of actin binding [GO_1904617]
- 3204: negative regulation of actin filament binding [GO_1904530]
- 3205: negative regulation of actin filament bundle assembly [GO_0032232]
- 3206: negative regulation of action potential [GO_0045759]
- 3207: negative regulation of activin receptor signaling pathway [GO_0032926]
- 3208: negative regulation of adenosine receptor signaling pathway [GO_0060169]
- 3209: negative regulation of adenylate cyclase activity [GO_0007194]
- 3210: negative regulation of adipose tissue development [GO_1904178]
- 3211: negative regulation of alkaline phosphatase activity [GO_0010693]
- 3212: negative regulation of alpha-(1->3)-fucosyltransferase activity [GO_1905620]
- 3213: negative regulation of amine transport [GO_0051953]
- 3214: negative regulation of amino acid transport [GO_0051956]
- 3215: negative regulation of aminoacyl-tRNA ligase activity [GO_1903631]
- 3216: negative regulation of amyloid precursor protein catabolic process [GO_1902992]
- 3217: negative regulation of androgen secretion [GO_2000835]
- 3218: negative regulation of angiogenesis [GO_0016525]
- 3219: negative regulation of animal organ morphogenesis [GO_0110111]
- 3220: negative regulation of anion channel activity [GO_0010360]
- 3221: negative regulation of anion transmembrane transport [GO_1903960]
- 3222: negative regulation of anion transport [GO_1903792]
- 3223: negative regulation of aorta morphogenesis [GO_1903848]
- 3224: negative regulation of aortic smooth muscle cell differentiation [GO_1904830]
- 3225: negative regulation of apical ectodermal ridge formation [GO_1905141]
- 3226: negative regulation of apolipoprotein binding [GO_2000657]
- 3227: negative regulation of apoptotic process [GO_0043066]
- 3228: negative regulation of apoptotic process involved in development [GO_1904746]
- 3229: negative regulation of apoptotic process involved in morphogenesis [GO_1902338]
- 3230: negative regulation of apoptotic process involved in outflow tract morphogenesis [GO_1902257]
- 3231: negative regulation of apoptotic signaling pathway [GO_2001234]
- 3232: negative regulation of artery morphogenesis [GO_1905652]
- 3233: negative regulation of aspartic endopeptidase activity, intramembrane cleaving [GO_0120288]
- 3234: negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO_1902960]
- 3235: negative regulation of aspartic-type peptidase activity [GO_1905246]
- 3236: negative regulation of asymmetric cell division [GO_0045769]
- 3237: negative regulation of ATP biosynthetic process [GO_2001170]
- 3238: negative regulation of ATP citrate synthase activity [GO_2000984]
- 3239: negative regulation of ATP metabolic process [GO_1903579]
- 3240: negative regulation of ATP-dependent activity [GO_0032780]
- 3241: negative regulation of ATP:ADP antiporter activity [GO_0070927]
- 3242: negative regulation of ATPase-coupled calcium transmembrane transporter activity [GO_1901895]
- 3243: negative regulation of AV node cell action potential [GO_1903950]
- 3244: negative regulation of axo-dendritic protein transport [GO_1905127]
- 3245: negative regulation of axon guidance [GO_1902668]
- 3246: negative regulation of axonemal microtubule depolymerization [GO_0007027]
- 3247: negative regulation of axonogenesis [GO_0050771]
- 3248: negative regulation of backward locomotion [GO_1905851]
- 3249: negative regulation of behavior [GO_0048521]
- 3250: negative regulation of beta-galactosidase activity [GO_1903770]
- 3251: negative regulation of bile acid biosynthetic process [GO_0070858]
- 3252: negative regulation of bile acid metabolic process [GO_1904252]
- 3253: negative regulation of bile acid secretion [GO_0120190]
- 3254: negative regulation of binding [GO_0051100]
- 3255: negative regulation of biological process [GO_0048519]
- 3256: negative regulation of biosynthetic process [GO_0009890]
- 3257: negative regulation of bleb assembly [GO_1904171]
- 3258: negative regulation of blood circulation [GO_1903523]
- 3259: negative regulation of blood vessel endothelial cell differentiation [GO_0110059]
- 3260: negative regulation of blood vessel morphogenesis [GO_2000181]
- 3261: negative regulation of BMP signaling pathway [GO_0030514]
- 3262: negative regulation of bone development [GO_1903011]
- 3263: negative regulation of branching involved in lung morphogenesis [GO_0061048]
- 3264: negative regulation of branching morphogenesis of a nerve [GO_2000173]
- 3265: negative regulation of calcium ion binding [GO_1901877]
- 3266: negative regulation of calcium ion transmembrane transport [GO_1903170]
- 3267: negative regulation of calcium ion transmembrane transporter activity [GO_1901020]
- 3268: negative regulation of calcium ion transport [GO_0051926]
- 3269: negative regulation of calcium-dependent ATPase activity [GO_1903611]
- 3270: negative regulation of calcium-mediated signaling [GO_0050849]
- 3271: negative regulation of calcium:sodium antiporter activity [GO_1903280]
- 3272: negative regulation of cAMP-dependent protein kinase activity [GO_2000480]
- 3273: negative regulation of cAMP-mediated signaling [GO_0043951]
- 3274: negative regulation of carbohydrate metabolic process [GO_0045912]
- 3275: negative regulation of cardiac chamber formation [GO_1901211]
- 3276: negative regulation of cardiac chamber morphogenesis [GO_1901220]
- 3277: negative regulation of cardiac conduction [GO_1903780]
- 3278: negative regulation of cardiac muscle adaptation [GO_0010616]
- 3279: negative regulation of cardiac muscle cell apoptotic process [GO_0010667]
- 3280: negative regulation of cardiac muscle cell differentiation [GO_2000726]
- 3281: negative regulation of cardiac muscle cell myoblast differentiation [GO_2000691]
- 3282: negative regulation of cardiac muscle cell proliferation [GO_0060044]
- 3283: negative regulation of cardiac muscle contraction [GO_0055118]
- 3284: negative regulation of cardiac muscle fiber development [GO_0055019]
- 3285: negative regulation of cardiac muscle hypertrophy [GO_0010614]
- 3286: negative regulation of cardiac muscle myoblast proliferation [GO_0110023]
- 3287: negative regulation of cardiac muscle tissue development [GO_0055026]
- 3288: negative regulation of cardiac muscle tissue growth [GO_0055022]
- 3289: negative regulation of cardiac myofibril assembly [GO_1905305]
- 3290: negative regulation of cardiac ventricle development [GO_1904413]
- 3291: negative regulation of cardiac ventricle formation [GO_1904943]
- 3292: negative regulation of cardioblast differentiation [GO_0051892]
- 3293: negative regulation of cardiocyte differentiation [GO_1905208]
- 3294: negative regulation of cartilage development [GO_0061037]
- 3295: negative regulation of catabolic process [GO_0009895]
- 3296: negative regulation of catalase activity [GO_1902552]
- 3297: negative regulation of catalytic activity [GO_0043086]
- 3298: negative regulation of catecholamine metabolic process [GO_0045914]
- 3299: negative regulation of catecholamine secretion [GO_0033604]
- 3300: negative regulation of cation channel activity [GO_2001258]
- 3301: negative regulation of cation transmembrane transport [GO_1904063]
- 3302: negative regulation of CD4 production [GO_0045225]
- 3303: negative regulation of cell adhesion [GO_0007162]
- 3304: negative regulation of cell communication [GO_0010648]
- 3305: negative regulation of cell cycle [GO_0045786]
- 3306: negative regulation of cell cycle process [GO_0010948]
- 3307: negative regulation of cell death [GO_0060548]
- 3308: negative regulation of cell development [GO_0010721]
- 3309: negative regulation of cell differentiation [GO_0045596]
- 3310: negative regulation of cell differentiation involved in embryonic placenta development [GO_0060806]
- 3311: negative regulation of cell division [GO_0051782]
- 3312: negative regulation of cell fate commitment [GO_0010454]
- 3313: negative regulation of cell growth [GO_0030308]
- 3314: negative regulation of cell growth involved in cardiac muscle cell development [GO_0061052]
- 3315: negative regulation of cell junction assembly [GO_1901889]
- 3316: negative regulation of cell maturation [GO_1903430]
- 3317: negative regulation of cell migration [GO_0030336]
- 3318: negative regulation of cell morphogenesis involved in differentiation [GO_0010771]
- 3319: negative regulation of cell motility [GO_2000146]
- 3320: negative regulation of cell population proliferation [GO_0008285]
- 3321: negative regulation of cell projection organization [GO_0031345]
- 3322: negative regulation of cell proliferation in midbrain [GO_1904934]
- 3323: negative regulation of cell proliferation involved in compound eye morphogenesis [GO_2000496]
- 3324: negative regulation of cell proliferation involved in heart morphogenesis [GO_2000137]
- 3325: negative regulation of cell-cell adhesion [GO_0022408]
- 3326: negative regulation of cellular amide metabolic process [GO_0034249]
- 3327: negative regulation of cellular amine catabolic process [GO_0033242]
- 3328: negative regulation of cellular amine metabolic process [GO_0033239]
- 3329: negative regulation of cellular amino acid biosynthetic process [GO_2000283]
- 3330: negative regulation of cellular amino acid metabolic process [GO_0045763]
- 3331: negative regulation of cellular biosynthetic process [GO_0031327]
- 3332: negative regulation of cellular carbohydrate metabolic process [GO_0010677]
- 3333: negative regulation of cellular carbohydrate metabolic process by negative regulation of transcription, DNA-templated [GO_0010678]
- 3334: negative regulation of cellular catabolic process [GO_0031330]
- 3335: negative regulation of cellular component movement [GO_0051271]
- 3336: negative regulation of cellular component organization [GO_0051129]
- 3337: negative regulation of cellular macromolecule biosynthetic process [GO_2000113]
- 3338: negative regulation of cellular metabolic process [GO_0031324]
- 3339: negative regulation of cellular process [GO_0048523]
- 3340: negative regulation of cellular protein metabolic process [GO_0032269]
- 3341: negative regulation of cellular respiration [GO_1901856]
- 3342: negative regulation of cellular response to alcohol [GO_1905958]
- 3343: negative regulation of cellular response to caffeine [GO_1901181]
- 3344: negative regulation of cellular response to drug [GO_2001039]
- 3345: negative regulation of cellular response to growth factor stimulus [GO_0090288]
- 3346: negative regulation of cellular response to insulin stimulus [GO_1900077]
- 3347: negative regulation of cellular response to oxidative stress [GO_1900408]
- 3348: negative regulation of chemokine activity [GO_1900137]
- 3349: negative regulation of chemorepellent activity [GO_1903668]
- 3350: negative regulation of chemotaxis [GO_0050922]
- 3351: negative regulation of chloride transport [GO_2001226]
- 3352: negative regulation of cholangiocyte apoptotic process [GO_1904193]
- 3353: negative regulation of cholangiocyte proliferation [GO_1904055]
- 3354: negative regulation of cholesterol transporter activity [GO_0060695]
- 3355: negative regulation of choline O-acetyltransferase activity [GO_1902770]
- 3356: negative regulation of chondrocyte development [GO_0061182]
- 3357: negative regulation of chondrocyte differentiation [GO_0032331]
- 3358: negative regulation of chorionic trophoblast cell proliferation [GO_1901383]
- 3359: negative regulation of chromatin assembly or disassembly [GO_0045798]
- 3360: negative regulation of chromatin binding [GO_0035562]
- 3361: negative regulation of chromatin organization [GO_1905268]
- 3362: negative regulation of chromosome condensation [GO_1902340]
- 3363: negative regulation of chromosome organization [GO_2001251]
- 3364: negative regulation of chromosome segregation [GO_0051985]
- 3365: negative regulation of cilium assembly [GO_1902018]
- 3366: negative regulation of circadian rhythm [GO_0042754]
- 3367: negative regulation of circadian sleep/wake cycle, sleep [GO_0042321]
- 3368: negative regulation of CoA-transferase activity [GO_1905919]
- 3369: negative regulation of collagen binding [GO_0033342]
- 3370: negative regulation of collagen biosynthetic process [GO_0032966]
- 3371: negative regulation of collagen catabolic process [GO_0010711]
- 3372: negative regulation of collagen fibril organization [GO_1904027]
- 3373: negative regulation of collagen metabolic process [GO_0010713]
- 3374: negative regulation of colon smooth muscle contraction [GO_1904342]
- 3375: negative regulation of compound eye photoreceptor cell differentiation [GO_0110118]
- 3376: negative regulation of compound eye retinal cell apoptotic process [GO_1901693]
- 3377: negative regulation of compound eye retinal cell programmed cell death [GO_0046673]
- 3378: negative regulation of copper ion transmembrane transport [GO_1902312]
- 3379: negative regulation of core promoter binding [GO_1904797]
- 3380: negative regulation of coreceptor activity involved in epidermal growth factor receptor signaling pathway [GO_0060728]
- 3381: negative regulation of cyclase activity [GO_0031280]
- 3382: negative regulation of cyclic nucleotide-gated ion channel activity [GO_1902160]
- 3383: negative regulation of cyclic-nucleotide phosphodiesterase activity [GO_0051344]
- 3384: negative regulation of cyclin-dependent protein kinase activity [GO_1904030]
- 3385: negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO_0045736]
- 3386: negative regulation of cystathionine beta-synthase activity [GO_1904042]
- 3387: negative regulation of cysteine metabolic process [GO_1901495]
- 3388: negative regulation of cysteine-type endopeptidase activity [GO_2000117]
- 3389: negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO_0043154]
- 3390: negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO_2001271]
- 3391: negative regulation of cytochrome-c oxidase activity [GO_1905376]
- 3392: negative regulation of cytokine activity [GO_0060302]
- 3393: negative regulation of cytokine-mediated signaling pathway [GO_0001960]
- 3394: negative regulation of cytokinesis [GO_0032466]
- 3395: negative regulation of cytoskeleton organization [GO_0051494]
- 3396: negative regulation of D-amino-acid oxidase activity [GO_1900758]
- 3397: negative regulation of deacetylase activity [GO_0150066]
- 3398: negative regulation of defecation [GO_2000293]
- 3399: negative regulation of delayed rectifier potassium channel activity [GO_1902260]
- 3400: negative regulation of deoxyribonuclease activity [GO_0032076]
- 3401: negative regulation of dephosphorylation [GO_0035305]
- 3402: negative regulation of dermatome development [GO_0061185]
- 3403: negative regulation of detection of mechanical stimulus involved in sensory perception of touch [GO_1905788]
- 3404: negative regulation of developmental growth [GO_0048640]
- 3405: negative regulation of developmental pigmentation [GO_0048086]
- 3406: negative regulation of developmental process [GO_0051093]
- 3407: negative regulation of diacylglycerol kinase activity [GO_1905688]
- 3408: negative regulation of digestive system process [GO_0060457]
- 3409: negative regulation of dipeptide transmembrane transport [GO_2001149]
- 3410: negative regulation of dipeptide transport [GO_2000879]
- 3411: negative regulation of DNA binding [GO_0043392]
- 3412: negative regulation of DNA biosynthetic process [GO_2000279]
- 3413: negative regulation of DNA duplex unwinding [GO_1905463]
- 3414: negative regulation of DNA helicase activity [GO_1905775]
- 3415: negative regulation of DNA metabolic process [GO_0051053]
- 3416: negative regulation of DNA N-glycosylase activity [GO_1902545]
- 3417: negative regulation of DNA repair [GO_0045738]
- 3418: negative regulation of DNA replication [GO_0008156]
- 3419: negative regulation of DNA replication origin binding [GO_1902596]
- 3420: negative regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO_2000372]
- 3421: negative regulation of DNA-binding transcription factor activity [GO_0043433]
- 3422: negative regulation of DNA-directed DNA polymerase activity [GO_1900263]
- 3423: negative regulation of DNA-templated DNA replication [GO_2000104]
- 3424: negative regulation of DNA-templated transcription [GO_0045892]
- 3425: negative regulation of dopamine receptor signaling pathway [GO_0060160]
- 3426: negative regulation of dopamine secretion [GO_0033602]
- 3427: negative regulation of double-stranded telomeric DNA binding [GO_1905768]
- 3428: negative regulation of dUTP diphosphatase activity [GO_1903628]
- 3429: negative regulation of eclosion [GO_0045804]
- 3430: negative regulation of ectoderm development [GO_2000384]
- 3431: negative regulation of electron transfer activity [GO_1904733]
- 3432: negative regulation of embryonic camera-type eye development [GO_1902864]
- 3433: negative regulation of embryonic development [GO_0045992]
- 3434: negative regulation of endocytosis [GO_0045806]
- 3435: negative regulation of endodeoxyribonuclease activity [GO_0032078]
- 3436: negative regulation of endodermal cell differentiation [GO_1903225]
- 3437: negative regulation of endopeptidase activity [GO_0010951]
- 3438: negative regulation of endoribonuclease activity [GO_0060702]
- 3439: negative regulation of endothelial cell apoptotic process [GO_2000352]
- 3440: negative regulation of endothelial cell development [GO_1901551]
- 3441: negative regulation of endothelial cell differentiation [GO_0045602]
- 3442: negative regulation of endothelial cell proliferation [GO_0001937]
- 3443: negative regulation of endothelial tube morphogenesis [GO_1905955]
- 3444: negative regulation of entry into reproductive diapause [GO_0061964]
- 3445: negative regulation of ephrin receptor signaling pathway [GO_1901188]
- 3446: negative regulation of epidermal cell differentiation [GO_0045605]
- 3447: negative regulation of epidermal growth factor receptor signaling pathway [GO_0042059]
- 3448: negative regulation of epidermal growth factor-activated receptor activity [GO_0007175]
- 3449: negative regulation of epidermis development [GO_0045683]
- 3450: negative regulation of epithelial cell apoptotic process [GO_1904036]
- 3451: negative regulation of epithelial cell differentiation [GO_0030857]
- 3452: negative regulation of epithelial cell proliferation [GO_0050680]
- 3453: negative regulation of epithelial cell proliferation involved in lung morphogenesis [GO_2000795]
- 3454: negative regulation of epithelial to mesenchymal transition [GO_0010719]
- 3455: negative regulation of epithelial tube formation [GO_1905277]
- 3456: negative regulation of ERBB signaling pathway [GO_1901185]
- 3457: negative regulation of erythrocyte apoptotic process [GO_1902251]
- 3458: negative regulation of erythrocyte differentiation [GO_0045647]
- 3459: negative regulation of establishment of protein localization [GO_1904950]
- 3460: negative regulation of establishment or maintenance of neuroblast polarity [GO_2000248]
- 3461: negative regulation of euchromatin binding [GO_1904794]
- 3462: negative regulation of excitatory postsynaptic potential [GO_0090394]
- 3463: negative regulation of execution phase of apoptosis [GO_1900118]
- 3464: negative regulation of exocytosis [GO_0045920]
- 3465: negative regulation of exodeoxyribonuclease activity [GO_1902393]
- 3466: negative regulation of exonuclease activity [GO_1905778]
- 3467: negative regulation of exoribonuclease activity [GO_1901918]
- 3468: negative regulation of exosomal secretion [GO_1903542]
- 3469: negative regulation of extracellular exosome assembly [GO_1903552]
- 3470: negative regulation of extracellular matrix assembly [GO_1901202]
- 3471: negative regulation of extracellular matrix disassembly [GO_0010716]
- 3472: negative regulation of extracellular matrix organization [GO_1903054]
- 3473: negative regulation of eye photoreceptor cell development [GO_0042480]
- 3474: negative regulation of fat cell apoptotic process [GO_1904650]
- 3475: negative regulation of fat cell differentiation [GO_0045599]
- 3476: negative regulation of fat cell proliferation [GO_0070345]
- 3477: negative regulation of fatty acid biosynthetic process [GO_0045717]
- 3478: negative regulation of fatty acid metabolic process [GO_0045922]
- 3479: negative regulation of fatty acid transport [GO_2000192]
- 3480: negative regulation of feeding behavior [GO_2000252]
- 3481: negative regulation of female gonad development [GO_2000195]
- 3482: negative regulation of ferrous iron binding [GO_1904433]
- 3483: negative regulation of fertilization [GO_0060467]
- 3484: negative regulation of fibroblast apoptotic process [GO_2000270]
- 3485: negative regulation of fibroblast growth factor receptor signaling pathway [GO_0040037]
- 3486: negative regulation of fibroblast proliferation [GO_0048147]
- 3487: negative regulation of formation of translation initiation ternary complex [GO_1901191]
- 3488: negative regulation of forward locomotion [GO_1905849]
- 3489: negative regulation of G protein-coupled receptor signaling pathway [GO_0045744]
- 3490: negative regulation of G-quadruplex DNA binding [GO_1905494]
- 3491: negative regulation of GABA-A receptor activity [GO_0106042]
- 3492: negative regulation of gamma-aminobutyric acid secretion [GO_0014053]
- 3493: negative regulation of gastric acid secretion [GO_0060455]
- 3494: negative regulation of gastric mucosal blood circulation [GO_1904345]
- 3495: negative regulation of gastro-intestinal system smooth muscle contraction [GO_1904305]
- 3496: negative regulation of gastrulation [GO_2000542]
- 3497: negative regulation of gene expression [GO_0010629]
- 3498: negative regulation of gene expression, epigenetic [GO_0045814]
- 3499: negative regulation of gene silencing by RNA [GO_0060967]
- 3500: negative regulation of germ cell proliferation [GO_1905937]
- 3501: negative regulation of glial cell apoptotic process [GO_0034351]
- 3502: negative regulation of glial cell differentiation [GO_0045686]
- 3503: negative regulation of glial cell proliferation [GO_0060253]
- 3504: negative regulation of gliogenesis [GO_0014014]
- 3505: negative regulation of glucagon secretion [GO_0070093]
- 3506: negative regulation of glucokinase activity [GO_0033132]
- 3507: negative regulation of gluconeogenesis [GO_0045721]
- 3508: negative regulation of glucose transmembrane transport [GO_0010829]
- 3509: negative regulation of glucosylceramidase activity [GO_1905124]
- 3510: negative regulation of glucuronosyltransferase activity [GO_1904224]
- 3511: negative regulation of glutamate receptor signaling pathway [GO_1900450]
- 3512: negative regulation of glutamate secretion [GO_0014050]
- 3513: negative regulation of glutamate secretion, neurotransmission [GO_1903295]
- 3514: negative regulation of glutamate-ammonia ligase activity [GO_1905479]
- 3515: negative regulation of glutamate-cysteine ligase activity [GO_0035228]
- 3516: negative regulation of glutathione biosynthetic process [GO_1903787]
- 3517: negative regulation of glutathione peroxidase activity [GO_1903283]
- 3518: negative regulation of glycine secretion, neurotransmission [GO_1904625]
- 3519: negative regulation of glycogen (starch) synthase activity [GO_2000466]
- 3520: negative regulation of glycogen biosynthetic process [GO_0045719]
- 3521: negative regulation of glycogen catabolic process [GO_0045818]
- 3522: negative regulation of glycogen metabolic process [GO_0070874]
- 3523: negative regulation of glycolytic process [GO_0045820]
- 3524: negative regulation of glycolytic process through fructose-6-phosphate [GO_1904539]
- 3525: negative regulation of glycoprotein biosynthetic process [GO_0010561]
- 3526: negative regulation of glycoprotein metabolic process [GO_1903019]
- 3527: negative regulation of Golgi to plasma membrane protein transport [GO_0042997]
- 3528: negative regulation of gonad development [GO_1905940]
- 3529: negative regulation of growth [GO_0045926]
- 3530: negative regulation of GTP binding [GO_1904425]
- 3531: negative regulation of GTP cyclohydrolase I activity [GO_0043105]
- 3532: negative regulation of GTPase activity [GO_0034260]
- 3533: negative regulation of guanyl-nucleotide exchange factor activity [GO_1905098]
- 3534: negative regulation of guanylate cyclase activity [GO_0031283]
- 3535: negative regulation of heart contraction [GO_0045822]
- 3536: negative regulation of heart growth [GO_0061117]
- 3537: negative regulation of helicase activity [GO_0051097]
- 3538: negative regulation of hematopoietic progenitor cell differentiation [GO_1901533]
- 3539: negative regulation of hematopoietic stem cell differentiation [GO_1902037]
- 3540: negative regulation of hematopoietic stem cell proliferation [GO_1902034]
- 3541: negative regulation of heme oxygenase activity [GO_0061962]
- 3542: negative regulation of hemopoiesis [GO_1903707]
- 3543: negative regulation of heparan sulfate proteoglycan binding [GO_1905859]
- 3544: negative regulation of hepatocyte apoptotic process [GO_1903944]
- 3545: negative regulation of hepatocyte differentiation [GO_0070367]
- 3546: negative regulation of heterochromatin assembly [GO_0031452]
- 3547: negative regulation of heterochromatin organization [GO_0120262]
- 3548: negative regulation of hexokinase activity [GO_1903300]
- 3549: negative regulation of high voltage-gated calcium channel activity [GO_1901842]
- 3550: negative regulation of hindgut contraction [GO_0060451]
- 3551: negative regulation of histone deacetylase activity [GO_1901726]
- 3552: negative regulation of histone deacetylation [GO_0031064]
- 3553: negative regulation of histone demethylase activity (H3-K4 specific) [GO_1904174]
- 3554: negative regulation of histone modification [GO_0031057]
- 3555: negative regulation of hormone metabolic process [GO_0032351]
- 3556: negative regulation of hormone secretion [GO_0046888]
- 3557: negative regulation of hyaluronan biosynthetic process [GO_1900126]
- 3558: negative regulation of hydrolase activity [GO_0051346]
- 3559: negative regulation of immune effector process [GO_0002698]
- 3560: negative regulation of immune response [GO_0050777]
- 3561: negative regulation of immune system process [GO_0002683]
- 3562: negative regulation of inorganic anion transmembrane transport [GO_1903796]
- 3563: negative regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO_0031586]
- 3564: negative regulation of insulin receptor signaling pathway [GO_0046627]
- 3565: negative regulation of insulin secretion [GO_0046676]
- 3566: negative regulation of intestinal absorption [GO_1904479]
- 3567: negative regulation of intestinal epithelial cell development [GO_1905299]
- 3568: negative regulation of intracellular calcium activated chloride channel activity [GO_1902939]
- 3569: negative regulation of intracellular lipid transport [GO_0032378]
- 3570: negative regulation of intracellular protein transport [GO_0090317]
- 3571: negative regulation of intracellular signal transduction [GO_1902532]
- 3572: negative regulation of intracellular sterol transport [GO_0032381]
- 3573: negative regulation of intracellular transport [GO_0032387]
- 3574: negative regulation of inward rectifier potassium channel activity [GO_1903609]
- 3575: negative regulation of ion transmembrane transport [GO_0034766]
- 3576: negative regulation of ion transmembrane transporter activity [GO_0032413]
- 3577: negative regulation of ion transport [GO_0043271]
- 3578: negative regulation of iron ion transmembrane transport [GO_0034760]
- 3579: negative regulation of iron ion transmembrane transporter activity [GO_1904255]
- 3580: negative regulation of iron ion transport [GO_0034757]
- 3581: negative regulation of isoleucine-tRNA ligase activity [GO_1905016]
- 3582: negative regulation of isoprenoid metabolic process [GO_0045827]
- 3583: negative regulation of JNK cascade [GO_0046329]
- 3584: negative regulation of JUN kinase activity [GO_0043508]
- 3585: negative regulation of kinase activity [GO_0033673]
- 3586: negative regulation of L-dopa decarboxylase activity [GO_1903199]
- 3587: negative regulation of large conductance calcium-activated potassium channel activity [GO_1902607]
- 3588: negative regulation of leucine-tRNA ligase activity [GO_1903634]
- 3589: negative regulation of leukocyte apoptotic process [GO_2000107]
- 3590: negative regulation of leukocyte differentiation [GO_1902106]
- 3591: negative regulation of leukocyte mediated immunity [GO_0002704]
- 3592: negative regulation of leukocyte proliferation [GO_0070664]
- 3593: negative regulation of ligase activity [GO_0051352]
- 3594: negative regulation of light-activated channel activity [GO_0045831]
- 3595: negative regulation of lipase activity [GO_0060192]
- 3596: negative regulation of lipid binding [GO_1900131]
- 3597: negative regulation of lipid biosynthetic process [GO_0051055]
- 3598: negative regulation of lipid catabolic process [GO_0050995]
- 3599: negative regulation of lipid kinase activity [GO_0090219]
- 3600: negative regulation of lipid localization [GO_1905953]
- 3601: negative regulation of lipid metabolic process [GO_0045833]
- 3602: negative regulation of lipid storage [GO_0010888]
- 3603: negative regulation of lipid transport [GO_0032369]
- 3604: negative regulation of lipid transporter activity [GO_0110114]
- 3605: negative regulation of lipopolysaccharide-mediated signaling pathway [GO_0031665]
- 3606: negative regulation of lipoprotein lipase activity [GO_0051005]
- 3607: negative regulation of locomotion [GO_0040013]
- 3608: negative regulation of locomotion involved in locomotory behavior [GO_0090327]
- 3609: negative regulation of locomotor rhythm [GO_1904060]
- 3610: negative regulation of low-density lipoprotein particle receptor binding [GO_1905596]
- 3611: negative regulation of low-density lipoprotein receptor activity [GO_1905598]
- 3612: negative regulation of lung ciliated cell differentiation [GO_1901247]
- 3613: negative regulation of lyase activity [GO_0051350]
- 3614: negative regulation of lysozyme activity [GO_1903591]
- 3615: negative regulation of macromolecule biosynthetic process [GO_0010558]
- 3616: negative regulation of macromolecule metabolic process [GO_0010605]
- 3617: negative regulation of malate dehydrogenase (decarboxylating) (NADP+) activity [GO_1903219]
- 3618: negative regulation of male mating behavior [GO_1902436]
- 3619: negative regulation of MAP kinase activity [GO_0043407]
- 3620: negative regulation of MAPK cascade [GO_0043409]
- 3621: negative regulation of megakaryocyte differentiation [GO_0045653]
- 3622: negative regulation of meiotic cell cycle [GO_0051447]
- 3623: negative regulation of meiotic cell cycle process involved in oocyte maturation [GO_1904145]
- 3624: negative regulation of meiotic nuclear division [GO_0045835]
- 3625: negative regulation of membrane invagination [GO_1905154]
- 3626: negative regulation of mesenchymal cell apoptotic process [GO_2001054]
- 3627: negative regulation of mesenchymal cell proliferation [GO_0072201]
- 3628: negative regulation of mesenchymal cell proliferation involved in lung development [GO_2000791]
- 3629: negative regulation of mesoderm development [GO_2000381]
- 3630: negative regulation of mesoderm formation [GO_1905903]
- 3631: negative regulation of mesodermal cell differentiation [GO_1905771]
- 3632: negative regulation of metabolic process [GO_0009892]
- 3633: negative regulation of metalloendopeptidase activity [GO_1904684]
- 3634: negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO_1902963]
- 3635: negative regulation of metallopeptidase activity [GO_1905049]
- 3636: negative regulation of methionine-tRNA ligase activity [GO_1905019]
- 3637: negative regulation of microtubule binding [GO_1904527]
- 3638: negative regulation of microtubule depolymerization [GO_0007026]
- 3639: negative regulation of microtubule nucleation [GO_1905833]
- 3640: negative regulation of microtubule plus-end binding [GO_1903032]
- 3641: negative regulation of microtubule polymerization [GO_0031115]
- 3642: negative regulation of microtubule polymerization or depolymerization [GO_0031111]
- 3643: negative regulation of microvillus assembly [GO_1903697]
- 3644: negative regulation of miRNA-mediated gene silencing [GO_0060965]
- 3645: negative regulation of mitochondrial ATP synthesis coupled proton transport [GO_1905707]
- 3646: negative regulation of mitochondrial DNA metabolic process [GO_1901859]
- 3647: negative regulation of mitochondrial DNA replication [GO_0090298]
- 3648: negative regulation of mitochondrial mRNA catabolic process [GO_1905638]
- 3649: negative regulation of mitochondrial RNA catabolic process [GO_0000961]
- 3650: negative regulation of mitochondrial translation [GO_0070130]
- 3651: negative regulation of mitochondrial translational elongation [GO_1905083]
- 3652: negative regulation of mitochondrial translational initiation [GO_0070133]
- 3653: negative regulation of mitochondrion organization [GO_0010823]
- 3654: negative regulation of mitotic cell cycle [GO_0045930]
- 3655: negative regulation of mitotic cell cycle DNA replication [GO_1903464]
- 3656: negative regulation of mitotic cell cycle, embryonic [GO_0045976]
- 3657: negative regulation of mitotic chromosome condensation [GO_1905213]
- 3658: negative regulation of mitotic nuclear division [GO_0045839]
- 3659: negative regulation of mitotic nuclear envelope disassembly [GO_1905558]
- 3660: negative regulation of mitotic sister chromatid segregation [GO_0033048]
- 3661: negative regulation of molecular function [GO_0044092]
- 3662: negative regulation of mononuclear cell proliferation [GO_0032945]
- 3663: negative regulation of monooxygenase activity [GO_0032769]
- 3664: negative regulation of morphogenesis of an epithelium [GO_1905331]
- 3665: negative regulation of motor neuron apoptotic process [GO_2000672]
- 3666: negative regulation of mRNA 3'-UTR binding [GO_1903838]
- 3667: negative regulation of mRNA binding [GO_1904572]
- 3668: negative regulation of mRNA catabolic process [GO_1902373]
- 3669: negative regulation of mRNA metabolic process [GO_1903312]
- 3670: negative regulation of mucus secretion [GO_0070256]
- 3671: negative regulation of multicellular organism growth [GO_0040015]
- 3672: negative regulation of multicellular organismal process [GO_0051241]
- 3673: negative regulation of muscle adaptation [GO_0014745]
- 3674: negative regulation of muscle cell apoptotic process [GO_0010656]
- 3675: negative regulation of muscle cell differentiation [GO_0051148]
- 3676: negative regulation of muscle contraction [GO_0045932]
- 3677: negative regulation of muscle hypertrophy [GO_0014741]
- 3678: negative regulation of muscle organ development [GO_0048635]
- 3679: negative regulation of muscle tissue development [GO_1901862]
- 3680: negative regulation of myeloid cell apoptotic process [GO_0033033]
- 3681: negative regulation of myeloid cell differentiation [GO_0045638]
- 3682: negative regulation of myeloid leukocyte differentiation [GO_0002762]
- 3683: negative regulation of myeloid leukocyte mediated immunity [GO_0002887]
- 3684: negative regulation of myeloid progenitor cell differentiation [GO_1905454]
- 3685: negative regulation of myoblast differentiation [GO_0045662]
- 3686: negative regulation of myoblast proliferation [GO_2000818]
- 3687: negative regulation of myosin light chain kinase activity [GO_0035506]
- 3688: negative regulation of myotube differentiation [GO_0010832]
- 3689: negative regulation of NAD+ ADP-ribosyltransferase activity [GO_1901665]
- 3690: negative regulation of NAD+ kinase activity [GO_0033671]
- 3691: negative regulation of negative chemotaxis [GO_0050925]
- 3692: negative regulation of nervous system development [GO_0051961]
- 3693: negative regulation of nervous system process [GO_0031645]
- 3694: negative regulation of netrin-activated signaling pathway [GO_1902842]
- 3695: negative regulation of neural crest cell differentiation [GO_1905293]
- 3696: negative regulation of neural crest formation [GO_0090301]
- 3697: negative regulation of neural precursor cell proliferation [GO_2000178]
- 3698: negative regulation of neural retina development [GO_0061076]
- 3699: negative regulation of neuroblast proliferation [GO_0007406]
- 3700: negative regulation of neurogenesis [GO_0050768]
- 3701: negative regulation of neuromuscular junction development [GO_1904397]
- 3702: negative regulation of neuron apoptotic process [GO_0043524]
- 3703: negative regulation of neuron death [GO_1901215]
- 3704: negative regulation of neuron differentiation [GO_0045665]
- 3705: negative regulation of neuron maturation [GO_0014043]
- 3706: negative regulation of neuron projection development [GO_0010977]
- 3707: negative regulation of neuronal action potential [GO_1904456]
- 3708: negative regulation of neurotransmitter secretion [GO_0046929]
- 3709: negative regulation of neurotransmitter transport [GO_0051589]
- 3710: negative regulation of neurotransmitter uptake [GO_0051581]
- 3711: negative regulation of nitric-oxide synthase activity [GO_0051001]
- 3712: negative regulation of nitrogen compound metabolic process [GO_0051172]
- 3713: negative regulation of NMDA glutamate receptor activity [GO_1904782]
- 3714: negative regulation of non-membrane spanning protein tyrosine kinase activity [GO_1903996]
- 3715: negative regulation of norepinephrine secretion [GO_0010700]
- 3716: negative regulation of norepinephrine uptake [GO_0051622]
- 3717: negative regulation of nuclear cell cycle DNA replication [GO_1902576]
- 3718: negative regulation of nuclear division [GO_0051784]
- 3719: negative regulation of nuclear migration along microtubule [GO_1902839]
- 3720: negative regulation of nuclease activity [GO_0032074]
- 3721: negative regulation of nucleic acid-templated transcription [GO_1903507]
- 3722: negative regulation of nucleobase-containing compound metabolic process [GO_0045934]
- 3723: negative regulation of nucleobase-containing compound transport [GO_0032240]
- 3724: negative regulation of nucleocytoplasmic transport [GO_0046823]
- 3725: negative regulation of nucleoside metabolic process [GO_0045978]
- 3726: negative regulation of nucleoside transport [GO_0032243]
- 3727: negative regulation of nucleotide biosynthetic process [GO_0030809]
- 3728: negative regulation of nucleotide metabolic process [GO_0045980]
- 3729: negative regulation of oligopeptide transport [GO_2000877]
- 3730: negative regulation of oocyte development [GO_0060283]
- 3731: negative regulation of oocyte maturation [GO_1900194]
- 3732: negative regulation of oogenesis [GO_1905880]
- 3733: negative regulation of organ growth [GO_0046621]
- 3734: negative regulation of organelle assembly [GO_1902116]
- 3735: negative regulation of organelle organization [GO_0010639]
- 3736: negative regulation of organic acid transport [GO_0032891]
- 3737: negative regulation of ossification [GO_0030279]
- 3738: negative regulation of oviposition [GO_1901045]
- 3739: negative regulation of oxidative phosphorylation [GO_0090324]
- 3740: negative regulation of oxidoreductase activity [GO_0051354]
- 3741: negative regulation of oxygen metabolic process [GO_2000375]
- 3742: negative regulation of P-type sodium:potassium-exchanging transporter activity [GO_1903407]
- 3743: negative regulation of pancreatic A cell differentiation [GO_2000227]
- 3744: negative regulation of peptidase activity [GO_0010466]
- 3745: negative regulation of peptide hormone secretion [GO_0090278]
- 3746: negative regulation of peptide secretion [GO_0002792]
- 3747: negative regulation of peptidyl-tyrosine phosphorylation [GO_0050732]
- 3748: negative regulation of peroxidase activity [GO_2000469]
- 3749: negative regulation of pharynx morphogenesis [GO_0110042]
- 3750: negative regulation of phosphatase activity [GO_0010923]
- 3751: negative regulation of phosphate metabolic process [GO_0045936]
- 3752: negative regulation of phosphate transmembrane transport [GO_2000186]
- 3753: negative regulation of phosphatidate phosphatase activity [GO_1903741]
- 3754: negative regulation of phosphatidylcholine biosynthetic process [GO_2001246]
- 3755: negative regulation of phosphatidylcholine metabolic process [GO_0150174]
- 3756: negative regulation of phosphatidylinositol 3-kinase activity [GO_0043553]
- 3757: negative regulation of phosphatidylinositol biosynthetic process [GO_0010512]
- 3758: negative regulation of phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO_0120140]
- 3759: negative regulation of phospholipase A2 activity [GO_1900138]
- 3760: negative regulation of phospholipase activity [GO_0010519]
- 3761: negative regulation of phospholipase C activity [GO_1900275]
- 3762: negative regulation of phospholipase D activity [GO_1904006]
- 3763: negative regulation of phospholipid biosynthetic process [GO_0071072]
- 3764: negative regulation of phospholipid metabolic process [GO_1903726]
- 3765: negative regulation of phospholipid scramblase activity [GO_1900162]
- 3766: negative regulation of phospholipid translocation [GO_0061093]
- 3767: negative regulation of phospholipid transport [GO_2001139]
- 3768: negative regulation of phosphoprotein phosphatase activity [GO_0032515]
- 3769: negative regulation of phosphorus metabolic process [GO_0010563]
- 3770: negative regulation of phosphorylation [GO_0042326]
- 3771: negative regulation of photoreceptor cell differentiation [GO_0046533]
- 3772: negative regulation of pigment cell differentiation [GO_0050941]
- 3773: negative regulation of placenta blood vessel development [GO_0110081]
- 3774: negative regulation of plasma membrane bounded cell projection assembly [GO_0120033]
- 3775: negative regulation of poly(A)-specific ribonuclease activity [GO_0106247]
- 3776: negative regulation of polyamine transmembrane transport [GO_1902268]
- 3777: negative regulation of polynucleotide adenylyltransferase activity [GO_1904246]
- 3778: negative regulation of polysome binding [GO_1905697]
- 3779: negative regulation of positive chemotaxis [GO_0050928]
- 3780: negative regulation of post-embryonic development [GO_0048581]
- 3781: negative regulation of post-transcriptional gene silencing [GO_0060149]
- 3782: negative regulation of post-transcriptional gene silencing by RNA [GO_1900369]
- 3783: negative regulation of potassium ion transmembrane transport [GO_1901380]
- 3784: negative regulation of potassium ion transmembrane transporter activity [GO_1901017]
- 3785: negative regulation of potassium ion transport [GO_0043267]
- 3786: negative regulation of presynapse assembly [GO_1905607]
- 3787: negative regulation of primary amine oxidase activity [GO_1902283]
- 3788: negative regulation of programmed cell death [GO_0043069]
- 3789: negative regulation of prostaglandin-E synthase activity [GO_2000362]
- 3790: negative regulation of proteasomal protein catabolic process [GO_1901799]
- 3791: negative regulation of protein ADP-ribosylation [GO_0010836]
- 3792: negative regulation of protein binding [GO_0032091]
- 3793: negative regulation of protein catabolic process [GO_0042177]
- 3794: negative regulation of protein catabolic process in the vacuole [GO_1904351]
- 3795: negative regulation of protein dephosphorylation [GO_0035308]
- 3796: negative regulation of protein depolymerization [GO_1901880]
- 3797: negative regulation of protein deubiquitination [GO_0090086]
- 3798: negative regulation of protein folding [GO_1903333]
- 3799: negative regulation of protein glycosylation [GO_0060051]
- 3800: negative regulation of protein homodimerization activity [GO_0090074]
- 3801: negative regulation of protein K48-linked deubiquitination [GO_1903094]
- 3802: negative regulation of protein K63-linked deubiquitination [GO_1903005]
- 3803: negative regulation of protein kinase activity [GO_0006469]
- 3804: negative regulation of protein localization [GO_1903828]
- 3805: negative regulation of protein localization to cell cortex [GO_1904777]
- 3806: negative regulation of protein localization to cell leading edge [GO_1905872]
- 3807: negative regulation of protein localization to cell periphery [GO_1904376]
- 3808: negative regulation of protein localization to cell-cell junction [GO_0150119]
- 3809: negative regulation of protein localization to chromatin [GO_0120186]
- 3810: negative regulation of protein localization to ciliary membrane [GO_1903568]
- 3811: negative regulation of protein localization to cilium [GO_1903565]
- 3812: negative regulation of protein localization to membrane [GO_1905476]
- 3813: negative regulation of protein localization to microtubule [GO_1902817]
- 3814: negative regulation of protein localization to nucleolus [GO_1904750]
- 3815: negative regulation of protein localization to nucleus [GO_1900181]
- 3816: negative regulation of protein localization to plasma membrane [GO_1903077]
- 3817: negative regulation of protein localization to presynapse [GO_1905385]
- 3818: negative regulation of protein metabolic process [GO_0051248]
- 3819: negative regulation of protein modification by small protein conjugation or removal [GO_1903321]
- 3820: negative regulation of protein modification process [GO_0031400]
- 3821: negative regulation of protein O-linked glycosylation [GO_1904099]
- 3822: negative regulation of protein phosphorylation [GO_0001933]
- 3823: negative regulation of protein polymerization [GO_0032272]
- 3824: negative regulation of protein secretion [GO_0050709]
- 3825: negative regulation of protein serine/threonine kinase activity [GO_0071901]
- 3826: negative regulation of protein serine/threonine phosphatase activity [GO_1905183]
- 3827: negative regulation of protein sumoylation [GO_0033234]
- 3828: negative regulation of protein transport [GO_0051224]
- 3829: negative regulation of protein tyrosine kinase activity [GO_0061099]
- 3830: negative regulation of protein tyrosine phosphatase activity [GO_1903614]
- 3831: negative regulation of protein ubiquitination [GO_0031397]
- 3832: negative regulation of protein-containing complex assembly [GO_0031333]
- 3833: negative regulation of protein-containing complex disassembly [GO_0043242]
- 3834: negative regulation of protein-glutamine gamma-glutamyltransferase activity [GO_0150075]
- 3835: negative regulation of proteolysis [GO_0045861]
- 3836: negative regulation of proteolysis involved in protein catabolic process [GO_1903051]
- 3837: negative regulation of proton-transporting ATP synthase activity, rotational mechanism [GO_1905272]
- 3838: negative regulation of purine nucleotide biosynthetic process [GO_1900372]
- 3839: negative regulation of purine nucleotide metabolic process [GO_1900543]
- 3840: negative regulation of pyrimidine nucleotide biosynthetic process [GO_1900398]
- 3841: negative regulation of pyruvate dehydrogenase activity [GO_1904183]
- 3842: negative regulation of pyruvate kinase activity [GO_1903303]
- 3843: negative regulation of reactive oxygen species metabolic process [GO_2000378]
- 3844: negative regulation of receptor binding [GO_1900121]
- 3845: negative regulation of receptor-mediated endocytosis [GO_0048261]
- 3846: negative regulation of release of sequestered calcium ion into cytosol [GO_0051280]
- 3847: negative regulation of removal of superoxide radicals [GO_1904832]
- 3848: negative regulation of reproductive process [GO_2000242]
- 3849: negative regulation of respiratory gaseous exchange [GO_1903941]
- 3850: negative regulation of response to alcohol [GO_1901420]
- 3851: negative regulation of response to biotic stimulus [GO_0002832]
- 3852: negative regulation of response to calcium ion [GO_1905946]
- 3853: negative regulation of response to cytokine stimulus [GO_0060761]
- 3854: negative regulation of response to DNA damage stimulus [GO_2001021]
- 3855: negative regulation of response to drug [GO_2001024]
- 3856: negative regulation of response to external stimulus [GO_0032102]
- 3857: negative regulation of response to extracellular stimulus [GO_0032105]
- 3858: negative regulation of response to nutrient levels [GO_0032108]
- 3859: negative regulation of response to oxidative stress [GO_1902883]
- 3860: negative regulation of response to reactive oxygen species [GO_1901032]
- 3861: negative regulation of response to stimulus [GO_0048585]
- 3862: negative regulation of response to wounding [GO_1903035]
- 3863: negative regulation of retina development in camera-type eye [GO_1902867]
- 3864: negative regulation of retinal cell programmed cell death [GO_0046671]
- 3865: negative regulation of retrograde trans-synaptic signaling by neuropeptide [GO_1905433]
- 3866: negative regulation of Rho-dependent protein serine/threonine kinase activity [GO_2000299]
- 3867: negative regulation of ribonuclease activity [GO_0060701]
- 3868: negative regulation of ribosome biogenesis [GO_0090071]
- 3869: negative regulation of RNA binding [GO_1905215]
- 3870: negative regulation of RNA biosynthetic process [GO_1902679]
- 3871: negative regulation of RNA catabolic process [GO_1902369]
- 3872: negative regulation of RNA helicase activity [GO_1902281]
- 3873: negative regulation of RNA metabolic process [GO_0051253]
- 3874: negative regulation of RNA polymerase I regulatory region sequence-specific DNA binding [GO_1901840]
- 3875: negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO_1903026]
- 3876: negative regulation of RNA polymerase III activity [GO_1903623]
- 3877: negative regulation of RNA splicing [GO_0033119]
- 3878: negative regulation of rRNA processing [GO_2000233]
- 3879: negative regulation of ryanodine-sensitive calcium-release channel activity [GO_0060315]
- 3880: negative regulation of saliva secretion [GO_1905747]
- 3881: negative regulation of sarcomere organization [GO_0060299]
- 3882: negative regulation of secondary metabolite biosynthetic process [GO_1900377]
- 3883: negative regulation of secretion [GO_0051048]
- 3884: negative regulation of secretion by cell [GO_1903531]
- 3885: negative regulation of secretory granule organization [GO_1904410]
- 3886: negative regulation of semaphorin-plexin signaling pathway [GO_2001261]
- 3887: negative regulation of sensory perception of bitter taste [GO_1904661]
- 3888: negative regulation of sensory perception of pain [GO_1904057]
- 3889: negative regulation of sensory perception of sweet taste [GO_1904657]
- 3890: negative regulation of sequestering of calcium ion [GO_0051283]
- 3891: negative regulation of serine C-palmitoyltransferase activity [GO_1904221]
- 3892: negative regulation of serine-type endopeptidase activity [GO_1900004]
- 3893: negative regulation of serine-type peptidase activity [GO_1902572]
- 3894: negative regulation of serotonin biosynthetic process [GO_1905628]
- 3895: negative regulation of serotonin secretion [GO_0014063]
- 3896: negative regulation of serotonin uptake [GO_0051612]
- 3897: negative regulation of signal transduction [GO_0009968]
- 3898: negative regulation of signaling [GO_0023057]
- 3899: negative regulation of signaling receptor activity [GO_2000272]
- 3900: negative regulation of sister chromatid segregation [GO_0033046]
- 3901: negative regulation of skeletal muscle cell differentiation [GO_2001015]
- 3902: negative regulation of skeletal muscle cell proliferation [GO_0014859]
- 3903: negative regulation of skeletal muscle fiber development [GO_0048744]
- 3904: negative regulation of skeletal muscle fiber differentiation [GO_1902810]
- 3905: negative regulation of skeletal muscle hypertrophy [GO_1904205]
- 3906: negative regulation of skeletal muscle tissue development [GO_0048642]
- 3907: negative regulation of skeletal muscle tissue growth [GO_0048632]
- 3908: negative regulation of small GTPase binding [GO_1904476]
- 3909: negative regulation of small intestine smooth muscle contraction [GO_1904348]
- 3910: negative regulation of small molecule metabolic process [GO_0062014]
- 3911: negative regulation of smooth muscle cell apoptotic process [GO_0034392]
- 3912: negative regulation of smooth muscle cell differentiation [GO_0051151]
- 3913: negative regulation of smooth muscle cell proliferation [GO_0048662]
- 3914: negative regulation of smooth muscle contraction [GO_0045986]
- 3915: negative regulation of smooth muscle hypertrophy [GO_1905148]
- 3916: negative regulation of smooth muscle tissue development [GO_1905900]
- 3917: negative regulation of sodium ion transmembrane transport [GO_1902306]
- 3918: negative regulation of sodium ion transmembrane transporter activity [GO_2000650]
- 3919: negative regulation of sodium ion transport [GO_0010766]
- 3920: negative regulation of sodium:proton antiporter activity [GO_0032416]
- 3921: negative regulation of somatic stem cell division [GO_1904676]
- 3922: negative regulation of somatostatin secretion [GO_0090275]
- 3923: negative regulation of stem cell differentiation [GO_2000737]
- 3924: negative regulation of stem cell proliferation [GO_2000647]
- 3925: negative regulation of steroid biosynthetic process [GO_0010894]
- 3926: negative regulation of steroid hormone secretion [GO_2000832]
- 3927: negative regulation of steroid metabolic process [GO_0045939]
- 3928: negative regulation of sterol transport [GO_0032372]
- 3929: negative regulation of stomach neuroendocrine cell differentiation [GO_0061106]
- 3930: negative regulation of store-operated calcium channel activity [GO_1901340]
- 3931: negative regulation of stress-activated MAPK cascade [GO_0032873]
- 3932: negative regulation of stress-activated protein kinase signaling cascade [GO_0070303]
- 3933: negative regulation of striated muscle cell apoptotic process [GO_0010664]
- 3934: negative regulation of striated muscle cell differentiation [GO_0051154]
- 3935: negative regulation of striated muscle contraction [GO_0045988]
- 3936: negative regulation of striated muscle tissue development [GO_0045843]
- 3937: negative regulation of succinate dehydrogenase activity [GO_1904230]
- 3938: negative regulation of sulfur amino acid metabolic process [GO_0031336]
- 3939: negative regulation of sulfur metabolic process [GO_0051175]
- 3940: negative regulation of SUMO transferase activity [GO_1903183]
- 3941: negative regulation of superoxide dismutase activity [GO_1901670]
- 3942: negative regulation of supramolecular fiber organization [GO_1902904]
- 3943: negative regulation of synapse assembly [GO_0051964]
- 3944: negative regulation of synapse organization [GO_1905809]
- 3945: negative regulation of synapse pruning [GO_1905807]
- 3946: negative regulation of synaptic transmission [GO_0050805]
- 3947: negative regulation of synaptic transmission, cholinergic [GO_0032223]
- 3948: negative regulation of synaptic transmission, dopaminergic [GO_0032227]
- 3949: negative regulation of synaptic transmission, GABAergic [GO_0032229]
- 3950: negative regulation of synaptic transmission, glutamatergic [GO_0051967]
- 3951: negative regulation of synaptic transmission, glycinergic [GO_0060093]
- 3952: negative regulation of syncytium formation by plasma membrane fusion [GO_0034242]
- 3953: negative regulation of tau-protein kinase activity [GO_1902948]
- 3954: negative regulation of telomerase activity [GO_0051974]
- 3955: negative regulation of telomeric DNA binding [GO_1904743]
- 3956: negative regulation of termination of DNA-templated transcription [GO_0060567]
- 3957: negative regulation of tetrapyrrole biosynthetic process [GO_1901464]
- 3958: negative regulation of tetrapyrrole catabolic process [GO_1901405]
- 3959: negative regulation of tetrapyrrole metabolic process [GO_1901402]
- 3960: negative regulation of thioredoxin peroxidase activity [GO_1903124]
- 3961: negative regulation of threonine-tRNA ligase activity [GO_1905022]
- 3962: negative regulation of transcription by RNA polymerase I [GO_0016479]
- 3963: negative regulation of transcription by RNA polymerase II [GO_0000122]
- 3964: negative regulation of transcription by RNA polymerase III [GO_0016480]
- 3965: negative regulation of transcription regulatory region DNA binding [GO_2000678]
- 3966: negative regulation of transferase activity [GO_0051348]
- 3967: negative regulation of translation [GO_0017148]
- 3968: negative regulation of translation in response to oxidative stress [GO_0032938]
- 3969: negative regulation of translation in response to stress [GO_0032055]
- 3970: negative regulation of translational elongation [GO_0045900]
- 3971: negative regulation of translational initiation [GO_0045947]
- 3972: negative regulation of translational initiation in response to stress [GO_0032057]
- 3973: negative regulation of translational termination [GO_0045904]
- 3974: negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway [GO_0090101]
- 3975: negative regulation of transmembrane transport [GO_0034763]
- 3976: negative regulation of transmission of nerve impulse [GO_0051970]
- 3977: negative regulation of transport [GO_0051051]
- 3978: negative regulation of transporter activity [GO_0032410]
- 3979: negative regulation of triglyceride biosynthetic process [GO_0010868]
- 3980: negative regulation of triglyceride metabolic process [GO_0090209]
- 3981: negative regulation of tRNA metabolic process [GO_1903327]
- 3982: negative regulation of tRNA processing [GO_2000236]
- 3983: negative regulation of trophectodermal cell proliferation [GO_1904074]
- 3984: negative regulation of tube lumen cavitation [GO_1903133]
- 3985: negative regulation of turning behavior involved in mating [GO_0061096]
- 3986: negative regulation of type B pancreatic cell apoptotic process [GO_2000675]
- 3987: negative regulation of type B pancreatic cell development [GO_2000077]
- 3988: negative regulation of type B pancreatic cell proliferation [GO_1904691]
- 3989: negative regulation of tyrosinase activity [GO_0032772]
- 3990: negative regulation of tyrosine 3-monooxygenase activity [GO_1903177]
- 3991: negative regulation of ubiquitin protein ligase activity [GO_1904667]
- 3992: negative regulation of ubiquitin-dependent protein catabolic process [GO_2000059]
- 3993: negative regulation of ubiquitin-protein transferase activity [GO_0051444]
- 3994: negative regulation of ubiquitin-specific protease activity [GO_2000157]
- 3995: negative regulation of vacuolar transport [GO_1903336]
- 3996: negative regulation of vascular associated smooth muscle cell apoptotic process [GO_1905460]
- 3997: negative regulation of vascular associated smooth muscle cell differentiation [GO_1905064]
- 3998: negative regulation of vascular associated smooth muscle cell proliferation [GO_1904706]
- 3999: negative regulation of vascular endothelial cell proliferation [GO_1905563]
- 4000: negative regulation of vasculature development [GO_1901343]
- 4001: negative regulation of vasculogenesis [GO_2001213]
- 4002: negative regulation of vesicle fusion [GO_0031339]
- 4003: negative regulation of vesicle fusion with Golgi apparatus [GO_0106215]
- 4004: negative regulation of vesicle transport along microtubule [GO_1901609]
- 4005: negative regulation of vessel branching [GO_1905554]
- 4006: negative regulation of vitamin metabolic process [GO_0046137]
- 4007: negative regulation of voltage-gated calcium channel activity [GO_1901386]
- 4008: negative regulation of voltage-gated chloride channel activity [GO_1902942]
- 4009: negative regulation of voltage-gated potassium channel activity [GO_1903817]
- 4010: negative regulation of voltage-gated sodium channel activity [GO_1905151]
- 4011: negative regulation of water channel activity [GO_1902428]
- 4012: negative regulation of Wnt signaling pathway [GO_0030178]
- 4013: negative regulation of wound healing [GO_0061045]
- 4014: negative regulation of zinc ion transmembrane transport [GO_0071583]
- 4015: negative regulation of zinc ion transport [GO_0071582]
- 4016: NEIL1,NEIL2 incises DNA strand 5' to the AP site [GO_0003906]
- 4017: NEIL3 cleaves 5-guanidinohydantoin [GO_0019104]
- 4018: nephrocyte filtration [GO_0097206]
- 4019: nerve development [GO_0021675]
- 4020: nerve maturation [GO_0021682]
- 4021: nervous system development [GO_0007399]
- 4022: nervous system process [GO_0050877]
- 4023: netrin receptor activity [GO_0005042]
- 4024: netrin receptor activity involved in chemoattraction [GO_0038006]
- 4025: netrin receptor activity involved in chemorepulsion [GO_0005043]
- 4026: netrin-activated signaling pathway [GO_0038007]
- 4027: network-forming collagen trimer [GO_0098642]
- 4028: neural crest cell development [GO_0014032]
- 4029: neural crest cell differentiation [GO_0014033]
- 4030: neural crest formation [GO_0014029]
- 4031: neural fold formation [GO_0001842]
- 4032: neural keel formation [GO_0014025]
- 4033: neural nucleus development [GO_0048857]
- 4034: neural plate anterior/posterior regionalization [GO_0021999]
- 4035: neural plate development [GO_0001840]
- 4036: neural plate formation [GO_0021990]
- 4037: neural plate morphogenesis [GO_0001839]
- 4038: neural plate pattern specification [GO_0060896]
- 4039: neural plate regionalization [GO_0060897]
- 4040: neural precursor cell proliferation [GO_0061351]
- 4041: neural retina development [GO_0003407]
- 4042: neural rod cavitation [GO_0014024]
- 4043: neural rod formation [GO_0014023]
- 4044: neural tube development [GO_0021915]
- 4045: neural tube formation [GO_0001841]
- 4046: neural tube patterning [GO_0021532]
- 4047: neurexin family protein binding [GO_0042043]
- 4048: neuroblast development [GO_0014019]
- 4049: neuroblast differentiation [GO_0014016]
- 4050: neuroblast division [GO_0055057]
- 4051: neuroblast proliferation [GO_0007405]
- 4052: neuroendocrine cell differentiation [GO_0061101]
- 4053: neuroepithelial cell differentiation [GO_0060563]
- 4054: neurogenesis [GO_0022008]
- 4055: neuroligin family protein binding [GO_0097109]
- 4056: neuromedin U binding [GO_0042924]
- 4057: neuromedin U receptor activity [GO_0001607]
- 4058: neuromuscular junction [GO_0031594]
- 4059: neuromuscular junction development [GO_0007528]
- 4060: neuromuscular junction of myotube [GO_0098523]
- 4061: neuromuscular process [GO_0050905]
- 4062: neuromuscular process controlling balance [GO_0050885]
- 4063: neuromuscular process controlling posture [GO_0050884]
- 4064: neuron apoptotic process [GO_0051402]
- 4065: neuron cellular homeostasis [GO_0070050]
- 4066: neuron death [GO_0070997]
- 4067: neuron development [GO_0048666]
- 4068: neuron differentiation [GO_0030182]
- 4069: neuron maturation [GO_0042551]
- 4070: neuron projection [GO_0043005]
- 4071: neuron projection cytoplasm [GO_0120111]
- 4072: neuron projection development [GO_0031175]
- 4073: neuron projection guidance [GO_0097485]
- 4074: neuron projection membrane [GO_0032589]
- 4075: neuron projection morphogenesis [GO_0048812]
- 4076: neuron projection organization [GO_0106027]
- 4077: neuron-glial cell signaling [GO_0150099]
- 4078: neuron-neuron synaptic transmission [GO_0007270]
- 4079: neuronal action potential [GO_0019228]
- 4080: neuronal cell body [GO_0043025]
- 4081: neuropeptide activity [GO_0160041]
- 4082: neuropeptide binding [GO_0042923]
- 4083: neuropeptide F receptor activity [GO_0042263]
- 4084: neuropeptide F receptor binding [GO_0071859]
- 4085: neuropeptide hormone activity [GO_0005184]
- 4086: neuropeptide receptor activity [GO_0008188]
- 4087: neuropeptide receptor binding [GO_0071855]
- 4088: neuropeptide signaling pathway [GO_0007218]
- 4089: neuropeptide Y receptor activity [GO_0004983]
- 4090: neurotransmitter binding [GO_0042165]
- 4091: neurotransmitter receptor activity [GO_0030594]
- 4092: neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential [GO_0099529]
- 4093: neurotransmitter receptor regulator activity [GO_0099602]
- 4094: neurotransmitter reuptake [GO_0098810]
- 4095: neurotransmitter secretion [GO_0007269]
- 4096: neurotransmitter transport [GO_0006836]
- 4097: neurotransmitter uptake [GO_0001504]
- 4098: neurotransmitter:sodium symporter activity [GO_0005328]
- 4099: neurotrophin binding [GO_0043121]
- 4100: neurotrophin receptor activity [GO_0005030]
- 4101: neurotrophin signaling pathway [GO_0038179]
- 4102: neutral amino acid transmembrane transporter activity [GO_0015175]
- 4103: neutral amino acid transport [GO_0015804]
- 4104: neutral lipid biosynthetic process [GO_0046460]
- 4105: neutral lipid metabolic process [GO_0006638]
- 4106: NF-kappaB binding [GO_0051059]
- 4107: nicotinamidase activity [GO_0008936]
- 4108: nicotinate phosphoribosyltransferase activity [GO_0004516]
- 4109: nitric-oxide synthase activity [GO_0004517]
- 4110: nitric-oxide synthase binding [GO_0050998]
- 4111: nitric-oxide synthase inhibitor activity [GO_0036487]
- 4112: nitric-oxide synthase regulator activity [GO_0030235]
- 4113: nitrite reductase (NO-forming) activity [GO_0050421]
- 4114: nitrite reductase activity [GO_0098809]
- 4115: nitrogen compound metabolic process [GO_0006807]
- 4116: nitrogen compound transport [GO_0071705]
- 4117: NMDA glutamate receptor activity [GO_0004972]
- 4118: NMNAT1 transfers an adenylyl group from ATP to NAMN to yield NAAD [GO_0004515]
- 4119: NMNAT2 transfers an adenylyl group from ATP to NMN to yield NAD+ [GO_0000309]
- 4120: NMRK2 phosphorylates NR to yield NMN [GO_0050262]
- 4121: non-membrane spanning protein tyrosine phosphatase activity [GO_0004726]
- 4122: non-membrane-bounded organelle [GO_0043228]
- 4123: non-membrane-bounded organelle assembly [GO_0140694]
- 4124: non-ribosomal peptide synthetase activity [GO_1904091]
- 4125: nonribosomal peptide biosynthetic process [GO_0019184]
- 4126: NOP2 (NSUN1) methylates cytidine-4447 of 28S rRNA yielding 5-methylcytidine-4447 [GO_0009383]
- 4127: Noradrenaline clearance from the synaptic cleft [GO_0005326]
- 4128: norepinephrine binding [GO_0051380]
- 4129: norepinephrine biosynthetic process [GO_0042421]
- 4130: norepinephrine catabolic process [GO_0042422]
- 4131: norepinephrine metabolic process [GO_0042415]
- 4132: norepinephrine secretion [GO_0048243]
- 4133: norepinephrine transport [GO_0015874]
- 4134: norepinephrine uptake [GO_0051620]
- 4135: Notch binding [GO_0005112]
- 4136: notochord development [GO_0030903]
- 4137: notochord formation [GO_0014028]
- 4138: notochord morphogenesis [GO_0048570]
- 4139: NOX3 complex:RAC1:GTP generates superoxide from oxygen [GO_0016175]
- 4140: NRAMP1 transports divalent metal ions across phagosomal membranes of macrophages [GO_0051139]
- 4141: NSF-dependent ATP hydrolysis disassembles the cis-SNARE at the TGN [GO_0016887]
- 4142: nsp12 transfers guanylyl onto SARS-CoV-2 plus strand subgenomic RNAs [GO_0004484]
- 4143: nsp13 helicase melts secondary structures in SARS-CoV-2 genomic RNA template [GO_0032574]
- 4144: nsp14 acts as a 3'-to-5' exonuclease to remove misincorporated nucleotides from nascent RNA [GO_0000175]
- 4145: nsp3-4 cleaves itself [GO_0004197]
- 4146: NSUN2 methylates cytidine-34, cytidine-48 of unspliced tRNA(Leu)(CAA) [GO_0016428]
- 4147: NTPDase2 hydrolyzes nucleoside triphosphates [GO_0017111]
- 4148: nuclear chromosome [GO_0000228]
- 4149: nuclear chromosome segregation [GO_0098813]
- 4150: nuclear division [GO_0000280]
- 4151: nuclear DNA replication [GO_0033260]
- 4152: nuclear DNA replication DNA duplex unwinding [GO_1902320]
- 4153: Nuclear DUSPs dephosphorylate MAPKs [GO_0008138]
- 4154: nuclear envelope [GO_0005635]
- 4155: nuclear envelope organization [GO_0006998]
- 4156: nuclear export [GO_0051168]
- 4157: nuclear export signal receptor activity [GO_0005049]
- 4158: nuclear fragmentation involved in apoptotic nuclear change [GO_0030264]
- 4159: nuclear glucocorticoid receptor binding [GO_0035259]
- 4160: nuclear import signal receptor activity [GO_0061608]
- 4161: nuclear localization sequence binding [GO_0008139]
- 4162: nuclear lumen [GO_0031981]
- 4163: nuclear membrane [GO_0031965]
- 4164: nuclear membrane biogenesis [GO_0101025]
- 4165: nuclear membrane disassembly [GO_0051081]
- 4166: nuclear membrane fusion [GO_0000740]
- 4167: nuclear membrane fusion involved in karyogamy [GO_0048288]
- 4168: nuclear membrane organization [GO_0071763]
- 4169: nuclear microtubule [GO_0005880]
- 4170: nuclear migration [GO_0007097]
- 4171: nuclear migration along microfilament [GO_0031022]
- 4172: nuclear migration along microtubule [GO_0030473]
- 4173: nuclear outer membrane [GO_0005640]
- 4174: nuclear outer membrane organization [GO_0071764]
- 4175: nuclear outer membrane-endoplasmic reticulum membrane network [GO_0042175]
- 4176: nuclear pore [GO_0005643]
- 4177: nuclear protein-containing complex [GO_0140513]
- 4178: nuclear receptor activity [GO_0004879]
- 4179: nuclear receptor binding [GO_0016922]
- 4180: nuclear receptor coactivator activity [GO_0030374]
- 4181: nuclear receptor corepressor activity [GO_0140536]
- 4182: nuclear steroid receptor activity [GO_0003707]
- 4183: nuclear transport [GO_0051169]
- 4184: nuclease activity [GO_0004518]
- 4185: nuclease inhibitor activity [GO_0140721]
- 4186: nucleate erythrocyte development [GO_0048823]
- 4187: nucleate erythrocyte differentiation [GO_0043363]
- 4188: nucleate erythrocyte maturation [GO_0043362]
- 4189: nucleic acid binding [GO_0003676]
- 4190: nucleic acid metabolic process [GO_0090304]
- 4191: nucleic acid phosphodiester bond hydrolysis [GO_0090305]
- 4192: nucleic acid transmembrane transporter activity [GO_0051032]
- 4193: nucleic acid transport [GO_0050657]
- 4194: nucleic acid-templated transcription [GO_0097659]
- 4195: nucleobase binding [GO_0002054]
- 4196: nucleobase biosynthetic process [GO_0046112]
- 4197: nucleobase catabolic process [GO_0046113]
- 4198: nucleobase metabolic process [GO_0009112]
- 4199: nucleobase transmembrane transporter activity [GO_0015205]
- 4200: nucleobase transport [GO_0015851]
- 4201: nucleobase-containing compound biosynthetic process [GO_0034654]
- 4202: nucleobase-containing compound catabolic process [GO_0034655]
- 4203: nucleobase-containing compound kinase activity [GO_0019205]
- 4204: nucleobase-containing compound metabolic process [GO_0006139]
- 4205: nucleobase-containing compound transmembrane transporter activity [GO_0015932]
- 4206: nucleobase-containing compound transport [GO_0015931]
- 4207: nucleobase-containing small molecule catabolic process [GO_0034656]
- 4208: nucleobase-containing small molecule metabolic process [GO_0055086]
- 4209: nucleocytoplasmic carrier activity [GO_0140142]
- 4210: nucleocytoplasmic transport [GO_0006913]
- 4211: nucleoid [GO_0009295]
- 4212: nucleologenesis [GO_0017126]
- 4213: nucleolus [GO_0005730]
- 4214: nucleolus organization [GO_0007000]
- 4215: nucleoside binding [GO_0001882]
- 4216: nucleoside catabolic process [GO_0009164]
- 4217: nucleoside diphosphate metabolic process [GO_0009132]
- 4218: nucleoside diphosphate phosphatase activity [GO_0017110]
- 4219: nucleoside diphosphate phosphorylation [GO_0006165]
- 4220: nucleoside kinase activity [GO_0019206]
- 4221: nucleoside metabolic process [GO_0009116]
- 4222: nucleoside monophosphate biosynthetic process [GO_0009124]
- 4223: nucleoside monophosphate metabolic process [GO_0009123]
- 4224: nucleoside monophosphate phosphorylation [GO_0046940]
- 4225: nucleoside phosphate binding [GO_1901265]
- 4226: nucleoside phosphate biosynthetic process [GO_1901293]
- 4227: nucleoside phosphate metabolic process [GO_0006753]
- 4228: nucleoside transmembrane transport [GO_1901642]
- 4229: nucleoside transport [GO_0015858]
- 4230: nucleoside triphosphate adenylate kinase activity [GO_0046899]
- 4231: nucleoside triphosphate biosynthetic process [GO_0009142]
- 4232: nucleoside triphosphate diphosphatase activity [GO_0047429]
- 4233: nucleoside triphosphate metabolic process [GO_0009141]
- 4234: nucleoside-triphosphatase regulator activity [GO_0060589]
- 4235: nucleosomal DNA binding [GO_0031492]
- 4236: nucleosome [GO_0000786]
- 4237: nucleosome array spacer activity [GO_0140750]
- 4238: nucleosome binding [GO_0031491]
- 4239: nucleotidase activity [GO_0008252]
- 4240: nucleotide binding [GO_0000166]
- 4241: nucleotide biosynthetic process [GO_0009165]
- 4242: nucleotide metabolic process [GO_0009117]
- 4243: nucleotide phosphorylation [GO_0046939]
- 4244: nucleotide transmembrane transport [GO_1901679]
- 4245: nucleotide transmembrane transporter activity [GO_0015215]
- 4246: nucleotide transport [GO_0006862]
- 4247: nucleotide-sugar transmembrane transport [GO_0015780]
- 4248: nucleotide-sugar transmembrane transporter activity [GO_0005338]
- 4249: nucleus [GO_0005634]
- 4250: nucleus disassembly [GO_1905690]
- 4251: nucleus localization [GO_0051647]
- 4252: nucleus organization [GO_0006997]
- 4253: NUDT12 hydrolyses NADH to NMNH [GO_0035529]
- 4254: NUDT16 hydrolyses IDP to IMP [GO_1990003]
- 4255: NUDT18 hydrolyses 8-oxo-dGDP to 8-oxo-dGMP [GO_0044715]
- 4256: nutrient reservoir activity [GO_0045735]
- 4257: O-acetyltransferase activity [GO_0016413]
- 4258: O-glycosylation of 3a is terminated [GO_0008373]
- 4259: O-linoleoyltransferase activity [GO_0032576]
- 4260: O-methyltransferase activity [GO_0008171]
- 4261: O-phospho-L-serine:2-oxoglutarate aminotransferase activity [GO_0004648]
- 4262: OCT1 transports organic cations out of hepatic cells [GO_0015101]
- 4263: octanol dehydrogenase activity [GO_0004552]
- 4264: octanoyltransferase activity [GO_0016415]
- 4265: octopamine receptor activity [GO_0004989]
- 4266: octopamine secretion [GO_0061539]
- 4267: octopamine secretion, neurotransmission [GO_0061540]
- 4268: odorant binding [GO_0005549]
- 4269: olefinic compound metabolic process [GO_0120254]
- 4270: olfactory behavior [GO_0042048]
- 4271: olfactory learning [GO_0008355]
- 4272: olfactory receptor activity [GO_0004984]
- 4273: oligopeptidase activity [GO_0070012]
- 4274: oligopeptide binding [GO_1900750]
- 4275: oligopeptide transmembrane transport [GO_0035672]
- 4276: oligopeptide transmembrane transporter activity [GO_0035673]
- 4277: oligopeptide transport [GO_0006857]
- 4278: oligosaccharide metabolic process [GO_0009311]
- 4279: oligosaccharide transmembrane transporter activity [GO_0015157]
- 4280: oligosaccharide transport [GO_0015772]
- 4281: oligosaccharide-lipid intermediate biosynthetic process [GO_0006490]
- 4282: oligosaccharyl transferase activity [GO_0004576]
- 4283: OMA1 hydrolyses OPA1 [GO_0004222]
- 4284: omega peptidase activity [GO_0008242]
- 4285: one-carbon compound transport [GO_0019755]
- 4286: oocyte construction [GO_0007308]
- 4287: oocyte development [GO_0048599]
- 4288: oocyte differentiation [GO_0009994]
- 4289: oocyte growth [GO_0001555]
- 4290: oocyte localization involved in germarium-derived egg chamber formation [GO_0030720]
- 4291: oocyte maturation [GO_0001556]
- 4292: oocyte microtubule cytoskeleton organization [GO_0016325]
- 4293: oocyte morphogenesis [GO_0048601]
- 4294: oogenesis [GO_0048477]
- 4295: ooplasm [GO_1990917]
- 4296: opsin binding [GO_0002046]
- 4297: optic cup morphogenesis involved in camera-type eye development [GO_0002072]
- 4298: optic vesicle formation [GO_0003403]
- 4299: optic vesicle morphogenesis [GO_0003404]
- 4300: optokinetic behavior [GO_0007634]
- 4301: optomotor response [GO_0071632]
- 4302: organ growth [GO_0035265]
- 4303: organ or tissue specific immune response [GO_0002251]
- 4304: organellar ribosome [GO_0000313]
- 4305: organelle [GO_0043226]
- 4306: organelle assembly [GO_0070925]
- 4307: organelle disassembly [GO_1903008]
- 4308: organelle envelope [GO_0031967]
- 4309: organelle fission [GO_0048285]
- 4310: organelle fusion [GO_0048284]
- 4311: organelle inheritance [GO_0048308]
- 4312: organelle localization [GO_0051640]
- 4313: organelle localization by membrane tethering [GO_0140056]
- 4314: organelle lumen [GO_0043233]
- 4315: organelle membrane [GO_0031090]
- 4316: organelle membrane fusion [GO_0090174]
- 4317: organelle organization [GO_0006996]
- 4318: organelle outer membrane [GO_0031968]
- 4319: organelle transport along microtubule [GO_0072384]
- 4320: organic acid binding [GO_0043177]
- 4321: organic acid biosynthetic process [GO_0016053]
- 4322: organic acid catabolic process [GO_0016054]
- 4323: organic acid metabolic process [GO_0006082]
- 4324: organic acid transmembrane transport [GO_1903825]
- 4325: organic acid transmembrane transporter activity [GO_0005342]
- 4326: organic acid transport [GO_0015849]
- 4327: organic anion transport [GO_0015711]
- 4328: organic cation transport [GO_0015695]
- 4329: organic cyclic compound binding [GO_0097159]
- 4330: organic cyclic compound biosynthetic process [GO_1901362]
- 4331: organic cyclic compound catabolic process [GO_1901361]
- 4332: organic cyclic compound metabolic process [GO_1901360]
- 4333: organic hydroxy compound biosynthetic process [GO_1901617]
- 4334: organic hydroxy compound catabolic process [GO_1901616]
- 4335: organic hydroxy compound metabolic process [GO_1901615]
- 4336: organic hydroxy compound transmembrane transporter activity [GO_1901618]
- 4337: organic hydroxy compound transport [GO_0015850]
- 4338: organic substance biosynthetic process [GO_1901576]
- 4339: organic substance catabolic process [GO_1901575]
- 4340: organic substance metabolic process [GO_0071704]
- 4341: organic substance transport [GO_0071702]
- 4342: organism emergence from protective structure [GO_0071684]
- 4343: organonitrogen compound biosynthetic process [GO_1901566]
- 4344: organonitrogen compound catabolic process [GO_1901565]
- 4345: organonitrogen compound metabolic process [GO_1901564]
- 4346: organophosphate biosynthetic process [GO_0090407]
- 4347: organophosphate ester transmembrane transporter activity [GO_0015605]
- 4348: organophosphate ester transport [GO_0015748]
- 4349: organophosphate metabolic process [GO_0019637]
- 4350: organophosphate:inorganic phosphate antiporter activity [GO_0015315]
- 4351: ornithine (cytosolic) + citrulline (mitochondrial) => ornithine (mitochondrial) + citrulline (cytosolic) [GO_0000064]
- 4352: ornithine => putrescine + CO2 [GO_0004586]
- 4353: ornithine decarboxylase activator activity [GO_0042978]
- 4354: ornithine decarboxylase inhibitor activity [GO_0008073]
- 4355: ornithine decarboxylase regulator activity [GO_0042979]
- 4356: ornithine transport [GO_0015822]
- 4357: ornithine-oxo-acid transaminase activity [GO_0004587]
- 4358: orotidine-5'-phosphate decarboxylase activity [GO_0004590]
- 4359: osmosensor activity [GO_0005034]
- 4360: ossification [GO_0001503]
- 4361: ossification involved in bone maturation [GO_0043931]
- 4362: outer membrane [GO_0019867]
- 4363: outflow tract morphogenesis [GO_0003151]
- 4364: outflow tract septum morphogenesis [GO_0003148]
- 4365: outward rectifier potassium channel activity [GO_0015271]
- 4366: outward rectifier potassium channel inhibitor activity [GO_0140628]
- 4367: oviduct development [GO_0060066]
- 4368: oviduct epithelium development [GO_0035846]
- 4369: oviduct morphogenesis [GO_0035848]
- 4370: oviposition [GO_0018991]
- 4371: ovulation cycle [GO_0042698]
- 4372: ovulation cycle process [GO_0022602]
- 4373: oxalate transmembrane transporter activity [GO_0019531]
- 4374: oxalate transport [GO_0019532]
- 4375: oxaloacetate + GTP => phosphoenolpyruvate + GDP + CO2 [cytosol] [GO_0004613]
- 4376: oxaloacetate transmembrane transporter activity [GO_0015131]
- 4377: oxaloacetate transport [GO_0015729]
- 4378: oxaloacetate(2-) transmembrane transport [GO_1902356]
- 4379: oxidative DNA demethylase activity [GO_0035516]
- 4380: oxidative phosphorylation [GO_0006119]
- 4381: oxidized base lesion DNA N-glycosylase activity [GO_0000702]
- 4382: oxidized DNA binding [GO_0032356]
- 4383: oxidized purine DNA binding [GO_0032357]
- 4384: oxidoreductase activity, acting on a heme group of donors [GO_0016675]
- 4385: oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor [GO_0016671]
- 4386: oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor [GO_0016668]
- 4387: oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor [GO_0016670]
- 4388: oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor [GO_0016672]
- 4389: oxidoreductase activity, acting on CH or CH2 groups [GO_0016725]
- 4390: oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor [GO_0016728]
- 4391: oxidoreductase activity, acting on diphenols and related substances as donors [GO_0016679]
- 4392: oxidoreductase activity, acting on diphenols and related substances as donors, oxygen as acceptor [GO_0016682]
- 4393: oxidoreductase activity, acting on iron-sulfur proteins as donors [GO_0016730]
- 4394: oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor [GO_0016731]
- 4395: oxidoreductase activity, acting on metal ions, oxygen as acceptor [GO_0016724]
- 4396: oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor [GO_0016653]
- 4397: oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor [GO_0016657]
- 4398: oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor [GO_0050664]
- 4399: oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO_0016655]
- 4400: oxidoreductase activity, acting on other nitrogenous compounds as donors [GO_0016661]
- 4401: oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor [GO_0016662]
- 4402: oxidoreductase activity, acting on other nitrogenous compounds as donors, oxygen as acceptor [GO_0016663]
- 4403: oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen [GO_0016705]
- 4404: oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen [GO_0016716]
- 4405: oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen [GO_0016709]
- 4406: oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen [GO_0016715]
- 4407: oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen [GO_0016713]
- 4408: oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen [GO_0016714]
- 4409: oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water [GO_0016717]
- 4410: oxidoreductase activity, acting on peroxide as acceptor [GO_0016684]
- 4411: oxidoreductase activity, acting on single donors with incorporation of molecular oxygen [GO_0016701]
- 4412: oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases) [GO_0016703]
- 4413: oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO_0016702]
- 4414: oxidoreductase activity, acting on superoxide radicals as acceptor [GO_0016721]
- 4415: oxidoreductase activity, acting on the aldehyde or oxo group of donors [GO_0016903]
- 4416: oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor [GO_0016624]
- 4417: oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor [GO_0016623]
- 4418: oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor [GO_0016634]
- 4419: oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor [GO_0016635]
- 4420: oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor [GO_0052890]
- 4421: oxidoreductase activity, acting on the CH-NH group of donors [GO_0016645]
- 4422: oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor [GO_0016646]
- 4423: oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor [GO_0016647]
- 4424: oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor [GO_0016649]
- 4425: oxidoreductase activity, acting on the CH-NH2 group of donors [GO_0016638]
- 4426: oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor [GO_0016639]
- 4427: oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor [GO_0016641]
- 4428: oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor [GO_0016899]
- 4429: oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor [GO_0016901]
- 4430: oxidoreduction-driven active transmembrane transporter activity [GO_0015453]
- 4431: oxoacid metabolic process [GO_0043436]
- 4432: oxoglutarate dehydrogenase (succinyl-transferring) activity [GO_0004591]
- 4433: oxygen binding [GO_0019825]
- 4434: oxygen carrier activity [GO_0005344]
- 4435: oxygen homeostasis [GO_0032364]
- 4436: oxygen metabolic process [GO_0072592]
- 4437: oxygen transport [GO_0015671]
- 4438: p-AMPK phosphorylates TSC1:TSC2 [GO_0004679]
- 4439: P-element binding [GO_0003693]
- 4440: p-hydroxyphenylpyruvate + glutamate <=> tyrosine + alpha-ketoglutarate [GO_0004838]
- 4441: p-S256-Aquaporin-2 passively transports water into cell [GO_0015250]
- 4442: p-S295-PDE3B hydrolyses cAMP to AMP [GO_0004114]
- 4443: p-S400-Cot phosphorylates NIK [GO_0004709]
- 4444: p-S54-PDE4B hydrolyses cAMP [GO_0004115]
- 4445: p-SPHK1 phosphorylates sphingosine to sphingosine 1-phosphate [GO_0017050]
- 4446: P-TEFb complex binding [GO_0106140]
- 4447: P-type ATPases type IV transport internal-facing APLs to external side of the plasma membrane [GO_0140326]
- 4448: P-type manganese transporter activity [GO_0140613]
- 4449: P-type potassium transmembrane transporter activity [GO_0008556]
- 4450: P-type sodium transporter activity [GO_0008554]
- 4451: P-type sodium:potassium-exchanging transporter activity [GO_0005391]
- 4452: P-type transmembrane transporter activity [GO_0140358]
- 4453: p120-RasGAP activates GTP hydrolysis on RAS, inactivating it [GO_0005096]
- 4454: p53 binding [GO_0002039]
- 4455: PA is converted to CDP-DAG by CDS2 [GO_0004605]
- 4456: pagA(197-794):ANTRX2 oligomer transports cya and lef (target cell endosome to cytosol) [GO_0008320]
- 4457: palmitoyl hydrolase activity [GO_0098599]
- 4458: palmitoyl-CoA + serine => 3-ketosphinganine + CoASH + CO2 [GO_0004758]
- 4459: palmitoylation of eNOS [GO_0016409]
- 4460: pancreas development [GO_0031016]
- 4461: pancreas morphogenesis [GO_0061113]
- 4462: pancreatic A cell development [GO_0003322]
- 4463: pancreatic A cell differentiation [GO_0003310]
- 4464: pancreatic bud formation [GO_0061130]
- 4465: pancreatic D cell development [GO_0003324]
- 4466: pancreatic D cell differentiation [GO_0003311]
- 4467: pancreatic PP cell development [GO_0003325]
- 4468: pancreatic PP cell differentiation [GO_0003312]
- 4469: pantothenate kinase activity [GO_0004594]
- 4470: paramesonephric duct development [GO_0061205]
- 4471: paraxial mesoderm development [GO_0048339]
- 4472: paraxial mesoderm formation [GO_0048341]
- 4473: paraxial mesoderm morphogenesis [GO_0048340]
- 4474: parietal peritoneum development [GO_1904819]
- 4475: PARN deadenylates mRNA [GO_0004535]
- 4476: PARPs transfer ADP-D-ribose to proteins (poly(ADP-ribosyl)ation) [GO_0003950]
- 4477: Passive I- efflux mediated by SMCT1 [GO_0022803]
- 4478: patched binding [GO_0005113]
- 4479: pattern recognition receptor activity [GO_0038187]
- 4480: pattern specification process [GO_0007389]
- 4481: PC is converted to PS by PTDSS1 [GO_0016740]
- 4482: PC is hydrolyzed to 2-acyl LPC by PLA2G4C [GO_0008970]
- 4483: PC is hydrolyzed to PA and choline by PLD1/2 [GO_0004630]
- 4484: PCho and CTP are condensed to CDP-Cho by PCYT1 dimer [GO_0004105]
- 4485: PCMT1 transfers CH3 from AdoMet to isoAsp to form MetAsp [GO_0004719]
- 4486: PDE6 hydrolyses cGMP to GMP [GO_0047555]
- 4487: PDK isoforms phosphorylate lipo-PDH [GO_0004740]
- 4488: PDPK1 activates PRKCZ [GO_0004676]
- 4489: PDZ domain binding [GO_0030165]
- 4490: Pellino ubiquitinates hp-IRAK1 [GO_0034450]
- 4491: pentosyltransferase activity [GO_0016763]
- 4492: peptidase activator activity [GO_0016504]
- 4493: peptidase activator activity involved in apoptotic process [GO_0016505]
- 4494: peptidase inhibitor activity [GO_0030414]
- 4495: peptidase regulator activity [GO_0061134]
- 4496: peptide binding [GO_0042277]
- 4497: peptide biosynthetic process [GO_0043043]
- 4498: peptide catabolic process [GO_0043171]
- 4499: peptide deformylase activity [GO_0042586]
- 4500: peptide hormone binding [GO_0017046]
- 4501: peptide hormone receptor binding [GO_0051428]
- 4502: peptide hormone secretion [GO_0030072]
- 4503: peptide metabolic process [GO_0006518]
- 4504: peptide receptor activity [GO_0001653]
- 4505: peptide secretion [GO_0002790]
- 4506: peptide transport [GO_0015833]
- 4507: peptide-glutamate-alpha-N-acetyltransferase activity [GO_1990190]
- 4508: peptide-serine-alpha-N-acetyltransferase activity [GO_1990189]
- 4509: peptidoglycan binding [GO_0042834]
- 4510: peptidoglycan immune receptor activity [GO_0016019]
- 4511: peptidoglycan muralytic activity [GO_0061783]
- 4512: peptidyl-amino acid modification [GO_0018193]
- 4513: peptidyl-aspartic acid 3-dioxygenase activity [GO_0062101]
- 4514: peptidyl-cysteine S-nitrosylase activity [GO_0035605]
- 4515: peptidyl-dipeptidase activity [GO_0008241]
- 4516: peptidyl-lysine 5-dioxygenase activity [GO_0070815]
- 4517: peptidyl-lysine modification [GO_0018205]
- 4518: peptidyl-proline dioxygenase activity [GO_0031543]
- 4519: peptidyl-proline hydroxylation [GO_0019511]
- 4520: peptidyl-proline modification [GO_0018208]
- 4521: peptidyl-tyrosine modification [GO_0018212]
- 4522: peptidyl-tyrosine phosphorylation [GO_0018108]
- 4523: peptidylamidoglycolate lyase activity [GO_0004598]
- 4524: peptidylglycine monooxygenase activity [GO_0004504]
- 4525: pericardium development [GO_0060039]
- 4526: pericardium morphogenesis [GO_0003344]
- 4527: peripheral nervous system development [GO_0007422]
- 4528: peripheral nervous system neuron development [GO_0048935]
- 4529: peripheral nervous system neuron differentiation [GO_0048934]
- 4530: peristalsis [GO_0030432]
- 4531: peritoneum development [GO_1904820]
- 4532: peroxidase activity [GO_0004601]
- 4533: peroxisome matrix targeting signal-1 binding [GO_0005052]
- 4534: peroxisome matrix targeting signal-2 binding [GO_0005053]
- 4535: peroxisome membrane targeting sequence binding [GO_0033328]
- 4536: peroxisome targeting sequence binding [GO_0000268]
- 4537: Peroxynitrite is reduced by AhpE [GO_0051920]
- 4538: PETA and CTP are condensed to CDP-ETA by PCY2 [GO_0004306]
- 4539: PEX1:PEX6:PEX26:ZFAND6:Ub:PEX5S,L:PEX14:PEX13:PEX2:PEX10:PEX12 dissociates yielding cytosolic Ub:PEX5S,L and membrane PEX14:PEX13:PEX2:PEX10:PEX12 [GO_0042626]
- 4540: PGLYRP2 hydrolyzes bacterial peptidoglycan [GO_0008745]
- 4541: PGM:Mg2+ isomerise G1P to G6P [GO_0004614]
- 4542: PGM2:Mg2+ isomerises dR1P to dR5P [GO_0008973]
- 4543: pH-gated chloride channel activity [GO_0061797]
- 4544: pharyngeal arch artery morphogenesis [GO_0061626]
- 4545: pharyngeal gland morphogenesis [GO_1905905]
- 4546: pharyngeal system development [GO_0060037]
- 4547: pharynx development [GO_0060465]
- 4548: pharynx morphogenesis [GO_0110040]
- 4549: phasic smooth muscle contraction [GO_0014821]
- 4550: phenol-containing compound biosynthetic process [GO_0046189]
- 4551: phenol-containing compound catabolic process [GO_0019336]
- 4552: phenol-containing compound metabolic process [GO_0018958]
- 4553: phenylalanine + tRNA(Phe) + ATP => Phe-tRNA(Phe) + AMP + pyrophosphate [GO_0004826]
- 4554: phenylalkylamine binding [GO_0008145]
- 4555: pheromone binding [GO_0005550]
- 4556: pheromone receptor activity [GO_0016503]
- 4557: PHF8 demethylates histone H4K20me1 [GO_0035575]
- 4558: PHGHD tetramer dehydrogenates 3PG [GO_0004617]
- 4559: phosphatase activator activity [GO_0019211]
- 4560: phosphatase activity [GO_0016791]
- 4561: phosphatase binding [GO_0019902]
- 4562: phosphatase inhibitor activity [GO_0019212]
- 4563: phosphatase regulator activity [GO_0019208]
- 4564: phosphate ion binding [GO_0042301]
- 4565: phosphate ion homeostasis [GO_0055062]
- 4566: phosphate ion transmembrane transport [GO_0035435]
- 4567: phosphate ion transmembrane transporter activity [GO_0015114]
- 4568: phosphate ion transport [GO_0006817]
- 4569: phosphate-containing compound metabolic process [GO_0006796]
- 4570: phosphatidic acid binding [GO_0070300]
- 4571: phosphatidic acid transfer activity [GO_1990050]
- 4572: phosphatidylcholine binding [GO_0031210]
- 4573: phosphatidylcholine biosynthetic process [GO_0006656]
- 4574: phosphatidylcholine metabolic process [GO_0046470]
- 4575: phosphatidylcholine transporter activity [GO_0008525]
- 4576: phosphatidylcholine:cardiolipin O-linoleoyltransferase activity [GO_0032577]
- 4577: phosphatidylethanolamine binding [GO_0008429]
- 4578: phosphatidylinositol + UDP-N-acetyl-D-glucosamine -> N-acetylglucosaminyl-PI + UDP [GO_0008194]
- 4579: phosphatidylinositol 3-kinase binding [GO_0043548]
- 4580: phosphatidylinositol 3-kinase catalytic subunit binding [GO_0036313]
- 4581: phosphatidylinositol 3-kinase regulator activity [GO_0035014]
- 4582: phosphatidylinositol binding [GO_0035091]
- 4583: phosphatidylinositol biosynthetic process [GO_0006661]
- 4584: phosphatidylinositol bisphosphate binding [GO_1902936]
- 4585: phosphatidylinositol bisphosphate kinase activity [GO_0052813]
- 4586: phosphatidylinositol bisphosphate phosphatase activity [GO_0034593]
- 4587: phosphatidylinositol kinase activity [GO_0052742]
- 4588: phosphatidylinositol metabolic process [GO_0046488]
- 4589: phosphatidylinositol monophosphate phosphatase activity [GO_0052744]
- 4590: phosphatidylinositol phosphate 5-phosphatase activity [GO_0034595]
- 4591: phosphatidylinositol phosphate binding [GO_1901981]
- 4592: phosphatidylinositol phosphate biosynthetic process [GO_0046854]
- 4593: phosphatidylinositol phosphate kinase activity [GO_0016307]
- 4594: phosphatidylinositol phosphate phosphatase activity [GO_0052866]
- 4595: phosphatidylinositol trisphosphate phosphatase activity [GO_0034594]
- 4596: phosphatidylinositol-3-phosphate binding [GO_0032266]
- 4597: phosphatidylinositol-3-phosphate biosynthetic process [GO_0036092]
- 4598: phosphatidylinositol-3,4-bisphosphate binding [GO_0043325]
- 4599: phosphatidylinositol-3,4-bisphosphate phosphatase activity [GO_0106017]
- 4600: phosphatidylinositol-3,4,5-trisphosphate binding [GO_0005547]
- 4601: phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity [GO_0052629]
- 4602: phosphatidylinositol-3,5-bisphosphate binding [GO_0080025]
- 4603: phosphatidylinositol-3,5-bisphosphate phosphatase activity [GO_0106018]
- 4604: phosphatidylinositol-4-phosphate binding [GO_0070273]
- 4605: phosphatidylinositol-4-phosphate phosphatase activity [GO_0043812]
- 4606: phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity [GO_0034597]
- 4607: phosphatidylinositol-4,5-bisphosphate binding [GO_0005546]
- 4608: phosphatidylinositol-4,5-bisphosphate phosphatase activity [GO_0106019]
- 4609: phosphatidylinositol-5-phosphate binding [GO_0010314]
- 4610: phosphatidylserine binding [GO_0001786]
- 4611: phosphatidylserine decarboxylase activity [GO_0004609]
- 4612: phosphoenolpyruvate + ADP => pyruvate + ATP [GO_0004743]
- 4613: phosphoenolpyruvate carboxykinase activity [GO_0004611]
- 4614: phosphofructokinase activity [GO_0008443]
- 4615: phosphogluconate dehydrogenase (decarboxylating) activity [GO_0004616]
- 4616: phospholipase A2 activator activity [GO_0016005]
- 4617: phospholipase activator activity [GO_0016004]
- 4618: phospholipase C-inhibiting G protein-coupled receptor signaling pathway [GO_0030845]
- 4619: phospholipase D activator activity [GO_1990583]
- 4620: phospholipid binding [GO_0005543]
- 4621: phospholipid biosynthetic process [GO_0008654]
- 4622: phospholipid metabolic process [GO_0006644]
- 4623: phospholipid scramblase activity [GO_0017128]
- 4624: phospholipid transfer activity [GO_0120014]
- 4625: phospholipid translocation [GO_0045332]
- 4626: phospholipid transport [GO_0015914]
- 4627: phosphopantetheine binding [GO_0031177]
- 4628: phosphopantetheine-dependent carrier activity [GO_0140414]
- 4629: phosphoprotein binding [GO_0051219]
- 4630: phosphoribosylaminoimidazole carboxylase activity [GO_0004638]
- 4631: phosphoribosylaminoimidazolecarboxamide formyltransferase activity [GO_0004643]
- 4632: phosphoribosylformylglycinamidine cyclo-ligase activity [GO_0004641]
- 4633: phosphoribosylglycinamide formyltransferase activity [GO_0004644]
- 4634: phosphoric diester hydrolase activity [GO_0008081]
- 4635: phosphoric ester hydrolase activity [GO_0042578]
- 4636: phosphorus metabolic process [GO_0006793]
- 4637: phosphorus-oxygen lyase activity [GO_0016849]
- 4638: phosphorylase kinase regulator activity [GO_0008607]
- 4639: Phosphorylated GYS1 catalyzes the polyglucosylation of oligoGlc-GYG1 [GO_0004373]
- 4640: phosphorylation [GO_0016310]
- 4641: Phosphorylation of NEFL by the P-TEFb(Cyclin T1:Cdk9) complex [GO_0008353]
- 4642: Phosphorylation of human JNKs by activated MKK4/MKK7 [GO_0008545]
- 4643: Phosphorylation of STAT1 at Ser727 [GO_0004697]
- 4644: phosphoserine residue binding [GO_0050815]
- 4645: phosphotransferase activity, alcohol group as acceptor [GO_0016773]
- 4646: phosphotransferase activity, carboxyl group as acceptor [GO_0016774]
- 4647: phosphotransferase activity, for other substituted phosphate groups [GO_0016780]
- 4648: phosphotransferase activity, nitrogenous group as acceptor [GO_0016775]
- 4649: phosphotransferase activity, phosphate group as acceptor [GO_0016776]
- 4650: phosphotyrosine residue binding [GO_0001784]
- 4651: photoperiodism [GO_0009648]
- 4652: photoreceptor activity [GO_0009881]
- 4653: photoreceptor cell development [GO_0042461]
- 4654: photoreceptor cell differentiation [GO_0046530]
- 4655: photoreceptor cell morphogenesis [GO_0008594]
- 4656: phototaxis [GO_0042331]
- 4657: phototransduction [GO_0007602]
- 4658: phototransduction, visible light [GO_0007603]
- 4659: physiological cardiac muscle hypertrophy [GO_0003301]
- 4660: physiological muscle hypertrophy [GO_0003298]
- 4661: PI is phosphorylated to PI4P by PI4KB at the Golgi membrane [GO_0004430]
- 4662: PI(3,4)P2 is dephosphorylated to PI4P by PTEN at the plasma membrane [GO_0051800]
- 4663: PI(3,5)P2 is dephosphorylated to PI3P by SYNJ at the plasma membrane [GO_0043813]
- 4664: PI(4,5)P2, PI(3,4)P2 and PI(3,4,5)P3 are dephosphorylated to PI5P, PI3P and PI(3,4)P by INPP5F at the endosome membrane [GO_0034596]
- 4665: PI3K-containing complexes phosphorylate PIP2 to PIP3 [GO_0016303]
- 4666: PI3P is dephosphorylated to PI by MTMR9-bound MTMR8 or MTMR6 at the plasma membrane [GO_0004438]
- 4667: PI4P is phosphorylated to PI(3,4)P2 by PIK3C2A/G at the Golgi membrane [GO_0035005]
- 4668: PI4P is phosphorylated to PI(4,5)P2 by PIP5K1A-C at the plasma membrane [GO_0016308]
- 4669: pigment binding [GO_0031409]
- 4670: pigment cell development [GO_0070285]
- 4671: pigment cell differentiation [GO_0050931]
- 4672: pigment granule [GO_0048770]
- 4673: pigment granule localization [GO_0051875]
- 4674: pigment granule membrane [GO_0090741]
- 4675: pigment granule organization [GO_0048753]
- 4676: pigment granule transport [GO_0051904]
- 4677: pigmentation [GO_0043473]
- 4678: piRNA binding [GO_0034584]
- 4679: PITPNM1,2,3 exchange PI for PA [GO_0008526]
- 4680: PLA2G15 hydrolyses LPC to GPCho and LCFA(-) [GO_0047499]
- 4681: placenta blood vessel development [GO_0060674]
- 4682: placenta development [GO_0001890]
- 4683: plasma membrane [GO_0005886]
- 4684: plasma membrane bounded cell projection [GO_0120025]
- 4685: plasma membrane bounded cell projection assembly [GO_0120031]
- 4686: plasma membrane bounded cell projection cytoplasm [GO_0032838]
- 4687: plasma membrane bounded cell projection morphogenesis [GO_0120039]
- 4688: plasma membrane bounded cell projection organization [GO_0120036]
- 4689: plasma membrane fusion [GO_0045026]
- 4690: plasma membrane organization [GO_0007009]
- 4691: plasma membrane phospholipid scrambling [GO_0017121]
- 4692: plasma membrane protein complex [GO_0098797]
- 4693: plasma membrane region [GO_0098590]
- 4694: PLC gamma 2-mediated PIP2 hydrolysis [GO_0004629]
- 4695: plus-end directed microfilament motor activity [GO_0060002]
- 4696: plus-end-directed microtubule motor activity [GO_0008574]
- 4697: PNPLA4 hydrolyzes TAG [GO_0004806]
- 4698: POFUT2 transfers fucose to TSR domain-containing proteins [GO_0046922]
- 4699: POLB incorporates a single nucleotide in place of excised AP residue in NEIL1,NEIL2-mediated AP site resolution [GO_0003887]
- 4700: poly-ADP-D-ribose binding [GO_0072572]
- 4701: poly-purine tract binding [GO_0070717]
- 4702: poly-pyrimidine tract binding [GO_0008187]
- 4703: poly((1,4)-alpha-glycosyl) glycogenin-1 + n orthophosphate => glycogenin-1 + n D-glucose 1-phosphate [PYGM,PYGB] [GO_0008184]
- 4704: poly(A) binding [GO_0008143]
- 4705: poly(G) binding [GO_0034046]
- 4706: poly(U) RNA binding [GO_0008266]
- 4707: polyamine oxidase activity [GO_0046592]
- 4708: polyamine transmembrane transport [GO_1902047]
- 4709: polyamine transmembrane transporter activity [GO_0015203]
- 4710: polyamine transport [GO_0015846]
- 4711: Polyglutamylase complex (TTLL1) polyglutamylates alpha subunits of tubulin [GO_0070740]
- 4712: polymeric cytoskeletal fiber [GO_0099513]
- 4713: polynucleotide 5'-hydroxyl-kinase activity [GO_0051731]
- 4714: polynucleotide adenylyltransferase activator activity [GO_1990749]
- 4715: polypeptide N-acetylgalactosaminyltransferase activity [GO_0004653]
- 4716: polysaccharide binding [GO_0030247]
- 4717: polysaccharide biosynthetic process [GO_0000271]
- 4718: polysaccharide catabolic process [GO_0000272]
- 4719: polysaccharide localization [GO_0033037]
- 4720: polysaccharide metabolic process [GO_0005976]
- 4721: polysaccharide transmembrane transporter activity [GO_0015159]
- 4722: polysaccharide transport [GO_0015774]
- 4723: polysome binding [GO_1905538]
- 4724: polyubiquitin modification-dependent protein binding [GO_0031593]
- 4725: POMGNT2 transfers GlcNAc to Man-DAG1 [GO_0008375]
- 4726: pons development [GO_0021548]
- 4727: pons formation [GO_0021584]
- 4728: pons maturation [GO_0021586]
- 4729: pons morphogenesis [GO_0021583]
- 4730: POR reduces CYP450:Fe3+ to CYP450:Fe2+ [GO_0003958]
- 4731: porin activity [GO_0015288]
- 4732: positive chemotaxis [GO_0050918]
- 4733: positive regulation of 1-phosphatidylinositol 4-kinase activity [GO_0043128]
- 4734: positive regulation of 1-phosphatidylinositol-3-kinase activity [GO_0061903]
- 4735: positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO_0090216]
- 4736: positive regulation of acetylcholine secretion, neurotransmission [GO_0014057]
- 4737: positive regulation of acid-sensing ion channel activity [GO_1901587]
- 4738: positive regulation of acinar cell proliferation [GO_1904699]
- 4739: positive regulation of aconitate hydratase activity [GO_1904234]
- 4740: positive regulation of actin binding [GO_1904618]
- 4741: positive regulation of actin filament binding [GO_1904531]
- 4742: positive regulation of actin filament bundle assembly [GO_0032233]
- 4743: positive regulation of actin filament-based movement [GO_1903116]
- 4744: positive regulation of action potential [GO_0045760]
- 4745: positive regulation of activin receptor signaling pathway [GO_0032927]
- 4746: positive regulation of adenosine receptor signaling pathway [GO_0060168]
- 4747: positive regulation of adenylate cyclase activity [GO_0045762]
- 4748: positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway [GO_0071879]
- 4749: positive regulation of adipose tissue development [GO_1904179]
- 4750: positive regulation of alkaline phosphatase activity [GO_0010694]
- 4751: positive regulation of alpha-(1->3)-fucosyltransferase activity [GO_1905621]
- 4752: positive regulation of amine transport [GO_0051954]
- 4753: positive regulation of amino acid transport [GO_0051957]
- 4754: positive regulation of aminoacyl-tRNA ligase activity [GO_1903632]
- 4755: positive regulation of amyloid precursor protein catabolic process [GO_1902993]
- 4756: positive regulation of androgen receptor activity [GO_2000825]
- 4757: positive regulation of androgen secretion [GO_2000836]
- 4758: positive regulation of angiogenesis [GO_0045766]
- 4759: positive regulation of animal organ morphogenesis [GO_0110110]
- 4760: positive regulation of anion channel activity [GO_1901529]
- 4761: positive regulation of anion transmembrane transport [GO_1903961]
- 4762: positive regulation of anion transport [GO_1903793]
- 4763: positive regulation of aorta morphogenesis [GO_1903849]
- 4764: positive regulation of aortic smooth muscle cell differentiation [GO_1904831]
- 4765: positive regulation of apical ectodermal ridge formation [GO_1905142]
- 4766: positive regulation of apolipoprotein binding [GO_2000658]
- 4767: positive regulation of apoptotic process [GO_0043065]
- 4768: positive regulation of apoptotic process involved in development [GO_1904747]
- 4769: positive regulation of apoptotic process involved in morphogenesis [GO_1902339]
- 4770: positive regulation of apoptotic process involved in outflow tract morphogenesis [GO_1902258]
- 4771: positive regulation of apoptotic signaling pathway [GO_2001235]
- 4772: positive regulation of argininosuccinate synthase activity [GO_1905753]
- 4773: positive regulation of artery morphogenesis [GO_1905653]
- 4774: positive regulation of aspartic endopeptidase activity, intramembrane cleaving [GO_0120289]
- 4775: positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO_1902961]
- 4776: positive regulation of aspartic-type peptidase activity [GO_1905247]
- 4777: positive regulation of asymmetric cell division [GO_0045770]
- 4778: positive regulation of ATP biosynthetic process [GO_2001171]
- 4779: positive regulation of ATP citrate synthase activity [GO_2000985]
- 4780: positive regulation of ATP metabolic process [GO_1903580]
- 4781: positive regulation of ATP-dependent activity [GO_0032781]
- 4782: positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO_1901896]
- 4783: positive regulation of AV node cell action potential [GO_1903951]
- 4784: positive regulation of axo-dendritic protein transport [GO_1905128]
- 4785: positive regulation of axon guidance [GO_1902669]
- 4786: positive regulation of axonogenesis [GO_0050772]
- 4787: positive regulation of backward locomotion [GO_1905852]
- 4788: positive regulation of behavior [GO_0048520]
- 4789: positive regulation of beta-galactosidase activity [GO_1903771]
- 4790: positive regulation of bile acid biosynthetic process [GO_0070859]
- 4791: positive regulation of bile acid metabolic process [GO_1904253]
- 4792: positive regulation of bile acid secretion [GO_0120189]
- 4793: positive regulation of binding [GO_0051099]
- 4794: positive regulation of biological process [GO_0048518]
- 4795: positive regulation of biosynthetic process [GO_0009891]
- 4796: positive regulation of bleb assembly [GO_1904172]
- 4797: positive regulation of blood circulation [GO_1903524]
- 4798: positive regulation of blood vessel branching [GO_1905555]
- 4799: positive regulation of blood vessel endothelial cell differentiation [GO_0110058]
- 4800: positive regulation of BMP signaling pathway [GO_0030513]
- 4801: positive regulation of bone development [GO_1903012]
- 4802: positive regulation of branching involved in lung morphogenesis [GO_0061047]
- 4803: positive regulation of branching morphogenesis of a nerve [GO_1905492]
- 4804: positive regulation of calcium ion binding [GO_1901878]
- 4805: positive regulation of calcium ion transmembrane transport [GO_1904427]
- 4806: positive regulation of calcium ion transmembrane transporter activity [GO_1901021]
- 4807: positive regulation of calcium ion transport [GO_0051928]
- 4808: positive regulation of calcium-dependent ATPase activity [GO_1903612]
- 4809: positive regulation of calcium-mediated signaling [GO_0050850]
- 4810: positive regulation of calcium:sodium antiporter activity [GO_1903281]
- 4811: positive regulation of cAMP-dependent protein kinase activity [GO_2000481]
- 4812: positive regulation of cAMP-mediated signaling [GO_0043950]
- 4813: positive regulation of carbohydrate metabolic process [GO_0045913]
- 4814: positive regulation of cardiac chamber formation [GO_1901212]
- 4815: positive regulation of cardiac chamber morphogenesis [GO_1901221]
- 4816: positive regulation of cardiac conduction [GO_1903781]
- 4817: positive regulation of cardiac muscle adaptation [GO_0010615]
- 4818: positive regulation of cardiac muscle cell apoptotic process [GO_0010666]
- 4819: positive regulation of cardiac muscle cell differentiation [GO_2000727]
- 4820: positive regulation of cardiac muscle cell myoblast differentiation [GO_2000700]
- 4821: positive regulation of cardiac muscle cell proliferation [GO_0060045]
- 4822: positive regulation of cardiac muscle contraction [GO_0060452]
- 4823: positive regulation of cardiac muscle fiber development [GO_0055020]
- 4824: positive regulation of cardiac muscle hypertrophy [GO_0010613]
- 4825: positive regulation of cardiac muscle myoblast proliferation [GO_0110024]
- 4826: positive regulation of cardiac muscle tissue development [GO_0055025]
- 4827: positive regulation of cardiac muscle tissue growth [GO_0055023]
- 4828: positive regulation of cardiac myofibril assembly [GO_1905306]
- 4829: positive regulation of cardiac ventricle development [GO_1904414]
- 4830: positive regulation of cardiac ventricle formation [GO_1904944]
- 4831: positive regulation of cardioblast differentiation [GO_0051891]
- 4832: positive regulation of cardiocyte differentiation [GO_1905209]
- 4833: positive regulation of cartilage development [GO_0061036]
- 4834: positive regulation of catabolic process [GO_0009896]
- 4835: positive regulation of catalase activity [GO_1902553]
- 4836: positive regulation of catalytic activity [GO_0043085]
- 4837: positive regulation of catecholamine metabolic process [GO_0045915]
- 4838: positive regulation of catecholamine secretion [GO_0033605]
- 4839: positive regulation of cation channel activity [GO_2001259]
- 4840: positive regulation of cation transmembrane transport [GO_1904064]
- 4841: positive regulation of CD4 production [GO_0045224]
- 4842: positive regulation of cell adhesion [GO_0045785]
- 4843: positive regulation of cell communication [GO_0010647]
- 4844: positive regulation of cell cycle [GO_0045787]
- 4845: positive regulation of cell cycle process [GO_0090068]
- 4846: positive regulation of cell death [GO_0010942]
- 4847: positive regulation of cell development [GO_0010720]
- 4848: positive regulation of cell differentiation [GO_0045597]
- 4849: positive regulation of cell division [GO_0051781]
- 4850: positive regulation of cell fate commitment [GO_0010455]
- 4851: positive regulation of cell growth [GO_0030307]
- 4852: positive regulation of cell growth involved in cardiac muscle cell development [GO_0061051]
- 4853: positive regulation of cell junction assembly [GO_1901890]
- 4854: positive regulation of cell maturation [GO_1903431]
- 4855: positive regulation of cell migration [GO_0030335]
- 4856: positive regulation of cell morphogenesis involved in differentiation [GO_0010770]
- 4857: positive regulation of cell motility [GO_2000147]
- 4858: positive regulation of cell population proliferation [GO_0008284]
- 4859: positive regulation of cell projection organization [GO_0031346]
- 4860: positive regulation of cell proliferation in midbrain [GO_1904935]
- 4861: positive regulation of cell proliferation involved in compound eye morphogenesis [GO_2000497]
- 4862: positive regulation of cell proliferation involved in heart morphogenesis [GO_2000138]
- 4863: positive regulation of cell proliferation involved in outflow tract morphogenesis [GO_1901964]
- 4864: positive regulation of cell-cell adhesion [GO_0022409]
- 4865: positive regulation of cellular amide metabolic process [GO_0034250]
- 4866: positive regulation of cellular amine catabolic process [GO_0033243]
- 4867: positive regulation of cellular amine metabolic process [GO_0033240]
- 4868: positive regulation of cellular amino acid biosynthetic process [GO_2000284]
- 4869: positive regulation of cellular amino acid metabolic process [GO_0045764]
- 4870: positive regulation of cellular biosynthetic process [GO_0031328]
- 4871: positive regulation of cellular carbohydrate metabolic process [GO_0010676]
- 4872: positive regulation of cellular catabolic process [GO_0031331]
- 4873: positive regulation of cellular component biogenesis [GO_0044089]
- 4874: positive regulation of cellular component movement [GO_0051272]
- 4875: positive regulation of cellular component organization [GO_0051130]
- 4876: positive regulation of cellular metabolic process [GO_0031325]
- 4877: positive regulation of cellular process [GO_0048522]
- 4878: positive regulation of cellular protein metabolic process [GO_0032270]
- 4879: positive regulation of cellular respiration [GO_1901857]
- 4880: positive regulation of cellular response to alcohol [GO_1905959]
- 4881: positive regulation of cellular response to drug [GO_2001040]
- 4882: positive regulation of cellular response to insulin stimulus [GO_1900078]
- 4883: positive regulation of cellular response to oxidative stress [GO_1900409]
- 4884: positive regulation of chemorepellent activity [GO_1903669]
- 4885: positive regulation of chemotaxis [GO_0050921]
- 4886: positive regulation of cholangiocyte apoptotic process [GO_1904194]
- 4887: positive regulation of cholangiocyte proliferation [GO_1904056]
- 4888: positive regulation of choline O-acetyltransferase activity [GO_1902771]
- 4889: positive regulation of chondrocyte development [GO_1902761]
- 4890: positive regulation of chondrocyte differentiation [GO_0032332]
- 4891: positive regulation of chorionic trophoblast cell proliferation [GO_1901384]
- 4892: positive regulation of chromatin assembly or disassembly [GO_0045799]
- 4893: positive regulation of chromatin binding [GO_0035563]
- 4894: positive regulation of chromatin organization [GO_1905269]
- 4895: positive regulation of chromosome condensation [GO_1905821]
- 4896: positive regulation of chromosome organization [GO_2001252]
- 4897: positive regulation of chromosome segregation [GO_0051984]
- 4898: positive regulation of cilium assembly [GO_0045724]
- 4899: positive regulation of circadian rhythm [GO_0042753]
- 4900: positive regulation of circadian sleep/wake cycle, sleep [GO_0045938]
- 4901: positive regulation of CoA-transferase activity [GO_1905920]
- 4902: positive regulation of collagen binding [GO_0033343]
- 4903: positive regulation of collagen biosynthetic process [GO_0032967]
- 4904: positive regulation of collagen catabolic process [GO_0120158]
- 4905: positive regulation of collagen fibril organization [GO_1904028]
- 4906: positive regulation of collagen metabolic process [GO_0010714]
- 4907: positive regulation of colon smooth muscle contraction [GO_1904343]
- 4908: positive regulation of compound eye photoreceptor cell differentiation [GO_0110117]
- 4909: positive regulation of compound eye retinal cell apoptotic process [GO_1901694]
- 4910: positive regulation of compound eye retinal cell programmed cell death [GO_0046672]
- 4911: positive regulation of copper ion transmembrane transport [GO_1902313]
- 4912: positive regulation of core promoter binding [GO_1904798]
- 4913: positive regulation of coreceptor activity involved in epidermal growth factor receptor signaling pathway [GO_0060727]
- 4914: positive regulation of cyclase activity [GO_0031281]
- 4915: positive regulation of cyclic nucleotide-gated ion channel activity [GO_1902161]
- 4916: positive regulation of cyclic-nucleotide phosphodiesterase activity [GO_0051343]
- 4917: positive regulation of cyclin-dependent protein kinase activity [GO_1904031]
- 4918: positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO_0045737]
- 4919: positive regulation of cystathionine beta-synthase activity [GO_1904043]
- 4920: positive regulation of cysteine metabolic process [GO_1901496]
- 4921: positive regulation of cysteine-type endopeptidase activity [GO_2001056]
- 4922: positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO_0043280]
- 4923: positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO_2001272]
- 4924: positive regulation of cytochrome-c oxidase activity [GO_1904960]
- 4925: positive regulation of cytokine activity [GO_0060301]
- 4926: positive regulation of cytokine-mediated signaling pathway [GO_0001961]
- 4927: positive regulation of cytokinesis [GO_0032467]
- 4928: positive regulation of cytoskeleton organization [GO_0051495]
- 4929: positive regulation of D-amino-acid oxidase activity [GO_1900759]
- 4930: positive regulation of D-erythro-sphingosine kinase activity [GO_1900023]
- 4931: positive regulation of deacetylase activity [GO_0090045]
- 4932: positive regulation of defecation [GO_2000294]
- 4933: positive regulation of delayed rectifier potassium channel activity [GO_1902261]
- 4934: positive regulation of deoxyribonuclease activity [GO_0032077]
- 4935: positive regulation of dephosphorylation [GO_0035306]
- 4936: positive regulation of dermatome development [GO_0061184]
- 4937: positive regulation of detection of mechanical stimulus involved in sensory perception of touch [GO_1905789]
- 4938: positive regulation of developmental growth [GO_0048639]
- 4939: positive regulation of developmental pigmentation [GO_0048087]
- 4940: positive regulation of developmental process [GO_0051094]
- 4941: positive regulation of diacylglycerol kinase activity [GO_1905689]
- 4942: positive regulation of digestive system process [GO_0060456]
- 4943: positive regulation of dipeptide transmembrane transport [GO_2001150]
- 4944: positive regulation of dipeptide transport [GO_2000880]
- 4945: positive regulation of DNA binding [GO_0043388]
- 4946: positive regulation of DNA biosynthetic process [GO_2000573]
- 4947: positive regulation of DNA duplex unwinding [GO_1905464]
- 4948: positive regulation of DNA helicase activity [GO_1905776]
- 4949: positive regulation of DNA metabolic process [GO_0051054]
- 4950: positive regulation of DNA N-glycosylase activity [GO_1902546]
- 4951: positive regulation of DNA repair [GO_0045739]
- 4952: positive regulation of DNA replication [GO_0045740]
- 4953: positive regulation of DNA replication origin binding [GO_1902597]
- 4954: positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO_2000373]
- 4955: positive regulation of DNA-binding transcription factor activity [GO_0051091]
- 4956: positive regulation of DNA-directed DNA polymerase activity [GO_1900264]
- 4957: positive regulation of DNA-templated DNA replication [GO_2000105]
- 4958: positive regulation of DNA-templated transcription [GO_0045893]
- 4959: positive regulation of dopamine receptor signaling pathway [GO_0060161]
- 4960: positive regulation of dopamine secretion [GO_0033603]
- 4961: positive regulation of double-stranded telomeric DNA binding [GO_1905769]
- 4962: positive regulation of dUTP diphosphatase activity [GO_1903629]
- 4963: positive regulation of eclosion [GO_0045805]
- 4964: positive regulation of ectoderm development [GO_2000385]
- 4965: positive regulation of electron transfer activity [GO_1904734]
- 4966: positive regulation of embryonic camera-type eye development [GO_1902865]
- 4967: positive regulation of embryonic development [GO_0040019]
- 4968: positive regulation of endocytosis [GO_0045807]
- 4969: positive regulation of endodeoxyribonuclease activity [GO_0032079]
- 4970: positive regulation of endodermal cell differentiation [GO_1903226]
- 4971: positive regulation of endopeptidase activity [GO_0010950]
- 4972: positive regulation of endoribonuclease activity [GO_1902380]
- 4973: positive regulation of endothelial cell apoptotic process [GO_2000353]
- 4974: positive regulation of endothelial cell development [GO_1901552]
- 4975: positive regulation of endothelial cell differentiation [GO_0045603]
- 4976: positive regulation of endothelial cell proliferation [GO_0001938]
- 4977: positive regulation of endothelial tube morphogenesis [GO_1905956]
- 4978: positive regulation of entry into reproductive diapause [GO_0061965]
- 4979: positive regulation of ephrin receptor signaling pathway [GO_1901189]
- 4980: positive regulation of epidermal cell differentiation [GO_0045606]
- 4981: positive regulation of epidermal growth factor receptor signaling pathway [GO_0045742]
- 4982: positive regulation of epidermal growth factor-activated receptor activity [GO_0045741]
- 4983: positive regulation of epidermis development [GO_0045684]
- 4984: positive regulation of epithelial cell apoptotic process [GO_1904037]
- 4985: positive regulation of epithelial cell differentiation [GO_0030858]
- 4986: positive regulation of epithelial cell proliferation [GO_0050679]
- 4987: positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO_0060501]
- 4988: positive regulation of epithelial to mesenchymal transition [GO_0010718]
- 4989: positive regulation of epithelial tube formation [GO_1905278]
- 4990: positive regulation of ERBB signaling pathway [GO_1901186]
- 4991: positive regulation of erythrocyte apoptotic process [GO_1902252]
- 4992: positive regulation of erythrocyte differentiation [GO_0045648]
- 4993: positive regulation of establishment of protein localization [GO_1904951]
- 4994: positive regulation of euchromatin binding [GO_1904795]
- 4995: positive regulation of excitatory postsynaptic potential [GO_2000463]
- 4996: positive regulation of execution phase of apoptosis [GO_1900119]
- 4997: positive regulation of exocytosis [GO_0045921]
- 4998: positive regulation of exodeoxyribonuclease activity [GO_1902394]
- 4999: positive regulation of exonuclease activity [GO_1905779]
- 5000: positive regulation of exoribonuclease activity [GO_1901919]
- 5001: positive regulation of exosomal secretion [GO_1903543]
- 5002: positive regulation of extracellular exosome assembly [GO_1903553]
- 5003: positive regulation of extracellular matrix assembly [GO_1901203]
- 5004: positive regulation of extracellular matrix disassembly [GO_0090091]
- 5005: positive regulation of extracellular matrix organization [GO_1903055]
- 5006: positive regulation of eye photoreceptor cell development [GO_0042479]
- 5007: positive regulation of fat cell apoptotic process [GO_1904651]
- 5008: positive regulation of fat cell differentiation [GO_0045600]
- 5009: positive regulation of fat cell proliferation [GO_0070346]
- 5010: positive regulation of fatty acid biosynthetic process [GO_0045723]
- 5011: positive regulation of fatty acid metabolic process [GO_0045923]
- 5012: positive regulation of fatty acid transport [GO_2000193]
- 5013: positive regulation of feeding behavior [GO_2000253]
- 5014: positive regulation of female gonad development [GO_2000196]
- 5015: positive regulation of ferrous iron binding [GO_1904434]
- 5016: positive regulation of fertilization [GO_1905516]
- 5017: positive regulation of fibroblast apoptotic process [GO_2000271]
- 5018: positive regulation of fibroblast growth factor receptor signaling pathway [GO_0045743]
- 5019: positive regulation of fibroblast proliferation [GO_0048146]
- 5020: positive regulation of formation of translation initiation ternary complex [GO_1901192]
- 5021: positive regulation of forward locomotion [GO_1905850]
- 5022: positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity [GO_0060550]
- 5023: positive regulation of G protein-coupled receptor signaling pathway [GO_0045745]
- 5024: positive regulation of G-quadruplex DNA binding [GO_1905495]
- 5025: positive regulation of GABA-A receptor activity [GO_0106041]
- 5026: positive regulation of gamma-aminobutyric acid secretion [GO_0014054]
- 5027: positive regulation of gastric acid secretion [GO_0060454]
- 5028: positive regulation of gastric mucosal blood circulation [GO_1904346]
- 5029: positive regulation of gastro-intestinal system smooth muscle contraction [GO_1904306]
- 5030: positive regulation of gastrulation [GO_2000543]
- 5031: positive regulation of gene expression [GO_0010628]
- 5032: positive regulation of germ cell proliferation [GO_1905938]
- 5033: positive regulation of glial cell apoptotic process [GO_0034352]
- 5034: positive regulation of glial cell differentiation [GO_0045687]
- 5035: positive regulation of glial cell proliferation [GO_0060252]
- 5036: positive regulation of gliogenesis [GO_0014015]
- 5037: positive regulation of glucagon secretion [GO_0070094]
- 5038: positive regulation of glucokinase activity [GO_0033133]
- 5039: positive regulation of gluconeogenesis [GO_0045722]
- 5040: positive regulation of glucose metabolic process [GO_0010907]
- 5041: positive regulation of glucose transmembrane transport [GO_0010828]
- 5042: positive regulation of glucosylceramidase activity [GO_1905125]
- 5043: positive regulation of glucuronosyltransferase activity [GO_1904225]
- 5044: positive regulation of glutamate receptor signaling pathway [GO_1900451]
- 5045: positive regulation of glutamate secretion [GO_0014049]
- 5046: positive regulation of glutamate secretion, neurotransmission [GO_1903296]
- 5047: positive regulation of glutamate-ammonia ligase activity [GO_1905480]
- 5048: positive regulation of glutamate-cysteine ligase activity [GO_0035229]
- 5049: positive regulation of glutathione biosynthetic process [GO_1903788]
- 5050: positive regulation of glutathione peroxidase activity [GO_1903284]
- 5051: positive regulation of glycine hydroxymethyltransferase activity [GO_0080114]
- 5052: positive regulation of glycine secretion, neurotransmission [GO_1904626]
- 5053: positive regulation of glycogen (starch) synthase activity [GO_2000467]
- 5054: positive regulation of glycogen biosynthetic process [GO_0045725]
- 5055: positive regulation of glycogen catabolic process [GO_0045819]
- 5056: positive regulation of glycogen metabolic process [GO_0070875]
- 5057: positive regulation of glycolytic process [GO_0045821]
- 5058: positive regulation of glycolytic process through fructose-6-phosphate [GO_1904540]
- 5059: positive regulation of glycoprotein biosynthetic process [GO_0010560]
- 5060: positive regulation of glycoprotein metabolic process [GO_1903020]
- 5061: positive regulation of Golgi to plasma membrane protein transport [GO_0042998]
- 5062: positive regulation of gonad development [GO_1905941]
- 5063: positive regulation of growth [GO_0045927]
- 5064: positive regulation of GTP binding [GO_1904426]
- 5065: positive regulation of GTP cyclohydrolase I activity [GO_0043104]
- 5066: positive regulation of GTPase activity [GO_0043547]
- 5067: positive regulation of guanyl-nucleotide exchange factor activity [GO_1905099]
- 5068: positive regulation of guanylate cyclase activity [GO_0031284]
- 5069: positive regulation of heart contraction [GO_0045823]
- 5070: positive regulation of heart growth [GO_0060421]
- 5071: positive regulation of helicase activity [GO_0051096]
- 5072: positive regulation of hematopoietic progenitor cell differentiation [GO_1901534]
- 5073: positive regulation of hematopoietic stem cell differentiation [GO_1902038]
- 5074: positive regulation of hematopoietic stem cell proliferation [GO_1902035]
- 5075: positive regulation of heme oxygenase activity [GO_0061961]
- 5076: positive regulation of hemopoiesis [GO_1903708]
- 5077: positive regulation of heparan sulfate proteoglycan binding [GO_1905860]
- 5078: positive regulation of hepatocyte apoptotic process [GO_1903945]
- 5079: positive regulation of hepatocyte differentiation [GO_0070368]
- 5080: positive regulation of heterochromatin assembly [GO_0031453]
- 5081: positive regulation of heterochromatin organization [GO_0120263]
- 5082: positive regulation of hexokinase activity [GO_1903301]
- 5083: positive regulation of high voltage-gated calcium channel activity [GO_1901843]
- 5084: positive regulation of hindgut contraction [GO_0060450]
- 5085: positive regulation of histone deacetylase activity [GO_1901727]
- 5086: positive regulation of histone deacetylation [GO_0031065]
- 5087: positive regulation of histone demethylase activity (H3-K4 specific) [GO_1904175]
- 5088: positive regulation of histone modification [GO_0031058]
- 5089: positive regulation of hormone metabolic process [GO_0032352]
- 5090: positive regulation of hormone secretion [GO_0046887]
- 5091: positive regulation of hyaluronan biosynthetic process [GO_1900127]
- 5092: positive regulation of hydrolase activity [GO_0051345]
- 5093: positive regulation of immune effector process [GO_0002699]
- 5094: positive regulation of immune response [GO_0050778]
- 5095: positive regulation of immune system process [GO_0002684]
- 5096: positive regulation of inorganic anion transmembrane transport [GO_1903797]
- 5097: positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO_0031587]
- 5098: positive regulation of inositol-polyphosphate 5-phosphatase activity [GO_0010925]
- 5099: positive regulation of insulin receptor signaling pathway [GO_0046628]
- 5100: positive regulation of insulin secretion [GO_0032024]
- 5101: positive regulation of intestinal absorption [GO_1904480]
- 5102: positive regulation of intestinal epithelial cell development [GO_1905300]
- 5103: positive regulation of intracellular calcium activated chloride channel activity [GO_1902940]
- 5104: positive regulation of intracellular lipid transport [GO_0032379]
- 5105: positive regulation of intracellular protein transport [GO_0090316]
- 5106: positive regulation of intracellular signal transduction [GO_1902533]
- 5107: positive regulation of intracellular sterol transport [GO_0032382]
- 5108: positive regulation of intracellular transport [GO_0032388]
- 5109: positive regulation of inward rectifier potassium channel activity [GO_1901980]
- 5110: positive regulation of ion transmembrane transport [GO_0034767]
- 5111: positive regulation of ion transmembrane transporter activity [GO_0032414]
- 5112: positive regulation of ion transport [GO_0043270]
- 5113: positive regulation of iron ion transmembrane transport [GO_0034761]
- 5114: positive regulation of iron ion transmembrane transporter activity [GO_1904256]
- 5115: positive regulation of iron ion transport [GO_0034758]
- 5116: positive regulation of isoleucine-tRNA ligase activity [GO_1905017]
- 5117: positive regulation of isomerase activity [GO_0010912]
- 5118: positive regulation of isoprenoid metabolic process [GO_0045828]
- 5119: positive regulation of JNK cascade [GO_0046330]
- 5120: positive regulation of JUN kinase activity [GO_0043507]
- 5121: positive regulation of kinase activity [GO_0033674]
- 5122: positive regulation of L-dopa decarboxylase activity [GO_1903200]
- 5123: positive regulation of large conductance calcium-activated potassium channel activity [GO_1902608]
- 5124: positive regulation of leucine-tRNA ligase activity [GO_1903635]
- 5125: positive regulation of leukocyte apoptotic process [GO_2000108]
- 5126: positive regulation of leukocyte differentiation [GO_1902107]
- 5127: positive regulation of leukocyte mediated immunity [GO_0002705]
- 5128: positive regulation of leukocyte proliferation [GO_0070665]
- 5129: positive regulation of ligase activity [GO_0051351]
- 5130: positive regulation of light-activated channel activity [GO_0045832]
- 5131: positive regulation of lipase activity [GO_0060193]
- 5132: positive regulation of lipid binding [GO_1900132]
- 5133: positive regulation of lipid biosynthetic process [GO_0046889]
- 5134: positive regulation of lipid catabolic process [GO_0050996]
- 5135: positive regulation of lipid kinase activity [GO_0090218]
- 5136: positive regulation of lipid localization [GO_1905954]
- 5137: positive regulation of lipid metabolic process [GO_0045834]
- 5138: positive regulation of lipid storage [GO_0010884]
- 5139: positive regulation of lipid transport [GO_0032370]
- 5140: positive regulation of lipid transporter activity [GO_0110113]
- 5141: positive regulation of lipopolysaccharide-mediated signaling pathway [GO_0031666]
- 5142: positive regulation of lipoprotein lipase activity [GO_0051006]
- 5143: positive regulation of locomotion [GO_0040017]
- 5144: positive regulation of locomotion involved in locomotory behavior [GO_0090326]
- 5145: positive regulation of locomotor rhythm [GO_1904061]
- 5146: positive regulation of low-density lipoprotein particle receptor binding [GO_1905597]
- 5147: positive regulation of low-density lipoprotein receptor activity [GO_1905599]
- 5148: positive regulation of lung ciliated cell differentiation [GO_1901248]
- 5149: positive regulation of lyase activity [GO_0051349]
- 5150: positive regulation of Lys63-specific deubiquitinase activity [GO_1903007]
- 5151: positive regulation of lysozyme activity [GO_1903592]
- 5152: positive regulation of m7G(5')pppN diphosphatase activity [GO_1903399]
- 5153: positive regulation of macromolecule biosynthetic process [GO_0010557]
- 5154: positive regulation of macromolecule metabolic process [GO_0010604]
- 5155: positive regulation of malate dehydrogenase (decarboxylating) (NADP+) activity [GO_1903220]
- 5156: positive regulation of male mating behavior [GO_1902437]
- 5157: positive regulation of MAP kinase activity [GO_0043406]
- 5158: positive regulation of MAPK cascade [GO_0043410]
- 5159: positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO_0090080]
- 5160: positive regulation of megakaryocyte differentiation [GO_0045654]
- 5161: positive regulation of meiotic cell cycle [GO_0051446]
- 5162: positive regulation of meiotic cell cycle process involved in oocyte maturation [GO_1904146]
- 5163: positive regulation of meiotic nuclear division [GO_0045836]
- 5164: positive regulation of membrane invagination [GO_1905155]
- 5165: positive regulation of mesenchymal cell apoptotic process [GO_2001055]
- 5166: positive regulation of mesenchymal cell proliferation [GO_0002053]
- 5167: positive regulation of mesenchymal cell proliferation involved in lung development [GO_2000792]
- 5168: positive regulation of mesoderm development [GO_2000382]
- 5169: positive regulation of mesoderm formation [GO_1905904]
- 5170: positive regulation of mesodermal cell differentiation [GO_1905772]
- 5171: positive regulation of metabolic process [GO_0009893]
- 5172: positive regulation of metalloendopeptidase activity [GO_1904685]
- 5173: positive regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO_1902964]
- 5174: positive regulation of metallopeptidase activity [GO_1905050]
- 5175: positive regulation of methionine-tRNA ligase activity [GO_1905020]
- 5176: positive regulation of microtubule binding [GO_1904528]
- 5177: positive regulation of microtubule depolymerization [GO_0031117]
- 5178: positive regulation of microtubule minus-end binding [GO_1902620]
- 5179: positive regulation of microtubule nucleation [GO_0090063]
- 5180: positive regulation of microtubule plus-end binding [GO_1903033]
- 5181: positive regulation of microtubule polymerization [GO_0031116]
- 5182: positive regulation of microtubule polymerization or depolymerization [GO_0031112]
- 5183: positive regulation of microvillus assembly [GO_1903698]
- 5184: positive regulation of miRNA-mediated gene silencing [GO_2000637]
- 5185: positive regulation of mitochondrial DNA metabolic process [GO_1901860]
- 5186: positive regulation of mitochondrial DNA replication [GO_0090297]
- 5187: positive regulation of mitochondrial mRNA catabolic process [GO_1905639]
- 5188: positive regulation of mitochondrial RNA catabolic process [GO_0000962]
- 5189: positive regulation of mitochondrial transcription [GO_1903109]
- 5190: positive regulation of mitochondrial translation [GO_0070131]
- 5191: positive regulation of mitochondrial translation in response to stress [GO_0010892]
- 5192: positive regulation of mitochondrial translational elongation [GO_1905084]
- 5193: positive regulation of mitochondrial translational initiation [GO_0070134]
- 5194: positive regulation of mitochondrion organization [GO_0010822]
- 5195: positive regulation of mitotic cell cycle [GO_0045931]
- 5196: positive regulation of mitotic cell cycle DNA replication [GO_1903465]
- 5197: positive regulation of mitotic cell cycle, embryonic [GO_0045977]
- 5198: positive regulation of mitotic chromosome condensation [GO_1903380]
- 5199: positive regulation of mitotic nuclear division [GO_0045840]
- 5200: positive regulation of mitotic nuclear envelope disassembly [GO_1905559]
- 5201: positive regulation of mitotic sister chromatid segregation [GO_0062033]
- 5202: positive regulation of molecular function [GO_0044093]
- 5203: positive regulation of mononuclear cell proliferation [GO_0032946]
- 5204: positive regulation of monooxygenase activity [GO_0032770]
- 5205: positive regulation of morphogenesis of an epithelium [GO_1905332]
- 5206: positive regulation of motor neuron apoptotic process [GO_2000673]
- 5207: positive regulation of mRNA 3'-UTR binding [GO_1903839]
- 5208: positive regulation of mRNA binding [GO_1902416]
- 5209: positive regulation of mRNA catabolic process [GO_0061014]
- 5210: positive regulation of mRNA metabolic process [GO_1903313]
- 5211: positive regulation of mucus secretion [GO_0070257]
- 5212: positive regulation of multicellular organism growth [GO_0040018]
- 5213: positive regulation of multicellular organismal process [GO_0051240]
- 5214: positive regulation of muscle adaptation [GO_0014744]
- 5215: positive regulation of muscle cell apoptotic process [GO_0010661]
- 5216: positive regulation of muscle cell differentiation [GO_0051149]
- 5217: positive regulation of muscle contraction [GO_0045933]
- 5218: positive regulation of muscle hypertrophy [GO_0014742]
- 5219: positive regulation of muscle organ development [GO_0048636]
- 5220: positive regulation of muscle tissue development [GO_1901863]
- 5221: positive regulation of myeloid cell apoptotic process [GO_0033034]
- 5222: positive regulation of myeloid cell differentiation [GO_0045639]
- 5223: positive regulation of myeloid leukocyte differentiation [GO_0002763]
- 5224: positive regulation of myeloid leukocyte mediated immunity [GO_0002888]
- 5225: positive regulation of myeloid progenitor cell differentiation [GO_1905455]
- 5226: positive regulation of myoblast differentiation [GO_0045663]
- 5227: positive regulation of myoblast proliferation [GO_2000288]
- 5228: positive regulation of myosin light chain kinase activity [GO_0035505]
- 5229: positive regulation of myotome development [GO_2000287]
- 5230: positive regulation of myotube differentiation [GO_0010831]
- 5231: positive regulation of NAD+ ADP-ribosyltransferase activity [GO_1901666]
- 5232: positive regulation of NAD+ kinase activity [GO_0033672]
- 5233: positive regulation of negative chemotaxis [GO_0050924]
- 5234: positive regulation of nervous system development [GO_0051962]
- 5235: positive regulation of nervous system process [GO_0031646]
- 5236: positive regulation of netrin-activated signaling pathway [GO_1902843]
- 5237: positive regulation of neural crest cell differentiation [GO_1905294]
- 5238: positive regulation of neural crest formation [GO_0090300]
- 5239: positive regulation of neural precursor cell proliferation [GO_2000179]
- 5240: positive regulation of neural retina development [GO_0061075]
- 5241: positive regulation of neuroblast proliferation [GO_0002052]
- 5242: positive regulation of neuroepithelial cell differentiation [GO_1902913]
- 5243: positive regulation of neurogenesis [GO_0050769]
- 5244: positive regulation of neuromuscular junction development [GO_1904398]
- 5245: positive regulation of neuron apoptotic process [GO_0043525]
- 5246: positive regulation of neuron death [GO_1901216]
- 5247: positive regulation of neuron differentiation [GO_0045666]
- 5248: positive regulation of neuron maturation [GO_0014042]
- 5249: positive regulation of neuron projection development [GO_0010976]
- 5250: positive regulation of neuronal action potential [GO_1904457]
- 5251: positive regulation of neurotransmitter secretion [GO_0001956]
- 5252: positive regulation of neurotransmitter transport [GO_0051590]
- 5253: positive regulation of neurotransmitter uptake [GO_0051582]
- 5254: positive regulation of nitric-oxide synthase activity [GO_0051000]
- 5255: positive regulation of nitrogen compound metabolic process [GO_0051173]
- 5256: positive regulation of NMDA glutamate receptor activity [GO_1904783]
- 5257: positive regulation of non-membrane spanning protein tyrosine kinase activity [GO_1903997]
- 5258: positive regulation of norepinephrine secretion [GO_0010701]
- 5259: positive regulation of norepinephrine uptake [GO_0051623]
- 5260: positive regulation of nuclear cell cycle DNA replication [GO_0010571]
- 5261: positive regulation of nuclear division [GO_0051785]
- 5262: positive regulation of nuclear migration along microtubule [GO_1902840]
- 5263: positive regulation of nuclease activity [GO_0032075]
- 5264: positive regulation of nucleic acid-templated transcription [GO_1903508]
- 5265: positive regulation of nucleobase-containing compound metabolic process [GO_0045935]
- 5266: positive regulation of nucleobase-containing compound transport [GO_0032241]
- 5267: positive regulation of nucleocytoplasmic transport [GO_0046824]
- 5268: positive regulation of nucleoside metabolic process [GO_0045979]
- 5269: positive regulation of nucleoside transport [GO_0032244]
- 5270: positive regulation of nucleotide biosynthetic process [GO_0030810]
- 5271: positive regulation of nucleotide metabolic process [GO_0045981]
- 5272: positive regulation of oligopeptide transport [GO_2000878]
- 5273: positive regulation of oocyte development [GO_0060282]
- 5274: positive regulation of oocyte maturation [GO_1900195]
- 5275: positive regulation of oogenesis [GO_1905881]
- 5276: positive regulation of organ growth [GO_0046622]
- 5277: positive regulation of organelle assembly [GO_1902117]
- 5278: positive regulation of organelle organization [GO_0010638]
- 5279: positive regulation of organic acid transport [GO_0032892]
- 5280: positive regulation of ossification [GO_0045778]
- 5281: positive regulation of oviposition [GO_1901046]
- 5282: positive regulation of oxidative phosphorylation [GO_1903862]
- 5283: positive regulation of oxidoreductase activity [GO_0051353]
- 5284: positive regulation of oxygen metabolic process [GO_2000376]
- 5285: positive regulation of P-type sodium:potassium-exchanging transporter activity [GO_1903408]
- 5286: positive regulation of pancreatic A cell differentiation [GO_2000228]
- 5287: positive regulation of peptidase activity [GO_0010952]
- 5288: positive regulation of peptide hormone secretion [GO_0090277]
- 5289: positive regulation of peptide secretion [GO_0002793]
- 5290: positive regulation of peptidyl-tyrosine phosphorylation [GO_0050731]
- 5291: positive regulation of peroxidase activity [GO_2000470]
- 5292: positive regulation of pharynx morphogenesis [GO_0110043]
- 5293: positive regulation of phosphatase activity [GO_0010922]
- 5294: positive regulation of phosphate metabolic process [GO_0045937]
- 5295: positive regulation of phosphate transmembrane transport [GO_2000187]
- 5296: positive regulation of phosphatidate phosphatase activity [GO_1903740]
- 5297: positive regulation of phosphatidylcholine biosynthetic process [GO_2001247]
- 5298: positive regulation of phosphatidylcholine metabolic process [GO_0150173]
- 5299: positive regulation of phosphatidylinositol 3-kinase activity [GO_0043552]
- 5300: positive regulation of phosphatidylinositol biosynthetic process [GO_0010513]
- 5301: positive regulation of phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO_0120139]
- 5302: positive regulation of phospholipase A2 activity [GO_0032430]
- 5303: positive regulation of phospholipase activity [GO_0010518]
- 5304: positive regulation of phospholipase C activity [GO_0010863]
- 5305: positive regulation of phospholipase D activity [GO_1904007]
- 5306: positive regulation of phospholipid biosynthetic process [GO_0071073]
- 5307: positive regulation of phospholipid metabolic process [GO_1903727]
- 5308: positive regulation of phospholipid scramblase activity [GO_1900163]
- 5309: positive regulation of phospholipid translocation [GO_0061092]
- 5310: positive regulation of phospholipid transport [GO_2001140]
- 5311: positive regulation of phosphoprotein phosphatase activity [GO_0032516]
- 5312: positive regulation of phosphorus metabolic process [GO_0010562]
- 5313: positive regulation of phosphorylation [GO_0042327]
- 5314: positive regulation of photoreceptor cell differentiation [GO_0046534]
- 5315: positive regulation of pigment cell differentiation [GO_0050942]
- 5316: positive regulation of placenta blood vessel development [GO_0110080]
- 5317: positive regulation of plasma membrane bounded cell projection assembly [GO_0120034]
- 5318: positive regulation of poly(A)-specific ribonuclease activity [GO_0106248]
- 5319: positive regulation of polyamine transmembrane transport [GO_1902269]
- 5320: positive regulation of polynucleotide adenylyltransferase activity [GO_1904247]
- 5321: positive regulation of polysome binding [GO_1905698]
- 5322: positive regulation of positive chemotaxis [GO_0050927]
- 5323: positive regulation of post-embryonic development [GO_0048582]
- 5324: positive regulation of post-transcriptional gene silencing [GO_0060148]
- 5325: positive regulation of post-transcriptional gene silencing by RNA [GO_1900370]
- 5326: positive regulation of potassium ion transmembrane transport [GO_1901381]
- 5327: positive regulation of potassium ion transmembrane transporter activity [GO_1901018]
- 5328: positive regulation of potassium ion transport [GO_0043268]
- 5329: positive regulation of presynapse assembly [GO_1905608]
- 5330: positive regulation of programmed cell death [GO_0043068]
- 5331: positive regulation of prostaglandin-E synthase activity [GO_2000363]
- 5332: positive regulation of proteasomal protein catabolic process [GO_1901800]
- 5333: positive regulation of protein binding [GO_0032092]
- 5334: positive regulation of protein catabolic process [GO_0045732]
- 5335: positive regulation of protein catabolic process in the vacuole [GO_1904352]
- 5336: positive regulation of protein deacetylation [GO_0090312]
- 5337: positive regulation of protein dephosphorylation [GO_0035307]
- 5338: positive regulation of protein depolymerization [GO_1901881]
- 5339: positive regulation of protein deubiquitination [GO_1903003]
- 5340: positive regulation of protein folding [GO_1903334]
- 5341: positive regulation of protein glycosylation [GO_0060050]
- 5342: positive regulation of protein homodimerization activity [GO_0090073]
- 5343: positive regulation of protein K63-linked deubiquitination [GO_1903006]
- 5344: positive regulation of protein kinase activity [GO_0045860]
- 5345: positive regulation of protein kinase C activity [GO_1900020]
- 5346: positive regulation of protein localization [GO_1903829]
- 5347: positive regulation of protein localization to cell cortex [GO_1904778]
- 5348: positive regulation of protein localization to cell leading edge [GO_1905873]
- 5349: positive regulation of protein localization to cell periphery [GO_1904377]
- 5350: positive regulation of protein localization to cell-cell junction [GO_0150107]
- 5351: positive regulation of protein localization to chromatin [GO_0120187]
- 5352: positive regulation of protein localization to ciliary membrane [GO_1903569]
- 5353: positive regulation of protein localization to cilium [GO_1903566]
- 5354: positive regulation of protein localization to membrane [GO_1905477]
- 5355: positive regulation of protein localization to nucleolus [GO_1904751]
- 5356: positive regulation of protein localization to nucleus [GO_1900182]
- 5357: positive regulation of protein localization to plasma membrane [GO_1903078]
- 5358: positive regulation of protein localization to presynapse [GO_1905386]
- 5359: positive regulation of protein localization to synapse [GO_1902474]
- 5360: positive regulation of protein metabolic process [GO_0051247]
- 5361: positive regulation of protein modification by small protein conjugation or removal [GO_1903322]
- 5362: positive regulation of protein modification process [GO_0031401]
- 5363: positive regulation of protein O-linked glycosylation [GO_1904100]
- 5364: positive regulation of protein phosphorylation [GO_0001934]
- 5365: positive regulation of protein polymerization [GO_0032273]
- 5366: positive regulation of protein secretion [GO_0050714]
- 5367: positive regulation of protein serine/threonine kinase activity [GO_0071902]
- 5368: positive regulation of protein serine/threonine phosphatase activity [GO_1905184]
- 5369: positive regulation of protein sumoylation [GO_0033235]
- 5370: positive regulation of protein transport [GO_0051222]
- 5371: positive regulation of protein tyrosine kinase activity [GO_0061098]
- 5372: positive regulation of protein tyrosine phosphatase activity [GO_1903615]
- 5373: positive regulation of protein ubiquitination [GO_0031398]
- 5374: positive regulation of protein-containing complex assembly [GO_0031334]
- 5375: positive regulation of protein-containing complex disassembly [GO_0043243]
- 5376: positive regulation of protein-glutamine gamma-glutamyltransferase activity [GO_0150074]
- 5377: positive regulation of proteolysis [GO_0045862]
- 5378: positive regulation of proteolysis involved in protein catabolic process [GO_1903052]
- 5379: positive regulation of proton-transporting ATP synthase activity, rotational mechanism [GO_1905273]
- 5380: positive regulation of purine nucleotide biosynthetic process [GO_1900373]
- 5381: positive regulation of purine nucleotide metabolic process [GO_1900544]
- 5382: positive regulation of pyrimidine nucleotide biosynthetic process [GO_1900399]
- 5383: positive regulation of pyrroline-5-carboxylate reductase activity [GO_1903168]
- 5384: positive regulation of pyruvate dehydrogenase activity [GO_1904184]
- 5385: positive regulation of pyruvate kinase activity [GO_1903304]
- 5386: positive regulation of reactive oxygen species metabolic process [GO_2000379]
- 5387: positive regulation of receptor binding [GO_1900122]
- 5388: positive regulation of receptor-mediated endocytosis [GO_0048260]
- 5389: positive regulation of release of sequestered calcium ion into cytosol [GO_0051281]
- 5390: positive regulation of removal of superoxide radicals [GO_1904833]
- 5391: positive regulation of reproductive process [GO_2000243]
- 5392: positive regulation of respiratory gaseous exchange [GO_1903942]
- 5393: positive regulation of response to alcohol [GO_1901421]
- 5394: positive regulation of response to biotic stimulus [GO_0002833]
- 5395: positive regulation of response to calcium ion [GO_1905947]
- 5396: positive regulation of response to cytokine stimulus [GO_0060760]
- 5397: positive regulation of response to DNA damage stimulus [GO_2001022]
- 5398: positive regulation of response to drug [GO_2001025]
- 5399: positive regulation of response to external stimulus [GO_0032103]
- 5400: positive regulation of response to extracellular stimulus [GO_0032106]
- 5401: positive regulation of response to nutrient levels [GO_0032109]
- 5402: positive regulation of response to oxidative stress [GO_1902884]
- 5403: positive regulation of response to reactive oxygen species [GO_1901033]
- 5404: positive regulation of response to stimulus [GO_0048584]
- 5405: positive regulation of response to wounding [GO_1903036]
- 5406: positive regulation of retina development in camera-type eye [GO_1902868]
- 5407: positive regulation of retinal cell programmed cell death [GO_0046670]
- 5408: positive regulation of retrograde trans-synaptic signaling by neuropeptide [GO_1905434]
- 5409: positive regulation of ribonucleoside-diphosphate reductase activity [GO_1905118]
- 5410: positive regulation of ribosome biogenesis [GO_0090070]
- 5411: positive regulation of RNA binding [GO_1905216]
- 5412: positive regulation of RNA biosynthetic process [GO_1902680]
- 5413: positive regulation of RNA metabolic process [GO_0051254]
- 5414: positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO_1905636]
- 5415: positive regulation of RNA splicing [GO_0033120]
- 5416: positive regulation of rRNA processing [GO_2000234]
- 5417: positive regulation of ryanodine-sensitive calcium-release channel activity [GO_0060316]
- 5418: positive regulation of saliva secretion [GO_0046878]
- 5419: positive regulation of sarcomere organization [GO_0060298]
- 5420: positive regulation of sclerotome development [GO_0061189]
- 5421: positive regulation of secondary metabolite biosynthetic process [GO_1900378]
- 5422: positive regulation of secretion [GO_0051047]
- 5423: positive regulation of secretion by cell [GO_1903532]
- 5424: positive regulation of secretory granule organization [GO_1904411]
- 5425: positive regulation of semaphorin-plexin signaling pathway [GO_2001262]
- 5426: positive regulation of sensory perception of bitter taste [GO_1904662]
- 5427: positive regulation of sensory perception of pain [GO_1904058]
- 5428: positive regulation of sensory perception of sweet taste [GO_1904658]
- 5429: positive regulation of sequestering of calcium ion [GO_0051284]
- 5430: positive regulation of serine C-palmitoyltransferase activity [GO_1904222]
- 5431: positive regulation of serine-type endopeptidase activity [GO_1900005]
- 5432: positive regulation of serine-type peptidase activity [GO_1902573]
- 5433: positive regulation of serotonin biosynthetic process [GO_1905629]
- 5434: positive regulation of serotonin secretion [GO_0014064]
- 5435: positive regulation of serotonin uptake [GO_0051613]
- 5436: positive regulation of signal transduction [GO_0009967]
- 5437: positive regulation of signaling [GO_0023056]
- 5438: positive regulation of signaling receptor activity [GO_2000273]
- 5439: positive regulation of single-stranded telomeric DNA binding [GO_0060381]
- 5440: positive regulation of skeletal muscle cell differentiation [GO_2001016]
- 5441: positive regulation of skeletal muscle cell proliferation [GO_0014858]
- 5442: positive regulation of skeletal muscle fiber development [GO_0048743]
- 5443: positive regulation of skeletal muscle fiber differentiation [GO_1902811]
- 5444: positive regulation of skeletal muscle hypertrophy [GO_1904206]
- 5445: positive regulation of skeletal muscle tissue development [GO_0048643]
- 5446: positive regulation of skeletal muscle tissue growth [GO_0048633]
- 5447: positive regulation of small GTPase binding [GO_1904477]
- 5448: positive regulation of small intestine smooth muscle contraction [GO_1904349]
- 5449: positive regulation of small molecule metabolic process [GO_0062013]
- 5450: positive regulation of smooth muscle cell apoptotic process [GO_0034393]
- 5451: positive regulation of smooth muscle cell differentiation [GO_0051152]
- 5452: positive regulation of smooth muscle cell proliferation [GO_0048661]
- 5453: positive regulation of smooth muscle contraction [GO_0045987]
- 5454: positive regulation of smooth muscle hypertrophy [GO_1905149]
- 5455: positive regulation of smooth muscle tissue development [GO_1905901]
- 5456: positive regulation of sodium ion transmembrane transport [GO_1902307]
- 5457: positive regulation of sodium ion transmembrane transporter activity [GO_2000651]
- 5458: positive regulation of sodium ion transport [GO_0010765]
- 5459: positive regulation of sodium:proton antiporter activity [GO_0032417]
- 5460: positive regulation of somatic stem cell division [GO_1904677]
- 5461: positive regulation of somatostatin secretion [GO_0090274]
- 5462: positive regulation of stem cell differentiation [GO_2000738]
- 5463: positive regulation of stem cell proliferation [GO_2000648]
- 5464: positive regulation of steroid biosynthetic process [GO_0010893]
- 5465: positive regulation of steroid hormone secretion [GO_2000833]
- 5466: positive regulation of steroid metabolic process [GO_0045940]
- 5467: positive regulation of sterol transport [GO_0032373]
- 5468: positive regulation of store-operated calcium channel activity [GO_1901341]
- 5469: positive regulation of stress-activated MAPK cascade [GO_0032874]
- 5470: positive regulation of stress-activated protein kinase signaling cascade [GO_0070304]
- 5471: positive regulation of striated muscle cell apoptotic process [GO_0010663]
- 5472: positive regulation of striated muscle cell differentiation [GO_0051155]
- 5473: positive regulation of striated muscle contraction [GO_0045989]
- 5474: positive regulation of striated muscle tissue development [GO_0045844]
- 5475: positive regulation of succinate dehydrogenase activity [GO_1904231]
- 5476: positive regulation of sulfur amino acid metabolic process [GO_0031337]
- 5477: positive regulation of sulfur metabolic process [GO_0051176]
- 5478: positive regulation of SUMO transferase activity [GO_1903755]
- 5479: positive regulation of superoxide dismutase activity [GO_1901671]
- 5480: positive regulation of supramolecular fiber organization [GO_1902905]
- 5481: positive regulation of synapse assembly [GO_0051965]
- 5482: positive regulation of synapse pruning [GO_1905808]
- 5483: positive regulation of synaptic transmission [GO_0050806]
- 5484: positive regulation of synaptic transmission, cholinergic [GO_0032224]
- 5485: positive regulation of synaptic transmission, dopaminergic [GO_0032226]
- 5486: positive regulation of synaptic transmission, GABAergic [GO_0032230]
- 5487: positive regulation of synaptic transmission, glutamatergic [GO_0051968]
- 5488: positive regulation of synaptic transmission, glycinergic [GO_0060094]
- 5489: positive regulation of syncytium formation by plasma membrane fusion [GO_0060143]
- 5490: positive regulation of tau-protein kinase activity [GO_1902949]
- 5491: positive regulation of telomerase activity [GO_0051973]
- 5492: positive regulation of telomeric DNA binding [GO_1904744]
- 5493: positive regulation of termination of DNA-templated transcription [GO_0060566]
- 5494: positive regulation of tetrapyrrole biosynthetic process [GO_1901465]
- 5495: positive regulation of tetrapyrrole catabolic process [GO_1901406]
- 5496: positive regulation of tetrapyrrole metabolic process [GO_1901403]
- 5497: positive regulation of threonine-tRNA ligase activity [GO_1905023]
- 5498: positive regulation of transcription by RNA polymerase I [GO_0045943]
- 5499: positive regulation of transcription by RNA polymerase II [GO_0045944]
- 5500: positive regulation of transcription by RNA polymerase III [GO_0045945]
- 5501: positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO_1901522]
- 5502: positive regulation of transcription from RNA polymerase II promoter involved in neuron differentiation [GO_1904081]
- 5503: positive regulation of transcription regulatory region DNA binding [GO_2000679]
- 5504: positive regulation of transferase activity [GO_0051347]
- 5505: positive regulation of translation [GO_0045727]
- 5506: positive regulation of translation in response to oxidative stress [GO_0032939]
- 5507: positive regulation of translation in response to stress [GO_0032056]
- 5508: positive regulation of translational elongation [GO_0045901]
- 5509: positive regulation of translational initiation [GO_0045948]
- 5510: positive regulation of translational initiation in response to stress [GO_0032058]
- 5511: positive regulation of translational termination [GO_0045905]
- 5512: positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway [GO_0090100]
- 5513: positive regulation of transmembrane transport [GO_0034764]
- 5514: positive regulation of transmission of nerve impulse [GO_0051971]
- 5515: positive regulation of transport [GO_0051050]
- 5516: positive regulation of transporter activity [GO_0032411]
- 5517: positive regulation of triglyceride biosynthetic process [GO_0010867]
- 5518: positive regulation of triglyceride lipase activity [GO_0061365]
- 5519: positive regulation of triglyceride metabolic process [GO_0090208]
- 5520: positive regulation of tRNA metabolic process [GO_1903328]
- 5521: positive regulation of tRNA methylation [GO_0110004]
- 5522: positive regulation of tRNA processing [GO_2000237]
- 5523: positive regulation of trophectodermal cell proliferation [GO_1904075]
- 5524: positive regulation of turning behavior involved in mating [GO_0061095]
- 5525: positive regulation of type B pancreatic cell apoptotic process [GO_2000676]
- 5526: positive regulation of type B pancreatic cell development [GO_2000078]
- 5527: positive regulation of type B pancreatic cell proliferation [GO_1904692]
- 5528: positive regulation of tyrosinase activity [GO_0032773]
- 5529: positive regulation of tyrosine 3-monooxygenase activity [GO_1903178]
- 5530: positive regulation of ubiquitin protein ligase activity [GO_1904668]
- 5531: positive regulation of ubiquitin-dependent protein catabolic process [GO_2000060]
- 5532: positive regulation of ubiquitin-protein transferase activity [GO_0051443]
- 5533: positive regulation of ubiquitin-specific protease activity [GO_2000158]
- 5534: positive regulation of vacuolar transport [GO_1903337]
- 5535: positive regulation of vacuole organization [GO_0044090]
- 5536: positive regulation of vascular associated smooth muscle cell apoptotic process [GO_1905461]
- 5537: positive regulation of vascular associated smooth muscle cell differentiation [GO_1905065]
- 5538: positive regulation of vascular associated smooth muscle cell proliferation [GO_1904707]
- 5539: positive regulation of vascular endothelial cell proliferation [GO_1905564]
- 5540: positive regulation of vasculature development [GO_1904018]
- 5541: positive regulation of vasculogenesis [GO_2001214]
- 5542: positive regulation of vesicle fusion [GO_0031340]
- 5543: positive regulation of vesicle fusion with Golgi apparatus [GO_0106216]
- 5544: positive regulation of vesicle transport along microtubule [GO_1901610]
- 5545: positive regulation of vitamin D 24-hydroxylase activity [GO_0010980]
- 5546: positive regulation of vitamin metabolic process [GO_0046136]
- 5547: positive regulation of voltage-gated calcium channel activity [GO_1901387]
- 5548: positive regulation of voltage-gated chloride channel activity [GO_1902943]
- 5549: positive regulation of voltage-gated potassium channel activity [GO_1903818]
- 5550: positive regulation of voltage-gated sodium channel activity [GO_1905152]
- 5551: positive regulation of water channel activity [GO_1902429]
- 5552: positive regulation of Wnt signaling pathway [GO_0030177]
- 5553: positive regulation of Wnt signaling pathway by BMP signaling pathway [GO_0060804]
- 5554: positive regulation of wound healing [GO_0090303]
- 5555: post-embryonic development [GO_0009791]
- 5556: post-Golgi vesicle-mediated transport [GO_0006892]
- 5557: post-transcriptional gene silencing [GO_0016441]
- 5558: postsynapse [GO_0098794]
- 5559: postsynapse assembly [GO_0099068]
- 5560: postsynapse of neuromuscular junction [GO_0098975]
- 5561: postsynapse organization [GO_0099173]
- 5562: postsynaptic actin cytoskeleton [GO_0098871]
- 5563: postsynaptic actin cytoskeleton organization [GO_0098974]
- 5564: postsynaptic cytoskeleton [GO_0099571]
- 5565: postsynaptic cytoskeleton organization [GO_0099188]
- 5566: postsynaptic endocytosis [GO_0140239]
- 5567: postsynaptic membrane [GO_0045211]
- 5568: postsynaptic modulation of chemical synaptic transmission [GO_0099170]
- 5569: postsynaptic neurotransmitter receptor activity [GO_0098960]
- 5570: postsynaptic signal transduction [GO_0098926]
- 5571: posttranscriptional regulation of gene expression [GO_0010608]
- 5572: potassium channel activating, G protein-coupled receptor signaling pathway [GO_0099109]
- 5573: potassium channel activator activity [GO_0099104]
- 5574: potassium channel activator activity involved in G protein-coupled receptor signaling pathway [GO_0099108]
- 5575: potassium channel inhibitor activity [GO_0019870]
- 5576: potassium channel regulator activity [GO_0015459]
- 5577: potassium ion binding [GO_0030955]
- 5578: potassium ion leak channel activity [GO_0022841]
- 5579: potassium ion transmembrane transport [GO_0071805]
- 5580: potassium ion transmembrane transporter activity [GO_0015079]
- 5581: potassium ion transport [GO_0006813]
- 5582: potassium:proton antiporter activity [GO_0015386]
- 5583: potassium:sodium symporter activity [GO_0009674]
- 5584: POZ domain binding [GO_0031208]
- 5585: PP2A dephosphorylates RAF1 [GO_0004722]
- 5586: PP2A methylation by LCMT1 [GO_0018423]
- 5587: pPR-AP:pAP cleaves the MCP:pPR-AP:pAP Complex [GO_0004176]
- 5588: PRC2-EZH2 trimethylates nucleosomes associated with CDKN2A promoter [GO_0046976]
- 5589: pre-miRNA binding [GO_0070883]
- 5590: pre-mRNA 3'-splice site binding [GO_0030628]
- 5591: pre-mRNA 5'-splice site binding [GO_0030627]
- 5592: pre-mRNA binding [GO_0036002]
- 5593: pre-mRNA branch point binding [GO_0045131]
- 5594: pre-mRNA intronic binding [GO_0097157]
- 5595: pre-mRNA intronic pyrimidine-rich binding [GO_0097158]
- 5596: Pre-snRNA transcript initiation, Integrator binding, LEC binding [GO_0001055]
- 5597: prechordal plate formation [GO_0021501]
- 5598: prekallikrein:kininogen:C1q binding protein tetramer -> kallikrein:kininogen:C1q binding protein tetramer [GO_0004185]
- 5599: prenyltransferase activity [GO_0004659]
- 5600: preribosome binding [GO_1990275]
- 5601: presynapse [GO_0098793]
- 5602: presynapse assembly [GO_0099054]
- 5603: presynapse organization [GO_0099172]
- 5604: presynaptic actin cytoskeleton [GO_0099143]
- 5605: presynaptic actin cytoskeleton organization [GO_0099140]
- 5606: presynaptic active zone [GO_0048786]
- 5607: presynaptic active zone organization [GO_1990709]
- 5608: presynaptic cytoskeleton [GO_0099569]
- 5609: presynaptic cytoskeleton organization [GO_0099187]
- 5610: presynaptic endocytosis [GO_0140238]
- 5611: presynaptic membrane [GO_0042734]
- 5612: presynaptic modulation of chemical synaptic transmission [GO_0099171]
- 5613: presynaptic process involved in chemical synaptic transmission [GO_0099531]
- 5614: presynaptic signal transduction [GO_0098928]
- 5615: primary active transmembrane transporter activity [GO_0015399]
- 5616: primary alcohol metabolic process [GO_0034308]
- 5617: primary amine secretion [GO_0061531]
- 5618: primary amine secretion, neurotransmission [GO_0061532]
- 5619: primary amino compound biosynthetic process [GO_1901162]
- 5620: primary amino compound catabolic process [GO_1901161]
- 5621: primary amino compound metabolic process [GO_1901160]
- 5622: primary lung bud formation [GO_0060431]
- 5623: primary metabolic process [GO_0044238]
- 5624: primary miRNA binding [GO_0070878]
- 5625: primary neural tube formation [GO_0014020]
- 5626: pristanoyl-CoA oxidase activity [GO_0016402]
- 5627: PRMT1 methylates arginine-12 of histone H2A (H2AR11) [GO_0016274]
- 5628: PRMT1 methylates ESRs [GO_0008276]
- 5629: PRMT5 methylates TP53 [GO_0035243]
- 5630: pro-RAS proteins are farnesylated [GO_0004660]
- 5631: proboscis extension reflex [GO_0007637]
- 5632: Procollagen triple helix formation [GO_0003755]
- 5633: procollagen-lysine 5-dioxygenase activity [GO_0008475]
- 5634: procollagen-proline dioxygenase activity [GO_0019798]
- 5635: proctolin receptor activity [GO_0035236]
- 5636: proctolin receptor binding [GO_0071860]
- 5637: Production of AA by iPLA2 upon FCGR activation [GO_0016787]
- 5638: proepicardium development [GO_0003342]
- 5639: programmed cell death [GO_0012501]
- 5640: programmed cell death involved in cell development [GO_0010623]
- 5641: proline dehydrogenase activity [GO_0004657]
- 5642: proline-rich region binding [GO_0070064]
- 5643: Prolyl 4-hydroxylase converts collagen prolines to 4-hydroxyprolines [GO_0004656]
- 5644: promoter-enhancer loop anchoring activity [GO_0140585]
- 5645: promoter-specific chromatin binding [GO_1990841]
- 5646: propionate-CoA ligase activity [GO_0050218]
- 5647: proprioception [GO_0019230]
- 5648: proprioception involved in equilibrioception [GO_0051355]
- 5649: Prorenin:Prorenin Receptor hydrolyzes Angiotensinogen to Angiotensin-(1-10) [GO_0004190]
- 5650: Prostaglandin E synthase isomerizes PGH2 to PGE2 [GO_0050220]
- 5651: prostaglandin-D synthase activity [GO_0004667]
- 5652: prosthetic group binding [GO_0051192]
- 5653: proteasomal protein catabolic process [GO_0010498]
- 5654: proteasome binding [GO_0070628]
- 5655: proteasome-activating activity [GO_0036402]
- 5656: protein alkylation [GO_0008213]
- 5657: protein arginine phosphatase activity [GO_0098627]
- 5658: protein arginylation [GO_0016598]
- 5659: protein binding [GO_0005515]
- 5660: protein C-terminal carboxyl O-methyltransferase activity [GO_0003880]
- 5661: protein C-terminus binding [GO_0008022]
- 5662: protein carboxyl O-methyltransferase activity [GO_0051998]
- 5663: protein carrier chaperone [GO_0140597]
- 5664: protein catabolic process [GO_0030163]
- 5665: protein catabolic process at postsynapse [GO_0140249]
- 5666: protein catabolic process at presynapse [GO_0140247]
- 5667: protein catabolic process at synapse [GO_0140246]
- 5668: protein catabolic process in the vacuole [GO_0007039]
- 5669: protein catabolic process, modulating synaptic transmission [GO_0099546]
- 5670: protein complex involved in cell adhesion [GO_0098636]
- 5671: protein deacetylation [GO_0006476]
- 5672: protein deacylation [GO_0035601]
- 5673: protein demethylase activity [GO_0140457]
- 5674: protein dephosphorylation [GO_0006470]
- 5675: protein depolymerization [GO_0051261]
- 5676: protein deubiquitination [GO_0016579]
- 5677: protein deubiquitination involved in ubiquitin-dependent protein catabolic process [GO_0071947]
- 5678: protein dimerization activity [GO_0046983]
- 5679: protein domain specific binding [GO_0019904]
- 5680: protein folding [GO_0006457]
- 5681: protein folding chaperone [GO_0044183]
- 5682: protein geranylgeranyltransferase activity [GO_0004661]
- 5683: protein glycosylation [GO_0006486]
- 5684: protein heterodimerization activity [GO_0046982]
- 5685: protein histidine phosphatase activity [GO_0101006]
- 5686: protein homodimerization activity [GO_0042803]
- 5687: protein hydroxylation [GO_0018126]
- 5688: protein K48-linked deubiquitination [GO_0071108]
- 5689: protein K63-linked deubiquitination [GO_0070536]
- 5690: protein kinase A binding [GO_0051018]
- 5691: protein kinase A catalytic subunit binding [GO_0034236]
- 5692: protein kinase A regulatory subunit binding [GO_0034237]
- 5693: protein kinase activator activity [GO_0030295]
- 5694: protein kinase binding [GO_0019901]
- 5695: protein kinase C binding [GO_0005080]
- 5696: protein kinase C inhibitor activity [GO_0008426]
- 5697: protein kinase inhibitor activity [GO_0004860]
- 5698: protein kinase regulator activity [GO_0019887]
- 5699: protein localization [GO_0008104]
- 5700: protein localization to actin cytoskeleton [GO_1903119]
- 5701: protein localization to actin filament bundle [GO_1903120]
- 5702: protein localization to cell cortex [GO_0072697]
- 5703: protein localization to cell junction [GO_1902414]
- 5704: protein localization to cell leading edge [GO_1902463]
- 5705: protein localization to cell periphery [GO_1990778]
- 5706: protein localization to cell-cell junction [GO_0150105]
- 5707: protein localization to chromatin [GO_0071168]
- 5708: protein localization to chromosome [GO_0034502]
- 5709: protein localization to ciliary membrane [GO_1903441]
- 5710: protein localization to ciliary transition zone [GO_1904491]
- 5711: protein localization to cilium [GO_0061512]
- 5712: protein localization to cytoplasmic microtubule [GO_1905755]
- 5713: protein localization to cytoskeleton [GO_0044380]
- 5714: protein localization to extracellular region [GO_0071692]
- 5715: protein localization to Golgi apparatus [GO_0034067]
- 5716: protein localization to Golgi membrane [GO_1903292]
- 5717: protein localization to heterochromatin [GO_0097355]
- 5718: protein localization to membrane [GO_0072657]
- 5719: protein localization to microtubule [GO_0035372]
- 5720: protein localization to microtubule cytoskeleton [GO_0072698]
- 5721: protein localization to microvillus [GO_1904106]
- 5722: protein localization to nuclear envelope [GO_0090435]
- 5723: protein localization to nucleolus [GO_1902570]
- 5724: protein localization to nucleus [GO_0034504]
- 5725: protein localization to organelle [GO_0033365]
- 5726: protein localization to plasma membrane [GO_0072659]
- 5727: protein localization to postsynapse [GO_0062237]
- 5728: protein localization to presynapse [GO_1905383]
- 5729: protein localization to secretory granule [GO_0033366]
- 5730: protein localization to somatodendritic compartment [GO_0061938]
- 5731: protein localization to synapse [GO_0035418]
- 5732: protein localization to vacuolar membrane [GO_1903778]
- 5733: protein localization to vacuole [GO_0072665]
- 5734: protein metabolic process [GO_0019538]
- 5735: protein methylation [GO_0006479]
- 5736: protein modification by small protein conjugation [GO_0032446]
- 5737: protein modification by small protein conjugation or removal [GO_0070647]
- 5738: protein modification by small protein removal [GO_0070646]
- 5739: protein modification process [GO_0036211]
- 5740: protein N-acetylglucosaminyltransferase activity [GO_0016262]
- 5741: protein N-terminus binding [GO_0047485]
- 5742: protein O-acetylglucosaminyltransferase activity [GO_0097363]
- 5743: protein O-linked fucosylation [GO_0036066]
- 5744: protein O-linked glycosylation [GO_0006493]
- 5745: protein phosphatase 1 binding [GO_0008157]
- 5746: protein phosphatase 2A binding [GO_0051721]
- 5747: protein phosphatase activator activity [GO_0072542]
- 5748: protein phosphatase binding [GO_0019903]
- 5749: protein phosphatase inhibitor activity [GO_0004864]
- 5750: protein phosphorylated amino acid binding [GO_0045309]
- 5751: protein phosphorylation [GO_0006468]
- 5752: protein polymerization [GO_0051258]
- 5753: protein prenyltransferase activity [GO_0008318]
- 5754: protein secretion [GO_0009306]
- 5755: protein self-association [GO_0043621]
- 5756: protein sequestering activity [GO_0140311]
- 5757: protein serine/threonine kinase activator activity [GO_0043539]
- 5758: protein serine/threonine kinase inhibitor activity [GO_0030291]
- 5759: protein serine/threonine phosphatase inhibitor activity [GO_0004865]
- 5760: protein sumoylation [GO_0016925]
- 5761: protein tag [GO_0031386]
- 5762: protein transmembrane transport [GO_0071806]
- 5763: protein transport [GO_0015031]
- 5764: protein transport along microtubule [GO_0098840]
- 5765: protein transport within lipid bilayer [GO_0032594]
- 5766: protein transport within plasma membrane [GO_0099632]
- 5767: protein tyrosine kinase activator activity [GO_0030296]
- 5768: protein tyrosine kinase binding [GO_1990782]
- 5769: protein tyrosine kinase collagen receptor activity [GO_0038062]
- 5770: protein tyrosine kinase inhibitor activity [GO_0030292]
- 5771: protein tyrosine phosphatase activator activity [GO_0008160]
- 5772: protein tyrosine phosphatase activity, metal-dependent [GO_0030946]
- 5773: protein tyrosine/threonine phosphatase activity [GO_0008330]
- 5774: protein ubiquitination [GO_0016567]
- 5775: protein-arginine omega-N asymmetric methyltransferase activity [GO_0035242]
- 5776: protein-arginine omega-N monomethyltransferase activity [GO_0035241]
- 5777: protein-containing complex [GO_0032991]
- 5778: protein-containing complex assembly [GO_0065003]
- 5779: protein-containing complex binding [GO_0044877]
- 5780: protein-containing complex destabilizing activity [GO_0140776]
- 5781: protein-containing complex disassembly [GO_0032984]
- 5782: protein-containing complex localization [GO_0031503]
- 5783: protein-containing complex organization [GO_0043933]
- 5784: protein-cysteine methyltransferase activity [GO_0106363]
- 5785: protein-cysteine S-acyltransferase activity [GO_0019707]
- 5786: protein-cysteine S-palmitoyltransferase activity [GO_0019706]
- 5787: protein-disulfide reductase (NAD(P)) activity [GO_0047134]
- 5788: protein-DNA complex [GO_0032993]
- 5789: protein-DNA complex organization [GO_0071824]
- 5790: protein-glutamic acid ligase activity [GO_0070739]
- 5791: protein-glutamine N-methyltransferase activity [GO_0036009]
- 5792: protein-glycine ligase activity [GO_0070735]
- 5793: protein-glycine ligase activity, elongating [GO_0070737]
- 5794: protein-glycine ligase activity, initiating [GO_0070736]
- 5795: protein-hormone receptor activity [GO_0016500]
- 5796: protein-lipid complex binding [GO_0071814]
- 5797: protein-lysine N-methyltransferase activity [GO_0016279]
- 5798: protein-macromolecule adaptor activity [GO_0030674]
- 5799: protein-membrane adaptor activity [GO_0043495]
- 5800: protein-N-terminal asparagine amidohydrolase activity [GO_0008418]
- 5801: protein-N-terminal glutamine amidohydrolase activity [GO_0070773]
- 5802: protein-RNA adaptor activity [GO_0140517]
- 5803: protein-tyrosine sulfotransferase activity [GO_0008476]
- 5804: proteoglycan binding [GO_0043394]
- 5805: proteolysis [GO_0006508]
- 5806: proteolysis involved in protein catabolic process [GO_0051603]
- 5807: protoheme IX farnesyltransferase activity [GO_0008495]
- 5808: proton channel activity [GO_0015252]
- 5809: proton motive force-driven ATP synthesis [GO_0015986]
- 5810: proton motive force-driven mitochondrial ATP synthesis [GO_0042776]
- 5811: proton transmembrane transport [GO_1902600]
- 5812: proton-dependent oligopeptide secondary active transmembrane transporter activity [GO_0005427]
- 5813: proton-transporting ATP synthase activity, rotational mechanism [GO_0046933]
- 5814: proton-transporting ATPase activity, rotational mechanism [GO_0046961]
- 5815: PS is hydrolyzed to 2-acyl LPS by PLA2[10] [GO_0004623]
- 5816: pseudouridine synthase activity [GO_0009982]
- 5817: PTB domain binding [GO_0051425]
- 5818: PTEN cancer mutants do not dephosphorylate PIP3 [GO_0016314]
- 5819: PTPLs dehydrate VLC3HA-CoA to VLCTDA-CoA [GO_0080023]
- 5820: PTPS is phosphorylated by cGMP-dependant protein kinase II [GO_0004692]
- 5821: pulmonary artery endothelial tube morphogenesis [GO_0061155]
- 5822: pulmonary artery morphogenesis [GO_0061156]
- 5823: pulmonary vein morphogenesis [GO_0060577]
- 5824: purine deoxyribonucleoside monophosphate biosynthetic process [GO_0009171]
- 5825: purine deoxyribonucleoside monophosphate metabolic process [GO_0009170]
- 5826: purine deoxyribonucleotide biosynthetic process [GO_0009153]
- 5827: purine deoxyribonucleotide metabolic process [GO_0009151]
- 5828: purine nucleoside binding [GO_0001883]
- 5829: purine nucleoside diphosphate metabolic process [GO_0009135]
- 5830: purine nucleoside monophosphate biosynthetic process [GO_0009127]
- 5831: purine nucleoside monophosphate metabolic process [GO_0009126]
- 5832: purine nucleoside triphosphate biosynthetic process [GO_0009145]
- 5833: purine nucleoside triphosphate metabolic process [GO_0009144]
- 5834: purine nucleotide binding [GO_0017076]
- 5835: purine nucleotide biosynthetic process [GO_0006164]
- 5836: purine nucleotide metabolic process [GO_0006163]
- 5837: purine nucleotide transmembrane transporter activity [GO_0015216]
- 5838: purine nucleotide transport [GO_0015865]
- 5839: purine ribonucleoside diphosphate metabolic process [GO_0009179]
- 5840: purine ribonucleoside monophosphate biosynthetic process [GO_0009168]
- 5841: purine ribonucleoside monophosphate metabolic process [GO_0009167]
- 5842: purine ribonucleoside triphosphate binding [GO_0035639]
- 5843: purine ribonucleoside triphosphate biosynthetic process [GO_0009206]
- 5844: purine ribonucleoside triphosphate metabolic process [GO_0009205]
- 5845: purine ribonucleotide binding [GO_0032555]
- 5846: purine ribonucleotide biosynthetic process [GO_0009152]
- 5847: purine ribonucleotide metabolic process [GO_0009150]
- 5848: purine ribonucleotide transmembrane transporter activity [GO_0005346]
- 5849: purine ribonucleotide transport [GO_0015868]
- 5850: purine-containing compound biosynthetic process [GO_0072522]
- 5851: purine-containing compound metabolic process [GO_0072521]
- 5852: purine-containing compound transmembrane transport [GO_0072530]
- 5853: purine-nucleoside phosphorylase activity [GO_0004731]
- 5854: purine-rich negative regulatory element binding [GO_0032422]
- 5855: purinergic nucleotide receptor signaling pathway [GO_0035590]
- 5856: Purkinje myocyte action potential [GO_0086017]
- 5857: Purkinje myocyte development [GO_0003165]
- 5858: Purkinje myocyte differentiation [GO_0003168]
- 5859: Purkinje myocyte to ventricular cardiac muscle cell communication [GO_0086068]
- 5860: Purkinje myocyte to ventricular cardiac muscle cell signaling [GO_0086029]
- 5861: PXKLP-K305-CSAD decarboxylates 3-sulfinoalanine to hypotaurine [GO_0004782]
- 5862: PXLP-CBS tetramers condenses HCYS and L-Ser to form L-Cystathionine [GO_0004122]
- 5863: PXLP-K212-CTH cleaves L-Cystathionine [GO_0004123]
- 5864: PXLP-K314-GPT transaminates PYR to form L-Ala [GO_0004021]
- 5865: PXLP-K333-GADL1 decarboxylates CSA to HTAU [GO_0016831]
- 5866: PXLP-K357-ABAT dimer:2Fe-2S transforms GABA to SUCCSA [GO_0003867]
- 5867: PYCR1 decamer reduces (S)-1-pyrroline-5-carboxylate to L-Pro [GO_0004735]
- 5868: pyridine-containing compound biosynthetic process [GO_0072525]
- 5869: pyridine-containing compound metabolic process [GO_0072524]
- 5870: pyridoxal oxidase activity [GO_0004732]
- 5871: pyridoxal phosphate binding [GO_0030170]
- 5872: pyridoxal phosphate biosynthetic process [GO_0042823]
- 5873: pyridoxal phosphate metabolic process [GO_0042822]
- 5874: pyrimidine nucleobase binding [GO_0002061]
- 5875: pyrimidine nucleoside catabolic process [GO_0046135]
- 5876: pyrimidine nucleoside metabolic process [GO_0006213]
- 5877: pyrimidine nucleoside monophosphate biosynthetic process [GO_0009130]
- 5878: pyrimidine nucleoside monophosphate metabolic process [GO_0009129]
- 5879: pyrimidine nucleotide biosynthetic process [GO_0006221]
- 5880: pyrimidine nucleotide metabolic process [GO_0006220]
- 5881: pyrimidine nucleotide transmembrane transporter activity [GO_0015218]
- 5882: pyrimidine nucleotide transport [GO_0006864]
- 5883: pyrimidine nucleotide-sugar transmembrane transport [GO_0090481]
- 5884: pyrimidine nucleotide-sugar transmembrane transporter activity [GO_0015165]
- 5885: pyrimidine ribonucleoside catabolic process [GO_0046133]
- 5886: pyrimidine ribonucleoside metabolic process [GO_0046131]
- 5887: pyrimidine ribonucleoside monophosphate biosynthetic process [GO_0009174]
- 5888: pyrimidine ribonucleoside monophosphate metabolic process [GO_0009173]
- 5889: pyrimidine ribonucleotide biosynthetic process [GO_0009220]
- 5890: pyrimidine ribonucleotide metabolic process [GO_0009218]
- 5891: pyrimidine-containing compound biosynthetic process [GO_0072528]
- 5892: pyrimidine-containing compound catabolic process [GO_0072529]
- 5893: pyrimidine-containing compound metabolic process [GO_0072527]
- 5894: pyrimidine-containing compound transmembrane transport [GO_0072531]
- 5895: pyrimidine-specific mismatch base pair DNA N-glycosylase activity [GO_0008263]
- 5896: pyroglutamyl-peptidase activity [GO_0016920]
- 5897: pyrophosphatase activity [GO_0016462]
- 5898: pyrophosphate + H2O => 2 orthophosphate [cytosolic] [GO_0004427]
- 5899: pyrophosphate hydrolysis-driven proton transmembrane transporter activity [GO_0009678]
- 5900: pyruvate carboxylase activity [GO_0004736]
- 5901: pyruvate dehydrogenase (acetyl-transferring) activity [GO_0004739]
- 5902: pyruvate metabolic process [GO_0006090]
- 5903: pyruvate transmembrane transport [GO_1901475]
- 5904: pyruvate transport [GO_0006848]
- 5905: quaternary ammonium group binding [GO_0050997]
- 5906: quaternary ammonium group transmembrane transporter activity [GO_0015651]
- 5907: quaternary ammonium group transport [GO_0015697]
- 5908: quinone binding [GO_0048038]
- 5909: Rab GDP-dissociation inhibitor activity [GO_0005093]
- 5910: Rab geranylgeranyltransferase activity [GO_0004663]
- 5911: racemase activity, acting on amino acids and derivatives [GO_0036361]
- 5912: racemase and epimerase activity [GO_0016854]
- 5913: racemase and epimerase activity, acting on amino acids and derivatives [GO_0016855]
- 5914: RBKS phosphorylates ribose to R5P [GO_0004747]
- 5915: RDH11 reduces RBP2:atRAL to RBP2:atROL [GO_0016616]
- 5916: RDH5 oxidises 11cROL to 11cRAL [GO_0004745]
- 5917: rDNA binding [GO_0000182]
- 5918: reactive oxygen species metabolic process [GO_0072593]
- 5919: receptor antagonist activity [GO_0048019]
- 5920: receptor ligand activity [GO_0048018]
- 5921: receptor serine/threonine kinase binding [GO_0033612]
- 5922: receptor tyrosine kinase binding [GO_0030971]
- 5923: receptor-mediated endocytosis [GO_0006898]
- 5924: Reduction of disulphide bonds in MHC II antigens [GO_0016667]
- 5925: reflex [GO_0060004]
- 5926: regeneration [GO_0031099]
- 5927: regionalization [GO_0003002]
- 5928: regulation of 1-phosphatidylinositol 4-kinase activity [GO_0043126]
- 5929: regulation of 1-phosphatidylinositol-3-kinase activity [GO_0061901]
- 5930: regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity [GO_0090215]
- 5931: regulation of acetylcholine secretion, neurotransmission [GO_0014056]
- 5932: regulation of acetylcholine-gated cation channel activity [GO_1903048]
- 5933: regulation of acid-sensing ion channel activity [GO_1901585]
- 5934: regulation of acinar cell proliferation [GO_1904697]
- 5935: regulation of aconitate hydratase activity [GO_1904232]
- 5936: regulation of actin binding [GO_1904616]
- 5937: regulation of actin cytoskeleton organization [GO_0032956]
- 5938: regulation of actin filament binding [GO_1904529]
- 5939: regulation of actin filament bundle assembly [GO_0032231]
- 5940: regulation of actin filament organization [GO_0110053]
- 5941: regulation of actin filament-based movement [GO_1903115]
- 5942: regulation of actin filament-based process [GO_0032970]
- 5943: regulation of action potential [GO_0098900]
- 5944: regulation of activin receptor signaling pathway [GO_0032925]
- 5945: regulation of actomyosin structure organization [GO_0110020]
- 5946: regulation of adenosine receptor signaling pathway [GO_0060167]
- 5947: regulation of adenylate cyclase activity [GO_0045761]
- 5948: regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway [GO_0010578]
- 5949: regulation of adipose tissue development [GO_1904177]
- 5950: regulation of aerobic respiration [GO_1903715]
- 5951: regulation of alkaline phosphatase activity [GO_0010692]
- 5952: regulation of alpha-(1->3)-fucosyltransferase activity [GO_1905619]
- 5953: regulation of amine transport [GO_0051952]
- 5954: regulation of amino acid transmembrane transport [GO_1903789]
- 5955: regulation of amino acid transport [GO_0051955]
- 5956: regulation of aminoacyl-tRNA ligase activity [GO_1903630]
- 5957: regulation of amyloid precursor protein catabolic process [GO_1902991]
- 5958: regulation of anatomical structure morphogenesis [GO_0022603]
- 5959: regulation of androgen secretion [GO_2000834]
- 5960: regulation of angiogenesis [GO_0045765]
- 5961: regulation of animal organ formation [GO_0003156]
- 5962: regulation of animal organ morphogenesis [GO_2000027]
- 5963: regulation of anion channel activity [GO_0010359]
- 5964: regulation of anion transmembrane transport [GO_1903959]
- 5965: regulation of anion transport [GO_0044070]
- 5966: regulation of aorta morphogenesis [GO_1903847]
- 5967: regulation of aortic smooth muscle cell differentiation [GO_1904829]
- 5968: regulation of apical ectodermal ridge formation [GO_1905140]
- 5969: regulation of apolipoprotein binding [GO_2000656]
- 5970: regulation of apoptosis involved in tissue homeostasis [GO_0060785]
- 5971: regulation of apoptotic process [GO_0042981]
- 5972: regulation of apoptotic process involved in development [GO_1904748]
- 5973: regulation of apoptotic process involved in morphogenesis [GO_1902337]
- 5974: regulation of apoptotic process involved in outflow tract morphogenesis [GO_1902256]
- 5975: regulation of apoptotic signaling pathway [GO_2001233]
- 5976: regulation of argininosuccinate synthase activity [GO_1905752]
- 5977: regulation of artery morphogenesis [GO_1905651]
- 5978: regulation of aspartic endopeptidase activity, intramembrane cleaving [GO_0120287]
- 5979: regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO_1902959]
- 5980: regulation of aspartic-type peptidase activity [GO_1905245]
- 5981: regulation of asymmetric cell division [GO_0009786]
- 5982: regulation of ATP biosynthetic process [GO_2001169]
- 5983: regulation of ATP citrate synthase activity [GO_2000983]
- 5984: regulation of ATP metabolic process [GO_1903578]
- 5985: regulation of ATP-dependent activity [GO_0043462]
- 5986: regulation of ATP:ADP antiporter activity [GO_0070926]
- 5987: regulation of ATPase-coupled calcium transmembrane transporter activity [GO_1901894]
- 5988: regulation of AV node cell action potential [GO_0098904]
- 5989: regulation of axo-dendritic protein transport [GO_1905126]
- 5990: regulation of axon guidance [GO_1902667]
- 5991: regulation of axonogenesis [GO_0050770]
- 5992: regulation of backward locomotion [GO_0043058]
- 5993: regulation of basement membrane organization [GO_0110011]
- 5994: regulation of behavior [GO_0050795]
- 5995: regulation of bile acid biosynthetic process [GO_0070857]
- 5996: regulation of bile acid metabolic process [GO_1904251]
- 5997: regulation of bile acid secretion [GO_0120188]
- 5998: regulation of binding [GO_0051098]
- 5999: regulation of biological process [GO_0050789]
- 6000: regulation of biological quality [GO_0065008]
- 6001: regulation of biosynthetic process [GO_0009889]
- 6002: regulation of blastocyst development [GO_0120222]
- 6003: regulation of bleb assembly [GO_1904170]
- 6004: regulation of blood circulation [GO_1903522]
- 6005: regulation of blood vessel branching [GO_1905553]
- 6006: regulation of blood vessel endothelial cell differentiation [GO_0110057]
- 6007: regulation of BMP signaling pathway [GO_0030510]
- 6008: regulation of body fluid levels [GO_0050878]
- 6009: regulation of bone development [GO_1903010]
- 6010: regulation of branching involved in lung morphogenesis [GO_0061046]
- 6011: regulation of branching morphogenesis of a nerve [GO_2000172]
- 6012: regulation of calcium ion binding [GO_1901876]
- 6013: regulation of calcium ion transmembrane transport [GO_1903169]
- 6014: regulation of calcium ion transmembrane transporter activity [GO_1901019]
- 6015: regulation of calcium ion transport [GO_0051924]
- 6016: regulation of calcium-dependent ATPase activity [GO_1903610]
- 6017: regulation of calcium-mediated signaling [GO_0050848]
- 6018: regulation of calcium:sodium antiporter activity [GO_1903279]
- 6019: regulation of cAMP-dependent protein kinase activity [GO_2000479]
- 6020: regulation of cAMP-mediated signaling [GO_0043949]
- 6021: regulation of carbohydrate biosynthetic process [GO_0043255]
- 6022: regulation of carbohydrate catabolic process [GO_0043470]
- 6023: regulation of carbohydrate metabolic process [GO_0006109]
- 6024: regulation of carbohydrate phosphatase activity [GO_0032113]
- 6025: regulation of cardiac chamber formation [GO_1901210]
- 6026: regulation of cardiac chamber morphogenesis [GO_1901219]
- 6027: regulation of cardiac conduction [GO_1903779]
- 6028: regulation of cardiac muscle adaptation [GO_0010612]
- 6029: regulation of cardiac muscle cell action potential [GO_0098901]
- 6030: regulation of cardiac muscle cell apoptotic process [GO_0010665]
- 6031: regulation of cardiac muscle cell differentiation [GO_2000725]
- 6032: regulation of cardiac muscle cell myoblast differentiation [GO_2000690]
- 6033: regulation of cardiac muscle cell proliferation [GO_0060043]
- 6034: regulation of cardiac muscle contraction [GO_0055117]
- 6035: regulation of cardiac muscle fiber development [GO_0055018]
- 6036: regulation of cardiac muscle hypertrophy [GO_0010611]
- 6037: regulation of cardiac muscle myoblast proliferation [GO_0110022]
- 6038: regulation of cardiac muscle tissue development [GO_0055024]
- 6039: regulation of cardiac muscle tissue growth [GO_0055021]
- 6040: regulation of cardiac myofibril assembly [GO_1905304]
- 6041: regulation of cardiac ventricle development [GO_1904412]
- 6042: regulation of cardiac ventricle formation [GO_1904942]
- 6043: regulation of cardioblast differentiation [GO_0051890]
- 6044: regulation of cardiocyte differentiation [GO_1905207]
- 6045: regulation of cartilage development [GO_0061035]
- 6046: regulation of catabolic process [GO_0009894]
- 6047: regulation of catalase activity [GO_1902551]
- 6048: regulation of catalytic activity [GO_0050790]
- 6049: regulation of catecholamine metabolic process [GO_0042069]
- 6050: regulation of catecholamine secretion [GO_0050433]
- 6051: regulation of cation channel activity [GO_2001257]
- 6052: regulation of cation transmembrane transport [GO_1904062]
- 6053: regulation of CD4 production [GO_0045223]
- 6054: regulation of cell adhesion [GO_0030155]
- 6055: regulation of cell adhesion involved in heart morphogenesis [GO_0061344]
- 6056: regulation of cell communication [GO_0010646]
- 6057: regulation of cell cycle [GO_0051726]
- 6058: regulation of cell cycle process [GO_0010564]
- 6059: regulation of cell death [GO_0010941]
- 6060: regulation of cell development [GO_0060284]
- 6061: regulation of cell differentiation [GO_0045595]
- 6062: regulation of cell differentiation involved in embryonic placenta development [GO_0060800]
- 6063: regulation of cell differentiation involved in tissue homeostasis [GO_0060786]
- 6064: regulation of cell division [GO_0051302]
- 6065: regulation of cell fate commitment [GO_0010453]
- 6066: regulation of cell growth [GO_0001558]
- 6067: regulation of cell growth involved in cardiac muscle cell development [GO_0061050]
- 6068: regulation of cell junction assembly [GO_1901888]
- 6069: regulation of cell maturation [GO_1903429]
- 6070: regulation of cell migration [GO_0030334]
- 6071: regulation of cell morphogenesis [GO_0022604]
- 6072: regulation of cell morphogenesis involved in differentiation [GO_0010769]
- 6073: regulation of cell motility [GO_2000145]
- 6074: regulation of cell population proliferation [GO_0042127]
- 6075: regulation of cell projection assembly [GO_0060491]
- 6076: regulation of cell projection organization [GO_0031344]
- 6077: regulation of cell proliferation in midbrain [GO_1904933]
- 6078: regulation of cell proliferation involved in compound eye morphogenesis [GO_2000495]
- 6079: regulation of cell proliferation involved in embryonic placenta development [GO_0060723]
- 6080: regulation of cell proliferation involved in heart morphogenesis [GO_2000136]
- 6081: regulation of cell proliferation involved in outflow tract morphogenesis [GO_1901963]
- 6082: regulation of cell proliferation involved in tissue homeostasis [GO_0060784]
- 6083: regulation of cell-cell adhesion [GO_0022407]
- 6084: regulation of cellular amide metabolic process [GO_0034248]
- 6085: regulation of cellular amine catabolic process [GO_0033241]
- 6086: regulation of cellular amine metabolic process [GO_0033238]
- 6087: regulation of cellular amino acid biosynthetic process [GO_2000282]
- 6088: regulation of cellular amino acid metabolic process [GO_0006521]
- 6089: regulation of cellular biosynthetic process [GO_0031326]
- 6090: regulation of cellular carbohydrate catabolic process [GO_0043471]
- 6091: regulation of cellular carbohydrate metabolic process [GO_0010675]
- 6092: regulation of cellular catabolic process [GO_0031329]
- 6093: regulation of cellular component biogenesis [GO_0044087]
- 6094: regulation of cellular component movement [GO_0051270]
- 6095: regulation of cellular component organization [GO_0051128]
- 6096: regulation of cellular ketone metabolic process [GO_0010565]
- 6097: regulation of cellular localization [GO_0060341]
- 6098: regulation of cellular macromolecule biosynthetic process [GO_2000112]
- 6099: regulation of cellular metabolic process [GO_0031323]
- 6100: regulation of cellular process [GO_0050794]
- 6101: regulation of cellular protein metabolic process [GO_0032268]
- 6102: regulation of cellular respiration [GO_0043457]
- 6103: regulation of cellular response to alcohol [GO_1905957]
- 6104: regulation of cellular response to drug [GO_2001038]
- 6105: regulation of cellular response to growth factor stimulus [GO_0090287]
- 6106: regulation of cellular response to insulin stimulus [GO_1900076]
- 6107: regulation of cellular response to oxidative stress [GO_1900407]
- 6108: regulation of cellular response to stress [GO_0080135]
- 6109: regulation of chemokine activity [GO_1900136]
- 6110: regulation of chemorepellent activity [GO_1903667]
- 6111: regulation of chemotaxis [GO_0050920]
- 6112: regulation of chloride transport [GO_2001225]
- 6113: regulation of cholangiocyte apoptotic process [GO_1904192]
- 6114: regulation of cholangiocyte proliferation [GO_1904054]
- 6115: regulation of cholesterol transporter activity [GO_0060694]
- 6116: regulation of choline O-acetyltransferase activity [GO_1902769]
- 6117: regulation of chondrocyte development [GO_0061181]
- 6118: regulation of chondrocyte differentiation [GO_0032330]
- 6119: regulation of chondrocyte differentiation involved in endochondral bone morphogenesis [GO_1902738]
- 6120: regulation of chorionic trophoblast cell proliferation [GO_1901382]
- 6121: regulation of chromatin assembly [GO_0010847]
- 6122: regulation of chromatin assembly or disassembly [GO_0001672]
- 6123: regulation of chromatin binding [GO_0035561]
- 6124: regulation of chromatin disassembly [GO_0010848]
- 6125: regulation of chromatin organization [GO_1902275]
- 6126: regulation of chromosome condensation [GO_0060623]
- 6127: regulation of chromosome organization [GO_0033044]
- 6128: regulation of chromosome segregation [GO_0051983]
- 6129: regulation of cilium assembly [GO_1902017]
- 6130: regulation of circadian rhythm [GO_0042752]
- 6131: regulation of circadian sleep/wake cycle [GO_0042749]
- 6132: regulation of circadian sleep/wake cycle, sleep [GO_0045187]
- 6133: regulation of CoA-transferase activity [GO_1905918]
- 6134: regulation of collagen binding [GO_0033341]
- 6135: regulation of collagen biosynthetic process [GO_0032965]
- 6136: regulation of collagen catabolic process [GO_0010710]
- 6137: regulation of collagen fibril organization [GO_1904026]
- 6138: regulation of collagen metabolic process [GO_0010712]
- 6139: regulation of colon smooth muscle contraction [GO_1904341]
- 6140: regulation of compound eye photoreceptor cell differentiation [GO_0110116]
- 6141: regulation of compound eye retinal cell apoptotic process [GO_1901692]
- 6142: regulation of compound eye retinal cell programmed cell death [GO_0046669]
- 6143: regulation of copper ion transmembrane transport [GO_1902311]
- 6144: regulation of core promoter binding [GO_1904796]
- 6145: regulation of coreceptor activity [GO_0060725]
- 6146: regulation of coreceptor activity involved in epidermal growth factor receptor signaling pathway [GO_0060726]
- 6147: regulation of cyclase activity [GO_0031279]
- 6148: regulation of cyclic nucleotide-gated ion channel activity [GO_1902159]
- 6149: regulation of cyclic-nucleotide phosphodiesterase activity [GO_0051342]
- 6150: regulation of cyclin-dependent protein kinase activity [GO_1904029]
- 6151: regulation of cyclin-dependent protein serine/threonine kinase activity [GO_0000079]
- 6152: regulation of cystathionine beta-synthase activity [GO_1904041]
- 6153: regulation of cysteine metabolic process [GO_1901494]
- 6154: regulation of cysteine-type endopeptidase activity [GO_2000116]
- 6155: regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO_0043281]
- 6156: regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO_2001270]
- 6157: regulation of cytochrome-c oxidase activity [GO_1904959]
- 6158: regulation of cytokine activity [GO_0060300]
- 6159: regulation of cytokine-mediated signaling pathway [GO_0001959]
- 6160: regulation of cytokinesis [GO_0032465]
- 6161: regulation of cytoplasmic microtubule depolymerization [GO_0010937]
- 6162: regulation of cytoskeleton organization [GO_0051493]
- 6163: regulation of D-amino-acid oxidase activity [GO_1900757]
- 6164: regulation of D-erythro-sphingosine kinase activity [GO_1900022]
- 6165: regulation of deacetylase activity [GO_0150065]
- 6166: regulation of defecation [GO_2000292]
- 6167: regulation of delayed rectifier potassium channel activity [GO_1902259]
- 6168: regulation of deoxyribonuclease activity [GO_0032070]
- 6169: regulation of dephosphorylation [GO_0035303]
- 6170: regulation of dermatome development [GO_0061183]
- 6171: regulation of detection of mechanical stimulus involved in sensory perception of touch [GO_1905787]
- 6172: regulation of development, heterochronic [GO_0040034]
- 6173: regulation of developmental growth [GO_0048638]
- 6174: regulation of developmental pigmentation [GO_0048070]
- 6175: regulation of developmental process [GO_0050793]
- 6176: regulation of diacylglycerol kinase activity [GO_1905687]
- 6177: regulation of digestive system process [GO_0044058]
- 6178: regulation of dipeptide transmembrane transport [GO_2001148]
- 6179: regulation of dipeptide transport [GO_0090089]
- 6180: regulation of DNA binding [GO_0051101]
- 6181: regulation of DNA biosynthetic process [GO_2000278]
- 6182: regulation of DNA duplex unwinding [GO_1905462]
- 6183: regulation of DNA helicase activity [GO_1905774]
- 6184: regulation of DNA metabolic process [GO_0051052]
- 6185: regulation of DNA N-glycosylase activity [GO_1902544]
- 6186: regulation of DNA repair [GO_0006282]
- 6187: regulation of DNA replication [GO_0006275]
- 6188: regulation of DNA replication origin binding [GO_1902595]
- 6189: regulation of DNA topoisomerase (ATP-hydrolyzing) activity [GO_2000371]
- 6190: regulation of DNA-binding transcription factor activity [GO_0051090]
- 6191: regulation of DNA-directed DNA polymerase activity [GO_1900262]
- 6192: regulation of DNA-templated DNA replication [GO_0090329]
- 6193: regulation of DNA-templated transcription [GO_0006355]
- 6194: regulation of dopamine receptor signaling pathway [GO_0060159]
- 6195: regulation of dopamine secretion [GO_0014059]
- 6196: regulation of double-stranded telomeric DNA binding [GO_1905767]
- 6197: regulation of dUTP diphosphatase activity [GO_1903627]
- 6198: regulation of eclosion [GO_0007563]
- 6199: regulation of ectoderm development [GO_2000383]
- 6200: regulation of electron transfer activity [GO_1904732]
- 6201: regulation of embryonic camera-type eye development [GO_1902863]
- 6202: regulation of embryonic development [GO_0045995]
- 6203: regulation of endocrine process [GO_0044060]
- 6204: regulation of endocytosis [GO_0030100]
- 6205: regulation of endodeoxyribonuclease activity [GO_0032071]
- 6206: regulation of endodermal cell differentiation [GO_1903224]
- 6207: regulation of endopeptidase activity [GO_0052548]
- 6208: regulation of endoribonuclease activity [GO_0060699]
- 6209: regulation of endothelial cell apoptotic process [GO_2000351]
- 6210: regulation of endothelial cell development [GO_1901550]
- 6211: regulation of endothelial cell differentiation [GO_0045601]
- 6212: regulation of endothelial cell proliferation [GO_0001936]
- 6213: regulation of endothelial tube morphogenesis [GO_1901509]
- 6214: regulation of entry into reproductive diapause [GO_0061963]
- 6215: regulation of ephrin receptor signaling pathway [GO_1901187]
- 6216: regulation of epidermal cell differentiation [GO_0045604]
- 6217: regulation of epidermal cell division [GO_0010482]
- 6218: regulation of epidermal growth factor receptor signaling pathway [GO_0042058]
- 6219: regulation of epidermal growth factor-activated receptor activity [GO_0007176]
- 6220: regulation of epidermis development [GO_0045682]
- 6221: regulation of epithelial cell apoptotic process [GO_1904035]
- 6222: regulation of epithelial cell differentiation [GO_0030856]
- 6223: regulation of epithelial cell proliferation [GO_0050678]
- 6224: regulation of epithelial cell proliferation involved in lung morphogenesis [GO_2000794]
- 6225: regulation of epithelial to mesenchymal transition [GO_0010717]
- 6226: regulation of epithelial tube formation [GO_1905276]
- 6227: regulation of ERBB signaling pathway [GO_1901184]
- 6228: regulation of erythrocyte apoptotic process [GO_1902250]
- 6229: regulation of erythrocyte differentiation [GO_0045646]
- 6230: regulation of establishment of cell polarity [GO_2000114]
- 6231: regulation of establishment of planar polarity [GO_0090175]
- 6232: regulation of establishment of protein localization [GO_0070201]
- 6233: regulation of establishment of protein localization to chromosome [GO_0070202]
- 6234: regulation of establishment or maintenance of cell polarity [GO_0032878]
- 6235: regulation of euchromatin binding [GO_1904793]
- 6236: regulation of excretion [GO_0044062]
- 6237: regulation of execution phase of apoptosis [GO_1900117]
- 6238: regulation of exocytosis [GO_0017157]
- 6239: regulation of exodeoxyribonuclease activity [GO_1902392]
- 6240: regulation of exonuclease activity [GO_1905777]
- 6241: regulation of exoribonuclease activity [GO_1901917]
- 6242: regulation of exosomal secretion [GO_1903541]
- 6243: regulation of extracellular exosome assembly [GO_1903551]
- 6244: regulation of extracellular matrix assembly [GO_1901201]
- 6245: regulation of extracellular matrix disassembly [GO_0010715]
- 6246: regulation of extracellular matrix organization [GO_1903053]
- 6247: regulation of eye photoreceptor cell development [GO_0042478]
- 6248: regulation of fat cell apoptotic process [GO_1904649]
- 6249: regulation of fat cell differentiation [GO_0045598]
- 6250: regulation of fat cell proliferation [GO_0070344]
- 6251: regulation of fatty acid biosynthetic process [GO_0042304]
- 6252: regulation of fatty acid metabolic process [GO_0019217]
- 6253: regulation of fatty acid transport [GO_2000191]
- 6254: regulation of feeding behavior [GO_0060259]
- 6255: regulation of female gonad development [GO_2000194]
- 6256: regulation of female receptivity [GO_0045924]
- 6257: regulation of ferrochelatase activity [GO_0010722]
- 6258: regulation of ferrous iron binding [GO_1904432]
- 6259: regulation of fertilization [GO_0080154]
- 6260: regulation of fibroblast apoptotic process [GO_2000269]
- 6261: regulation of fibroblast growth factor receptor signaling pathway [GO_0040036]
- 6262: regulation of fibroblast proliferation [GO_0048145]
- 6263: regulation of formation of translation initiation ternary complex [GO_1901190]
- 6264: regulation of forward locomotion [GO_0043059]
- 6265: regulation of fructose 1,6-bisphosphate 1-phosphatase activity [GO_0060549]
- 6266: regulation of G protein-coupled receptor signaling pathway [GO_0008277]
- 6267: regulation of G-quadruplex DNA binding [GO_1905493]
- 6268: regulation of GABA-A receptor activity [GO_0106040]
- 6269: regulation of gamma-aminobutyric acid secretion [GO_0014052]
- 6270: regulation of gastric acid secretion [GO_0060453]
- 6271: regulation of gastric mucosal blood circulation [GO_1904344]
- 6272: regulation of gastro-intestinal system smooth muscle contraction [GO_1904304]
- 6273: regulation of gastrulation [GO_0010470]
- 6274: regulation of gene expression [GO_0010468]
- 6275: regulation of gene expression, epigenetic [GO_0040029]
- 6276: regulation of gene silencing by RNA [GO_0060966]
- 6277: regulation of generation of precursor metabolites and energy [GO_0043467]
- 6278: regulation of germ cell proliferation [GO_1905936]
- 6279: regulation of glial cell apoptotic process [GO_0034350]
- 6280: regulation of glial cell differentiation [GO_0045685]
- 6281: regulation of glial cell proliferation [GO_0060251]
- 6282: regulation of gliogenesis [GO_0014013]
- 6283: regulation of glucagon secretion [GO_0070092]
- 6284: regulation of glucan biosynthetic process [GO_0010962]
- 6285: regulation of glucokinase activity [GO_0033131]
- 6286: regulation of gluconeogenesis [GO_0006111]
- 6287: regulation of glucose metabolic process [GO_0010906]
- 6288: regulation of glucose transmembrane transport [GO_0010827]
- 6289: regulation of glucosylceramidase activity [GO_1905123]
- 6290: regulation of glucuronosyltransferase activity [GO_1904223]
- 6291: regulation of glutamate receptor signaling pathway [GO_1900449]
- 6292: regulation of glutamate secretion [GO_0014048]
- 6293: regulation of glutamate secretion, neurotransmission [GO_1903294]
- 6294: regulation of glutamate-ammonia ligase activity [GO_1905478]
- 6295: regulation of glutamate-cysteine ligase activity [GO_0035227]
- 6296: regulation of glutathione biosynthetic process [GO_1903786]
- 6297: regulation of glutathione peroxidase activity [GO_1903282]
- 6298: regulation of glycine secretion, neurotransmission [GO_1904624]
- 6299: regulation of glycogen (starch) synthase activity [GO_2000465]
- 6300: regulation of glycogen biosynthetic process [GO_0005979]
- 6301: regulation of glycogen catabolic process [GO_0005981]
- 6302: regulation of glycogen metabolic process [GO_0070873]
- 6303: regulation of glycolytic process [GO_0006110]
- 6304: regulation of glycolytic process through fructose-6-phosphate [GO_1904538]
- 6305: regulation of glycoprotein biosynthetic process [GO_0010559]
- 6306: regulation of glycoprotein metabolic process [GO_1903018]
- 6307: regulation of Golgi inheritance [GO_0090170]
- 6308: regulation of Golgi organization [GO_1903358]
- 6309: regulation of Golgi to plasma membrane protein transport [GO_0042996]
- 6310: regulation of gonad development [GO_1905939]
- 6311: regulation of grooming behavior [GO_2000821]
- 6312: regulation of growth [GO_0040008]
- 6313: regulation of GTP binding [GO_1904424]
- 6314: regulation of GTP cyclohydrolase I activity [GO_0043095]
- 6315: regulation of GTPase activity [GO_0043087]
- 6316: regulation of guanyl-nucleotide exchange factor activity [GO_1905097]
- 6317: regulation of guanylate cyclase activity [GO_0031282]
- 6318: regulation of heart contraction [GO_0008016]
- 6319: regulation of heart growth [GO_0060420]
- 6320: regulation of heart morphogenesis [GO_2000826]
- 6321: regulation of heart rate [GO_0002027]
- 6322: regulation of helicase activity [GO_0051095]
- 6323: regulation of hematopoietic progenitor cell differentiation [GO_1901532]
- 6324: regulation of hematopoietic stem cell differentiation [GO_1902036]
- 6325: regulation of hematopoietic stem cell proliferation [GO_1902033]
- 6326: regulation of heme oxygenase activity [GO_0061960]
- 6327: regulation of hemopoiesis [GO_1903706]
- 6328: regulation of heparan sulfate proteoglycan binding [GO_1905858]
- 6329: regulation of hepatocyte apoptotic process [GO_1903943]
- 6330: regulation of hepatocyte differentiation [GO_0070366]
- 6331: regulation of heterochromatin assembly [GO_0031445]
- 6332: regulation of heterochromatin organization [GO_0120261]
- 6333: regulation of hexokinase activity [GO_1903299]
- 6334: regulation of high voltage-gated calcium channel activity [GO_1901841]
- 6335: regulation of hindgut contraction [GO_0043134]
- 6336: regulation of histone deacetylase activity [GO_1901725]
- 6337: regulation of histone deacetylation [GO_0031063]
- 6338: regulation of histone demethylase activity (H3-K4 specific) [GO_1904173]
- 6339: regulation of histone modification [GO_0031056]
- 6340: regulation of hormone levels [GO_0010817]
- 6341: regulation of hormone metabolic process [GO_0032350]
- 6342: regulation of hormone secretion [GO_0046883]
- 6343: regulation of hyaluronan biosynthetic process [GO_1900125]
- 6344: regulation of hydrolase activity [GO_0051336]
- 6345: regulation of immune effector process [GO_0002697]
- 6346: regulation of immune response [GO_0050776]
- 6347: regulation of immune system process [GO_0002682]
- 6348: regulation of inorganic anion transmembrane transport [GO_1903795]
- 6349: regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO_0031585]
- 6350: regulation of inositol-polyphosphate 5-phosphatase activity [GO_0010924]
- 6351: regulation of insulin receptor signaling pathway [GO_0046626]
- 6352: regulation of insulin secretion [GO_0050796]
- 6353: regulation of intestinal absorption [GO_1904478]
- 6354: regulation of intestinal epithelial cell development [GO_1905298]
- 6355: regulation of intracellular calcium activated chloride channel activity [GO_1902938]
- 6356: regulation of intracellular lipid transport [GO_0032377]
- 6357: regulation of intracellular protein transport [GO_0033157]
- 6358: regulation of intracellular signal transduction [GO_1902531]
- 6359: regulation of intracellular sterol transport [GO_0032380]
- 6360: regulation of intracellular transport [GO_0032386]
- 6361: regulation of inward rectifier potassium channel activity [GO_1901979]
- 6362: regulation of ion transmembrane transport [GO_0034765]
- 6363: regulation of ion transmembrane transporter activity [GO_0032412]
- 6364: regulation of ion transport [GO_0043269]
- 6365: regulation of iron ion transmembrane transport [GO_0034759]
- 6366: regulation of iron ion transmembrane transporter activity [GO_1904254]
- 6367: regulation of iron ion transport [GO_0034756]
- 6368: regulation of isoleucine-tRNA ligase activity [GO_1905015]
- 6369: regulation of isomerase activity [GO_0010911]
- 6370: regulation of isoprenoid metabolic process [GO_0019747]
- 6371: regulation of JNK cascade [GO_0046328]
- 6372: regulation of JUN kinase activity [GO_0043506]
- 6373: regulation of kainate selective glutamate receptor activity [GO_2000312]
- 6374: regulation of karyogamy [GO_0032871]
- 6375: regulation of ketone biosynthetic process [GO_0010566]
- 6376: regulation of ketone catabolic process [GO_0010567]
- 6377: regulation of kinase activity [GO_0043549]
- 6378: regulation of L-dopa decarboxylase activity [GO_1903198]
- 6379: regulation of large conductance calcium-activated potassium channel activity [GO_1902606]
- 6380: regulation of leucine-tRNA ligase activity [GO_1903633]
- 6381: regulation of leukocyte apoptotic process [GO_2000106]
- 6382: regulation of leukocyte differentiation [GO_1902105]
- 6383: regulation of leukocyte mediated immunity [GO_0002703]
- 6384: regulation of leukocyte proliferation [GO_0070663]
- 6385: regulation of ligase activity [GO_0051340]
- 6386: regulation of light-activated channel activity [GO_0016061]
- 6387: regulation of lipase activity [GO_0060191]
- 6388: regulation of lipid binding [GO_1900130]
- 6389: regulation of lipid biosynthetic process [GO_0046890]
- 6390: regulation of lipid catabolic process [GO_0050994]
- 6391: regulation of lipid kinase activity [GO_0043550]
- 6392: regulation of lipid localization [GO_1905952]
- 6393: regulation of lipid metabolic process [GO_0019216]
- 6394: regulation of lipid storage [GO_0010883]
- 6395: regulation of lipid transport [GO_0032368]
- 6396: regulation of lipid transporter activity [GO_0110112]
- 6397: regulation of lipopolysaccharide-mediated signaling pathway [GO_0031664]
- 6398: regulation of lipoprotein lipase activity [GO_0051004]
- 6399: regulation of localization [GO_0032879]
- 6400: regulation of locomotion [GO_0040012]
- 6401: regulation of locomotion involved in locomotory behavior [GO_0090325]
- 6402: regulation of locomotor rhythm [GO_1904059]
- 6403: regulation of low-density lipoprotein particle receptor binding [GO_1905595]
- 6404: regulation of lung ciliated cell differentiation [GO_1901246]
- 6405: regulation of lyase activity [GO_0051339]
- 6406: regulation of lysozyme activity [GO_1903590]
- 6407: regulation of m7G(5')pppN diphosphatase activity [GO_1903398]
- 6408: regulation of macromolecule biosynthetic process [GO_0010556]
- 6409: regulation of macromolecule metabolic process [GO_0060255]
- 6410: regulation of malate dehydrogenase (decarboxylating) (NADP+) activity [GO_1903218]
- 6411: regulation of male mating behavior [GO_1902435]
- 6412: regulation of MAP kinase activity [GO_0043405]
- 6413: regulation of MAPK cascade [GO_0043408]
- 6414: regulation of megakaryocyte differentiation [GO_0045652]
- 6415: regulation of meiotic cell cycle [GO_0051445]
- 6416: regulation of meiotic cell cycle process involved in oocyte maturation [GO_1903538]
- 6417: regulation of meiotic nuclear division [GO_0040020]
- 6418: regulation of membrane disassembly [GO_0010549]
- 6419: regulation of membrane invagination [GO_1905153]
- 6420: regulation of membrane lipid distribution [GO_0097035]
- 6421: regulation of membrane potential [GO_0042391]
- 6422: regulation of membrane potential in photoreceptor cell [GO_0016057]
- 6423: regulation of mesenchymal cell apoptotic process [GO_2001053]
- 6424: regulation of mesenchymal cell proliferation [GO_0010464]
- 6425: regulation of mesenchymal cell proliferation involved in lung development [GO_2000790]
- 6426: regulation of mesoderm development [GO_2000380]
- 6427: regulation of mesoderm formation [GO_1905902]
- 6428: regulation of mesodermal cell differentiation [GO_1905770]
- 6429: regulation of metabolic process [GO_0019222]
- 6430: regulation of metal ion transport [GO_0010959]
- 6431: regulation of metalloendopeptidase activity [GO_1904683]
- 6432: regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO_1902962]
- 6433: regulation of metallopeptidase activity [GO_1905048]
- 6434: regulation of methionine-tRNA ligase activity [GO_1905018]
- 6435: regulation of microtubule binding [GO_1904526]
- 6436: regulation of microtubule cytoskeleton organization [GO_0070507]
- 6437: regulation of microtubule depolymerization [GO_0031114]
- 6438: regulation of microtubule minus-end binding [GO_1902619]
- 6439: regulation of microtubule nucleation [GO_0010968]
- 6440: regulation of microtubule plus-end binding [GO_1903031]
- 6441: regulation of microtubule polymerization [GO_0031113]
- 6442: regulation of microtubule polymerization or depolymerization [GO_0031110]
- 6443: regulation of microtubule-based movement [GO_0060632]
- 6444: regulation of microtubule-based process [GO_0032886]
- 6445: regulation of microvillus assembly [GO_0032534]
- 6446: regulation of microvillus organization [GO_0032530]
- 6447: regulation of miRNA-mediated gene silencing [GO_0060964]
- 6448: regulation of mitochondrial ATP synthesis coupled proton transport [GO_1905706]
- 6449: regulation of mitochondrial DNA metabolic process [GO_1901858]
- 6450: regulation of mitochondrial DNA replication [GO_0090296]
- 6451: regulation of mitochondrial gene expression [GO_0062125]
- 6452: regulation of mitochondrial mRNA catabolic process [GO_1905637]
- 6453: regulation of mitochondrial RNA catabolic process [GO_0000960]
- 6454: regulation of mitochondrial transcription [GO_1903108]
- 6455: regulation of mitochondrial translation [GO_0070129]
- 6456: regulation of mitochondrial translational elongation [GO_1905082]
- 6457: regulation of mitochondrial translational initiation [GO_0070132]
- 6458: regulation of mitochondrion organization [GO_0010821]
- 6459: regulation of mitotic cell cycle [GO_0007346]
- 6460: regulation of mitotic cell cycle DNA replication [GO_1903463]
- 6461: regulation of mitotic cell cycle, embryonic [GO_0009794]
- 6462: regulation of mitotic chromosome condensation [GO_1903379]
- 6463: regulation of mitotic nuclear division [GO_0007088]
- 6464: regulation of mitotic nuclear envelope disassembly [GO_1905557]
- 6465: regulation of mitotic sister chromatid segregation [GO_0033047]
- 6466: regulation of molecular function [GO_0065009]
- 6467: regulation of mononuclear cell proliferation [GO_0032944]
- 6468: regulation of monooxygenase activity [GO_0032768]
- 6469: regulation of morphogenesis of a branching structure [GO_0060688]
- 6470: regulation of morphogenesis of an epithelium [GO_1905330]
- 6471: regulation of motor neuron apoptotic process [GO_2000671]
- 6472: regulation of mRNA 3'-UTR binding [GO_1903837]
- 6473: regulation of mRNA binding [GO_1902415]
- 6474: regulation of mRNA catabolic process [GO_0061013]
- 6475: regulation of mRNA metabolic process [GO_1903311]
- 6476: regulation of mRNA stability [GO_0043488]
- 6477: regulation of mRNA stability involved in response to oxidative stress [GO_2000815]
- 6478: regulation of mRNA stability involved in response to stress [GO_0010610]
- 6479: regulation of mucus secretion [GO_0070255]
- 6480: regulation of multicellular organism growth [GO_0040014]
- 6481: regulation of multicellular organismal development [GO_2000026]
- 6482: regulation of multicellular organismal process [GO_0051239]
- 6483: regulation of muscle adaptation [GO_0043502]
- 6484: regulation of muscle cell apoptotic process [GO_0010660]
- 6485: regulation of muscle cell differentiation [GO_0051147]
- 6486: regulation of muscle contraction [GO_0006937]
- 6487: regulation of muscle hypertrophy [GO_0014743]
- 6488: regulation of muscle organ development [GO_0048634]
- 6489: regulation of muscle system process [GO_0090257]
- 6490: regulation of muscle tissue development [GO_1901861]
- 6491: regulation of myeloid cell apoptotic process [GO_0033032]
- 6492: regulation of myeloid cell differentiation [GO_0045637]
- 6493: regulation of myeloid leukocyte differentiation [GO_0002761]
- 6494: regulation of myeloid leukocyte mediated immunity [GO_0002886]
- 6495: regulation of myeloid progenitor cell differentiation [GO_1905453]
- 6496: regulation of myoblast differentiation [GO_0045661]
- 6497: regulation of myoblast proliferation [GO_2000291]
- 6498: regulation of myosin light chain kinase activity [GO_0035504]
- 6499: regulation of myotome development [GO_2000290]
- 6500: regulation of myotube differentiation [GO_0010830]
- 6501: regulation of NAD+ ADP-ribosyltransferase activity [GO_1901664]
- 6502: regulation of NAD+ kinase activity [GO_0033670]
- 6503: regulation of negative chemotaxis [GO_0050923]
- 6504: regulation of nervous system development [GO_0051960]
- 6505: regulation of nervous system process [GO_0031644]
- 6506: regulation of netrin-activated signaling pathway [GO_1902841]
- 6507: regulation of neural crest cell differentiation [GO_1905292]
- 6508: regulation of neural crest formation [GO_0090299]
- 6509: regulation of neural precursor cell proliferation [GO_2000177]
- 6510: regulation of neural retina development [GO_0061074]
- 6511: regulation of neuroblast proliferation [GO_1902692]
- 6512: regulation of neurogenesis [GO_0050767]
- 6513: regulation of neuromuscular junction development [GO_1904396]
- 6514: regulation of neuron apoptotic process [GO_0043523]
- 6515: regulation of neuron death [GO_1901214]
- 6516: regulation of neuron differentiation [GO_0045664]
- 6517: regulation of neuron maturation [GO_0014041]
- 6518: regulation of neuron projection development [GO_0010975]
- 6519: regulation of neuronal action potential [GO_0098908]
- 6520: regulation of neurotransmitter levels [GO_0001505]
- 6521: regulation of neurotransmitter receptor activity [GO_0099601]
- 6522: regulation of neurotransmitter secretion [GO_0046928]
- 6523: regulation of neurotransmitter transport [GO_0051588]
- 6524: regulation of neurotransmitter uptake [GO_0051580]
- 6525: regulation of nitric-oxide synthase activity [GO_0050999]
- 6526: regulation of nitrogen compound metabolic process [GO_0051171]
- 6527: regulation of NMDA receptor activity [GO_2000310]
- 6528: regulation of non-membrane spanning protein tyrosine kinase activity [GO_1903995]
- 6529: regulation of norepinephrine secretion [GO_0014061]
- 6530: regulation of norepinephrine uptake [GO_0051621]
- 6531: regulation of nuclear cell cycle DNA replication [GO_0033262]
- 6532: regulation of nuclear division [GO_0051783]
- 6533: regulation of nuclear migration along microtubule [GO_1902838]
- 6534: regulation of nuclease activity [GO_0032069]
- 6535: regulation of nucleic acid-templated transcription [GO_1903506]
- 6536: regulation of nucleobase-containing compound metabolic process [GO_0019219]
- 6537: regulation of nucleobase-containing compound transport [GO_0032239]
- 6538: regulation of nucleocytoplasmic transport [GO_0046822]
- 6539: regulation of nucleoside metabolic process [GO_0009118]
- 6540: regulation of nucleoside transport [GO_0032242]
- 6541: regulation of nucleotide biosynthetic process [GO_0030808]
- 6542: regulation of nucleotide metabolic process [GO_0006140]
- 6543: regulation of nucleus organization [GO_1903353]
- 6544: regulation of olfactory learning [GO_0090328]
- 6545: regulation of oligopeptide transport [GO_0090088]
- 6546: regulation of oocyte development [GO_0060281]
- 6547: regulation of oocyte maturation [GO_1900193]
- 6548: regulation of oogenesis [GO_1905879]
- 6549: regulation of organ growth [GO_0046620]
- 6550: regulation of organelle assembly [GO_1902115]
- 6551: regulation of organelle organization [GO_0033043]
- 6552: regulation of organelle transport along microtubule [GO_1902513]
- 6553: regulation of organic acid transport [GO_0032890]
- 6554: regulation of ossification [GO_0030278]
- 6555: regulation of oviposition [GO_0046662]
- 6556: regulation of oxidative phosphorylation [GO_0002082]
- 6557: regulation of oxidoreductase activity [GO_0051341]
- 6558: regulation of oxygen metabolic process [GO_2000374]
- 6559: regulation of P-type sodium:potassium-exchanging transporter activity [GO_1903406]
- 6560: regulation of pancreatic A cell differentiation [GO_2000226]
- 6561: regulation of peptidase activity [GO_0052547]
- 6562: regulation of peptide hormone secretion [GO_0090276]
- 6563: regulation of peptide secretion [GO_0002791]
- 6564: regulation of peptide transport [GO_0090087]
- 6565: regulation of peptidyl-tyrosine phosphorylation [GO_0050730]
- 6566: regulation of peroxidase activity [GO_2000468]
- 6567: regulation of pharynx morphogenesis [GO_0110041]
- 6568: regulation of phosphatase activity [GO_0010921]
- 6569: regulation of phosphate metabolic process [GO_0019220]
- 6570: regulation of phosphate transmembrane transport [GO_2000185]
- 6571: regulation of phosphate transport [GO_0010966]
- 6572: regulation of phosphatidate phosphatase activity [GO_1903730]
- 6573: regulation of phosphatidylcholine biosynthetic process [GO_2001245]
- 6574: regulation of phosphatidylcholine metabolic process [GO_0150172]
- 6575: regulation of phosphatidylinositol 3-kinase activity [GO_0043551]
- 6576: regulation of phosphatidylinositol biosynthetic process [GO_0010511]
- 6577: regulation of phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity [GO_0120138]
- 6578: regulation of phospholipase A2 activity [GO_0032429]
- 6579: regulation of phospholipase activity [GO_0010517]
- 6580: regulation of phospholipase C activity [GO_1900274]
- 6581: regulation of phospholipase D activity [GO_1904005]
- 6582: regulation of phospholipid biosynthetic process [GO_0071071]
- 6583: regulation of phospholipid metabolic process [GO_1903725]
- 6584: regulation of phospholipid scramblase activity [GO_1900161]
- 6585: regulation of phospholipid translocation [GO_0061091]
- 6586: regulation of phospholipid transport [GO_2001138]
- 6587: regulation of phosphoprotein phosphatase activity [GO_0043666]
- 6588: regulation of phosphorus metabolic process [GO_0051174]
- 6589: regulation of phosphorylation [GO_0042325]
- 6590: regulation of photoreceptor cell differentiation [GO_0046532]
- 6591: regulation of pigment cell differentiation [GO_0050932]
- 6592: regulation of pigmentation [GO_0120305]
- 6593: regulation of placenta blood vessel development [GO_0110079]
- 6594: regulation of plasma membrane bounded cell projection assembly [GO_0120032]
- 6595: regulation of plasma membrane bounded cell projection organization [GO_0120035]
- 6596: regulation of plasma membrane organization [GO_1903729]
- 6597: regulation of poly(A)-specific ribonuclease activity [GO_0106246]
- 6598: regulation of polyamine transmembrane transport [GO_1902267]
- 6599: regulation of polynucleotide adenylyltransferase activity [GO_1904245]
- 6600: regulation of polysaccharide biosynthetic process [GO_0032885]
- 6601: regulation of polysaccharide metabolic process [GO_0032881]
- 6602: regulation of polysome binding [GO_1905696]
- 6603: regulation of positive chemotaxis [GO_0050926]
- 6604: regulation of post-embryonic development [GO_0048580]
- 6605: regulation of post-transcriptional gene silencing [GO_0060147]
- 6606: regulation of post-transcriptional gene silencing by RNA [GO_1900368]
- 6607: regulation of postsynapse assembly [GO_0150052]
- 6608: regulation of postsynapse organization [GO_0099175]
- 6609: regulation of postsynaptic membrane potential [GO_0060078]
- 6610: regulation of postsynaptic neurotransmitter receptor activity [GO_0098962]
- 6611: regulation of potassium ion transmembrane transport [GO_1901379]
- 6612: regulation of potassium ion transmembrane transporter activity [GO_1901016]
- 6613: regulation of potassium ion transport [GO_0043266]
- 6614: regulation of presynapse assembly [GO_1905606]
- 6615: regulation of presynapse organization [GO_0099174]
- 6616: regulation of primary metabolic process [GO_0080090]
- 6617: regulation of programmed cell death [GO_0043067]
- 6618: regulation of prostaglandin-E synthase activity [GO_2000361]
- 6619: regulation of proteasomal protein catabolic process [GO_0061136]
- 6620: regulation of protein ADP-ribosylation [GO_0010835]
- 6621: regulation of protein binding [GO_0043393]
- 6622: regulation of protein catabolic process [GO_0042176]
- 6623: regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO_0099576]
- 6624: regulation of protein catabolic process at presynapse, modulating synaptic transmission [GO_0099575]
- 6625: regulation of protein catabolic process at synapse, modulating synaptic transmission [GO_0099574]
- 6626: regulation of protein catabolic process in the vacuole [GO_1904350]
- 6627: regulation of protein deacetylation [GO_0090311]
- 6628: regulation of protein dephosphorylation [GO_0035304]
- 6629: regulation of protein depolymerization [GO_1901879]
- 6630: regulation of protein deubiquitination [GO_0090085]
- 6631: regulation of protein folding [GO_1903332]
- 6632: regulation of protein glycosylation [GO_0060049]
- 6633: regulation of protein heterodimerization activity [GO_0043497]
- 6634: regulation of protein homodimerization activity [GO_0043496]
- 6635: regulation of protein K48-linked deubiquitination [GO_1903093]
- 6636: regulation of protein K63-linked deubiquitination [GO_1903004]
- 6637: regulation of protein kinase activity [GO_0045859]
- 6638: regulation of protein kinase C activity [GO_1900019]
- 6639: regulation of protein localization [GO_0032880]
- 6640: regulation of protein localization to cell cortex [GO_1904776]
- 6641: regulation of protein localization to cell leading edge [GO_1905871]
- 6642: regulation of protein localization to cell periphery [GO_1904375]
- 6643: regulation of protein localization to cell-cell junction [GO_0150106]
- 6644: regulation of protein localization to chromatin [GO_1905634]
- 6645: regulation of protein localization to ciliary membrane [GO_1903567]
- 6646: regulation of protein localization to cilium [GO_1903564]
- 6647: regulation of protein localization to membrane [GO_1905475]
- 6648: regulation of protein localization to microtubule [GO_1902816]
- 6649: regulation of protein localization to nucleolus [GO_1904749]
- 6650: regulation of protein localization to nucleus [GO_1900180]
- 6651: regulation of protein localization to plasma membrane [GO_1903076]
- 6652: regulation of protein localization to presynapse [GO_1905384]
- 6653: regulation of protein localization to synapse [GO_1902473]
- 6654: regulation of protein metabolic process [GO_0051246]
- 6655: regulation of protein modification by small protein conjugation or removal [GO_1903320]
- 6656: regulation of protein modification process [GO_0031399]
- 6657: regulation of protein O-linked glycosylation [GO_1904098]
- 6658: regulation of protein phosphorylation [GO_0001932]
- 6659: regulation of protein polymerization [GO_0032271]
- 6660: regulation of protein secretion [GO_0050708]
- 6661: regulation of protein serine/threonine kinase activity [GO_0071900]
- 6662: regulation of protein sumoylation [GO_0033233]
- 6663: regulation of protein transport [GO_0051223]
- 6664: regulation of protein tyrosine kinase activity [GO_0061097]
- 6665: regulation of protein tyrosine phosphatase activity [GO_1903613]
- 6666: regulation of protein ubiquitination [GO_0031396]
- 6667: regulation of protein-containing complex assembly [GO_0043254]
- 6668: regulation of protein-containing complex disassembly [GO_0043244]
- 6669: regulation of protein-glutamine gamma-glutamyltransferase activity [GO_0150073]
- 6670: regulation of proteolysis [GO_0030162]
- 6671: regulation of proteolysis involved in protein catabolic process [GO_1903050]
- 6672: regulation of proton transport [GO_0010155]
- 6673: regulation of proton-transporting ATP synthase activity, rotational mechanism [GO_1905271]
- 6674: regulation of proton-transporting ATPase activity, rotational mechanism [GO_0010849]
- 6675: regulation of purine nucleotide biosynthetic process [GO_1900371]
- 6676: regulation of purine nucleotide metabolic process [GO_1900542]
- 6677: regulation of Purkinje myocyte action potential [GO_0098906]
- 6678: regulation of pyrimidine nucleotide biosynthetic process [GO_1900397]
- 6679: regulation of pyrroline-5-carboxylate reductase activity [GO_1903167]
- 6680: regulation of pyruvate dehydrogenase activity [GO_1904182]
- 6681: regulation of pyruvate kinase activity [GO_1903302]
- 6682: regulation of reactive oxygen species metabolic process [GO_2000377]
- 6683: regulation of receptor binding [GO_1900120]
- 6684: regulation of receptor-mediated endocytosis [GO_0048259]
- 6685: regulation of release of sequestered calcium ion into cytosol [GO_0051279]
- 6686: regulation of removal of superoxide radicals [GO_2000121]
- 6687: regulation of renal system process [GO_0098801]
- 6688: regulation of reproductive process [GO_2000241]
- 6689: regulation of respiratory gaseous exchange [GO_0043576]
- 6690: regulation of respiratory gaseous exchange by nervous system process [GO_0002087]
- 6691: regulation of respiratory system process [GO_0044065]
- 6692: regulation of response to alcohol [GO_1901419]
- 6693: regulation of response to biotic stimulus [GO_0002831]
- 6694: regulation of response to calcium ion [GO_1905945]
- 6695: regulation of response to cytokine stimulus [GO_0060759]
- 6696: regulation of response to DNA damage stimulus [GO_2001020]
- 6697: regulation of response to drug [GO_2001023]
- 6698: regulation of response to external stimulus [GO_0032101]
- 6699: regulation of response to extracellular stimulus [GO_0032104]
- 6700: regulation of response to nutrient levels [GO_0032107]
- 6701: regulation of response to osmotic stress [GO_0047484]
- 6702: regulation of response to oxidative stress [GO_1902882]
- 6703: regulation of response to reactive oxygen species [GO_1901031]
- 6704: regulation of response to stimulus [GO_0048583]
- 6705: regulation of response to stress [GO_0080134]
- 6706: regulation of response to wounding [GO_1903034]
- 6707: regulation of retina development in camera-type eye [GO_1902866]
- 6708: regulation of retinal cell programmed cell death [GO_0046668]
- 6709: regulation of retrograde trans-synaptic signaling by neuropeptide [GO_1905432]
- 6710: regulation of Rho-dependent protein serine/threonine kinase activity [GO_2000298]
- 6711: regulation of rhodopsin mediated signaling pathway [GO_0022400]
- 6712: regulation of ribonuclease activity [GO_0060700]
- 6713: regulation of ribonucleoside-diphosphate reductase activity [GO_1905117]
- 6714: regulation of ribosome biogenesis [GO_0090069]
- 6715: regulation of RNA binding [GO_1905214]
- 6716: regulation of RNA biosynthetic process [GO_2001141]
- 6717: regulation of RNA helicase activity [GO_1902280]
- 6718: regulation of RNA metabolic process [GO_0051252]
- 6719: regulation of RNA polymerase I regulatory region sequence-specific DNA binding [GO_1901839]
- 6720: regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO_1903025]
- 6721: regulation of RNA polymerase III activity [GO_1903622]
- 6722: regulation of RNA splicing [GO_0043484]
- 6723: regulation of RNA stability [GO_0043487]
- 6724: regulation of rRNA processing [GO_2000232]
- 6725: regulation of ryanodine-sensitive calcium-release channel activity [GO_0060314]
- 6726: regulation of SA node cell action potential [GO_0098907]
- 6727: regulation of saliva secretion [GO_0046877]
- 6728: regulation of sarcomere organization [GO_0060297]
- 6729: regulation of sclerotome development [GO_0061190]
- 6730: regulation of secondary metabolic process [GO_0043455]
- 6731: regulation of secondary metabolite biosynthetic process [GO_1900376]
- 6732: regulation of secretion [GO_0051046]
- 6733: regulation of secretion by cell [GO_1903530]
- 6734: regulation of secretory granule organization [GO_1904409]
- 6735: regulation of semaphorin-plexin signaling pathway [GO_2001260]
- 6736: regulation of sensory perception [GO_0051931]
- 6737: regulation of sensory perception of bitter taste [GO_1904660]
- 6738: regulation of sensory perception of pain [GO_0051930]
- 6739: regulation of sensory perception of sweet taste [GO_1904656]
- 6740: regulation of sequestering of calcium ion [GO_0051282]
- 6741: regulation of serine C-palmitoyltransferase activity [GO_1904220]
- 6742: regulation of serine-type endopeptidase activity [GO_1900003]
- 6743: regulation of serine-type peptidase activity [GO_1902571]
- 6744: regulation of serotonin biosynthetic process [GO_1905627]
- 6745: regulation of serotonin secretion [GO_0014062]
- 6746: regulation of serotonin uptake [GO_0051611]
- 6747: regulation of signal transduction [GO_0009966]
- 6748: regulation of signaling [GO_0023051]
- 6749: regulation of signaling receptor activity [GO_0010469]
- 6750: regulation of single-stranded telomeric DNA binding [GO_0060380]
- 6751: regulation of sister chromatid segregation [GO_0033045]
- 6752: regulation of skeletal muscle adaptation [GO_0014733]
- 6753: regulation of skeletal muscle cell differentiation [GO_2001014]
- 6754: regulation of skeletal muscle cell proliferation [GO_0014857]
- 6755: regulation of skeletal muscle contraction [GO_0014819]
- 6756: regulation of skeletal muscle contraction by action potential [GO_0100001]
- 6757: regulation of skeletal muscle contraction via regulation of action potential [GO_0014861]
- 6758: regulation of skeletal muscle fiber development [GO_0048742]
- 6759: regulation of skeletal muscle fiber differentiation [GO_1902809]
- 6760: regulation of skeletal muscle hypertrophy [GO_1904204]
- 6761: regulation of skeletal muscle tissue development [GO_0048641]
- 6762: regulation of skeletal muscle tissue growth [GO_0048631]
- 6763: regulation of small GTPase binding [GO_1904475]
- 6764: regulation of small intestine smooth muscle contraction [GO_1904347]
- 6765: regulation of small molecule metabolic process [GO_0062012]
- 6766: regulation of smooth muscle cell apoptotic process [GO_0034391]
- 6767: regulation of smooth muscle cell differentiation [GO_0051150]
- 6768: regulation of smooth muscle cell proliferation [GO_0048660]
- 6769: regulation of smooth muscle contraction [GO_0006940]
- 6770: regulation of smooth muscle hypertrophy [GO_1905147]
- 6771: regulation of smooth muscle tissue development [GO_1905899]
- 6772: regulation of sodium ion transmembrane transport [GO_1902305]
- 6773: regulation of sodium ion transmembrane transporter activity [GO_2000649]
- 6774: regulation of sodium ion transport [GO_0002028]
- 6775: regulation of sodium:proton antiporter activity [GO_0032415]
- 6776: regulation of somatic stem cell division [GO_1904675]
- 6777: regulation of somatostatin secretion [GO_0090273]
- 6778: regulation of somitogenesis [GO_0014807]
- 6779: regulation of stem cell differentiation [GO_2000736]
- 6780: regulation of stem cell division [GO_2000035]
- 6781: regulation of stem cell proliferation [GO_0072091]
- 6782: regulation of steroid biosynthetic process [GO_0050810]
- 6783: regulation of steroid hormone secretion [GO_2000831]
- 6784: regulation of steroid metabolic process [GO_0019218]
- 6785: regulation of sterol transport [GO_0032371]
- 6786: regulation of stomach neuroendocrine cell differentiation [GO_0061105]
- 6787: regulation of store-operated calcium channel activity [GO_1901339]
- 6788: regulation of stress-activated MAPK cascade [GO_0032872]
- 6789: regulation of stress-activated protein kinase signaling cascade [GO_0070302]
- 6790: regulation of striated muscle cell apoptotic process [GO_0010662]
- 6791: regulation of striated muscle cell differentiation [GO_0051153]
- 6792: regulation of striated muscle contraction [GO_0006942]
- 6793: regulation of striated muscle tissue development [GO_0016202]
- 6794: regulation of succinate dehydrogenase activity [GO_1904229]
- 6795: regulation of sulfur amino acid metabolic process [GO_0031335]
- 6796: regulation of sulfur metabolic process [GO_0042762]
- 6797: regulation of SUMO transferase activity [GO_1903182]
- 6798: regulation of superoxide dismutase activity [GO_1901668]
- 6799: regulation of superoxide metabolic process [GO_0090322]
- 6800: regulation of supramolecular fiber organization [GO_1902903]
- 6801: regulation of synapse assembly [GO_0051963]
- 6802: regulation of synapse organization [GO_0050807]
- 6803: regulation of synapse organization by posttranscriptional regulation of gene expression [GO_1904739]
- 6804: regulation of synapse pruning [GO_1905806]
- 6805: regulation of synapse structure or activity [GO_0050803]
- 6806: regulation of synaptic transmission, cholinergic [GO_0032222]
- 6807: regulation of synaptic transmission, dopaminergic [GO_0032225]
- 6808: regulation of synaptic transmission, GABAergic [GO_0032228]
- 6809: regulation of synaptic transmission, glutamatergic [GO_0051966]
- 6810: regulation of synaptic transmission, glycinergic [GO_0060092]
- 6811: regulation of syncytium formation by plasma membrane fusion [GO_0060142]
- 6812: regulation of system process [GO_0044057]
- 6813: regulation of tau-protein kinase activity [GO_1902947]
- 6814: regulation of telomerase activity [GO_0051972]
- 6815: regulation of telomeric DNA binding [GO_1904742]
- 6816: regulation of termination of DNA-templated transcription [GO_0031554]
- 6817: regulation of tetrapyrrole biosynthetic process [GO_1901463]
- 6818: regulation of tetrapyrrole catabolic process [GO_1901404]
- 6819: regulation of tetrapyrrole metabolic process [GO_1901401]
- 6820: regulation of thioredoxin peroxidase activity [GO_1903123]
- 6821: regulation of threonine-tRNA ligase activity [GO_1905021]
- 6822: regulation of timing of cell differentiation [GO_0048505]
- 6823: regulation of trans-synaptic signaling [GO_0099177]
- 6824: regulation of transcription by RNA polymerase I [GO_0006356]
- 6825: regulation of transcription by RNA polymerase II [GO_0006357]
- 6826: regulation of transcription by RNA polymerase III [GO_0006359]
- 6827: regulation of transcription regulatory region DNA binding [GO_2000677]
- 6828: regulation of transepithelial transport [GO_0150111]
- 6829: regulation of transferase activity [GO_0051338]
- 6830: regulation of translation [GO_0006417]
- 6831: regulation of translation at postsynapse [GO_0140245]
- 6832: regulation of translation at postsynapse, modulating synaptic transmission [GO_0099578]
- 6833: regulation of translation at presynapse [GO_0140244]
- 6834: regulation of translation at presynapse, modulating synaptic transmission [GO_0099577]
- 6835: regulation of translation at synapse [GO_0140243]
- 6836: regulation of translation at synapse, modulating synaptic transmission [GO_0099547]
- 6837: regulation of translation by machinery localization [GO_0043143]
- 6838: regulation of translation in response to oxidative stress [GO_0043556]
- 6839: regulation of translation in response to stress [GO_0043555]
- 6840: regulation of translational elongation [GO_0006448]
- 6841: regulation of translational fidelity [GO_0006450]
- 6842: regulation of translational initiation [GO_0006446]
- 6843: regulation of translational initiation in response to stress [GO_0043558]
- 6844: regulation of translational termination [GO_0006449]
- 6845: regulation of transmembrane receptor protein serine/threonine kinase signaling pathway [GO_0090092]
- 6846: regulation of transmembrane transport [GO_0034762]
- 6847: regulation of transmembrane transporter activity [GO_0022898]
- 6848: regulation of transmission of nerve impulse [GO_0051969]
- 6849: regulation of transport [GO_0051049]
- 6850: regulation of transporter activity [GO_0032409]
- 6851: regulation of triglyceride biosynthetic process [GO_0010866]
- 6852: regulation of triglyceride metabolic process [GO_0090207]
- 6853: regulation of tRNA metabolic process [GO_1903326]
- 6854: regulation of tRNA methylation [GO_0110002]
- 6855: regulation of tRNA processing [GO_2000235]
- 6856: regulation of trophectodermal cell proliferation [GO_1904073]
- 6857: regulation of tube lumen cavitation [GO_1903132]
- 6858: regulation of turning behavior involved in mating [GO_0061094]
- 6859: regulation of type B pancreatic cell apoptotic process [GO_2000674]
- 6860: regulation of type B pancreatic cell development [GO_2000074]
- 6861: regulation of type B pancreatic cell proliferation [GO_0061469]
- 6862: regulation of tyrosinase activity [GO_0032771]
- 6863: regulation of tyrosine 3-monooxygenase activity [GO_1903176]
- 6864: regulation of ubiquitin protein ligase activity [GO_1904666]
- 6865: regulation of ubiquitin-dependent protein catabolic process [GO_2000058]
- 6866: regulation of ubiquitin-protein transferase activity [GO_0051438]
- 6867: regulation of ubiquitin-specific protease activity [GO_2000152]
- 6868: regulation of vacuolar transport [GO_1903335]
- 6869: regulation of vacuole organization [GO_0044088]
- 6870: regulation of vascular associated smooth muscle cell apoptotic process [GO_1905459]
- 6871: regulation of vascular associated smooth muscle cell differentiation [GO_1905063]
- 6872: regulation of vascular associated smooth muscle cell proliferation [GO_1904705]
- 6873: regulation of vascular endothelial cell proliferation [GO_1905562]
- 6874: regulation of vasculature development [GO_1901342]
- 6875: regulation of vasculogenesis [GO_2001212]
- 6876: regulation of vesicle fusion [GO_0031338]
- 6877: regulation of vesicle fusion with Golgi apparatus [GO_0106214]
- 6878: regulation of vesicle targeting, to, from or within Golgi [GO_0048209]
- 6879: regulation of vesicle transport along microtubule [GO_1901608]
- 6880: regulation of vesicle-mediated transport [GO_0060627]
- 6881: regulation of vitamin D 24-hydroxylase activity [GO_0010979]
- 6882: regulation of vitamin metabolic process [GO_0030656]
- 6883: regulation of voltage-gated calcium channel activity [GO_1901385]
- 6884: regulation of voltage-gated chloride channel activity [GO_1902941]
- 6885: regulation of voltage-gated sodium channel activity [GO_1905150]
- 6886: regulation of water channel activity [GO_1902427]
- 6887: regulation of Wnt signaling pathway [GO_0030111]
- 6888: regulation of wound healing [GO_0061041]
- 6889: regulation of zinc ion transmembrane transport [GO_0071580]
- 6890: regulation of zinc ion transport [GO_0071579]
- 6891: regulation protein catabolic process at postsynapse [GO_0140252]
- 6892: regulation protein catabolic process at presynapse [GO_0140251]
- 6893: regulation protein catabolic process at synapse [GO_0140250]
- 6894: regulatory region RNA binding [GO_0001069]
- 6895: regulatory RNA binding [GO_0061980]
- 6896: release of sequestered calcium ion into cytosol [GO_0051209]
- 6897: Removal of remaining Flap from the C-strand [GO_0017108]
- 6898: removal of superoxide radicals [GO_0019430]
- 6899: renal filtration [GO_0097205]
- 6900: renal sodium ion transport [GO_0003096]
- 6901: renal system development [GO_0072001]
- 6902: renal system process [GO_0003014]
- 6903: renal tubular secretion [GO_0097254]
- 6904: replacement bone morphogenesis [GO_0061971]
- 6905: reproduction [GO_0000003]
- 6906: reproductive behavior [GO_0019098]
- 6907: reproductive process [GO_0022414]
- 6908: reproductive structure development [GO_0048608]
- 6909: reproductive system development [GO_0061458]
- 6910: respiratory electron transport chain [GO_0022904]
- 6911: respiratory gaseous exchange by respiratory system [GO_0007585]
- 6912: respiratory system development [GO_0060541]
- 6913: respiratory system process [GO_0003016]
- 6914: respiratory tube development [GO_0030323]
- 6915: response to abiotic stimulus [GO_0009628]
- 6916: response to acetylcholine [GO_1905144]
- 6917: response to acid chemical [GO_0001101]
- 6918: response to alcohol [GO_0097305]
- 6919: response to alkaloid [GO_0043279]
- 6920: response to amine [GO_0014075]
- 6921: response to amino acid [GO_0043200]
- 6922: response to ammonium ion [GO_0060359]
- 6923: response to antibiotic [GO_0046677]
- 6924: response to bacterium [GO_0009617]
- 6925: response to bile acid [GO_1903412]
- 6926: response to biotic stimulus [GO_0009607]
- 6927: response to blue light [GO_0009637]
- 6928: response to BMP [GO_0071772]
- 6929: response to caffeine [GO_0031000]
- 6930: response to calcium ion [GO_0051592]
- 6931: response to carbamate [GO_0046681]
- 6932: response to carbohydrate [GO_0009743]
- 6933: response to catecholamine [GO_0071869]
- 6934: response to chemical [GO_0042221]
- 6935: response to cold [GO_0009409]
- 6936: response to cytokine [GO_0034097]
- 6937: response to diuretic [GO_0036270]
- 6938: response to dopamine [GO_1903350]
- 6939: response to endogenous stimulus [GO_0009719]
- 6940: response to external biotic stimulus [GO_0043207]
- 6941: response to external stimulus [GO_0009605]
- 6942: response to extracellular stimulus [GO_0009991]
- 6943: response to farnesol [GO_0097307]
- 6944: response to fibroblast growth factor [GO_0071774]
- 6945: response to fungus [GO_0009620]
- 6946: response to glucagon [GO_0033762]
- 6947: response to glucose [GO_0009749]
- 6948: response to glycoprotein [GO_1904587]
- 6949: response to gravity [GO_0009629]
- 6950: response to growth factor [GO_0070848]
- 6951: response to heat [GO_0009408]
- 6952: response to hexose [GO_0009746]
- 6953: response to hormone [GO_0009725]
- 6954: response to inorganic substance [GO_0010035]
- 6955: response to insecticide [GO_0017085]
- 6956: response to insulin [GO_0032868]
- 6957: response to ketone [GO_1901654]
- 6958: response to light stimulus [GO_0009416]
- 6959: response to lipid [GO_0033993]
- 6960: response to lipopolysaccharide [GO_0032496]
- 6961: response to mechanical stimulus [GO_0009612]
- 6962: response to metal ion [GO_0010038]
- 6963: response to molecule of bacterial origin [GO_0002237]
- 6964: response to molecule of fungal origin [GO_0002238]
- 6965: response to monoamine [GO_0071867]
- 6966: response to monosaccharide [GO_0034284]
- 6967: response to nitrogen compound [GO_1901698]
- 6968: response to norepinephrine [GO_0071873]
- 6969: response to nutrient [GO_0007584]
- 6970: response to nutrient levels [GO_0031667]
- 6971: response to organic cyclic compound [GO_0014070]
- 6972: response to organic substance [GO_0010033]
- 6973: response to organonitrogen compound [GO_0010243]
- 6974: response to osmotic stress [GO_0006970]
- 6975: response to other organism [GO_0051707]
- 6976: response to oxidative stress [GO_0006979]
- 6977: response to oxygen radical [GO_0000305]
- 6978: response to oxygen-containing compound [GO_1901700]
- 6979: response to pain [GO_0048265]
- 6980: response to peptide [GO_1901652]
- 6981: response to peptide hormone [GO_0043434]
- 6982: response to pheromone [GO_0019236]
- 6983: response to purine-containing compound [GO_0014074]
- 6984: response to radiation [GO_0009314]
- 6985: response to reactive oxygen species [GO_0000302]
- 6986: response to salt [GO_1902074]
- 6987: response to serotonin [GO_1904014]
- 6988: response to starvation [GO_0042594]
- 6989: response to steroid hormone [GO_0048545]
- 6990: response to stimulus [GO_0050896]
- 6991: response to stimulus involved in regulation of muscle adaptation [GO_0014874]
- 6992: response to stress [GO_0006950]
- 6993: response to superoxide [GO_0000303]
- 6994: response to temperature stimulus [GO_0009266]
- 6995: response to toxic substance [GO_0009636]
- 6996: response to wounding [GO_0009611]
- 6997: response to xenobiotic stimulus [GO_0009410]
- 6998: response to yeast [GO_0001878]
- 6999: retina development in camera-type eye [GO_0060041]
- 7000: retina layer formation [GO_0010842]
- 7001: retina morphogenesis in camera-type eye [GO_0060042]
- 7002: retina vasculature development in camera-type eye [GO_0061298]
- 7003: retina vasculature morphogenesis in camera-type eye [GO_0061299]
- 7004: retinal binding [GO_0016918]
- 7005: retinal blood vessel morphogenesis [GO_0061304]
- 7006: retinal cell apoptotic process [GO_1990009]
- 7007: retinal cell programmed cell death [GO_0046666]
- 7008: retinal cone cell apoptotic process [GO_0097474]
- 7009: retinal cone cell development [GO_0046549]
- 7010: retinal cone cell differentiation [GO_0042670]
- 7011: retinal rod cell apoptotic process [GO_0097473]
- 7012: retinal rod cell development [GO_0046548]
- 7013: retinal rod cell differentiation [GO_0060221]
- 7014: retinoid binding [GO_0005501]
- 7015: retinoid metabolic process [GO_0001523]
- 7016: retinol binding [GO_0019841]
- 7017: retinol metabolic process [GO_0042572]
- 7018: retrograde trans-synaptic signaling [GO_0098917]
- 7019: retrograde trans-synaptic signaling by lipid [GO_0098920]
- 7020: retrograde trans-synaptic signaling by neuropeptide [GO_0099082]
- 7021: retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission [GO_0099083]
- 7022: Rho GDP-dissociation inhibitor activity [GO_0005094]
- 7023: Rho-dependent protein serine/threonine kinase activity [GO_0072518]
- 7024: rhodopsin mediated signaling pathway [GO_0016056]
- 7025: rhombomere boundary formation [GO_0021654]
- 7026: rhombomere cell migration [GO_0022035]
- 7027: rhombomere development [GO_0021546]
- 7028: rhombomere formation [GO_0021594]
- 7029: rhombomere morphogenesis [GO_0021593]
- 7030: rhythmic behavior [GO_0007622]
- 7031: rhythmic process [GO_0048511]
- 7032: riboflavin kinase activity [GO_0008531]
- 7033: riboflavin reductase (NADPH) activity [GO_0042602]
- 7034: riboflavin transport [GO_0032218]
- 7035: ribonuclease activity [GO_0004540]
- 7036: ribonuclease III activity [GO_0004525]
- 7037: ribonuclease inhibitor activity [GO_0008428]
- 7038: ribonuclease P RNA binding [GO_0033204]
- 7039: ribonucleoprotein complex [GO_1990904]
- 7040: ribonucleoprotein complex assembly [GO_0022618]
- 7041: ribonucleoprotein complex binding [GO_0043021]
- 7042: ribonucleoprotein complex biogenesis [GO_0022613]
- 7043: ribonucleoprotein complex disassembly [GO_0032988]
- 7044: ribonucleoprotein complex subunit organization [GO_0071826]
- 7045: ribonucleoside catabolic process [GO_0042454]
- 7046: ribonucleoside diphosphate metabolic process [GO_0009185]
- 7047: ribonucleoside metabolic process [GO_0009119]
- 7048: ribonucleoside monophosphate biosynthetic process [GO_0009156]
- 7049: ribonucleoside monophosphate metabolic process [GO_0009161]
- 7050: ribonucleoside triphosphate biosynthetic process [GO_0009201]
- 7051: ribonucleoside triphosphate metabolic process [GO_0009199]
- 7052: ribonucleoside-diphosphate reductase activity [GO_0061731]
- 7053: ribonucleotide binding [GO_0032553]
- 7054: ribonucleotide biosynthetic process [GO_0009260]
- 7055: ribonucleotide metabolic process [GO_0009259]
- 7056: ribose phosphate biosynthetic process [GO_0046390]
- 7057: ribose phosphate diphosphokinase activity [GO_0004749]
- 7058: ribose phosphate metabolic process [GO_0019693]
- 7059: ribosomal large subunit binding [GO_0043023]
- 7060: ribosomal protein S6 kinase activity [GO_0004711]
- 7061: ribosomal small subunit binding [GO_0043024]
- 7062: ribosome [GO_0005840]
- 7063: ribosome assembly [GO_0042255]
- 7064: ribosome binding [GO_0043022]
- 7065: ribosome biogenesis [GO_0042254]
- 7066: ribosome disassembly [GO_0032790]
- 7067: ribosome localization [GO_0033750]
- 7068: ribosylpyrimidine nucleosidase activity [GO_0050263]
- 7069: right horn of sinus venosus development [GO_0061080]
- 7070: right lung development [GO_0060458]
- 7071: right lung morphogenesis [GO_0060461]
- 7072: right ventricular cardiac muscle tissue morphogenesis [GO_0003221]
- 7073: RISC complex binding [GO_1905172]
- 7074: RNA (guanine-N7)-methylation [GO_0036265]
- 7075: RNA 2'-O-methyltransferase activity [GO_0062105]
- 7076: RNA 7-methylguanosine cap binding [GO_0000340]
- 7077: RNA adenylyltransferase activity [GO_1990817]
- 7078: RNA biosynthetic process [GO_0032774]
- 7079: RNA cap binding [GO_0000339]
- 7080: RNA catabolic process [GO_0006401]
- 7081: RNA destabilization [GO_0050779]
- 7082: RNA guanylyltransferase activity [GO_0008192]
- 7083: RNA lariat debranching enzyme activator activity [GO_0061632]
- 7084: RNA lariat debranching enzyme activity [GO_0008419]
- 7085: RNA ligase (ATP) activity [GO_0003972]
- 7086: RNA ligase activity [GO_0008452]
- 7087: RNA localization [GO_0006403]
- 7088: RNA localization to chromatin [GO_1990280]
- 7089: RNA localization to nucleus [GO_0090685]
- 7090: RNA metabolic process [GO_0016070]
- 7091: RNA methylation [GO_0001510]
- 7092: RNA modification [GO_0009451]
- 7093: RNA phosphodiester bond hydrolysis [GO_0090501]
- 7094: RNA phosphodiester bond hydrolysis, endonucleolytic [GO_0090502]
- 7095: RNA phosphodiester bond hydrolysis, exonucleolytic [GO_0090503]
- 7096: RNA polymerase activity [GO_0097747]
- 7097: RNA polymerase binding [GO_0070063]
- 7098: RNA polymerase core enzyme binding [GO_0043175]
- 7099: RNA polymerase I activity [GO_0001054]
- 7100: RNA polymerase I core binding [GO_0001042]
- 7101: RNA polymerase I general transcription initiation factor activity [GO_0001181]
- 7102: RNA polymerase I transcription regulatory region sequence-specific DNA binding [GO_0001163]
- 7103: RNA polymerase II C-terminal domain binding [GO_0099122]
- 7104: RNA polymerase II C-terminal domain phosphoserine binding [GO_1990269]
- 7105: RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO_0000978]
- 7106: RNA polymerase II complex binding [GO_0000993]
- 7107: RNA polymerase II core promoter sequence-specific DNA binding [GO_0000979]
- 7108: RNA polymerase II CTD heptapeptide repeat modifying activity [GO_0140994]
- 7109: RNA polymerase II CTD heptapeptide repeat phosphatase activity [GO_0008420]
- 7110: RNA polymerase II general transcription initiation factor activity [GO_0016251]
- 7111: RNA polymerase II general transcription initiation factor binding [GO_0001091]
- 7112: RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO_0000977]
- 7113: RNA polymerase II-specific DNA-binding transcription factor binding [GO_0061629]
- 7114: RNA polymerase III core binding [GO_0000994]
- 7115: RNA polymerase III transcribes microbial dsDNA to dsRNA [GO_0001056]
- 7116: RNA processing [GO_0006396]
- 7117: RNA sequestering activity [GO_0140610]
- 7118: RNA splicing [GO_0008380]
- 7119: RNA splicing, via transesterification reactions [GO_0000375]
- 7120: RNA stem-loop binding [GO_0035613]
- 7121: RNA strand annealing activity [GO_0033592]
- 7122: RNA strand-exchange activity [GO_0034057]
- 7123: RNA transmembrane transporter activity [GO_0051033]
- 7124: RNA transport [GO_0050658]
- 7125: RNA uridylyltransferase activity [GO_0050265]
- 7126: RNA-mediated gene silencing [GO_0031047]
- 7127: RNA-mediated post-transcriptional gene silencing [GO_0035194]
- 7128: RNA-templated DNA biosynthetic process [GO_0006278]
- 7129: RNase H-mediated cleavage of the template strand [GO_0004523]
- 7130: RNLS:FAD oxidises dh-beta-NAD to NAD+ [GO_0016651]
- 7131: RNR (M1M2B) reduces nucleotide diphosphates to deoxynucleotide diphosphates (thioredoxin) [GO_0004748]
- 7132: rostrocaudal neural tube patterning [GO_0021903]
- 7133: Roundabout binding [GO_0048495]
- 7134: RPE dimers isomerise RU5P to XY5P [GO_0004750]
- 7135: rRNA (adenine) methyltransferase activity [GO_0016433]
- 7136: rRNA (cytosine-N4-)-methyltransferase activity [GO_0071424]
- 7137: rRNA (cytosine) methyltransferase activity [GO_0016434]
- 7138: rRNA (guanine) methyltransferase activity [GO_0016435]
- 7139: rRNA (pseudouridine) methyltransferase activity [GO_0070037]
- 7140: rRNA (uridine-2'-O-)-methyltransferase activity [GO_0008650]
- 7141: rRNA (uridine) methyltransferase activity [GO_0016436]
- 7142: rRNA binding [GO_0019843]
- 7143: rRNA metabolic process [GO_0016072]
- 7144: rRNA methylation [GO_0031167]
- 7145: rRNA methyltransferase activity [GO_0008649]
- 7146: rRNA modification [GO_0000154]
- 7147: rRNA processing [GO_0006364]
- 7148: RYR tetramers transport Ca2+ from sarcoplasmic reticulum lumen to cytosol [GO_0005219]
- 7149: S-acetyltransferase activity [GO_0016418]
- 7150: S-acyltransferase activity [GO_0016417]
- 7151: S-adenosylmethionine-dependent methyltransferase activity [GO_0008757]
- 7152: S-adenosylmethionine-homocysteine S-methyltransferase activity [GO_0008898]
- 7153: S-methyl-5-thioadenosine phosphorylase activity [GO_0017061]
- 7154: S-nitrosoglutathione reductase activity [GO_0080007]
- 7155: S-succinyltransferase activity [GO_0016751]
- 7156: S100 protein binding [GO_0044548]
- 7157: SA node cell action potential [GO_0086015]
- 7158: SA node cell to atrial cardiac muscle cell communication [GO_0086070]
- 7159: SA node cell to atrial cardiac muscle cell signaling [GO_0086018]
- 7160: saccharopine dehydrogenase (NAD+, L-lysine-forming) activity [GO_0004754]
- 7161: saccharopine dehydrogenase activity [GO_0004753]
- 7162: saliva secretion [GO_0046541]
- 7163: salivary nucleus development [GO_0021751]
- 7164: salt transmembrane transporter activity [GO_1901702]
- 7165: salty taste receptor activity [GO_0033039]
- 7166: Salvage - Sepiapterin is reduced to BH2 [GO_0004757]
- 7167: SAM domain binding [GO_0032093]
- 7168: SAM50 complex inserts proteins into mitochondrial outer membrane [GO_0032977]
- 7169: sarcomere [GO_0030017]
- 7170: sarcomere organization [GO_0045214]
- 7171: sarcoplasm [GO_0016528]
- 7172: satellite DNA binding [GO_0003696]
- 7173: scaffold protein binding [GO_0097110]
- 7174: scavenger receptor activity [GO_0005044]
- 7175: SCD desaturates ST-CoA to OLE-CoA [GO_0004768]
- 7176: Schwann cell microvillus [GO_0097454]
- 7177: sclerotome development [GO_0061056]
- 7178: SCNN channels transport extracellular Na+ to cytosol [GO_0015280]
- 7179: second-messenger-mediated signaling [GO_0019932]
- 7180: secondary active monocarboxylate transmembrane transporter activity [GO_0015355]
- 7181: secondary active oligopeptide transmembrane transporter activity [GO_0015322]
- 7182: secondary metabolic process [GO_0019748]
- 7183: secondary metabolite biosynthetic process [GO_0044550]
- 7184: secretion [GO_0046903]
- 7185: secretion by cell [GO_0032940]
- 7186: secretion by tissue [GO_0032941]
- 7187: secretory granule [GO_0030141]
- 7188: secretory granule localization [GO_0032252]
- 7189: secretory granule maturation [GO_0061792]
- 7190: secretory granule membrane [GO_0030667]
- 7191: secretory granule organization [GO_0033363]
- 7192: secretory vesicle [GO_0099503]
- 7193: sedoheptulose 7-phosphate + D-glyceraldehyde 3-phosphate <=> D-erythrose 4-phosphate + D-fructose 6-phosphate [GO_0004801]
- 7194: segmentation [GO_0035282]
- 7195: selenotransferase activity [GO_0016785]
- 7196: semaphorin receptor activity [GO_0017154]
- 7197: semaphorin receptor binding [GO_0030215]
- 7198: semaphorin-plexin signaling pathway [GO_0071526]
- 7199: semaphorin-plexin signaling pathway involved in axon guidance [GO_1902287]
- 7200: semaphorin-plexin signaling pathway involved in neuron projection guidance [GO_1902285]
- 7201: sensory organ development [GO_0007423]
- 7202: sensory organ morphogenesis [GO_0090596]
- 7203: sensory perception [GO_0007600]
- 7204: sensory perception of bitter taste [GO_0050913]
- 7205: sensory perception of chemical stimulus [GO_0007606]
- 7206: sensory perception of cold stimulus [GO_0062035]
- 7207: sensory perception of high humidity [GO_0098510]
- 7208: sensory perception of hot stimulus [GO_0062036]
- 7209: sensory perception of humidity [GO_0098509]
- 7210: sensory perception of light stimulus [GO_0050953]
- 7211: sensory perception of low humidity [GO_0098511]
- 7212: sensory perception of mechanical stimulus [GO_0050954]
- 7213: sensory perception of pain [GO_0019233]
- 7214: sensory perception of salty taste [GO_0050914]
- 7215: sensory perception of smell [GO_0007608]
- 7216: sensory perception of sound [GO_0007605]
- 7217: sensory perception of sour taste [GO_0050915]
- 7218: sensory perception of sweet taste [GO_0050916]
- 7219: sensory perception of taste [GO_0050909]
- 7220: sensory perception of temperature stimulus [GO_0050951]
- 7221: sensory perception of touch [GO_0050975]
- 7222: sensory perception of umami taste [GO_0050917]
- 7223: sensory perception of wind [GO_0071063]
- 7224: sensory system development [GO_0048880]
- 7225: septum transversum development [GO_0003343]
- 7226: sequence-specific DNA binding [GO_0043565]
- 7227: sequence-specific double-stranded DNA binding [GO_1990837]
- 7228: sequence-specific mRNA binding [GO_1990825]
- 7229: sequence-specific single stranded DNA binding [GO_0098847]
- 7230: sequestering of calcium ion [GO_0051208]
- 7231: serine + tRNA(Ser) + ATP => Ser-tRNA(Ser) + AMP + pyrophosphate [GO_0004828]
- 7232: serine binding [GO_0070905]
- 7233: serine family amino acid biosynthetic process [GO_0009070]
- 7234: serine family amino acid metabolic process [GO_0009069]
- 7235: serine hydrolase activity [GO_0017171]
- 7236: serine racemase activity [GO_0030378]
- 7237: serine transmembrane transporter activity [GO_0022889]
- 7238: serine transport [GO_0032329]
- 7239: serine-pyruvate transaminase activity [GO_0004760]
- 7240: serine-type exopeptidase activity [GO_0070008]
- 7241: serotonin binding [GO_0051378]
- 7242: serotonin biosynthetic process [GO_0042427]
- 7243: serotonin catabolic process [GO_0042429]
- 7244: serotonin metabolic process [GO_0042428]
- 7245: serotonin receptor activity [GO_0099589]
- 7246: serotonin receptor signaling pathway [GO_0007210]
- 7247: serotonin secretion [GO_0001820]
- 7248: serotonin secretion, neurotransmission [GO_0060096]
- 7249: serotonin transport [GO_0006837]
- 7250: serotonin uptake [GO_0051610]
- 7251: serotonin:sodium:chloride symporter activity [GO_0005335]
- 7252: serous membrane development [GO_1904817]
- 7253: SET domain binding [GO_0070984]
- 7254: SETD8 methylates TP53 [GO_0016278]
- 7255: sevenless binding [GO_0005118]
- 7256: sex determination [GO_0007530]
- 7257: sex differentiation [GO_0007548]
- 7258: sexual reproduction [GO_0019953]
- 7259: SH2 domain binding [GO_0042169]
- 7260: SH3 domain binding [GO_0017124]
- 7261: SHMT1 tetramer cleaves HTMLYS to yield TEABL and Gly [GO_0004372]
- 7262: short-chain carboxylesterase activity [GO_0034338]
- 7263: short-chain fatty acid-CoA ligase activity [GO_0031955]
- 7264: short-chain-acyl-CoA dehydrogenase activity [GO_0016937]
- 7265: short-term memory [GO_0007614]
- 7266: sialylation [GO_0097503]
- 7267: signal recognition particle binding [GO_0005047]
- 7268: signal release [GO_0023061]
- 7269: signal release from synapse [GO_0099643]
- 7270: signal sequence binding [GO_0005048]
- 7271: signal transduction [GO_0007165]
- 7272: signal transduction involved in regulation of gene expression [GO_0023019]
- 7273: signaling [GO_0023052]
- 7274: signaling adaptor activity [GO_0035591]
- 7275: signaling receptor activator activity [GO_0030546]
- 7276: signaling receptor activity [GO_0038023]
- 7277: signaling receptor binding [GO_0005102]
- 7278: signaling receptor complex adaptor activity [GO_0030159]
- 7279: signaling receptor inhibitor activity [GO_0030547]
- 7280: signaling receptor regulator activity [GO_0030545]
- 7281: single-strand break-containing DNA binding [GO_1990165]
- 7282: single-stranded 3'-5' DNA helicase activity [GO_1990518]
- 7283: single-stranded DNA 3'-5' exodeoxyribonuclease activity [GO_0008310]
- 7284: single-stranded DNA 5'-3' exodeoxyribonuclease activity [GO_0045145]
- 7285: single-stranded DNA binding [GO_0003697]
- 7286: single-stranded DNA endodeoxyribonuclease activity [GO_0000014]
- 7287: single-stranded DNA exodeoxyribonuclease activity [GO_0008297]
- 7288: single-stranded DNA helicase activity [GO_0017116]
- 7289: single-stranded RNA binding [GO_0003727]
- 7290: single-stranded telomeric DNA binding [GO_0043047]
- 7291: single-subunit type RNA polymerase binding [GO_0001050]
- 7292: sinoatrial node cell development [GO_0060931]
- 7293: sinoatrial node cell differentiation [GO_0060921]
- 7294: sinoatrial node development [GO_0003163]
- 7295: sinus venosus development [GO_0003235]
- 7296: sinus venosus formation [GO_0003237]
- 7297: sinus venosus morphogenesis [GO_0003236]
- 7298: siRNA binding [GO_0035197]
- 7299: SIRT3 deacetylates ACCS2, GLUD, IDH2, SOD2 [GO_0034979]
- 7300: sister chromatid segregation [GO_0000819]
- 7301: skeletal muscle adaptation [GO_0043501]
- 7302: skeletal muscle cell differentiation [GO_0035914]
- 7303: skeletal muscle cell proliferation [GO_0014856]
- 7304: skeletal muscle contraction [GO_0003009]
- 7305: skeletal muscle fiber development [GO_0048741]
- 7306: skeletal muscle fiber differentiation [GO_0098528]
- 7307: skeletal muscle hypertrophy [GO_0014734]
- 7308: skeletal muscle myofibril [GO_0098723]
- 7309: skeletal muscle organ development [GO_0060538]
- 7310: skeletal muscle tissue development [GO_0007519]
- 7311: skeletal muscle tissue growth [GO_0048630]
- 7312: skeletal myofibril assembly [GO_0014866]
- 7313: skeletal system development [GO_0001501]
- 7314: skeletal system morphogenesis [GO_0048705]
- 7315: skin development [GO_0043588]
- 7316: skin epidermis development [GO_0098773]
- 7317: skin morphogenesis [GO_0043589]
- 7318: SLC12A1,2 cotransports Na+, K+, 2Cl- from extracellular region to cytosol [GO_0008511]
- 7319: SLC12A3 cotransports Cl-, Na+ from extracellular region to cytosol [GO_0015378]
- 7320: SLC16A1:BSG cotransports monocarboxylates, H+ from extracellular region to cytosol [GO_0008028]
- 7321: SLC1A1,2,3,6,7 cotransport L-Glu,L-Asp,D-Asp,H+,3Na+ from extracellular region to cytosol [GO_0005314]
- 7322: SLC25A16 transports cytosolic CoA-SH to mitichondrial matrix [GO_0015291]
- 7323: SLC25A18,A22 cotransport Glu, H+ from cytosol to mitochondrial matrix [GO_0005280]
- 7324: SLC25A29 transports basic amino acids from cytosol to mitochondrial matrix [GO_0015174]
- 7325: SLC27A1,4,6 transport LCFAs from extracellular region to cytosol [GO_0015245]
- 7326: SLC2A1 tetramer transports Glc from cytosol to Golgi lumen [GO_0005355]
- 7327: SLC2A1,3 transports DeHA from extracellular region to cytosol [GO_0033300]
- 7328: SLC2A2 tetramer transports Fru, Gal, Glc from cytosol to extracellular region [GO_0015149]
- 7329: SLC2A5 transports fructose from extracellular region to cytosol [GO_0005353]
- 7330: SLC35D1 hexamer transports UDP-GlcA, UDP-GlcNAc from cytosol to endoplasmic reticulum lumen [GO_0005461]
- 7331: SLC36A2 cotransports Gly, L-Pro with H+ from extracellular region to cytosol [GO_0015171]
- 7332: SLC46A1 transports FeHM, heme from extracellular region to cytosol [GO_0015232]
- 7333: SLC4A5,7,9 cotransport Na+ with 3HCO3- [GO_0008510]
- 7334: SLC52A1,2,3 transport RIB from extracellular region to cytosol [GO_0032217]
- 7335: